Studies in asymmetric catalysis by Soni, Rina
University of Warwick institutional repository: http://go.warwick.ac.uk/wrap
A Thesis Submitted for the Degree of PhD at the University of Warwick
http://go.warwick.ac.uk/wrap/45868
This thesis is made available online and is protected by original copyright.
Please scroll down to view the document itself.
Please refer to the repository record for this item for information to help you to
cite it. Our policy information is available from the repository home page.
JHG 05/2011 
 
 
Library Declaration and Deposit Agreement 
 
1. STUDENT DETAILS 
Please complete the following: 
Full name: ……………………………………………………………………………………………. 
University ID number: ……………………………………………………………………………… 
 
 
2. THESIS DEPOSIT 
2.1  I understand that under my registration at the University, I am required to deposit my thesis with the 
University in BOTH hard copy and in digital format. The digital version should normally be saved as a 
single pdf file. 
 
2.2  The hard copy will be housed in the University Library. The digital version will be deposited in the 
University’s Institutional Repository (WRAP). Unless otherwise indicated (see 2.3 below) this will be made 
openly accessible on the Internet and will be supplied to the British Library to be made available online via 
its Electronic Theses Online Service (EThOS) service. 
[At present, theses submitted for a Master’s degree by Research (MA, MSc, LLM, MS or MMedSci) are 
not being deposited in WRAP and not being made available via EthOS. This may change in future.] 
 
2.3  In exceptional circumstances, the Chair of the Board of Graduate Studies may grant permission for 
an embargo to be placed on public access to the hard copy thesis for a limited period. It is also possible to 
apply separately for an embargo on the digital version. (Further information is available in the Guide to 
Examinations for Higher Degrees by Research.) 
 
2.4  If you are depositing a thesis for a Master’s degree by Research, please complete section (a) below. 
For all other research degrees, please complete both sections (a) and (b) below: 
 
(a) Hard Copy 
 
I hereby deposit a hard copy of my thesis in the University Library to be made publicly available to 
readers (please delete as appropriate) EITHER immediately OR after an embargo period of 
……….................... months/years as agreed by the Chair of the Board of Graduate Studies.  
 
I agree that my thesis may be photocopied.        YES / NO (Please delete as appropriate) 
 
(b) Digital Copy 
 
I hereby deposit a digital copy of my thesis to be held in WRAP and made available via EThOS.  
 
Please choose one of the following options: 
 
EITHER   My thesis can be made publicly available online.      YES / NO (Please delete as appropriate) 
 
OR   My thesis can be made publicly available only after…..[date]  (Please give date) 
                YES / NO (Please delete as appropriate) 
 
OR   My full thesis cannot be made publicly available online but I am submitting a   separately 
identified   additional, abridged version that can be made available online. 
          YES / NO (Please delete as appropriate) 
 
OR   My thesis cannot be made publicly available online.          YES / NO (Please delete as appropriate) 
 
 
 
JHG 05/2011 
3. GRANTING OF NON-EXCLUSIVE RIGHTS 
Whether I deposit my Work personally or through an assistant or other agent, I agree to the following: 
 
Rights granted to the University of Warwick and the British Library and the user of the thesis through this 
agreement are non-exclusive. I retain all rights in the thesis in its present version or future versions. I 
agree that the institutional repository administrators and the British Library or their agents may, without 
changing content, digitise and migrate the thesis to any medium or format for the purpose of future 
preservation and accessibility. 
 
4. DECLARATIONS 
 
(a) I DECLARE THAT: 
 
 I am the author and owner of the copyright in the thesis and/or I have the authority of the 
authors and owners of the copyright in the thesis to make this agreement. Reproduction 
of any part of this thesis for teaching or in academic or other forms of publication is 
subject to the normal limitations on the use of copyrighted materials and to the proper and 
full acknowledgement of its source. 
 
 The digital version of the thesis I am supplying is the same version as the final, hard-
bound copy submitted in completion of my degree, once any minor corrections have been 
completed. 
 
 I have exercised reasonable care to ensure that the thesis is original, and does not to the 
best of my knowledge break any UK law or other Intellectual Property Right, or contain 
any confidential material. 
 
 I understand that, through the medium of the Internet, files will be available to automated 
agents, and may be searched and copied by, for example, text mining and plagiarism 
detection software. 
 
(b) IF I HAVE AGREED (in Section 2 above) TO MAKE MY THESIS PUBLICLY AVAILABLE 
DIGITALLY, I ALSO DECLARE THAT: 
 
 I grant the University of Warwick and the British Library a licence to make available on the 
Internet the thesis in digitised format through the Institutional Repository and through the 
British Library via the EThOS service. 
 
 If my thesis does include any substantial subsidiary material owned by third-party 
copyright holders, I have sought and obtained permission to include it in any version of 
my thesis available in digital format and that this permission encompasses the rights that I 
have granted to the University of Warwick and to the British Library. 
 
 
5. LEGAL INFRINGEMENTS 
 
I understand that neither the University of Warwick nor the British Library have any obligation to take legal 
action on behalf of myself, or other rights holders, in the event of infringement of intellectual property 
rights, breach of contract or of any other right, in the thesis. 
 
 
 
 
Please sign this agreement and return it to the Graduate School Office when you submit your thesis. 
 
 
 
Student’s signature: ......................................................…… Date: .......................................................... 
 
Studies in Asymmetric Catalysis
by
Rina Soni
A thesis submitted in partial fulfilment of the requirements for the
degree of
Doctor of Philosophy in Chemistry
University of Warwick, Department of Chemistry
September 2011
Contents
CONTENTS
Acknowledgments.......................................................................................................iv
Declaration ...................................................................................................................v
Abstract .......................................................................................................................vi
List of Abbreviations..................................................................................................vii
1 Introduction...............................................................................................1
1.1 Chirality ....................................................................................................1
1.1.1 Chirality in Nature ....................................................................................2
1.1.2 Chirality in Pharmaceutical molecules .....................................................3
1.2.1 Chiral pool synthesis.................................................................................5
1.2.2 Asymmetric induction...............................................................................6
1. 2.3 Asymmetric catalysis................................................................................6
1. 2.3.1 Biocatalysts ...............................................................................................8
1. 2.3.2 Chiral ligand derived metal complexes.....................................................9
1.2.3.3 Chiral organocatalysts.............................................................................11
1.3 Asymmetric organocatalysis...................................................................12
1.3.1 Classifications.........................................................................................13
1.3.2 Different asymmetric reactions...............................................................16
1.3.2.1 Michael addition.....................................................................................16
1.3.2.2 Aldol reaction.........................................................................................19
1.3.2.3 Henry reaction........................................................................................21
1.3.2.4 Diels-Alder reaction ...............................................................................22
1.3.2.5 α-Functionalization of carbonyl compounds..........................................22
1.4 Asymmetric transfer hydrogenation.......................................................24
1.4.1 Background ............................................................................................24
1.4.2 Hydrogen sources...................................................................................26
1.4.3 Ligand developments for asymmetric transfer hydrogenation ..............27
1.4.3.1 Tetrahydro bis(oxazole) ligands.............................................................27
1.4.3.2 Diamine ligands .....................................................................................29
1.4.3.3 Binol derivatives ....................................................................................31
1.4.3.4 Amino alcohol derivatives .....................................................................32
1.4.3.5 Ferrocene Ru complexes........................................................................35
Contents
1.4.3.6 Tridentate ligands ...................................................................................36
1.4.3.7 Tetradentate ligands................................................................................37
1.4.3.8 Peptide ligands........................................................................................38
1.4.3.9 Monotosylated 1,2-diamine derivatives..................................................39
1.4.4 Mechanistic investigations of asymmetric transfer hydrogenation of
ketones and imines ..................................................................................42
1.4.5 Factors affecting Enantioselectivity........................................................52
1.4.6 Recent Developments .............................................................................54
1.4.7 Substrate scope .......................................................................................63
1.4.8 Greener approaches to asymmetric transfer hydrogenation....................74
1.4.9 Application to pharmaceutical targets ....................................................83
1.5 Summary.................................................................................................85
1.6 Aim and Objectives.................................................................................85
2 Results and Discussion ...........................................................................87
2.1 Synthesis and applications of derivatives of 1,2-cyclohexanediamine as
asymmetric organocatalyst......................................................................87
2.2 Synthesis and application of derivatives of 1,2-diphenylethanediamine as
asymmetric organocatalysts ....................................................................97
2.2.1 Synthesis of derivatives of 1,2-diphenylethanediamine .........................99
2.2.2 Application of derivatives of 1,2-diphenylethanediamine as asymmetric
organocatalysts.......................................................................................102
2.3 Chiral Ru complexes for asymmetric transfer hydrogenation of ketones
and imines ..............................................................................................116
2.3.1 Asymmetric transfer hydrogenation of ketones and imines using N,N-
dimethyl-TsDPEN Ru catalyst ...............................................................117
2.3.2 Asymmetric transfer hydrogenation of ketones and imines using N-
alkylated Ru-3C-tethered catalysts ........................................................123
2.3.3 Comparative studies for asymmetric transfer hydrogenation of ketones
and imines using NMR ..........................................................................130
2.4 Asymmetric transfer hydrogenation of hindered ketones ......................138
2.4.1 Synthesis of derivatives of 1,3-cyclohexadione and cyclohexanone .....139
2.4.2 Synthesis of derivatives of ethyl acetoacetate and acetylacetone ..........146
Contents
2.4.3 Synthesis of derivatives of β-tetralone and α-tetralone ........................150
2.4.4 Asymmetric transfer hydrogenation of selected compounds using
Noyori’s catalyst 153 ............................................................................156
2.5 Conclusion .............................................................................................159
3 Experimental..........................................................................................163
3.1 Synthesis of derivatives of 1,2-cyalcohexanediamine...........................164
3.2 Synthesis of derivatives of 1,2-diphenylethanediamine ........................177
3.3 Use of synthesised derivatives as organocatalysts in asymmetric
reactions .................................................................................................184
3.4 Synthesis of Ru complexes.....................................................................194
3.5 Use of synthesised Ru complexes in pressure hydrogenation and transfer
hydrogenation.........................................................................................207
3.6 Synthesis of hindered ketones ...............................................................210
3.6.1 Derivatives of 1,3-cyclohexadione ........................................................210
3.6.2 Derivatives of cyclohexanone................................................................213
3.6.3 Derivatives of ethyl acetoacetate ...........................................................216
3.6.4 Synthesis of 1-(2-ethyl-2,3-Dihydro-1H-inden-2-yl)ethanone. .............220
3.6.5 Derivatives of β-tetralone.......................................................................222
3.6.6 Derivatives of α-tetralone.......................................................................227
3.7 Asymmetric transfer hydrogenation of α,α-disubstituted ketones.........229
4 References .............................................................................................265
5 Appendix ...............................................................................................279
5.1 X-ray data ..............................................................................................279
5.2 Data for Mosher’s esters........................................................................282
Acknowledgments
Acknowledgments
I owe my sincere gratitude to Professor Martin Wills, who gave me the opportunity
to conduct this valuable project. His extensive discussion, continuous guidance and
support have been very helpful throughout the three years of my PhD. This has
helped me to publish part of my research as three journal articles.
I am grateful for the kind support of past and present members of the Wills group
throughout my studies. In particular, Dr. David Morris, Dr. Silvia Gosiewska, Dr.
Jose Eduardo Damas Martins, Dr. Charles Manville, Dr. Jonathan Hopewell, Vimal
Parekh, Tarn Johnson, Muftah Darwish, Alex Bisset, Vicky Marlow, Katherine
Jolley, John-Michael Collinson, Charlotte Zammit and Zhijia Fang. It has been a
great pleasure working with all of them.
Many thanks to Dr. Guy Clarkson for the X-ray crystallography analysis, Dr. Adam
Clarke for the NMR studies, Lijiang Song for mass spectrometry and Rob Jenkins
for his technical support.
For financial support, I would like to acknowledge the generous funding from the
WPRS (Warwick Post-graduate Research Scholarship) and University of Warwick.
I would like to thank Dr. Brijesh Kumar Srivastava of Zydus Research Centre for
continuous motivation and support. I would also like to thank the management of my
previous organization, Zydus Research Centre, Ahmedabad, India for giving me
leave to pursue the PhD.
I would like to thank Dr. Shubhangi S. Soman, Mr. Satish Purohit and Ms. Anita
Patel for their kind help and support.
I would like to thank family members Amit, Nirav, Vaishali and Bhavya for their
moral support. I thank my friends Parul, Asha, Maulik, Harindran and my group
members at ZRC.
Lastly and most importantly, I wish to thank my parents Chandrakant and Rekhaben.
They raised me, supported me, taught me, encouraged me, inspired me and loved
me. I would like to dedicate this thesis to my late father who passed away during my
preparation for my PhD viva.
Declaration
Declaration
The research described in this thesis is solely the work of the author unless otherwise
stated. These studies were carried out at the Department of Chemistry, University of
Warwick between October 2008 and September 2011. The content of this thesis has
not been submitted, either wholly or partially for a degree at any other academic
institution.
Some of this work has appeared in the scientific literature in the following
publications:
1) R. Soni, J. -M. Collinson, G. J. Clarkson, M. Wills. Org. Lett. 2011, 13, 4304-
4307.
2) R. Soni, F. K. Cheung, G. J. Clarkson, J. E. D. Martins, M. A. Graham, M. Wills.
Org. Biomol. Chem. 2011, 9, 3290-3294.
3) S. Gosiewska, R. Soni, G. J. Clarkson, M. Wills. Tetrahedron Lett. 2010, 51,
4214-4217.
Abstract
Abstract
Derivatives of enantiomerically pure 1,2-cyclohexanediamine and 1,2-
diphenylethanediamine have been synthesised and used as organocatalysts for
asymmetric reactions. The derivatives of 1,2-diphenylethanediamine have been
employed for C-C, C-N bond formation reactions to determine their efficacy and
selectivity. Compound 278 has shown high efficiency and selectivity for addition of
aldehydes to DEAD.
Novel Ru-metal complexes containing enantiomerically pure N,N-dialkylated-1,2-
diamine ligands have been synthesised. Complexes 299 and 302 were used to study
asymmetric transfer hydrogenation of ketones and imines. These complexes were
found to be selective for the imine reduction compared to ketones reductions under
the conditions used. Results obtained by these complexes also provided support for
the proposal that reduction of the ketones involves a cyclic concerted mechanism for
the transfer of hydrogen, while reduction of imines involves transfer of hydride from
the complex through an ‘open’ transition state.
Asymmetric transfer hydrogenations of α,α-disubstituted ketones were carried out
using Ru-3C-tethered catalyst 181. Results obtained for asymmetric transfer
hydrogenation of these compounds show that unsaturation or an aromatic group in
substitution at the α-position of the ketone gave products of high enantioselectivity.
This may be due to the interaction between η
6-arene ring of Ru-complex and the
group placed on the α-position of the ketone.
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1 Introduction
1.1 Chirality
The term chirality is derived from the Greek word for hand (Cheir). In
chemistry, chirality usually refers to molecules. A chiral molecule is a type of
molecule that is non-superimposable on its mirror image. The two mirror images of
chiral molecules are called enantiomers (optical isomers). Most commonly, chirality
is created by the presence of an asymmetric carbon atom containing a bond to four
different groups (Figure 1). Molecular chirality is of interest due to the importance of
stereochemistry to different fields of chemistry. In a molecule, a chiral centre is also
referred to as a stereocentre or stereogenic centre, leading to a spatial arrangement of
attached ligands that result in non-superimposable mirror images.
Figure 1: Determination of chirality in a molecule.
Enantiomers have identical chemical and physical properties in the absence of an
external chiral influence.1 Thus, they have the same melting point, boiling point,
solubility properties, retention time in chromatography, IR and NMR spectra as each
other. They rotate the plane of polarised light in different directions, and for that
reason enantiomers are sometimes referred to as optical isomers. The isomer which
rotates the plane of light to the right is called the dextro isomer and is denoted as (+),
while the other isomer will rotate the plane to the left in an equal amount and is
known as the levo isomer denoted as (–).2 Enantiomeric purity is reported as
percentage enantiomeric excess (ee), which is calculated using equation ee = (R-
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S)/(R+S) x 100. Enantiomeric purity can also be reported as enantiomeric ratio as
R:S. In asymmetric synthesis, it is important to specify the enantiomeric purity and
the absolute configuration at a given stereogenic centre (chiral centre).
The absolute configuration can be named by D/L or R/S. The D/L configuration can
be identified by a relating molecule to glyceraldehyde and is mostly applied to
carbohydrate and amino acid stereochemistry. Two isomers of glyceraldehyde are
labelled as D and L. The absolute configuration R/S can be identified by using the
Cahn-Ingold-Prelog system.3 To determine the absolute configuration of a
tetrahedral chiral centre, the four groups are first placed in the order of priority based
on a series of priority rules. The tetrahedral centre is then viewed with the lowest
priority group at the back, and the remaining three groups considered. If the groups
lie in order of decreasing priority in clockwise direction it is denoted as the R (for
rectus, Latin for right), and in the contrast if the groups are arranged in an
anticlockwise direction it is denoted as the S (for sinister, Latin for left).1,3
1.1.1 Chirality in Nature
Chirality is an important factor in biological systems and in nature. Many
natural compounds are chiral, including amino acids (the building blocks of
proteins), sugars, and natural products. Out of the 21 natural amino acids, 20 have a
stereogenic centre at the α-carbon, the one exception is glycine.4 All natural amino
acids are of the L-configuration, and the proteins formed by these building blocks are
also chiral molecules. Proteins show high selectivity for the interaction with chiral
molecules in a biological system.5 Enzymes catalysing the chiral reactions show a
preference for the one chiral product over the other. Enantiomers may have a
Introduction
3
different test or smell, for example (R)-carvone smells like spearmint, while (S)-
carvone smells like caraway (Figure 2).
Figure 2: Chirality in nature.
1.1.2 Chirality in Pharmaceutical molecules
Nature has built its proteins only from L amino acids and therefore the biological
systems of all living organisms exist in a chiral environment of single handedness.
As a consequence, this is a major factor in the design of drug molecules.6 When
molecules are placed in chiral surroundings they actually behave very differently and
this may lead to different effects. For example, the infamous thalidomide 7 (Figure
3) introduced in 1950s as a non-toxic sedative drug,7 had antiemetic properties and
was prescribed to pregnant women to counter morning sickness. The (S)-enantiomer
had the desired antinausea effects, but the (R)-form was teratogenic and caused
abnormalities in the child such as severely underdeveloped limbs. Even giving the
pure (S)-enantiomer would not have prevented the tragedy. Unfortunately, the pure
enantiomer of thalidomide racemises within 10 minutes in the bloodstream.8 Thus
use of the enantiomerically pure drug would not have prevented the devastating side
effects and the drug was withdrawn from the market in 1961.
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Another example is (–)-DOPA 8 used in the treatment of Parkinson’s disease (Figure
3).9 The active drug is an achiral compound dopamine, formed by the
decarboxylation of 8. But dopamine as such, is not able to cross the blood-brain
barrier to reach the site of the action. If the compound given is racemic, the enzyme
dopamine decarboxylase can only metabolise (–)-DOPA, but not (+)-DOPA. This
would result in a dangerous build up of (+)-DOPA in the body, hence it is essential
to administer DOPA as the pure (–) form.
Figure 3: Chirality in pharmaceutical molecules.
Ethambutol 9 [(2S,2'S)-2,2'-(ethane-1,2-diyldiimino)dibutan-1-ol] is an
antimycobacterial drug used against tuberculosis (Figure 3). It is usually given in
combination with the other drugs such as rifampicin and pyrazinamide.10 Naproxen
10, as its sodium salt is a non-steroidal anti-inflammatory drug commonly used for
the treatment of pain and stiffness in the case of osteoarthritis and gout diseases
(Figure 3).11
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1.2 Asymmetric synthesis
Asymmetric synthesis is organic synthesis which involves introduction of one or
more elements of chirality. There are three different way to achieve an asymmetric
synthesis: (1) chiral pool synthesis (2) chiral auxiliaries and (3) asymmetric catalysis.
The oldest example for asymmetric synthesis was reported by Willy Marckwald in
1904.12 The decarboxylation of 2-ethyl-2-methyl malonic acid mediated by brucine
to give optically active 2-methyl butanoic acid with 10% ee (Scheme 1).
Scheme 1: Decarboxylation of 2-ethyl-2-methyl malonic acid.
1.2.1 Chiral pool synthesis
An enantiomerically pure starting compound (such as a sugar or amino acid)
can be used for transformations that retain its chirality, which require stoichiometric
amounts of the enantiopure starting material. For example, the enantiopure tartaric
acid is used for the synthesis of chiraphos (Scheme 2).13 Readily available (-)-
pantolactone is used to synthesise part of epothilone, which is a new class of cancer
drug.14
Scheme 2: Synthesis of Chiraphos.
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1.2.2 Asymmetric induction
Enantiomers can be converted to diastereomers, i.e. an enantiopure reagent is
used to create a second chiral centre, which is then removed as the desired product.
The compounds used for such induction are called chiral auxiliaries such as Evans
auxiliaries containing oxazolidinone groups or pseudoephedrine derivatives (Scheme
3). Evans chiral auxiliaries 16-19 can be used for the diastereoselective aldol
reaction and after the reaction the auxiliary can be removed to give an enantiopure
aldol product.15 Pseudoephedrine 24 is converted to the amide, which can be reacted
with an alkyl halide. The chiral auxiliary can be removed, for example by hydrolysis
or by reduction to give an enantioselective product.16
Scheme 3: Asymmetric induction using chiral auxiliaries.15-16
1. 2.3 Asymmetric catalysis
A catalyst changes the rate of reaction without itself being consumed or transformed.
Catalysis can be divided into homogenous catalysis (catalyst exists in the same phase
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as the reaction mixture) and heterogeneous catalysis (catalyst act in different phase
than the reaction mixture). In asymmetric catalysis, small amounts of a chiral
catalyst are used to synthesise large amounts of enantiomerically pure molecules.17
There are different kinds of asymmetric catalysis including; (1) biocatalysis:
involving the use of an enzyme (2) organometallic catalysis: involving the use of
metal complexes (3) organocatalysis: involving the use of small organic molecules.
All these asymmetric catalysis are widely used to form the enantiomerically pure
compounds in small to large scale synthesis, as they have significant advantages over
earlier methods of asymmetric synthesis which involve chiral resolution18 or
synthesis from enantiomerically pure starting compounds.
Figure 4: Chiral catalytic transition state.
In a standard laboratory synthesis, when achiral molecules undergo transformations
to generate an asymmetric centre, a racemic product is obtained due to the reaction
S R
S-TS
R-TSE
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following the same energetic pathway towards each enantiomer. The catalyst plays
an important role in the rate of reaction by providing different transition states for the
formation of each enantiomeric product and lowers the activation energy for the
favoured product. The catalyst itself must be enantiomerically pure, in order to
produce enantiomerically selective products via the energetically-preferred reaction
through one of a pair of diastereomeric transition states (Figure 4).
Although both R and S product enantiomers are identical in energy, the
diastereomeric transition states leading to the S product is at a high energy level
compared to that leading to the R product, and more energy is required to overcome
this activation barrier. Therefore the formation of the R product would be more
favourable, hence enantioselectivity is induced.16 Thus, asymmetric catalysis
reactions are very economical as very low mol% of catalysts may be required.
Moreover in many reactions, the chiral ligands are often stable to the reaction
conditions and may be recovered after use.
1. 2.3.1 Biocatalysts
Enzymes are highly selective catalysts in the biological system with quite specific
roles to play in different transformations. Isolated specific enzymes can be used as
catalysts in organic synthesis for asymmetric reactions, due to the high inherent
chirality present in them. But, enzyme catalysis has some draw backs such as lack of
stability in organic solvents, extreme pH and high temperatures. Thus, the current
level of use of enzymes in organic laboratories is quite low. Most enzymes have a
limited scope with respect to their application in different reactions and to increase
the scope of enzyme catalysis they must be modified via protein engineering.19
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1. 2.3.2 Chiral ligand derived metal complexes
In asymmetric organometallic catalysis, organometallic complexes have been
used as catalysts. Enantiopure organometallic complexes are usually obtained by
combining enantiomerically pure ligands and a metal centre. The first practical
example was asymmetric hydrogenation of alkenes using a Ru complex with
enantiomerically pure diphosphine ligand DiPAMP developed in 1968 by William S.
Knowles and used for the industrial production of L-DOPA (Scheme 4).20
Scheme 4: Example of asymmetric organometallic catalysts for hydrogenation.
Scheme 5: Asymmetric cyclopropanation of styrene.
In the same year, Noyori reported the cyclopropanation of styrene using a chiral
ligand, although for the first generation ligand the enantiomeric excess was very low
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(Scheme 5).21 Noyori has developed the chiral phosphine BINAP which can be used
as an asymmetric hydrogenation catalyst in combination with Ru or Rh complexes.22
Complexes of BINAP with Ru/Rh were found to be highly active for the
enantioselective hydrogenation and isomerisation (Scheme 6). This process is used
in the industrial synthesis of menthol using a chiral BINAP-Rh complex via
asymmetric isomerisation of an allylic amine intermediate.23
Scheme 6: Enantioselective hydrogenation and isomerisation using BINAP.
K. Barry Sharpless received the Nobel Prize in chemistry in 2001 along with
William S. Knowles and Ryoji Noyori, for his work in enantioselective epoxidation24
and enantioselective dihydroxylation25reactions (Scheme 7).
A number of organometallic complexes have been developed, studied and widely
used for hydrogenation. Enantiomerically pure organometallic complexes
comprising ruthenium, rhodium or iridium complexed with phosphine, amino
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alcohol or diamine ligands have been found to be very efficient for asymmetric
pressure hydrogenation and transfer hydrogenation of alkenes, carbonyl compounds
and imines. As the resulting enantiopure products have important applications in the
synthesis of enantiomerically pure biologically active molecules and natural
products.
Scheme 7: Enantioselective epoxidation and dihydroxylation.
1.2.3.3 Chiral organocatalysts
Scheme 8: L-Proline catalysed Hajos-Parrish-Eder-Sauer-Wiechert reaction.
The first example of organocatalysis was the Doebner modification of the
Knoevenagel condensation.26 In the 1970s the reactions were developed by the teams
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of Hoffmann-La Roche and Schering AG by using L-proline (45) as a catalyst for an
intramolecular aldol reaction, which is now known as Hajos-Parrish-Eder-Sauer-
Wiechert reaction (Scheme 8).27-29
A good chiral organocatalyst would be a small molecule, readily available in both
enantiomeric forms, and easily separable from the product without racemization.31
Chiral organic compounds which have been used to generate enantioselectivity in
this way include (1) proline and its derivatives,33-44 (2) primary amino acids and their
derivatives45-47 (3) cinchona alkaloids48-50 and (4) imidazolidinone derivatives51-63.
These catalysts were developed in earlier research because they are naturally
available and easy to transform in different derivatives.
In organocatalysis, current research is mainly focused on use of chiral
organocatalysts due to the number of applications and is referred asymmetric
organocatalysis. Small molecules with multiple chiral centres can be synthesised
using asymmetric organocatalysis to improve their selectivity towards biological
targets. This can result in very potent and efficient biologically active compounds
being prepared by short and efficient methods. In the synthesis of complex small
molecules, the frequently used reactions are C-C, C-N, C-O, C-S and C-X (X = F,
Cl, Br) bond-formation reactions. Asymmetric organocatalysis is now one of the
fastest emerging fields in organic synthesis as well as in pharmaceutical
chemistry.31,32
1.3 Asymmetric organocatalysis
Asymmetric organocatalysis is a developing area in the field of catalysis after
enzyme- and organometallic catalysis. Asymmetric organocatalysis has a number of
advantages over organometallic and enzyme catalysis such as more scope for
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variations, ease of handling and low toxicity. For organocatalysts, conditions like
inert atmosphere, low temperature or absolute solvents are not required.
Organocatalysts are free from transition metals which gives them a wide scope for
use in the synthesis of pharmaceutical and agricultural products.
1.3.1 Classifications
In the last few years, a number of research groups have developed novel
organocatalysts for asymmetric transformations with high efficiency and selectivity.
With the development of new organocatalysts, it has been revealed that they often
exhibit different mechanisms and catalytic cycles. This has resulted in different ways
to classifying organocatalysts.64,65 The most versatile classification is enamine
catalysis and iminium ion catalysis, depending on the intermediates formed in the
catalytic cycle.
Figure 5: Iminium ion and Enamine intermediates.
In enamine catalysis the reaction proceeds via enamine intermediate formation by
reaction of catalyst and substrate and also results in iminium ion formation at the end
of the cycle. Iminium ion catalysis proceeds in the opposite way via an iminium ion
formation by reaction of catalyst and substrate. Both enamine 49 and iminium ion 48
intermediates are interconvertable and complement each other (Figure 5).33
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List, Barbas and Lerner published the first report on the enamine class of catalysts in
an attempt to understand the reaction mechanism of the earlier reported Hajos-
Parrish-Eder-Sauer-Wiechert reaction.33 Following this, a number of reports were
published for enamine catalysis using new catalysts with applications in different
reactions such as the aldol reaction, Mannich reaction, Michael addition, α-
amination, α-oxygenation, α-halogenations, α-sulphenylation, etc. Proline is most
widely used in enamine catalysts. In recent years, several proline derivatives have
been developed which exhibit high selectivity in the reactions which they catalyse
(Figure 6).
Figure 6: Enamine catalysis and their mode of activation.59
The first report on iminium ion catalysis was published by MacMillan and co-
workers.51 This has opened a new direction in organocatalysis. This class of catalysts
forms an iminium ion intermediate with an unsaturated aldehyde (Figure 7). For this
class of catalyst, detailed reaction mechanisms have been studied and published by
MacMillan’s group. This class of catalysts has been developed for a number of
reactions including Diels-Alder reaction, Friedel-Crafts acylation, Mukaiyama-
Michael addition, conjugate hydride reduction, conjugate amination, conjugate
oxygenation, conjugate sulphenylation, epoxidation, etc.
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Figure 7: Iminium ion catalysis and their mode of activation.59
Earlier developed catalysts had a secondary or a primary amino group. In the last
few years, a new class of organocatalysts has been developed as bifunctional
catalysts. In this class, catalysts activate both substrate 51 and nucleophile 52 to give
high efficiency and stereoselectivity (Figure 8). Bifunctional organocatalysts have
been found to be very efficient for the Michael addition.66
Figure 8: Bifunctional catalysts and their mode of activation.66
Organocatalysts which rely on acidic or basic properties may be classified into the
following categories64: (1) Lewis Bases: these initiate the catalytic cycle via
nucleophilic addition to substrate; (2) Lewis Acids: these activate nucleophilic
substrates; (3) Brønsted Bases: the catalytic cycle is activated via deprotonation; (4)
Brønsted Acids: the catalytic cycle is activated via protonation.
Introduction
16
1.3.2 Different asymmetric reactions
In early work, proline and cinchona alkaloids were found to be promising as
asymmetric organocatalysts. Various derivatives of both classes have been
developed for different asymmetric reactions. In the last ten years, numbers of small
organic molecules have also been found to be as efficient as asymmetric
organocatalysts by different research groups. This has opened the new directions in
asymmetric organocatalysis. Asymmetric organocatalysis has shown exponential
growth in iminium-, enamine- and bifunctional based organocatalysis in reactions
such as Michael additions, aldol reactions, Diels-Alder reaction, nucleophilic
substitutions and many others.
1.3.2.1 Michael addition
Michael additions of ketones, aldehydes or 1,3-dicarbonyl compounds to
nitroolefins, provide chiral nitroalkane derivatives.67 These nitroalkane compounds
are versatile intermediates in organic synthesis and can provide access to numbers of
interesting compounds, as the nitro group can be converted into an amine,68 nitrile
oxide,69 or hydrogen.70 Several research groups are actively working on the
development of enantioselective organocatalysts for the Michael reaction.71-75
Recently several chiral derivatives have been developed for the Michael addition of
ketone or aldehyde to nitroolefins with a few representative examples as shown in
Figure 9.76-83 Similarly selected examples are shown in Figure 10 for Michael
addition of 1,3-dicarbonyl compound to nitroolefins in high efficiency and
selectivity.71,73, 84-87
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Figure 9: Asymmetric organocatalysts for the Michael addition of ketone or
aldehyde to nitroolefins.
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Figure 10: Asymmetric organocatalysts for the Michael addition of 1,3-dicarbonyl
derivatives to nitroolefins/unsaturated ketones.
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1.3.2.2 Aldol reaction
Asymmetric aldol reactions are useful for the α-functionalization of aldehydes and
ketones. These compounds can be used as very good building blocks for small
heterocyclic compounds, hydroxy derivatives and in carbohydrate chemistry.
Figure 11: Asymmetric organocatalysts for the aldol reaction.
Introduction
20
Moreover, β-hydroxy carbonyl derivatives are formed by aldol reactions, which are
very useful derivatives for natural products and even in medicinal chemistry.88 Due
to this huge demand, several groups are working on asymmetric aldol reaction using
organocatalysts.52,89-95 Recently, various asymmetric organocatalysts have been
found to be good for the aldol reaction (Figure 11).40, 96-97
The mechanism of an aldol reaction is illustrated in Figure 12 with an amine-based
organocatalyst. In the catalytic cycle the tautomerization of the imine form 93 into
the enamine form 94 is essential. Moreover, the enamine 93 has an extra N-H for
organocatalysts such as primary amine or amino acid, which may control the
structure of the enamine and direct the reaction to occur with enantioselectivity.98
Figure 12: Mechanism of the aldol reaction using organocatalysts.98
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1.3.2.3 Henry reaction
The Henry (nitroaldol) reaction is a good and quite economical C-C bond forming
reaction. This reaction allows a stereogenic centre to be generated at the β-position
of nitro functionality. The resulting β-nitro alcohol products can be converted in to α-
hydroxy ketones. Both these products are very useful as chiral building block for
natural products. Due to the recent development of asymmetric organocatalysis,
research groups have focused on asymmetric versions of the Henry reaction. Earlier,
different metal complexes have been combined with different chiral ligands.99
Recently, chiral ligands with Cu salts have been found to be very promising for
asymmetric Henry reactions (Figure 13).100-101
Figure 13: Chiral ligands developed for Henry reactions.
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1.3.2.4 Diels-Alder reaction
Asymmetric Diels-Alder reactions are very useful for synthesising bicyclic
derivatives and can be used to synthesise chiral building blocks. This reaction is a
fundamental C-C bond forming reaction and during this process, cyclic rings are
constructed with a number of stereocenters.51,102 Thus, it is another of the areas in
which research groups are working to develop efficient asymmetric organocatalysts
(Figure 14).51,102-103
Figure 14: Asymmetric organocatalysts for asymmetric Diels-Alder reactions.
1.3.2.5 α-Functionalization of carbonyl compounds
In the synthesis of small molecules, introduction of -N, -O, -S and -halogen at α-
position of aldehydes or ketones are useful transformations. The resulting products
can be transformed into chiral building blocks, biologically important molecules and
even new chiral ligands. The asymmetric Strecker104-107 and Mannich108-112 reactions
Introduction
23
are already known and used for C-C bond formation by addition of imines. Direct C-
N bond formation reaction is quite interesting as it directly gives a chiral molecule
containing a chiral centre bearing a nitrogen substituent. The direct asymmetric C-N
bond formation using organocatalysts has opened a new path in asymmetric
organocatalysis, as the resulting chiral products include α-amino acids, α-amino
aldehydes and α-amino alcohols which are very important in organic synthesis.
In C-N bond formation, azodicarboxylates may be used as a source of nitrogen
groups. The resulting addition product can be converted into an alcohol, amine or
oxazolidinone ring.113-117 The following asymmetric organocatalysts have been
found to be efficient and selective for the addition of aldehyde or ketone to
azodicarboxylate (Figure 15).116-117
Figure 15: Asymmetric organocatalysts for asymmetric C-N bond formation
reaction.
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Proline and its derivatives, bifunctional catalysts and MacMillan’s type of catalysts
have been found to be good for the addition reaction,118 α-functionalization of
aldehydes or ketones,119-125 epoxidation of α,β- unsaturated carbonyl compounds,126
γ-amination of α,β-unsaturated carbonyl compounds,127 addition of thioacetic acid to
nitroalkenes,128 and addition of nitroalkanes to enones.129.
These applications of asymmetric organocatalysts, have inspired different research
groups to find more interesting and challenging application of organocatalysts in
asymmetric synthesis.130-136
1.4 Asymmetric transfer hydrogenation
The pressure hydrogenation is a well developed area which requires the use of
gaseous hydrogen.21-23 In contrast, transfer hydrogenation requires use of small
molecules as source of hydrogen instead. Commercially used hydrogen donors
include alcohols as used in Meerwein-Ponndorf-Verley reduction. Transfer
hydrogenation often makes the reaction much easier to handle, safer and quite easy
to analyse. Due to this, asymmetric transfer hydrogenation has become an
economical and environmental friendly method to synthesise different chiral
molecules with applications in pharmaceuticals, functional materials and in natural
product synthesis.
1.4.1 Background
The first known example of transfer hydrogenation of carbonyl compounds was the
Meerwein-Ponndorf-Verley reduction discovered in 1925.137-139 The MPV reduction
involves the reduction of ketones and aldehydes to corresponding alcohols by
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aluminium isopropoxide in alcohol (Scheme 9).137 In earlier reaction conditions, it
was required to use stoichiometric amount of aluminium isopropoxide. Use of a
catalytic amount of aluminium reagent was reported by Nguyen group.140 The MPV
reduction is a homogenous reduction while heterogeneous reductions have also been
developed.141 The mechanistic cycle of MPV involves coordination of the carbonyl
group with the Lewis acidic aluminium isopropoxide, followed by hydride transfer
from one of the isopropoxide molecule (111) (Scheme 9).
Scheme 9: MPV reduction.
Stereoselective MPV reduction can be achieved by (1) use of a chiral alcohol as a
hydride donor, (2) intramolecular MPV reduction, or (3) use of chiral ligands. The
MPV reduction has been developed with use of Lanthanide alkoxide142 and
lanthanide.143 The rhodium complexes with chiral ligand derived from
phennanthroline were studied for asymmetric transfer hydrogenation of
acetophenone with high conversion and good selectivities.144 Bäckvall et al. have
reported the transfer hydrogenation of ketones using RuCl2(PPh3)3 and NaOH in
IPA.145
Evans et al. have reported the use of chiral Sm compound for enantioselective MPV
type reduction of different aryl methyl ketones with 68-96% ee.146 The reduction of
acetophenone was carried out using the chiral Sm catalyst 114 in IPA at room
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temperature for 24 h to give a product in 100% conversion and 96% ee (Scheme
10).146
Scheme 10: Asymmetric transfer hydrogenation of acetophenone using chiral Sm
compound 114.
1.4.2 Hydrogen sources
In earlier work, isopropanol was used as the hydrogen donor, together with a base
such as sodium or potassium hydroxide, alkoxides or carbonates. During this
process, isopropanol generates acetone, which can undergo a reversible process.
Most of the asymmetric transfer hydrogenation reactions were carried out with
IPA/KOH; under these conditions most of the metal complexes were stable enough
to give good selectivity. At the lower temperature, this method gives the kinetically
stable product and as the reaction progresses the rate of the reverse reaction becomes
higher and acetone is converted back to IPA.147 This results in a drop of selectivity.
Even the rate of the reverse reaction is dependent on the oxidation potentials148 of the
substrate, and 100% conversion using IPA is difficult to achieve. To overcome this
drawback the removal of acetone during the reaction or the use of high dilution
methods is required.
Formic acid and its salts are well known as a source of hydride back to 1885 and
1905 for reaction such as the Leuckart-Wallach reaction149 (reductive amination of
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aldehyde using ammonium formate) and Eschweiler–Clarke reaction150 (methylation
of primary or secondary amine). During both processes, formic acid gives CO2 as a
byproduct, which can be easily removed from the reaction. Formic acid has been
used as the source of hydrogen with a base or as an azeotropic mixture with base in
asymmetric transfer hydrogenations. An azeotropic mixture containing formic acid:
triethylamine (5:2) has been found to be a more efficient,151 easy to handle, single
phase reaction with a range of solvents. This mixture works well with temperature
from 20-60 oC and a high concentration of substrate compared to IPA/KOH. In
asymmetric transfer hydrogenation, different small molecules have been used as the
source of hydrogen including isopropanol, formic acid, formic acid:triethylamine
azeotrope and sodium formate depending on the solubility, stability and activity of
different chiral metal complexes.
1.4.3 Ligand developments for asymmetric transfer hydrogenation
A review on some of the ligands developed for asymmetric transfer hydrogenation is
presented in this section. Asymmetric transfer hydrogenation for acetophenone (112)
is used as a model reaction, unless otherwise stated, for comparison of ligands and
metal complexes or with isolated complexes under reported conditions.
1.4.3.1 Tetrahydro bis(oxazole) ligands
Figure 16: Oxazole derivatives.
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In 1991, Pfaltz et al. reported the synthesis and application of derivatives of
tetrahydro bis(oxazole) as ligands for enantioselective reduction of aryl alkyl ketones
(Figure 16).152 Compounds 115-116 were used for reduction of acetophenone with
the metal complex [Ir(COD)Cl2]2 using IPA/KOH at 80 oC. Compound 115 gave a
good conversion up to 89% and low enantioselectivity with 47% ee for reduction of
acetophenone in combination with [Ir(COD)Cl2]2 (Table 1). More interesting results
were obtained using compound 116a-b. Compound 116a gave 89% conversion and
58% ee within 3 h. While compound 116b with the hindered tert-butyl group, failed
to give any significant conversion under similar conditions (Table 1).152
Table 1: Asymmetric transfer hydrogenation of acetophenone 112 using
bis(oxazole) derivatives as chiral ligands 115-118.
Ligands Metal Hydrogensource S/C Temp Time % Conv % ee
115 [Ir(COD)Cl2]2 IPA/KOH 100 80 oC 3 h 89 47(R)
116a [Ir(COD)Cl2]2 IPA/KOH 100 80 oC 3 h 89 58(R)
116b [Ir(COD)Cl2]2 IPA/KOH 100 80 oC 3 h <5 -
117 Ru(PPh3)2Cl2 IPA/NaOiPr 100 82 oC 10 min 91 97(S)
118 Sn(OTf)2
MeOH/
PMHS
10 r.t. 12-14 h 95 58(R)
Modified C2-symmetric ligands with different bridges between the two oxazole
molecules have been reported as tridentate ligands for enantioselective transfer
hydrogenation (Figure 16).153-154 Compound 117 with an amine bridge was used for
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acetophenone reduction with Ru(PPh3)2Cl2 using IPA/NaOiPr at 82 oC. Compound
117 gave a very high conversion of 95 % within 10 min with high enantioselectivity
of 97% ee (Table 1).153 The pyridine bridged compound 118 was employed for
enantioselective reduction of ketones using Sn(OTf)2 and polymethylhydrosiloxane
(PMHS) as the reducing agent. Compound 118 gave a good conversion (95%) over a
period of 12-14 h, but enantioselectivity was quite low (58% ee) (Table 1).154
1.4.3.2 Diamine ligands
Figure 17: Diamine derivatives.
Lemaire et al. have reported the use of C2 symmetric diamine as chiral ligands with
[Rh(C6H10)Cl]2 for asymmetric transfer hydrogenation of carbonyl compound in
IPA/KOH.155 The best results were obtained with compound 119. For acetophenone
reduction, it gave 100% conversion over a period of 7 days with 67% ee with
[Rh(C6H10)Cl]2 (Figure 17, Table 2).155
Alper and Krasik reported series of compounds derived from 1,2-diamino
cyclohexane for asymmetric transfer hydrogenation using IPA.156 All derivatives
were applied to acetophenone reduction with [Ru(C6H6)Cl2]2 using IPA/KOH under
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reflux. Only compound 120 was found to give a useful result with 89% yield and
28% ee (Figure 17, Table 2).156
Table 2: Asymmetric transfer hydrogenation of acetophenone 112 using diamine
derivatives as chiral ligands 119-124.
Ligands Metal Hydrogensource S/C Temp Time
%
Yield % ee
119 [Rh(C6H10)Cl]2 IPA/KOH 100 r.t. 7 days 100 67(R)
120 [Rh(C6H10)Cl]2 IPA/KOH 100 Reflux 2-8 h 89 28(S)
121 [Ru(p-cymene)Cl2]2 IPA/KOH 100 -30 oC 120 h 95 80(R)
122 [Ru(p-cymene)Cl2]2 IPA/KOH 100 22 oC 24 h 97 56(R)
122 [Ru(p-cymene)Cl2]2 FA:TEA 100 33 oC 120 h 42 83(R)
123 [Ir(COD)Cl2]2 IPA/KOH 250 r.t. 12 h 74 78(R)
124 [Ru(p-cymene)Cl2]2 IPA/NaOiPr 100 25 oC 0.5 h 89 91(S)
In 1996, Knochel et al. reported a series of C2 symmetrical ferrocene derivatives as
chiral ligands for enantioselective transfer hydrogenation with Ru(p-cymene)Cl2]2.157
Compound 121 was found to be good for reduction of acetophenone with [Ru(p-
cymene)Cl2]2 using IPA/KOH at -33 oC. It gave 95% conversion over a period of
120 h with 85% ee (Figure 17, Table 2).157 Compound 122 was used under similar
conditions with [Ru(p-cymene)Cl2]2 at 22 oC to give 97% conversion with a drop in
ee (56% ee). When compound 122 was employed for transfer hydrogenation with
[Ru(p-cymene)Cl2]2 using FA:TEA at 33 oC, the enantioselectivity was 83% ee with
a drop in conversion to 42% (Table 2).157
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Diamine derivatives like compound 123 were used with [Ir(COD)Cl2]2 for
asymmetric transfer hydrogenation of various ketones.158 Compound 123 was found
to be good for acetophenone reduction with [Ir(COD)Cl2]2 at room temperature over
a period of 12 h with 74% conversion and 78% ee (Figure 17, Table 2). Compound
123 was found to be good with [Ir(COD)Cl2]2 for enantioselective transfer
hydrogenation of different ketones with 21-93% ee.158 Various diamines derived
from proline have been reported as chiral ligands for asymmetric transfer
hydrogenation.159 Compound 124 gave a good conversion 89% in 0.5 h at room
temperature and high enantioselectivity of 91% ee for acetophenone reduction with
[Ru(p-cymene)Cl2]2 using IPA/NaOiPr (Figure 17, Table 2).159
1.4.3.3 Binol derivatives
Figure 18: Binol derivatives.
Chiral complexes of Ru with derivatives of BINOL have been synthesised and used
for asymmetric transfer hydrogenation to give conversion up to 98% and
enantioselectivity up to 97% ee in ketone reduction.160 One representative example,
compound 125 with Ru(PPh3)2Cl2 gave a product in 94% yield and 96.7% ee in 15 h
at 28 oC for transfer hydrogenation of acetophenone using IPA/ KOtBu (Figure 18,
Table 3).160
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Reetz and Li reported the use of different BINOL derived diphosphinites as chiral
ligands for asymmetric transfer hydrogenation.161 Compound 126 was found to be
good compared to other derivatives for the reduction of acetophenone (Figure 18,
Table 3). Compound 126 gave high conversion 93% and high enantioselectivity 98%
ee at 40 oC in 40 h using [Ru(p-cymene)Cl2]2 as the metal source and NaOH as the
base in IPA.161 Compound 126 also worked well for a range of aryl alkyl ketones
with conversion in the range of 56-100% and enantioselectivity in the range of 76-
99% ee in combination with [Ru(p-cymene)Cl2]2.161
Table 3: Asymmetric transfer hydrogenation of acetophenone 112 using diamine
derivatives as chiral ligands 125-126.
Ligands Metal Hydrogensource S/C Temp Time
%
Yield % ee
125 Ru(PPh3)2Cl2 IPA/ KOtBu 100 28 oC 15 h 94.3 96.7(S)
126 [Ru(p-cymene)Cl2]2 IPA/NaOH 200 40 oC 40 h 93 98(R)
1.4.3.4 Amino alcohol derivatives
Noyori et al. reported amino alcohol derivatives with different Ru(arene) metal
complexes as efficient catalysts for asymmetric transfer hydrogenation using
IPA/KOH.162 The best result for acetophenone reduction was obtained with
compound 127 and [Ru(HMB)Cl2]2 at 28 oC which gave, in 1h, a product of 94%
yield and 92% ee (Figure 19, Table 4).162
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Figure 19: Amino alcohol derivatives.
Table 4: Asymmetric transfer hydrogenation of acetophenone 112 using amino
alcohols 127-130 as chiral ligands.
Ligands Metal Hydrogensource S/C Temp Time
%
Yield % ee
127 [Ru(HMB)Cl2]2 IPA/KOH 200 28 oC 1 h 94 92(S)
128 [Ru(p-cymene)Cl2]2 IPA/KOH 200 r.t. 1.5 h 70 91(S)
129 [Ru(p-cymene)Cl2]2 IPA/KOH 200 r.t. 2 h 95 23(S)
130 [Ru(p-cymene)Cl2]2 IPA/KOH 200 r.t. 2 h 95 23(S)
Wills has reported the use of chiral amino alcohols derived from aminoindanols as
chiral ligands for asymmetric transfer hydrogenation.163 Compound 128 was found
to be good with [Ru(p-cymene)Cl2]2 in IPA/KOH for reduction of acetophenone
with 70% conversion and 91% ee within 1.5 h at room temperature (Figure 19, Table
4). While the less rigid compound 129 gave a good conversion using [Ru(p-
cymene)Cl2]2under similar conditions with a high drop in selectivity.163 The -NMe
analogue compound 130 also showed a similar drop in enantioselectivity under the
reaction conditions in combination with [Ru(p-cymene)Cl2]2 (Figure 19, Table 4).
Results obtained for acetophenone reduction using compound 128 and 129, clearly
show the importance of rigidity and -NH in this series of compounds.163
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Andersson et al. reported a series of amino alcohols as chiral ligands with Ru for
asymmetric transfer hydrogenation.164 Compound 131 (prolinol) was found to be
poor as a chiral ligand with [Ru(HMB)Cl2]2 using IPA/KOH with very low
conversion (16%) and enantioselectivity (8% ee) (Figure 20, Table 5). The bicyclic
alcohol derivative (1S,3R,4R) compound 132 gave a very high conversion of 92%
and enantioselectivity of 95% ee with [Ru(HMB)Cl2]2 at room temperature within 5
h for acetophenone.164 While the substituted analogue (1S,3R,4R) compound 133
gave high conversion but a total loss in enantioselectivity under the similar reaction
conditions in combination with [Ru(HMB)Cl2]2 (Figure 20, Table 5).164
Figure 20: Amino alcohol derivatives.
In 2001, the same group reported different derivatives of bicyclic amino alcohols for
the transfer hydrogenation of ketones.165 Compound 134 gave 92% conversion and
96% ee in 1 h with [Ru(p-cymene)Cl2]2 using IPA/KOH (Figure 20, Table 5).
Compound 135 was found to be highly active for the transfer hydrogenation of
acetophenone with [Ru(p-cymene)Cl2]2 using IPA/KOH (Figure 20, Table 5).165
Compound 135 gave 97% conversion within 0.25 h and in a high enantioselectivity
of 96% ee for asymmetric transfer hydrogenation of acetophenone with [Ru(p-
cymene)Cl2]2. Compound 135 was studied at different S/C ratios and was found to
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be highly effective up to a S/C ratio of 5000 with [Ru(p-cymene)Cl2]2 which gave
similar high conversions and enantioselectivity in 90 min reaction time (Table 5).165
Table 5: Asymmetric transfer hydrogenation of acetophenone 112 using amino
alcohols 131-135 as ligands.
Ligands Metal Hydrogensource S/C Temp Time
%
Yield % ee
131 [Ru(HMB)Cl2]2 IPA/KOH 200 r.t. 6.5 h 16 8(S)
132 [Ru(HMB)Cl2]2 IPA/KOH 200 r.t. 5 h 92 95(S)
133 [Ru(HMB)Cl2]2 IPA/KOH 200 r.t. 16 h 85 Rac
134 [Ru(p-cymene)Cl2]2 IPA/KOH 100 r.t. 1 h 92 96(S)
135 [Ru(p-cymene)Cl2]2 IPA/KOH 100 r.t. 0.25 h 97 96(S)
135 [Ru(p-cymene)Cl2]2 IPA/KOH 200 r.t. 6 min 96 96(S)
135 [Ru(p-cymene)Cl2]2 IPA/KOH 5000 r.t. 90 min 97 96(S)
1.4.3.5 Ferrocene Ru complexes
Figure 21: Ferrocene Ru complexes.
The Hidai group has reported highly active Ru-ferrocene complexes for the
asymmetric transfer hydrogenation of different ketones.166 Compounds 136 and 137
were found to be very selective for the transfer hydrogenation of acetophenone
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giving up to 95% conversion and >99% ee in 2 h at room temperature using
IPA/NaOiPr (Figure 21, Table 6).166
Table 6: Asymmetric transfer hydrogenation of acetophenone 112 using complexes
136-137.
Compd Hydrogen source S/C Temp Time % Yield % ee
136 IPA/ NaOiPr 200 r.t. 2 h 94 >99.6 (R)
137 IPA/ NaOiPr 200 r.t. 2 h 95 >99.7(R)
1.4.3.6 Tridentate ligands
Figure 22: Tridentate ligands.
In 1996, Zhang reported C2 symmetric tridentate ligands for the asymmetric transfer
hydrogenation of ketones with [RuCl2(C6H6)]2.167 Compound 138 gave a good
conversion of 91%, but very low enantioselectivity of 35% ee in 24 h at room
temperature with [RuCl2(C6H6)]2 using IPA/NaOMe (Figure 22, Table 7).167
The same author reported NPN type tridentate chiral ligands for the asymmetric
transfer hydrogenation in 1997.168-169 Compound 139 has shown comparable result
for the reduction of acetophenone using [RuCl2(C6H6)]2 with 72% conversion and a
good ee of 79% within 0.2 h at 80 oC in IPA/KOH (Figure 22, Table 7).168 The
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tridentate compound 140, gave a good conversion (96%) but very low
enantioselectivity (19.8% ee) for acetophenone reduction using [RuCl2(C6H6)]2and
IPA/NaOiPr (Table 7).169
Table 7: Asymmetric transfer hydrogenation of acetophenone 112 using chiral
ligands 138-140.
Ligands Metal Hydrogensource S/C Temp Time % Yield % ee
138 [RuCl2(C6H6)]2 IPA/NaOMe 100 r.t. 24 h 91 35(R)
139 [RuCl2(C6H6)]2 IPA/KOH 100 80 oC 0.2 h 72 79(R)
140 [RuCl2(C6H6)]2 IPA/ NaOiPr 100 23 oC 24 h 96 19.8(R)
1.4.3.7 Tetradentate ligands
Figure 23: Tetradentate ligands.
Noyori et al. have reported the chiral-Ru complexes with C2 symmetric
diphosphino/diamino tetradentate ligands for asymmetric transfer hydrogenation of
aromatic ketones (Figure 23).170 Compound 141 was found to be good with a 91%
conversion and highly selective, giving a product of 97% ee for acetophenone
Introduction
38
reduction in 25 h at 23 oC in IPA/KOH (Table 8). On the other hand, compound 142
gave very low conversion and selectivity for transfer hydrogenation of acetophenone
under similar conditions (Table 8).170
Table 8: Asymmetric transfer hydrogenation of acetophenone 87 using chiral ligands
141-142.
Compd Hydrogen source S/C Temp Time % Yield % ee
141 (S,S) IPA/KOH 200 23 oC 25 h 91 97(S)
142 (S,S) IPA/KOH 200 23 oC 48 h 3 18(S)
1.4.3.8 Peptide ligands
Figure 24: Peptide ligands.
Adolfsson et al. have reported a series of peptide ligands for Ru catalysed
asymmetric transfer hydrogenation of ketones.171 Compound 143 and 144 gave a
good conversions of up to 90-92% and high enantioselectivities of 93-96% ee for the
transfer hydrogenation of acetophenone with [Ru(p-cymene)Cl2]2 in IPA/NaOH at
room temperature in 2h (Figure 24, Table 9).171
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Wills et al. have also reported a series of peptide derivatives as chiral ligands for
asymmetric transfer hydrogenation of ketones.172 Differently substituted compounds
were studied for the reduction of acetophenone to understand the mechanism and
requirement for a free alcohol group. Compounds 145-147 gave comparable
conversions of 31-80% with enantioselectivities of 88-91% ee for the reduction of
acetophenone using [Ru(p-cymene)Cl2]2 in IPA/NaOH at room temperature in 2 h
(Figure 24, Table 9).172
Table 9: Asymmetric transfer hydrogenation of acetophenone 112 using chiral
ligands 143-147.
Ligands Metal Hydrogensource S/C Temp Time
%
Yield % ee
143 [Ru(p-cymene)Cl2]2 IPA/NaOH 100 r.t. 2 h 90 96(S)
144 [Ru(p-cymene)Cl2]2 IPA/NaOH 100 r.t. 2 h 92 93(R)
145 [Ru(p-cymene)Cl2]2 IPA/NaOH 100 r.t. 2 h 31 91(S)
146 [Ru(p-cymene)Cl2]2 IPA/NaOH 100 r.t. 2 h 76 88(S)
147 [Ru(p-cymene)Cl2]2 IPA/NaOH 100 r.t. 2 h 80 90(S)
1.4.3.9 Monotosylated 1,2-diamine derivatives
A major breakthrough was obtained in 1995 by the Noyori group in the use of
monotosylated 1,2-diamines as chiral ligands for Ru catalysed transfer
hydrogenation.173 Compound 64 (TsDPEN) gave very high conversion of 95% and
high enantioselectivity of 97% ee with [Ru(mesitylene)Cl2]2 in IPA/KOH for
asymmetric transfer hydrogenation of acetophenone at room temperature in 15 h
Introduction
40
(Figure 25, Table 10).173 Compound 64 exhibited similar activity for a range of
ketones with 45-98% conversion and 72-98% ee.
Figure 25: Monotosylated 1,2-diamine derivatives.
In 1996, Knochel reported monotosylated 1,2-cyclohexanediamine as a chiral ligand
for enantioselective transfer hydrogenation.157a Compound 148 gave a very high
conversion of 97% with [Ru(p-cymene)Cl2]2 at room temperature in 24 h in
IPA/KOH, but the enantioselectivity was just comparable at 89% ee for
acetophenone reduction (Figure 25, Table 10). When compound 148 was used for a
similar reaction with [Ru(p-cymene)Cl2]2 in FA:TEA as the hydrogen source, a
product was formed in 99% conversion and 94% ee (Table 10).157a
The Wills group have reported a series of monotosylated diamine derivatives in
order to establish the importance of 1,2-anti-disubstitution in monotosylated
diamines.174 Compounds 64, 149-151 were employed for the reduction of
acetophenone with [Ru(p-cymene)Cl2]2 using FA:TEA as the hydrogen source
(Figure 25, Table 10). As already reported, compound 64 gave complete conversion
with 98% ee for acetophenone reduction in combination with [Ru(p-cymene)Cl2]2 in
22h at 28 oC. Compound 149 was found to be slow compared to 64 for reduction of
acetopheneone with [Ru(p-cymene)Cl2]2, with 95% conversion in 48 h and moderate
enantioselectivity (69% ee).174 In contrast, compound 150 in combination with
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[Ru(p-cymene)Cl2]2, showed almost total loss in catalytic activity with 48%
conversion and 33% ee over a long reaction period of 13 days (Table 10). The syn
analogue of compound 64, compound 151, was also found to be slow and less
efficient compared to 64, with 32% conversion and 70% ee at 28 oC in 220 h using
[Ru(p-cymene)Cl2]2 (Table 10). Results obtained for compounds 149-151, clearly
show the importance of anti-disubstitution in diamine ligands.174
Table 10: Asymmetric transfer hydrogenation of acetophenone 112 using chiral
ligands 64, 148-152.
Ligands Metal Hydrogensource S/C Temp Time
%
Yield % ee
64 [Ru(mesitylene)Cl2]2 IPA/KOH 200 r.t. 15 h 95 97(S)
148 [Ru(p-cymene)Cl2]2 IPA/KOH 100 22 oC 24 h 97 89(R)
148 [Ru(p-cymene)Cl2]2 FA:TEA 100 33 oC 24 h 99 94(R)
64 [Ru(p-cymene)Cl2]2 FA:TEA 200 28 oC 22 h 100 98(R)
149 [Ru(p-cymene)Cl2]2 FA:TEA 200 28 oC 48 h 95 69(S)
150 [Ru(p-cymene)Cl2]2 FA:TEA 200 28 oC 13 days 46 33(R)
151 [Ru(p-cymene)Cl2]2 FA:TEA 200 28 oC 220 h 32 70(S)
152 [Ru(C6H6)Cl2]2 FA:TEA 200 25 oC 15 h 98 93(S)
Chiral-Ru(arene) complex of a “roofed” cis-diamine has been reported by Ishizuka
group for asymmetric transfer hydrogenation of ketones.175 The preformed catalyst
of compound 152 with [Ru(C6H6)Cl2]2, gave high conversion of 98% and
enantioselectivity of 93% ee at 25 oC in 15 h for the asymmetric transfer
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hydrogenation of acetophenone (Figure 25, Table 10). The preformed complex of
compound 152 with [Ru(C6H6)Cl2]2 was found to be good for a range of ketones in
asymmetric transfer hydrogenation.175
1.4.4 Mechanistic investigations of asymmetric transfer hydrogenation of
ketones and imines
Figure 26: Mechanistic cycles in asymmetric transfer hydrogenation of ketones.
The combination of (1S,2S) TsDPEN (64) and [Ru(p-cymene)Cl2]2 was reported
to give the complex 153 as orange crystals.176 This chloride complex 153 is
converted to the ‘true’ active catalyst - “an amido complex 154” - with base in
IPA and is formed with a characteristic purple colour. Amido complex 154 is a
16-electron neutral complex having square–planar geometry and the metal bound
to two anionic nitrogen atoms. This amido complex 154 reacts with IPA to give a
single diastereomer of amine hydrido Ru complex 155 as a yellow powder. This
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amine hydrido Ru complex 155 is an 18-electron complex, and acts as the
hydride source in asymmetric reductions (Figure 26).176
For ketone reduction, Noyori has proposed that this transfer takes place via the cyclic
six-membered transition state depicted in a reversible manner 156.177 For the Ir
complex 158, the 16 electron and hydride complex were synthesised by a method
similar to the chiral Ru complex 153. While for the Rh complex 157 only the 16
electron species was detected.178 Related studies were carried out by Ikariya et al. for
Cp*Rh and Cp*Ir complexes having chiral ligands TsCYDN and TsDPEN using
KOtBu in IPA for transfer hydrogenation of aromatic ketones. The isolation and
catalytic study of Cp*IrH(R,R)TsCYDN 160 proved it to have a similar catalytic
cycle as observed for RuCl(p-cymene)TsDPEN complex 153 (Figure 27).179
Figure 27: Cp*Rh and Cp*Ir complexes.
The transfer of hydrogen between the alcohol and ketone by chiral-Ru(arene)
complexes has been well studied by different methods. In 2003, Casey reported the
kinetic isotope effect in the dehydrogenation of deuterated isopropanol by amido Ru
complex.180 It was found that the hydride and proton transfer occur simultaneously,
which again confirms the metal ligand bifunctional catalysis mechanism proposed by
Noyori.180 All these studies have indicated that transfer hydrogenation using IPA
takes place through a six membered pericyclic transition state.
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Figure 28: Possible path for transfer of hydride from metal to CO2.
Most of the recent asymmetric transfer hydrogenation reactions were developed
using formic acid: triethylamine (5:2). Matsubara has reported the DFT study on the
transfer of hydride from complex 161 to CO2 (Figure 28). He has described two
possible paths for this transformation and shown that path A with a low energy
barrier of 2.6 kcal/mol, is more favourable (Figure 28).181
Figure 29: Reaction of amide complex 154 with formic acid and hydride complex
155 with CO2.
In 2004, Ikariya reported detailed mechanistic and experimental studies on the
reaction of amide complex 154 with formic acid.182 This was followed by formation
of an ion pair intermediate, in contrast to the concerted process with IPA. The
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formate complex 162 gives amino Ru complex 155 by decarboxylation. Moreover,
hydrido Ru complex 155 reacts with CO2 to form formate complex 162 via
intermediate 163 (Figure 29). Thus, hydrido Ru complex 155 catalyses the
hydrogenation of CO2 to give formic acid. Due to this reversible process in the
reaction, it is important to remove the CO2 generated in the asymmetric reduction
with formic acid (Figure 29).182 Recently, a similar study was reported using DFT
calculation by Whitwood, for the formation of a formate complex in Rh(III)
catalysed transfer hydrogenation.183
Stroatman et al. have also reported the effect of CO2 on the asymmetric reductive
amination catalysed by compound 153.184 The rate of reaction was affected by CO2
formed during the reaction with a drop in yield and selectivity. The equilibrium
between Ru-formate complex 164 and Ru-hydrido complex 155 was affected by CO2
(Figure 30). This can be altered by purging CO2 from reaction mixture or trapping
CO2 with secondary amines.184
Figure 30: Equilibrium between Ru-formate complex 164 and Ru-hydrido complex
155.
For more economical processes and green synthesis, there is an interest in using
water as the solvent. Xiao has observed, that transfer hydrogenation using FA:TEA
became much slower in water.186 This interesting finding lead to use of sodium
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formate as an efficient source of hydrogen for asymmetric transfer hydrogenation in
water.
Scheme 11: Asymmetric transfer hydrogenation of acetophenone 112 with
compound 153.
Table 11: Asymmetric transfer hydrogenation of acetophenone 112 using compound
153 as catalyst with different hydrogen sources.
Hydrogen
source
Catalyst
loading Solvent Temp Time
%
Conv % ee
IPA/KOH 200:1 (S,S) IPA r.t. 15 h 95 97(S)
FA:TEA (5:2) 200:1 (S,S) - 28 oC 20 h >99 98(S)
FA:TEA (5:2) 100:1 (R,R) Water 40 oC
30 min
12 h
1
98
>99(R)
97(R)
HCOONa 100:1 (R,R) Water 40 oC 30 min 76 95(R)
The Ru-TsDPEN complex 153 was found to be very slow for the reduction of
acetophenone using FA:TEA in water, on the other hand the reaction was much
faster when carried out using sodium formate in water. Compound 153 gave 1%
conversion and >99% ee for asymmetric transfer hydrogenation of acetophenone
using FA:TEA (5:2) in water at 40 oC (Table 11). While under the similar conditions
compound 153 gave 76% conversion and 95% ee in 30 min using sodium formate
(Table 11).187
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Figure 31: Mechanistic cycles in asymmetric transfer hydrogenation of aryl ketones
in water at high and low pH.
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To understand the asymmetric transfer hydrogenation in aqueous media, Xiao has
reported the effect of pH on the catalytic cycle of transfer hydrogenation.187 He has
proposed that asymmetric transfer hydrogenation in aqueous media operates via two
competing catalytic cycles as shown in Figure 31, which are dependent on the pH of
the solution.187 When the pH of the solution is low; the tosylated amine of the ligand
gets protonated. This protonated form of the tosylated amine may lead to partial
dissociation from the metal, with loss of rigidity in the complex (Figure 31).
Figure 32: Asymmetric transfer hydrogenation of ketones and imines using
complex (1S,2S)-153.
Due to this, the transfer hydrogenation is no longer enantioselective. Thus, if the pH
of solution is adjusted to between 5-8 during the reaction by changing the ratio of
formic acid/triethylamine, this can give rise to high efficiency and excellent
enantioselectivities.187
One of the interesting findings to come from the transfer hydrogenation of ketones
and imines, is that the use of the same configuration of chiral complex for ketone and
imine reduction resulted in different product isomers (Figure 32).173,188 The transition
states for the corresponding imine reductions are less well understood, although there
is evidence that the iminium salt, formed by protonation, rather than the free imine,
is reduced.189
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Scheme 12: Reaction of complex 155 (preformed hydride complex) with imines and
ketones.
Bäckvall et al. have reported the experimental support for hydrogenation of imine by
an ionic pathway.190 They successfully carried out the reaction of acetone with
preformed hydrido Ru complex 155 to give alcohol, and at the same time the similar
reaction of hydrido complex 155 with imine 167 was unsuccessful (Scheme 12).
Moreover, even when the stoichiometric reaction of hydrido complex 155 with imine
167 was carried out in 1:1 ratio, transfer hydrogenation to give an amine was not
observed (Scheme 12).190 The stoichiometric reaction carried out with addition of
acid successfully resulted in formation of the amine product. This experimental data
clearly shows that imine reduction follows an ionic pathway in asymmetric transfer
hydrogenation and a source of protons is required to give reduction of the imine,
which may be from the solvent or by addition of an acid; in the case of FA/TEA as
solvent, the formic acid can supply the protons.190
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Scheme 13: Reduction of imine 165 using compound 157.
Xiao and Li have reported the asymmetric hydrogenation of imines using compound
157 with a range of counteranions.191a Out of the silver salts used, AgSbF6 has given
the highest conversion (94%) and highest selectivity (99% ee) for the asymmetric
hydrogenation of imine 165. Thus, the ionic nature of compound 157a with a large
counteranion (SbF6-) was found to be important for asymmetric hydrogenation for a
range of substituted imines.191a The addition of the silver salts gave high conversions
and enantioselectivities for the asymmetric pressure hydrogenation191a and
asymmetric transfer hydrogenation191b of imines. To study the effect of the
counteranion, Xiao et al. have reported the use of phosphate anions with Cp*Ir
complexes for asymmetric hydrogenation of acyclic imines.192,193 Ikariya et al. have
also reported the use of AgSbF6 with compound 160 for efficient and selective
asymmetric hydrogenation of acyclic imines.194
Wills et al. have also reported similar results and speculated the orientation for the
imine reduction shown in Figure 33.194 For asymmetric transfer hydrogenation of
imines, three different orientations are possible as shown in Figure 33. If the
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orientation of imine 165 is similar to that of acetophenone 112, the result will be
reduction to the imine of incorrect configuration (Figure 33, B). Two orientations C
& D exist (Figure 33), which will furnish the correct configuration of the product
amine. However, it is difficult to firmly identify the exact orientation of the catalyst
and imine during the transfer hydrogenation.194 Kačer et al. described molecular
modelling data of the transition states involved in asymmetric transfer hydrogenation
of ketones and imines, which can help to explain the experimental data obtained.195
Figure 33: Established (A) and speculated (B-D) transition states for asymmetric
transfer hydrogenation of ketones and imines using TsDPEN-Ru catalyst.
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1.4.5 Factors affecting Enantioselectivity
In asymmetric transfer hydrogenation, the stable complex 153 has been used, which
can be easily prepared in situ or isolated by reaction of [Ru(arene)Cl2]2 with chiral
ligands such as TsDPEN. Complex 153 is a precatalyst, as during the reaction it is
converted into the 16 electron species 154 by reaction with KOH in toluene. The 16
electron species reacts with IPA to give the hydride form of the catalyst 155.176
Figure 34: CH/π interaction in asymmetric transfer hydrogenation of ketones.
The enantioselectivity may arise due to a stereodetermining transition state with
electronic influences around the metal centre and also via space interactions between
the catalyst and substrate. The transition state structure was studied by hybrid density
functional theory-based calculations for compound 155. This study has revealed that
enantioselectivity originates not only from the well-defined cyclic transition state but
also through a CH/π interaction of η
6-arene of the complex and the aryl group of the
substrate as shown in Figure 34.197-198
Andersson et al. also reported the DFT calculation for three different mechanistic
models for the asymmetric transfer hydrogenation with Ru(arene)-aminoalcohol, (A)
direct transfer of an R-hydrogen of an alcohol to the carbonyl carbon of a ketone, (B)
migratory insertion (MI) of a coordinated ketone into a metal hydride bond, or (C) a
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concerted mechanism where a proton and a hydride are transferred simultaneously to
the ketone (Figure 35).199 The computational data has shown that the six membered
transition state has a strong preference for planarity. The planarity of the transition
state is also dependent on the conformational behavior of the O,N-linkage of the
amino alcohol ligand.199
Figure 35: Possible model for transfer hydrogenation between metal hydride and
ketones.
In 2004, Brandt, Roth and Andersson reported more experiments which provide an
insight into the asymmetric transfer hydrogenation of ketones.200 They reported
asymmetric transfer hydrogenation of different substituted aliphatic and aromatic
ketones and used these data for DFT calculations. Both experimental and
computational data were found which provided additional support for the interaction
between the substrate phenyl ring and metal arene ring, which is in contrast to
aliphatic ketones. At the same time, enantioselectivity in transfer hydrogenation of
ketones is also influenced by steric, electrostatic, dispersion and solvent effects.200
As a result, excellent enantiomeric excesses are observed for substrates containing a
combination of aryl and alkyl substituents on the carbonyl group. For substrates not
fitting this model, enantioselectivities are frequently lower and unpredictable,
although there are examples of alternative asymmetric transfer hydrogenation
catalysts which have a broad substrate range.200
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1.4.6 Recent Developments
The Wills group reported the first example of a “tethered” catalyst, where the chiral
ligand and arene ring are joined together in the metal complex (Figure 36).201-203 The
introduction of the tethering linkage allows ‘locking’ of the otherwise freely rotating
arene ring. The restriction of the metal-arene rotation subsequently permits the
addition of substituents on the arene ring, which will occupy fixed spatial positions
in the catalyst. Moreover, the three point attachment of ligand to the metal can give
more stability.201
Figure 36: Cp*Rh-tethered complexes.
Compound 170 gave almost 50% conversion in 10 min at room temperature with
S:C = 100:1, while almost 95% conversion was obtained in 10 min with S:C = 100:5,
whilst over the period of the reaction a decrease in ee was observed (Table 12). This
may be due to the low stability of the complex leading to racemisation of complex in
the reaction.201 In 2005 the Wills group reported a stable complex of Rh-metal,
compound 171.202 Compound 171 gave complete conversion with 98% ee for
asymmetric transfer hydrogenation of acetophenone in FA:TEA (Table 12).
Compound 171 was also found to be highly efficient and enantioselective for a range
of aryl alkyl ketones.202
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Table 12: Asymmetric transfer hydrogenation of acetophenone 112 using complexes
170-172.
Compd Hydrogen source S/C Solvent Temp Time % Conv % ee
170 IPA/KOtBu 100 IPA r.t.
1 min
10 min
60 min
18.5
50.4
62.1
74.9 (R)
68.6(R)
55.8(R)
170 IPA/ KOtBu 20 IPA r.t.
1 min
10 min
60 min
78.2
95.0
96.4
73.5(R)
68.0(R)
64.2(R)
171 FA:TEA 200 25 oC 10 h 100 98 (R)
172 FA:TEA 200 28 oC 2 h 100 96 (R)
172 HCOONa/H2O 200 28 oC 3 h 100 96 (R)
A similar compound with a TsCYDN chiral core, compound 172 has been reported
by the same group.203 Compound 172 showed high activity, giving complete
conversion in 2h for asymmetric transfer hydrogenation of ketones in FA:TEA with
enantioselectivities of up to 96% ee at 28 oC (Table 12). Compound 172 gave similar
results for various ketones tested. Moreover, compound 172 has shown similar
catalytic activity with sodium formate in water as the hydrogen donor.203
In 2004-2005, the Wills group reported a series of tethered catalysts containing a
chiral core derived from TsDPEN or a diphenyl aminoalcohol linked to the arene and
Ru complex.204-205 The synthesis of these complexes is now well established
(Scheme 14). The chiral ligands can be synthesised by reductive amination of the
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appropriate aldehyde and amine. The resulting ligands were reacted with RuCl3 to
give the corresponding dimer. The dimer can usually be converted into a monomer
complex under basic conditions (Scheme 14).204-205
Scheme 14: Synthesis of different Ru-tethered complexes.
Under these conditions compound 174 failed to give compound 175, however the
dimer itself can be used directly for asymmetric transfer hydrogenation, as during the
reaction it converts to the monomer in situ. The results obtained by the dimer and
isolated monomer for asymmetric transfer hydrogenation are shown in Table 13.204-
205 Compound 174 gave 96% conversion for transfer hydrogenation of acetophenone
with moderate enantioselectivity of 66% in IPA/KOH (Table 13).204 Compound 177
and the corresponding monomer 178 have shown similar high activity with >99%
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conversion and high enantioselectivity of up to 96% ee in FA:TEA at 28 oC in 18-20
h (Table 13).205 Interesting results were obtained with dimer 180 and corresponding
monomer 181. Both compounds 180 and 181 were found to be highly active and
efficient for acetophenone reduction with 100% conversion within 3 h and 96% ee
being obtained using FA:TEA (Table 13).205
Table 13: Asymmetric transfer hydrogenation of acetophenone 112 using complexes
174, 177, 178, 180 and 181.
Compd Hydrogen source S/C Temp Time % Yield % ee
174 IPA/KOH 200 28 oC 1 h 96 66(R)
177 FA:TEA 200 28 oC 18 h >99 96(R)
178 FA:TEA 200 28 oC 21 h >99 96(R)
180(S,S) FA:TEA 100 28 oC 3 h 100 96(S)
181(R,R) FA:TEA 100 28 oC 3 h 100 96(R)
Scheme 15: Modified tethered catalyst analogues with ether linkage.
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Modified tethered complexes, with ether linkages in the chain was reported by Wills
et al.206 Compounds 182-184 with ether linkages and different chiral cores with Ru
complex, were studied for asymmetric transfer hydrogenation of acetophenone
(Scheme 15).206 All of them showed comparable efficiency for conversion, but
enantioselectivities were moderate and in the range of 12-72% ee.
At the same time the variation in the length of the tether in the complex has been
studied by the same group (Figure 37).207 Compound 185 with “2C” tether length
has shown low reactivity compared to the “3C” analogue (Table 14). Compounds
188 and 189 with the “3C” in the tether length with methyl substitution, gave a
comparable results for asymmetric transfer hydrogenation of acetophenone with 38%
conversion and 93-96% ee in 4-5 h at 40 oC, but were not as good as the “4C”
analogue 186 with 100% conversion and 96% ee under similar reaction conditions
(Table 14).207 Compound 186 gave a very fast reaction, giving complete conversion
in 1.25 h at 28 oC with 96% ee.
Figure 37: Modified tethered analogues with change in linkage.
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Table 14: Asymmetric transfer hydrogenation of acetophenone 112 using complexes
185-191.
Compd Hydrogen source S/C Temp Time % Yield % ee
185 “2C” FA:TEA 200 40 oC 15 h 19 92 (R)
186 “4C” FA:TEA 200 40 oC 1.5 h 100 96 (R)
186 “4C” FA:TEA 10000 r.t. 70 h 100 96 (R)
187 “5C” FA:TEA 200 40 oC 6 h 38 94(R)
188 FA:TEA 200 40 oC 4 h 38 96(R)
189 FA:TEA 200 40 oC 5 h 38 93(R)
190 FA:TEA 200 40 oC 24h 100 98(R)
191 FA:TEA 200 28 oC 12 h 100 92(R)
Moreover, compound 186 can be used up to 0.01 mol% catalyst loading for
acetophenone reduction to give complete conversion in 70 h with intact
enantioselectivity (96% ee) (Table 14).207 Interestingly, compound 189 has shown
high enantioselectivity (90% ee) for asymmetric transfer hydrogenation of
cyclohexylmethyl ketone with complete conversion in an overnight reaction.207
Compound 190 with benzene in the tether, also gave similar results for acetophenone
reduction with complete conversion in 24 h at 40 oC and high enantioselectivity of
98% ee (Table 14).208 The TsCYDN analogue compound 191 was found to be less
active compared to 153 (TsDPEN analogue) with complete conversion in 12 h at 28
oC, but enantioselectivity was only 92% ee (Table 14).208
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The Wills group have reported various N-alkylated TsDPEN derivatives 192a-e as
chiral ligands for pressure hydrogenation with IrCl3 in presence of base for different
ketones (Figure 38).209 These N-alkylated TsDPEN chiral ligands 193a-e were also
used for Ru complex catalysed asymmetric transfer hydrogenation of different aryl
alkyl ketones and imines (Figure 38).195,210 Compound 193a with N-Me has shown
high efficiency and high selectivity for acetophenone reduction compared to its -NH2
analogue (Scheme 16).210
Figure 38: N-alkylated TsDPEN derivatives.
Scheme 16: Asymmetric transfer hydrogenation of acetophenone using complex
193a using FA:TEA.
Recently, different chiral ligands have been reported by various groups for
asymmetric transfer hydrogenation of ketones. Govender et al. have reported that
tetrahydroisoquinoline diamine compound 194, gave 81% conversion for
acetophenone reduction using [RhCp*Cl2]2 in IPA/KOtBu at 25 oC with moderate
enantioselectivity of 70% ee (Figure 39, Table 15).211
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Figure 39: Recently developed chiral ligands for asymmetric transfer hydrogenation
of ketones.
Ahlford and Adolfsson have reported a series of amino acid derived amide and
hydroxamic acid derivatives 195-200 as ligands for asymmetric transfer
hydrogenation using [IrCp*Cl2]2 in HCOOLi/H2O (Figure 39).212 Compound 195 (-
NHBoc) gave a very low conversion of 2% for the reduction of acetophenone under
reaction conditions. While deprotected compound 196 gave a high conversion of
99% with a moderate ee of 71% in combination with [IrCp*Cl2]2. Similar analogues
197-200 were found to be good in terms of conversion but the enantioselectivity was
poor with [RhCp*Cl2]2 or [IrCp*Cl2]2 (Table 15).212
Vo-Tanah has reported chiral N-heterocyclic carbene derivatives of (S)-pyroglutamic
acid as chiral ligands for Rh catalysed asymmetric transfer hydrogenation.213 In this
series, compound 201 was found good with 90% conversion and 80% ee achieved at
80 oC in 20 h for asymmetric transfer hydrogenation for acetophenone with
[Rh(COD)Cl2]2.213
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Table 15: Asymmetric transfer hydrogenation of acetophenone 112 using chiral
ligands 194-202 and 143.
Compd Metal Hydrogensource S/C Temp Time
%
Yield % ee
194 [RhCp*Cl2]2
IPA/KOtBu/
H2O
100 25 oC 81 70(S)
195 [RhCp*Cl2]2
HCOOLi/
H2O
100 28 oC 17-22h 2 -
196 [IrCp*Cl2]2
HCOOLi/
H2O
100 24 oC 17-22h 99 71(R)
197 [IrCp*Cl2]2
HCOOLi/
H2O
100 28 oC 17-22h 99 43(R)
198 [RhCp*Cl2]2
HCOOLi/
H2O
100 28 oC 17-22h 99 29(R)
199 [RhCp*Cl2]2
HCOOLi/
H2O
100 35 oC 17-22h 99 76(R)
200 [IrCp*Cl2]2
HCOOLi/
H2O
100 24 oC 17-22h 99 74(R)
201 [Rh(COD)Cl2]2 IPA/KOH 50 80 oC 20 h 90 80(R)
202 [Ru(p-cymene)Cl2]2 IPA/KOH 200 -10 oC 3 h 98 92(R)
143 (S) [Ru(p-cymene)Cl2]2 EtOH/LiCl 100 40 oC 2 h 83 97(S)
Zheng et al. have reported a series of amino alcohol ligands derived from 1-
phenylmethylamine.214 Promising results were obtained with compound 202 (Figure
39, Table 15). Compound 202 gave 98 % conversion with good enantioselectivity of
92% ee using [Ru(p-cymene)Cl2]2 in IPA/KOH at -10 oC in 3 h for transfer
hydrogenation of acetophenone.214
Introduction
63
A more interesting result was reported by Adolfsson et al. using compound 143.215
Compound 143 has been reported by this group for asymmetric transfer
hydrogenation of ketones using [Ru(p-cymene)Cl2]2 and IPA/NaOH.171 Compound
143 has been found to be effective in Ru catalysed asymmetric transfer
hydrogenation using EtOH/LiCl (Table 15).215 Compound 143 gave 83% conversion
with high 97% ee with [Ru(p-cymene)Cl2]2 for transfer hydrogenation of
acetophenone at 40 oC in 2 h, with 90% chemoselectivity (due to side reaction of
acetophenone and acetaldehyde).
1.4.7 Substrate scope
There is a large range of substrates that can be employed for asymmetric transfer
hydrogenation reactions especially (i) important substrates for biologically active
compounds and (ii) compounds which are structurally interesting and challenging. A
selection of these substrates is described in this section with highlights of some of
the applications of biologically relevant compounds.
1.4.7.1 Aryl Alkyl Ketones
A number of the chiral ligands and complexes have shown high efficacy and
selectivity for transfer hydrogenation of various aryl alkyl ketones as discussed in
sections 1.4.3 and 1.4.6. Compound 203 has shown high selectivity for a range
substituted ketones (Scheme 17, Table 16). For all tested compounds complete
conversion was obtained in 14-90 h using complex 203 with high
enantioselectivity.173
Introduction
64
Scheme 17: Asymmetric transfer hydrogenation of ketones using complex 203.
Table 16: Asymmetric transfer hydrogenation of ketones using complex 203.
Ketone Time %conv %ee Ketone Time %conv %ee
112 20 h >99 98 204d 50 h >99 98
204a 21 h >99 97 204e 60 h >99 97
204b 24 h >99 95 204f 60 h 96 97
204c 14 h >99 90 204g 90 h 99 95
1.4.7.2 α,β-Acetylenic Ketones
Asymmetric transfer hydrogenation of α,β-acetylenic ketones has been obtained
using compounds 153 and 203 (Scheme 18).216 Compounds 153 and 203 were found
to be highly efficient (58-99% conversion) and enantioselective (90-99% ee) for
asymmetric transfer hydrogenation of α,β-acetylenic ketones 206 to the
corresponding chiral propargylic alcohols 207.216 In contrast, pressure hydrogenation
of these compounds was less chemoselective and enantioselective due to conjugative
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reduction. Compound 203 was found to be effective for asymmetric transfer
hydrogenation of this series of compound in IPA, whereas demonstrated lower
activity when used in FA:TEA.216
Scheme 18: Asymmetric transfer hydrogenation of α,β-acetylenic ketones.
1.4.7.3 α-Substituted Ketones
Scheme 19: Asymmetric transfer hydrogenations of α-amino ketones.
Asymmetric transfer hydrogenations of α-amino ketones have been reported by the
Wills group using compounds 208 and 64 in combination with [Ru(p-cymene)Cl2]2
(Scheme 19).208,217 Compound 208 was found to be highly enantioselective, giving
products of 60-99% ee for different α-substituted ketones with [Ru(p-cymene)Cl2]2.
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The resulting enantiopure alcohols can be employed for synthesis of enantioselective
aziridines. 208,217
Scheme 20: Asymmetric transfer hydrogenation of α-substituted ketones.
A similar application was reported by Ikariya in 2002 for asymmetric transfer
hydrogenation of α-substituted ketones with groups such as -CN, N3 and -NO2 using
compound 153 (Scheme 20).218 Compound 153 gave a good efficiency (18-100%)
and high enantioselectivity (91-98% ee) for transfer hydrogenation. The resulting -
CN, N3, -NO2 substituted alcohols can be converted to optically pure amino alcohols
by reduction.218
In the same year, Ikariya et al. reported the synthesis of optically active styrene
oxides from 2-chloroacetophenones in a one-pot reduction-elimination procedure.219
The first step was the enantioselective reduction of 2-chloroacetophenone using
compound 157 giving 97% ee in FA:TEA and the resulting 2-chloro-1-
phenylethanol converted to optically active styrene oxide 214 using 2M NaOH
solution in isopropanol in 2 h (Scheme 21). This one-pot process is quite useful and
economical for large-scale production of styrene oxides.219
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Scheme 21: Asymmetric transfer hydrogenation of α-chloro ketones.
1.4.7.4 α,β-Unsaturated ketones
Püntener et al. reported asymmetric transfer hydrogenation of ketoisophorone 216
using in situ formed catalysts with different chiral ligands and [Ru(C6H6)Cl2]2 in
IPA/KOH (Scheme 22).220 Compound 215 in combination with [Ru(C6H6)Cl2]2 has
shown high diastereoselectivity dr = 92:7 and high enantioselectivity (97% ee) for
asymmetric transfer hydrogenation of compound 216.220
Scheme 22: Asymmetric transfer hydrogenation of ketoisophorone.
Similarly, different chiral compounds have been employed by the Wills group for
asymmetric transfer hydrogenation of α,β-unsaturated ketones using compound 153
Introduction
68
as the catalyst (Scheme 23).221 Substituted cyclic enones 220a-c were reduced with
yields in the range of 47-78% and good to high enantioselectivities.221
Scheme 23: Asymmetric transfer hydrogenation of cyclic enones.
1.4.7.5 Heterocyclic ketones
Chiral heterocyclic alcohols are useful intermediates for synthesis of biologically
active molecules, novel chiral ligands and natural products (Scheme 24). In 2000,
Ikariya reported the reduction of 2-pyridyl alkyl ketone 222 using compound 153
with a high yield of up to 97% and high enantioselectivity of up to 95% ee using
FA:TEA.222 Interesting results were also obtained for compound 224. The resulting
symmetrical alcohol 225 can be converted to chiral ligands.222
Scheme 24: Asymmetric transfer hydrogenation of heterocyclic ketones.
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1.4.7.6 β-Keto esters
Scheme 25: Asymmetric transfer hydrogenation of β-keto esters.
Table 17: Asymmetric transfer hydrogenation of β-keto esters.
Compd Chiralligand Metal Temp Time % Conv % ee
227a 226 [Ru(benzene)Cl2]2 30 oC 10 h 100 39(S)
227a 64 [Ru(hmb)Cl2]2 50 oC 20 h 63 56(R)
227b 226 [Ru(benzene)Cl2]2 20 oC 1 h 98 44(S)
227c 226 [Ru(benzene)Cl2]2 20 oC 4 h 100 40(S)
227d 226 [Ru(benzene)Cl2]2 50 oC 2 h 100 15(S)
227e 226 [Ru(p-cymene)Cl2]2 50 oC 15 h 85 94(S)
227e 64 [Ru(p-cymene)Cl2]2 50 oC 3 h 95 93(S)
Transfer hydrogenation of β-keto esters was studied using ephedrine and TsDPEN
with different Ru(arene) complexes by Carpentier (Scheme 25).223 Different esters
were studied by employing two chiral ligands; ephedrine 226 and TsDPEN 64 in
combinations with different Ru(arene) complexes. Ephedrine 226 showed good
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conversion but moderate enantioselectivity for asymmetric transfer hydrogenation of
compounds 227a-d in combination with Ru(arene) complexes. The best result was
obtained for β-keto ester with an aryl substituent 227d, using Ru(p-
cymene)/Ephedrine 226 (85% conv and 94% ee) and Ru(p-cymene)/TsDPEN 64
(95% conv and 93% ee) (Table 17).223
1.4.7.7 1,3-Diketones
Scheme 26: Asymmetric transfer hydrogenation of 1,3-diketones.
Cossy et al. have reported asymmetric transfer hydrogenations of 1,3-diketones
using chiral-Ru complexes (Scheme 26).224 Compound 153 gave asymmetric transfer
hydrogenation of compound 229 to give compound 230 with 83% conversion, 99.8%
ee and dr of 98.5:1.5. Compound 153 also worked well for a range of substituted 1,3-
diketones.224
1.4.7.8 Imines
Imines are important substrates for asymmetric transfer hydrogenation given the
wide range of applications of enantiomerically pure amines. Noyori et al. reported
high enantioselective and efficient transfer hydrogenation of imines using compound
153.188 Compound 165 was reduced to the corresponding amine 166 with more than
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99% yield and 95% ee with compound 153 using FA:TEA as the hydrogen source in
acetonitrile (Scheme 27). The transfer hydrogenation reaction was found to be very
slow under neat conditions.188 Similar results were obtained by the Wills group using
compound 193e (Scheme 27).195 High enantioselectivity was obtained for the
reduction of imines 165 and 165a (85% and 89% ee respectively) using compound
193e. 195
Scheme 27: Asymmetric transfer hydrogenation of imines.
Recently, asymmetric transfer hydrogenation of sulfinylimines was reported by
Guijarro using achiral amino alcohols and [Ru(p-cymene)Cl2]2 in IPA/KOtBu
(Scheme 28).225 Achiral ligands were screened for transfer hydrogenation of
compound 233a. The best result was obtained using compound 232 with [Ru(p-
cymene)Cl2]2 at 40 oC in 4 h with 95% yield and 97% ee (Table 18).225 Asymmetric
transfer hydrogenation of different sulfinylimines 233b-d was carried out under
optimised conditions using compound 232 with [Ru(p-cymene)Cl2]2 to give products
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of high optical purities in the range of 96-98% ee by diastereoselective reduction
(Scheme 28). The sulfinyl group can easily be removed under mild acidic condition
to give enantiomerically pure amine products.225
Scheme 28: Asymmetric transfer hydrogenation of sulfinylimines.
Table 18: Asymmetric transfer hydrogenation of sulfinylimines.
Compd Temp Time % Conv % ee
233a 50 oC 2 h 97 97
233b 50 oC 2 h 98 98
233c 50 oC 3 h 94 96
233d 50 oC 2.5 h 95 97
ent-233a 50 oC 2 h 96 98
1.4.7.9 Quinolines
The first report on asymmetric transfer hydrogenation of quinolines was by Xiao in
2010.226 1,2,3,4-Tetrahydroisoquinoline is an important structural unit present in
alkaloids, with applications in the drug and agrochemical industries. Compound 235
was identified as a promising catalyst for asymmetric transfer hydrogenation of 2-
methyl quinoline using HCOONa/ buffer pH 5 at 40 oC to give high conversion
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(96%) and high enantioselectivity of 97% ee (Scheme 29).226 Compound 235 was
employed for asymmetric transfer hydrogenation of differently substituted quinolines
236 under similar conditions to give tetrahydroquinolines 237 in high yields (87-
97%) and with high enantioselectivities (86-97% ee).226
Scheme 29: Asymmetric transfer hydrogenation of quinolines.
Recently the Wills group has also reported the asymmetric transfer hydrogenation of
quinolines using FA:TEA as hydrogen sources using Ru and Rh complexes.227
Compound 171 gave comparable conversion and high enantioselectivity for a range
of substituted quinolines using FA:TEA at 28 oC in 24 h (Scheme 30).227
Scheme 30: Asymmetric transfer hydrogenation of quinolines.
1.4.7.10 Aziridines
Andersson et al. reported the enantioselective transfer hydrogenation of azirines 238
to chiral aziridines 239 with [RuCl2(p-cymene)]2 using IPA/KOH.228 Asymmetric
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transfer hydrogenation of several azirine derivatives 238 was achieved in 2-20 min
with good yields of 72-92% and enantioselectivities of 0-72% ee using chiral ligand
135 in combination with [Ru(p-cymene)Cl2]2 (Scheme 31).228
Scheme 31: Asymmetric transfer hydrogenation of azirines.
1.4.8 Greener approaches to asymmetric transfer hydrogenation
To develop water soluble chiral ligands has considerable significance, as it enables
their metal complexes to catalyse asymmetric transfer hydrogenation in water.
Williams et al. have reported water soluble analogues 240-243, which are similar to
successful chiral ligands TsDPEN 64 and TsCYDN 148, with an additional
sulphonic acid group (Figure 40).229-230
These water-soluble ligands 240-243 were used for asymmetric transfer
hydrogenation of aromatic ketones with [Ru(p-cymene)Cl2]2 using IPA as the
hydrogen source. Compound 240 with a sulfonic acid group on the para position,
gave 96% conversion with an enantioselectivity of 94% ee for reduction of
acetophenone with [Ru(p-cymene)Cl2]2 (Table 19).229 Similar substitution in
TsCYDN, compound 241 gave a good conversion for acetophenone reduction but
only 88% ee with [Ru(p-cymene)Cl2]2. Compound 242 with a sulfonic group at the
ortho position, showed total loss in activity with only 11% conversion over period of
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48 h for transfer hydrogenation of acetophenone with [Ru(p-cymene)Cl2]2 (Table
19).229
Figure 40: Water soluble chiral ligands.
Table 19: Asymmetric transfer hydrogenation of acetophenone 112 using water
soluble chiral ligands 240-243 with [Ru(p-cymene)Cl2]2.
Ligands Hydrogen source S/C Solvent Temp Time % Yield % ee
240 IPA/KOtBu 100 H2O 22 oC 48h 96 94(S)
241 IPA/KOtBu 100 H2O 22 oC 48 h 91 88(R)
242 IPA/KOtBu 100 H2O 22 oC 48 h 11 91(S)
243 HCOONa 100
H2O/
PTC
40 oC 24 h >99 95(R)
Another water-soluble chiral ligand 243 has been reported by Deng (Figure 40).230
Compound 243 is found to be highly water soluble due to the presence of two
sulfonate groups. It exhibited good activity and excellent enantioselectivity for
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asymmetric transfer hydrogenation of ketones with [Ru(p-cymene)Cl2]2 in the
presence of the phase transfer catalyst SDS (sodium dodecyl sulphate).230 Compound
243 gave almost complete conversion and 95% ee for transfer hydrogenation of
acetophenone with [Ru(p-cymene)Cl2]2 at 40 oC in 24 h using sodium formate as the
hydrogen source under reaction conditions. Compound 243 has been recycled two
times without any loss of enantioselectivity (Table 19).230
Asymmetric transfer hydrogenation using chiral-metal complexes is now a well
developed field. It has now been used on an industrial scale for the synthesis of
biologically active compounds. However, the process is required to be economical,
on large scale synthesis. Use of transition metal makes the process quite expensive
due to price of chiral ligands and metal. Due to this, it is desirable to make
asymmetric transfer hydrogenation a heterogeneous reaction, which will allow the
catalyst to be recovered and it can then be recycled. Immobilisation of catalysts can
be achieved by preparing solid supported chiral ligands. Xiao et al. have reported
water-soluble polyethylene glycol-supported TsDPEN (PTsDPEN) 244 (Figure
41).186,231
Figure 41: Supported chiral ligands.
For initial investigations, PTsDPEN compound 244 was used for asymmetric
transfer hydrogenation of ketones in combination with [Ru(p-cymene)Cl2]2 in
FA:TEA. It has shown good activity and enantioselectivity, but to recycle the
catalyst use of green solvent is required such as water. Compound 244 gave very
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high (99%) conversion and good enantioselectivity (92% ee) for transfer
hydrogenation of acetophenone using [Ru(p-cymene)Cl2]2 in H2O with sodium
formate as the source of hydrogen at 40 oC (Table 20). 186,231 This PTsDPEN catalyst
with [Ru(p-cymene)Cl2]2 can be reused in the reduction of acetophenone in water,
just by extracting the product with diethyl ether along with addition of fresh
acetophenone and 1 equivalent of formic acid. Moreover, there was no deterioration
in enantioselectivity after more than 10 cycles. 186,231
Table 20: Asymmetric transfer hydrogenation of acetophenone 112 using supported
chiral ligands 244-245 with [Ru(p-cymene)Cl2]2.
Ligands Hydrogensource S/C Solvent Temp Time % Yield % ee
244 FA:TEA 100 50 oC 20 h 95 94(R)
244 HCOONa 100 H2O 40 oC 1 h 99 92(R)
245a HCOONa 100 H2O 40 oC 9 h >99 91(R)
Another efficient supported ligand was reported by the Tu group.232 The silica gel-
supported TsDPEN ligand 245 has been found to be a very efficient catalyst in both
organic and aqueous solvents for asymmetric transfer hydrogenation of ketones with
[Ru(p-cymene)Cl2]2. Supported compounds 245a-245c were used for asymmetric
transfer hydrogenation of acetophenone using [Ru(p-cymene)Cl2]2 with sodium
formate in water (Figure 41, Table 20-21).232 Compound 245a was able to reduce
acetophenone in 9 h with 91% ee with [Ru(p-cymene)Cl2]2. This result was
improved by using the phase transfer catalyst, tetrabutylammonium bromide
Introduction
78
(TBAB). Compound 245a gave a much faster conversion (>99% in 2h) for
acetophenone with high enantioselectivity of 96% ee using [Ru(p-cymene)Cl2]2.
Moreover, this supported ligand 245a can be reused up to 6 times for hydrogenation
of acetophenone in combination with [Ru(p-cymene)Cl2]2 without loss in
enantioselectivity or yields (Table 21). At the same time, a ligand supported with
MCM-41 245b and SBA-15 245c, was found to be recyclable in up to 5 runs, but
reactions were much slower compared to 245a using [Ru(p-cymene)Cl2]2 (Table
21).232
Table 21: Recycling supported chiral ligands 245a-c with [Ru(p-cymene)Cl2]2 for
asymmetric transfer hydrogenation of acetophenone 112.
245a 245b 245c
Run Time %conv % ee Run Time
%
conv % ee Run Time
%
conv % ee
1-3 2 h >99 96 1-3 5 h >99 93 1-5 6-28h
>99-
99
94-
95
4-6 3.5-12 h
>99-
99 96 4-5
6-37
h
87-
89 93 6 90 h 92 95
7 60 h 66 96
Figure 42: Supported chiral ligands.
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Recently, Zhou and Ma have reported PEG supported TsCYDN 246 and used this
for asymmetric transfer hydrogenation of ketones with [Ru(p-cymene)Cl2]2 using
sodium formate in water (Figure 42).233 Compound 246 gave complete transfer
hydrogenation of acetophenone with [Ru(p-cymene)Cl2]2 at 40 oC in 6 h with 86.5%
ee (Table 22). Moreover, the catalyst can be easily separated from reaction mixture
and recycled up to four cycles with no change in enantioselectivity. But fourth
reaction cycle was found to be slower (Table 23).233
Table 22: Asymmetric transfer hydrogenation of acetophenone 112 using supported
chiral ligands 246-249 with [Ru(p-cymene)Cl2]2.
Ligands Hydrogen source S/C Solvent Temp Time % Yield % ee
246 HCOONa 100 H2O 40 oC 6 h 100 86.5(R)
247e HCOONa 100 H2O 40 oC 15 h >99 94(S)
248 HCOONa 100 H2O 40 oC 15 h >99 94(S)
249 HCOONa 100 H2O 40 oC 1 h 97.2 97.7(R)
Li et al. have reported a series of N-pegylated TsDPEN derivatives 247a-e, 248 as
chiral ligands for asymmetric transfer hydrogenation of ketones with [Ru(p-
cymene)Cl2]2 using sodium formate in water (Figure 42).234 All of them have shown
high activity with almost complete reduction of acetophenone with [Ru(p-
cymene)Cl2]2 in 15 h at 40 oC and ~ 94% ee (Table 22). Compound 247e was found
to be efficient in up to ten catalytic cycles without any deterioration in
enantioselectivity for reduction of acetophenone in combination with [Ru(p-
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cymene)Cl2]2 (Table 23). At the same time compound 248 was also found to be good
in up to six catalytic cycles with [Ru(p-cymene)Cl2]2 but after that the reaction
became much slower with just 1% drop in ee (Table 23).234
Table 23: Recycling of supported chiral ligands 246, 247e and 248 with [Ru(p-
cymene)Cl2]2 for Asymmetric transfer hydrogenation of acetophenone 112 using
HCOONa and water.
246 247e 248
Run Time %conv % ee Run Time
%
conv % ee Run Time
%
conv % ee
1 6 h 100 86.5 1-8 6 h >99 94 1-5 6 h >99 93.7
2 6 h 100 86.4 9 6 h 97 93.8 6 6 h 98 93
3 6 h 100 86.5 10 6 h 85 94 7 12 h 80 92.5
4 24 h 73.8 86.6
More recently, Liu and Li have reported a magnetically recovered SiO2-coated Fe3O4
nanoparticles attached to TsDPEN for asymmetric transfer hydrogenation of
aromatic ketones with Rh in water.235 For asymmetric transfer hydrogenation of
acetophenone, compound 249 gave 97.2% conversion with high enantioselectivity of
97.7% ee in 1 h reaction time with [RhCp*Cl2]2 at 40 oC using sodium formate and
PTC (TBAB) in water (Figure 42, Table 22). Moreover, the catalyst can be
recovered by using a small magnet and showed the same catalytic activity in up to
ten consecutive reactions with 91.9% conversion and 92.5% ee for reduction of
acetophenone.235 Silica supported TsCYDN ligands 251a-b has been reported by
Somnathan for asymmetric transfer hydrogenation of ketones using RhCp* complex
in water (Figure 43).236 The supported catalyst can be easily synthesised from
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compound 250 with reduction of the nitro group to an amine followed by reaction
with silica or resin.236
Figure 43: Supported chiral ligands.
First, compound 250 was employed for the reduction of acetophenone with
[RhCp*Cl2]2 to give almost complete conversion in 0.3 h with 93% ee. Immobilized
ligand 251a gave a good conversion (98%) and good enantioselectivity (84% ee), but
a deterioration in enantioselectivity was observed during reuse with [RhCp*Cl2]2
(Table 24). On other hand, compound 251b also gave a good conversion for
reduction of acetophenone with [RhCp*Cl2]2, but with very low (46% ee)
enantioselectivity (Table 24).236
Table 24: Asymmetric transfer hydrogenation of acetophenone 112 using supported
chiral ligands 250-251 with [RhCp*Cl2]2.
Ligands Hydrogen source S/C Temp Time % conv % ee
250 HCOONa/H2O 300 40 oC 0.3 h >99 93
251a HCOONa/H2O 100 40 oC -a 98 84
251b HCOONa/H2O 100 40 oC - a 93 46
a The reaction was monitored by TLC for complete conversion.
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Zhou et al. have reported chiral TsDPEN derivatives 252-253 with an imidazolium
group as the chiral ligand for asymmetric transfer hydrogenation with Ru using
FA:TEA in an ionic liquid [bmim][PF6] (Figure 44).237 Chiral ligand 252 gave
complete reduction of acetophenone with 97% ee at 40 oC in 8 h using [Ru(p-
cymene)Cl2]2. Unfortunately, during recycling of the catalysts, the reaction became
slower and slower for reduction of acetophenone, although without any major drop
in enantioselectivity. Compound 253 also showed similar activity for reduction of
acetophenone with [Ru(p-cymene)Cl2]2 but low enantioselectivity (84% ee) (Table
25).237
Figure 44: Chiral ligands with imidazolium group.
Table 25: Asymmetric transfer hydrogenation of acetophenone 112 using supported
chiral ligands 252-253 with [Ru(p-cymene)Cl2]2.
Ligands Run Hydrogensource S/C Solvent Temp Time % conv % ee
252 1 FA:TEA 100 [bmim][PF6] 40 oC 8 h 100 97(R)
2 22 h 100 96(R)
3 80 h 100 94(R)
253 FA:TEA 100 [bmim][PF6] 40 oC 8 h 100 86(R)
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1.4.9 Application to pharmaceutical targets
1.4.9.1 Synthetic studies towards MA-20565
Substituted acetophenone was reduced with high enantioselectivity using compound
153. Tanka et al. have reported the asymmetric transfer hydrogenation of 3-
trifluoromethylcetophenone 254 using compound 153 to the corresponding (S)-
alcohol 255 with 96% yield and 91% ee (Scheme 32).238 This (S)-3-
trifluoromethylphenyl ethanol 255 is a key intermediate for the synthesis of MA-
20565 256, a wide-spectrum agricultural fungicide.238
Scheme 32: Synthesis towards MA-20565.
1.4.9.2 Synthesis towards (S)-Fluoxetine
Scheme 33: Synthesis towards (S)-Fluoxetine.
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Ikariya has reported a practical synthesis of (S)-Fluoxetine 257 by using asymmetric
transfer hydrogenation.219 Compound 153 gave enantioselective reduction of 2-
cyanoacetophenone 209a using FA:TEA in 98% ee. The resulting alcohol product
210a was reduced using BH3/S(CH3)2 to give amino alcohol compound 211, an
important intermediate towards the synthesis of (S)-Fluoxetine 257 (Scheme 33).219
1.4.9.3 An intermediate for NK1 receptor antagonist compounds
Optically pure 3,5-bistrifluoromethylphenyl ethanol is one of the important parts of
NK-1 receptor antagonists. 3,5-Bistrifluoromethylphenyl ethanol 259 can be
synthesised with good optical purity (~91% ee) using different chiral ligands and
Ru/Rh complexes.239 On an industrial scale, commercially available (1S,2R)-cis-
aminoindanol 128 has been used with [Ru(p-cymene)Cl2]2 in IPA/KOH to give high
conversion (98%) and good enantioselectivity of 91% ee for reduction of compound
258 (Scheme 34). Interestingly, by using a modified method the optical purity of 259
can be improved to >99%; this requires cocrystallization of compound 259 with
DABCO (Scheme 34). 239
Scheme 34: An intermediate for NK1 receptor antagonist compounds.
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1.5 Summary
In asymmetric catalysis, organometallic catalysis is a well developed area and
organocatalysis has also given promising results. Small molecules derived from
enantiomerically pure natural products such as amino acids and alkaloids have
shown good activity for C-C, C-N and C-X bond formation reactions. Recently,
enantiomerically pure diamine ligands have also been found to be good as
asymmetric organocatalysts and L-proline in particular works well for a range of
asymmetric reactions. A range of novel chiral diamine derivatives can be employed
as asymmetric organocatalysts.
Chiral ligands and metal complexes developed for asymmetric transfer
hydrogenation of ketones and imines have been discussed. Mechanistic studies
carried out by various research groups suggest that there are different mechanisms
for asymmetric transfer hydrogenation of ketones and imines. Substituted chiral
complexes can be used to get more insight into this mechanistic difference between
ketone and imine reductions.
Asymmetric transfer hydrogenation using η
6-arene-Ru- complexes was found to be
highly efficient and selective for a range of substrates such as aryl alkyl ketones,
heterocyclic ketones and imines. The enantioselectivity of products such as alcohols
and amines is mostly due to chirality at the metal centre and a CH-π interaction
between η
6-arene-Ru and the aryl group of the substrate. Because of this substrates
without aryl groups are reduced with lower enantioselectivities. To understand these
enantioselectivities, a range of substrates need to be studied in asymmetric transfer
hydrogenation using η
6-arene-Ru- complexes.
Introduction
86
1.6 Aims and Objectives
Aim: Synthesis of novel chiral diamine ligands, ruthenium metal complexes and
investigation of their use as asymmetric catalysts.
Objectives: A series of chiral diamine ligands will be synthesised and employed as
asymmetric organocatalysts. The synthesized ligands will be studied for optimization
of reaction conditions and stereoselectivity for different asymmetric reactions such
as Michael addition, aldol condensation, Diels-Alder reaction, nucelophilic addition,
nucleophilic substitution.
Novel ruthenium metal complexes with N,N-dialkylated chiral ligands will be
synthesised to study the asymmetric transfer hydrogenation of ketones and imines to
understand the mechanism of reduction for both class of substrates. Ketones with
hindered group at the α-position will be synthesized and used for asymmetric
transfer hydrogenation using Ru-3C-tethered catalyst 181, which will give more
insight into the substrate scope of this transformation.
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2 Results and Discussion
2.1 Synthesis and applications of derivatives of 1,2-cyclohexanediamine as
asymmetric organocatalyst
As discussed in section 1.3.2, derivatives of 1,2-cyclohexanediamine and 1,2-
diphenyl-1,2-ethanediamine have been used as organocatalysts for asymmetric
reactions. During the investigation into the use of new ligands for asymmetric
transfer hydrogenation carried out by the Wills group, (1R,2R)-PODPEN 56 was
studied as an asymmetric organocatalyst for the Michael addition of ketones to trans-
β-nitrostyrene as discussed in section 1.3.2.1.76 For initial investigations, similar
derivatives of 1,2-cyclohexanediamine 260-264 (Figure 45) were selected to
synthesise and study as asymmetric organocatalysts.
Figure 45: Derivatives of 1,2-cyclohexanediamine.
Compound 260 was synthesised as outlined in Scheme 35 starting from the mono
Boc- protection of 1,2-cyclohexanediamine 265 followed by reaction with
diphenylphosphinic chloride to afford compound 267. Deprotection of the Boc-
group of 267 using TFA resulted in the formation of compound 260.
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Scheme 35: Synthesis of (1S,2S)-N-(diphenylphosphinyl)-1,2-diaminocyclohexane.
The Michael addition of acetone to trans-β-nitrostyrene 53 (Scheme 36) was
attempted with compound 260 taking toluene as the solvent. The reaction was
monitored by 1H-NMR at different time intervals. There was no increase in the
conversion above 27% from 72 h to 5 days (Table 26, Entry 1) by 1H-NMR. The
reaction solvent was changed to hexane and this was found to be better, giving an
increase in conversion to 57% after 27 h. Again no further increase was seen in
conversion after 5 days by 1H-NMR. The reaction was worked up at this stage and
the product was isolated in 79% ee (major enantiomer R) (Table 26, Entry 2). In
order to calculate the enantiomeric excess, compound 54 was reduced to its alcohol
derivative 268 using NaBH4 and the stable product was analysed by chiral HPLC.
These results suggest that catalytic activity of compound 260 may be inhibited
during the reaction; hence the reaction did not proceed to complete conversion
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Scheme 36: Michael addition of acetone to trans-β-nitrostyrene using compound
260.
Table 26: Michael addition of acetone to trans-β-nitrostyrene using compound 260.
Entry Catalyst Solvent Time %Conva %eeb
1
260
Toluene
72 h 27%
ND
5 days 27%
2
260
Hexane
27 h 57%
79% (R)
72 h 57%
5days 57%
a The % conversion are calculated on basis of 1H-NMR. b The enantiomeric excess is
calculated from chiral HPLC data for reduced product, major enantiomer R. ND Not
determined.
The bifunctional catalysts containing urea and thiourea groups have shown superior
catalytic activity for Michael addition reactions as discussed in section 1.3.2.1.
Compound 261 was selected for synthesis as having two 1,2-cyclohexanediamine
rings attached to the P(O)Ph group may give similar activity to bifunctional
catalysts. To synthesise compound 261, compound 266 was reacted with
phenylphosphonic dichloride to give compound 269. The Boc- deprotection of 269
using TFA was unsuccessful due to the decomposition of the product during the
work up. The Boc- deprotection of 269 was attempted with zinc dibromide, however
this resulted in the mono deprotection to compound 270 in poor yield (Scheme 37).
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Scheme 37: Attempted synthesis of (1S,2S)-phenylphosphonic bis(1-amino-2-
cyclohexylamide) 261.
In view of the problems encountered during the removal of the Boc- group and the
low stability of the product under acidic conditions, the use of a phthalimide
protecting group was investigated as described in Scheme 38. Compound 261 was
synthesised by mono protection of 1,2-cyclohexanediamine 265. The mono protected
compound 271 was reacted with phenylphosphonic dichloride to afford compound
272, however the deprotection of compound 272 using hydrazine hydrate resulted in
the formation of a product with low molecular weight with [M+H]+ = 283.0 peak in
ESI-MS instead of the required product 261.
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Scheme 38: Attempted synthesis of (1S,2S)-phenylphosphonic bis(1-amino-2-
cyclohexylamide) 261.
During the attempts made to synthesis compound 261, the deprotection step resulted
in decomposition of the product under both acidic and basic conditions. This may be
due to the presence of the basic amino group or instability of the -(NH)2P=O group.
To overcome this problem with the deprotection step during synthesis, the
compound containing a dimethylamino group instead of a free amine was selected
for the synthesis.
Compound 262 was synthesised by the route outlined in the Scheme 39 starting from
the mono phthalimide protected compound 271 followed by dimethylation to give
273. Compound 273 was deprotected using hydrazine to give amine derivative 274,
which was further reacted with diphenylphosphinic chloride to give compound 262.
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Scheme 39: Synthesis of (1S,2S)-N,N-dimethyl-N’-(diphenylphosphinyl)-1,2-
diaminocyclohexane 262.
In contrast, the reaction of 274 with phenylphosphonic dichloride resulted in the
formation of compound 275 instead of the required product 263 (Scheme 40). The
31P-NMR spectrum of compound 275 exhibited two phosphorus peaks and HRMS
showed a high molecular weight, whilst the 1H-NMR was quite complex. On the
basis of the data obtained, compound 275 may be assigned the structure shown in the
Scheme 40.
Scheme 40: Attempted synthesis of (1S,2S)-phenylphosphonic bis(N,N-dimethyl-
cyclohexyl-2-amide) 263.
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Compound 264 was selected to compare the tosyl group with the Ph2P(O)group of
compound 262. Compound 264 was synthesised from the tosyl derivatives 148 by
dimethylation as outlined in Scheme 41.
Scheme 41: Synthesis of (1R,2R)-N,N-Dimethyl-N’-tosyl-1,2-diaminocyclohexane
264.
Compounds 260, 262 and 264 were selected as catalysts for the Michael addition of
1,3-dicarbonyl derivatives to trans-β-nitrostyrene (Scheme 42). The reaction
conversion was determined by monitoring with 1H-NMR at different time intervals.
The reactions gave very low conversions for the addition reaction with all three
compounds 260, 262 and 264 (Table 27, Entries 1-3). Due to the low conversions,
the enantiomeric excess was not determined for these reactions.
Scheme 42: Michael addition of dimethyl malonate to trans-β-nitrostyrene using
compounds 260, 262 and 264.
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Table 27: Michael addition of dimethyl malonate to trans-β-nitrostyrene using
compounds 260, 262 and 264.
Entry Catalyst Time %Conva %eeb
1
260
72h 27% ND
2
262
41h 16% ND
3 264 7 days 15% ND
a The % conversion are calculated on basis of 1H-NMR. b ND Not determined.
The Aldol reactions of aromatic aldehydes with appropriate ketones were attempted
under different conditions using compounds 260, 262 and 264; however none
showed any catalytic activity. Different metal salts were carried out with these
compounds to examine their combined effect on the aldol reaction. As shown in
Scheme 47, the reactions were tried using a combination of compounds 260, 262 and
264 with various metal salts. The reactions were monitored by TLC and 1H-NMR for
2-4 days. The reaction mixtures were purified and analysed by chiral HPLC after
significant conversion, but none of the reactions were found to be selective for the
aldol reaction (Table 28). This showed that there is little or no interaction between
compounds 260, 262 and 264 and the metal salts used for this aldol reaction.
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Scheme 43: Aldol reaction using compounds 260, 262 and 264.
Table 28: Aldol reaction using different compounds 260, 262 and 264 and the metal
complexes.
Entry Catalyst Ketone Metal salt Time %Conva %eeb
1
260
Acetone 5 days NC
2
262
Acetone Zn(OTf)2 20h 95% 0%
Cyclohexanone Zn(OTf)2 5 days NC
Acetone Sc(OTf)2 5 days 95% 0%
3
264
Acetone Zn(OTf)2 5 days NC
Cyclohexanone Zn(OTf)2 5 days NC
Acetone Sc(OTf)2 5 days 90% 0%
a The % conversion are calculated on basis of 1H-NMR. b The enantiomeric excess is
calculated from chiral HPLC data. NC No Conversion on basis of 1H-NMR.
Scheme 44: Henry reaction using compounds 260, 262 and 264.
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Table 29: Henry reaction of aromatic aldehyde with nitromethane using compounds
260, 262, 264 and the metal complexes.
Entry Catalyst Metal salt Time %Conv. %eea
1
260
None 22h 100% 0%
Cu(OAc)2 27h 100% 0%
2
262
CuCl 4 days 100% 2.5%
3
264
CuCl 4 days 100% 27%
Cu(OAc)2 27h 50% 6%
Cu(OTf)2 4days 87% 12%
Zn(OTf)2 21h 100% 0%
Sc(OTf)2 29h 90% 0%
a The enantiomeric excess is calculated from chiral HPLC data, major enantiomer R .
The Henry reaction was carried out using compounds 260, 262 and 264 with
different metal salts (Scheme 44). For the Henry reaction, the conversion was quite
good using compound 260 and Cu(OAc)2, however no selectivity was observed. The
reaction using compound 264 with CuCl showed some interaction between the
ligand and metal. However, the reaction was very slow (100% conversion in 4 days)
and exhibited low selectivity (27% ee) (Table 29, Entry 3).
Compounds 260, 262 and 264 were used as asymmetric organocatalysts for different
reactions such as the Michael addition, aldol and Henry reactions; however none of
the compounds showed good efficiency or selectivity. Derivatives of 1,2-
diphenylethanediamine were selected to investigate as asymmetric organocatalysts
for different asymmetric reactions.
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2.2 Synthesis and application of derivatives of 1,2-diphenylethanediamine as
asymmetric organocatalysts
In the literature, a number of ligands for asymmetric transfer hydrogenation catalysts
contain 1,2-diphenylethanediamine as a back-bone as discussed in sections 1.4.3 and
1.4.6. In the Wills group, ligands with 1,2-diphenylethanediamine and N-tosyl-1,2-
diphenylethanediamine have been developed for asymmetric transfer hydrogenation
as discussed in section 1.4.6.
Scheme 45: Isolation of stable cyclic aminal derivative 249.
During the course of studies on the functionalisation of TsDPEN 64 via reductive
alkylation,195,208 its reaction with α-trialkylsilyloxy-substituted aldehyde 276 resulted
in the formation of a stable aminal 278 instead of the required compound 277
(Scheme 45). This was not reduced in situ under conditions which have typically
been previously used for reductive alkylation, e.g. NaBH3CN, MeOH.206,208 Aminal
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278 could be reduced to the required product 279 (the TBDPS group was also
removed in this process) using LiAlH4. It was found to be quite stable and could be
readily purified by flash chromatography without hydrolysis.
Interestingly, compound 278 was formed significantly as a single diastereoisomer in
high yield upon acid-catalysed reaction of 64 with 276 (Scheme 45). The X-ray
crystallographic analysis of a purified sample of 278 revealed the relative
stereochemistry and the TBDPS group was found to be trans to the phenyl adjacent
to the basic amine (Scheme 45).
A similar reaction with TsCYDN, compound 148 resulted in the formation of imine
280 instead of cyclic aminal 281. This may possibly be due to a high level of strain
in the bicyclic product 281 (Scheme 46).
Scheme 46: Attempted synthesis of cyclic aminal 251.
The structure of compound 278 can be easily compared with the well known
MacMillan organocatalysts 50 (Imdiazolidinone catalysts) (Figure 46). MacMillan
organocatalysts have been used as asymmetric organocatalysts for different
asymmetric reactions such as the Diels-Alder reaction, the aldol reaction, and the α-
functionalization of carbonyl compounds as discussed in sections 1.3.1, 1.3.2.4 and
1.3.2.5 of this thesis.51-59
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Figure 46: Structural similarities between MacMillan organocatalyst and compound
278.
Due to the close structural similarity of compound 278 with 50, other derivatives
282-285 were selected for synthesis and to study as asymmetric organocatalysts
(Figure 47).
Figure 47: Derivatives of 1,2-diphenylethanediamine 278 and 282-285.
2.2.1 Synthesis of derivatives of 1,2-diphenylethanediamine
Compound 278 was synthesised following the route outlined in Scheme 47, starting
from mono TBDPS- protection of ethylene glycol 286 to give 287 followed by
Swern oxidation to give aldehyde 276. On reaction of aldehyde 276 with TsDPEN in
methanol, compound 278 separated out as a white solid. Compound 278 was isolated
as a single diastereoisomer by 1H-NMR. The deprotection of compound 278 was
carried out using TBAF to give hydroxy derivative 282.
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Scheme 47: Synthesis of (4R,5R)-2-[(t-butyldiphenylsilyloxy)methyl]-4,5-diphenyl-
1-tosylimidazolidine and (4R,5R)-4,5-diphenyl-1-tosylimidazolidine-2-methanol.
Scheme 48: Synthesis of (4R,5R)-2-[(benzyloxy)methyl]-4,5-diphenyl-1-
tosylimidazolidine 283.
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Similarly, compound 283 was synthesised as outlined in Scheme 48, wherein a
different protecting group was used. Aldehyde 289 was synthesised by the mono
benzylation of ethylene glycol 286 to form compound 288 followed by Swern
oxidation. When aldehyde 289 was reacted with TsDPEN no solid precipitated out.
The reaction mixture was purified by column chromatography to isolate compound
283 as a single diastereoisomer (relative configuration assigned by analogy with
compound 278). Compound 284 was synthesised by reaction of phenyl acetaldehyde
290 with TsDPEN as outlined in Scheme 49. Compound 284 was found to be less
stable during purification compared to compounds 278 and 283.
Scheme 49: Synthesis of (4R,5R)-2-benzyl-4,5-diphenyl-1-tosylimidazolidine.
Similarly, the synthesis of compound 285 was attempted by reaction of phenyl
acetaldehyde 291 and TsDPEN (Scheme 50). However, both starting materials were
recovered during the isolation due to the low stability of compound 285.
Scheme 50: Attempted synthesis of (4R,5R)-2-benzyl-4,5-diphenyl-1-
tosylimidazolidine.
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2.2.2 Application of derivatives of 1,2-diphenylethanediamine as asymmetric
organocatalysts
MacMillan organocatalysts are highly efficient and selective for the Diels-Alder
reaction as discussed in section 1.3.2.4.51 Due to the structural similarity of
compounds 278, 282-284 with compound 50, the Diels-Alder reaction was selected
for initial investigation. The Diels-Alder reaction (Scheme 51) between 1,3-
cyclohexadiene and acrolein was carried out using TsDPEN and compounds 278 and
282-284.
Scheme 51: Diels-Alder reaction using compounds 278, 282-284.
For the test reaction between 1,3-cyclohexadiene and acrolein in acetonitrile:water
(95:5), compound 278 gave a conversion in 22.5 h, without any selectivity. To cross
check the stability of compound 278, the same reaction was carried out using
TsDPEN 64, however there was no conversion. Since the imidazolidinone catalyst
50 is used as a salt, the reaction was carried out using the hydrochloride salt of
TsDPEN 64. The reaction using the hydrochloride salt of TsDPEN 64 gave complete
conversion in 23.5 h with 27% ee and endo:exo 7:1 (calculated by 1H-NMR) (Table
30, Entry 2). Under the similar set of reaction conditions, the hydrochloride salt of
compound 278 gave complete conversion in 24 h and predominantly the endo
cycloaddition product with an improved enantioselectivity of 72% ee for the endo
product (Table 30, Entry 3). The cycloaddition reaction using the hydroxyl analogue,
Results and Discussion
103
compound 282.HCl was completed in 18.5 h with exclusive endo product with a low
enantioselectivity of only 44% ee (Table 30, Entry 4). The benzyloxy analogue
compound 283.HCl also exhibited similar catalytic activity with a product of 45% ee
(Table 30, Entry 5).
Table 30: Diels-Alder reaction of 1,3-cyclohexadiene and acrolein using compounds
278, 282-284.
Entry Catalyst Time Yielda %eeb endo:exo
1
278
22.5h 23.5% 0% ND
2
64
22.5h 30% 27% (S) 7:1
3
278
24h 41%c 72% (S) 12:1
4
282
18.5h 36% 44% (S) 12:1
5
283
17.5h 35% 45% (S) 10:1
6
284
17.5h 35% 28% (S) 5:1
a The % yields are calculated on basis of isolated product, b The enantiomeric excess
was calculated from chiral GC data, an excess of endo isomer was formed of major
enantiomer S configuration. c 87% conversion by 1H-NMR
On the other hand, the benzyl analogue compound 284.HCl gave a product with an
ee similar to that obtained with TsDPEN 64.HCl and could not be recovered after the
reaction (Table 29, Entry 6). Thus, compound 284.HCl appeared to have hydrolysed
back to the starting materials under the reaction conditions. This is most likely to be
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due to its low stability as observed during the synthesis. At the same time, all of the
silyloxy, hydroxy and alkoxy derivatives 278, 282 and 283 respectively could be
isolated back from the reaction and reused.
This difference in the stability of compounds 278, 282-283 and 284 may be a result
of the electron-withdrawing effect of the alkoxy and silyloxy groups. In order to
confirm the stability of compound 278 under the reaction conditions, it was reacted
with excess of acrolein and then analysed by 1H-NMR. There was no change in the
1H-NMR spectrum of the starting compound 278, thus the cyclic aminal in
compound 278 appears to be stable under the reaction conditions. Compound 278
gave complete conversion to product under optimised conditions by 1H-NMR.
However, due to the low boiling point of the resulting products, the yields were quite
low.
Figure 48: Diels-Alder reaction of 1,3-cyclohexadiene and acrolein using compound
278.
To identify the configuration of the aldehyde product 293a, the product (with 72%
ee) obtained using compound 278.HCl was reduced to the alcohol and the optical
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rotation was compared with known literature values.240 The alcohol was found to be
present in the S configuration based on the optical rotation data, which also confirms
the S configuration of the starting aldehyde 293a. Thus, the addition reaction may
take place from the less hindered side of the E-iminium cation transition state as
shown in Figure 48.118
Compound 278 was used as a catalyst for the Michael addition of ketones to trans-β-
nitrostyrene; the addition of dimethyl malonate to trans-β-nitrostyrene; and an aldol
reaction. In each case however, no conversion was seen over. During the
investigation of the catalytic activity of compound 278, it exhibited high selectivity
for the addition of aldehyde to DEAD. Compounds 278, 282-284 and TsDPEN 64
were used as catalysts for the addition of aldehyde to DEAD in dichloromethane at
room temperature (Scheme 52, Table 31). The resulting addition product 108a may
undergo a reversible reaction or be deprotonated at the α-position, resulting in
decreased enantioselectivity. In order to overcome this problem, the addition product
108a was reduced to its alcohol and then cyclised to form the stable oxazolidinone
109a under basic conditions. This compound 109a was used for chiral HPLC or GC
to calculate the enantioselectivity.
Scheme 52: Nucleophilic addition of propionaldehyde to DEAD using compounds
278, 282-284 and TsDPEN 64.
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Table 31: Addition of propionaldehyde to DEAD using compounds 64, 278, and
282-283.
Entry Catalyst R Timea % Yieldb %eec
1 64 Me 47 h 42% 33%(R)
2 278 Me 14 h 55% 95% (R)
3
278
Me 3 days NC
4 282 Me 5 days NC
5
283
Me 32h 46% 62% (R)
a The time is for completion for first addition step, b The % yields are calculated on
basis of isolated product, NC = No conversion, c The enantiomeric excess is
calculated from chiral GC data, major enantiomer R.
Compound 278 was selected for optimisation of the reaction conditions for the
addition of aldehyde to DEAD due to the high selectivity shown in the initial study
(Table 31). The reaction was carried out in different solvents such as
dichloromethane, acetonitrile, toluene, hexane, ethyl acetate, dioxane,
dichloroethane, but none of them gave faster conversion. The reaction without any
solvent was found to be fast with the same selectivity using compound 278.
The addition reaction of propionaldehyde to DEAD was selected for earlier studies,
but during the optimisation studies the reaction was found to be quite fast and
difficult to monitor by 1H-NMR. However, the reaction using isovaleraldehyde was
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found to be suitable to monitor by 1H-NMR and due to this reason isovaleraldehyde
was selected for the optimisation of reaction conditions using compound 278.
Figure 49: Addition of isovaleraldehyde to DEAD using compound 278.
Conditions: compound 278 = 10 mol%, without acid or Acid = 10 mol%, aldehyde
= 0.861 mmol, DEAD = 0.574, 20 oC. Followed by 1H-NMR.
The addition of a catalytic amount of a range of acids with compound 278 was
investigated for the addition of isovaleraldehyde to DEAD. The various effects on
the rate of reaction are shown in Figure 49. Under the reaction conditions 10 mol%
of compound 278 and 10 mol% of acid were used and conversion was calculated by
taking 1H-NMR at different time intervals. The acids used included acetic acid,
benzoic acid, 4-nitro benzoic acid and all showed significant conversion with similar
selectivity. While the reaction using trifluoroacetic acid was quite fast compared to
the others, there was a drop in the enantioselectivity (Figure 50). The reaction with
acetic acid was found to be good for both efficiency and selectivity.
0
10
20
30
40
50
60
70
80
90
100
0 2 4 6 8
%
Co
nv
er
si
on
Time in h
A (CH3COOH)
B (CF3 COOH)
C (C6H5COOH)
D (4-NO2-
C6H4COOH)
Figure 50: Addition of isovaleraldehyde to DEAD using compound
Conditions: compound
DEAD = 0.574, 20
Figure 51: Addition of isovaleraldehyde to DEAD using compound
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0.861 mmol, DEAD = 0.574, 20
mol% catalyst loading side reaction of DEAD was observed.
The catalyst loading was optimised using 2, 5 and 10 mol% of compound
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51). With a 2 mol% catalyst loading, decomposition of DEAD was observed, while a
5 mol% loading was found to be quite slow compared to 10 mol%. Thus, 10 mol%
loading of compound 278 was required for the optimal rate of reaction.
The reactions were carried out without any acid and with 5, 10, 15, 20 mol% acetic
acid to see the effect of acid in the catalytic activity of compound 278 for the
addition reaction, (Figure 52). Under the reaction conditions, it was found that the
reaction was much slower without acetic acid and that 10 mol% of acetic acid is
optimal for a faster rate of reaction. Using 15 and 20 mol% of acetic acid gave
similar conversions to those achieved using 10 mol% of acetic acid and so offers no
improvement or benefits to the reaction.
Figure 52: Addition of isovaleraldehyde to DEAD using compound 278.
Conditions: compound 278 = 10 mol%, Acid = 5, 10, 15 and 20 mol%, aldehyde =
0.861 mmol, DEAD = 0.574, 20 oC.
The addition reaction of isovaleraldehyde to DEAD using 10 mol% of compound
278 and 10 mol% of acetic acid was carried out at three different temperatures; 0-5
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enantioselectivity (97% ee). At 4
addition for the first step in 2.5 h, with the drop in ee to 93.4% compared to 97 %
(Figure 53).
Figure 53: Addition of isovaleraldehyde to DEAD using compound
Conditions: compound
DEAD = 0.574, Temp = 0
For addition of the aldehyde to DEAD, the optimised conditions were found to be
neat conditions, 10 mol% of catalyst and 10 mol% of acetic acid loading, at room
temperature. Under the optimised conditions compounds
catalysts for the addition of propionaldehyde to DEAD (Scheme 53, Table 32).
91
92
93
94
95
96
97
98
%
ee
Results and Discussion
oC. The reaction was found to be much slower at 0
0 oC the reaction was much faster to give complete
278 = 10 mol%, Acid = 10 mol%, aldehyde = 0.861 mmol,
-5 oC, 22-23 oC and 40 o
282-283
A (0-5) B (22-23) C (40)
Temperature in oC
Effect of Temp on % ee
A (0-5)
B (22
C (40)
110
-5 oC with
-23 oC
278.
C.
were again used as
-23)
Results and Discussion
111
Scheme 53: Nucleophilic addition of propionaldehyde to DEAD using compounds
64, 278, 282-284.
Table 32: Addition of propionaldehyde to DEAD using different using compounds
64, 278, 282-284.
Entry Catalyst R Timea % Yieldb %eec
1
64
Me 50 min 66% 49%
2
278
Me 110 min 55% 95% (R)
3
282
Me 31h 37% 61% (R)
4
283
Me 50 min 66% 90% (R)
5
284
Me 115 min Crude 84%(R)
a The time is for completion for first addition step, b The % yields are calculated on
basis of isolated product, c The enantiomeric excess is calculated from chiral GC
data, major enantiomer R
The addition reaction using TsDPEN 64 was quite fast with a low selectivity under
the optimised conditions (Table 32, Entry 1). The reaction using compound 278 was
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completed in 110 min with high enantioselectivity of 95% ee (Table 32, Entry 2).
The hydroxyl analogue 282 exhibited catalytic reactivity under optimised conditions
with moderate selectivity (Table 32, Entry 3). Compounds 283 and 284 have also
showed high reactivity and good enantioselectivity; 90% and 84% ee respectively
(Table 32, Entries 4 & 5).
The formation of the product of R configuration using catalyst 278 suggests a
reaction via an E-enamine transition state. The high enantioselectivity for the R
enantiomer may be due to the addition taking place from the less hindered site as
shown in Figure 54.118
.
Figure 54: Addition of DEAD to aldehyde using compound 278.
Finally, the repeat additions of substrate (both with and without extra acid) were
examined and this revealed that catalyst 278 continued to catalyse the addition with
high enantioselectivity, although the reaction time increased with each addition
(Figures 55 & 56).
Figure 55: Effect of repeat addition of aldehyde, DEAD and acetic acid using
compound
Figure 56: Effect of repeat addition of aldehyde and DEAD using compound
The lower reactivity and high enantioselectivity, suggests that catalyst inhibition
may be taking place, rather than hydrolysis, since TsDP
product of much lower ee. Whilst 100% conversion of DEAD (limiting reagent) to
108a was observed by NMR, this product was not isolated because it was prone to
racemisation. Instead,
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oxazolidinone 109a in order to establish the ee. Since the reactions were followed by
taking samples at intervals, the isolated yields were not recorded for these reactions.
Table 33: Addition of different aldehydes to DEAD using catalyst 278.
Entry R Timea % Yieldb %eec
1 Me 110min 55% 95% (R)
2 Et 3h 65% 97% (R)
3 iPr 4.5h 60% 96% (R)
4 Benzyl 4h 38% 84% (R)
a The time is for completion for first addition step, b The % yields are calculated on
basis of isolated product, c The enantiomeric excess is calculated from chiral GC
data, major enantiomer R .
Scheme 54: Addition of carbonyl compounds to azodicarboxylate.
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The reaction was extended to alternative carbonyl substrates using compound 278
which gave mixed results. The addition of different aldehydes worked well, giving
products with high enantioselectivities except for phenylpropionaldehyde with 84%
ee (R enantiomer) (Table 33). The use of the DIAD 294a and DTAD 294b gave
products in good yields (Scheme 54). Enantiomeric excesses were not determined in
these cases. The addition reactions of acetone or formylcyclohexane to DEAD were
unsuccessful using compound 278 (Scheme 54) even after stirring the reaction
mixtures for 43-46 h.
In summary, the hydrochloride salt of compound 278 was found to be a good
organocatalyst for the Diels-Alder reaction between 1,3-cyclohexadiene and acrolein
with an enantioselectivity of 75% ee. The compound 278 was also shown good to
exhibit high efficacy and selectivity as organocatalyst for the addition reaction of
simple aldehydes to DEAD in the presence of catalytic amounts of acetic acid. The
addition reaction of aldehyde to DEAD was found to be much faster using 10 mol%
of compound 278 and same amount of acetic acid compared to the reaction without
any acid. Thus, added acetic acid helps in formation of enamine intermediate
between the compound 278 and aldehyde followed by providing proton during the
addition of DEAD to the enamine. However, compound 278 was found to be less
suitable for addition reaction of hindered aldehydes and ketones to DEAD.
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2.3 Chiral Ru complexes for asymmetric transfer hydrogenation of ketones
and imines
Compound 153 has shown high efficacy and selectivity for reduction of different
aryl alkyl ketones and imines under asymmetric transfer hydrogenation conditions as
discussed in section 1.4.7. The mechanism of asymmetric transfer hydrogenation of
ketones is well established using compound 153 as discussed in section 1.4.4. The
intermediates formed during catalytic cycles are 16 electron species 154 and
ruthenium hydride 155 (Section 1.4.4., Figure 26). The hydride derivative 155 is the
one of the intermediate in the transfer of hydrogen to the substrate.176 An unexpected
finding is that use of the same chiral complex for ketone and imine reduction
resulted in different product enantiomers (Section 1.4.4., Figure 32).173,188 To obtain
more insight into the reaction, a number of research groups have carried out
mechanistic studies using different hydrogen sources,189 reduction using an Ru-H
intermediate 155 with different acid190 and molecular modelling as discussed in
section 1.4.4. The outcome of all the studies indicates that ketone reduction is likely
to involve a cyclic transition state via a concerted mechanism, whereas imine
reduction appears to involve an ionic pathway.177,180,189-190 In order to eliminate the
possibility of involvement of an N-H bond in the reduction transition state, TsDPEN
derivatives with two alkyl substituents on the basic nitrogen are required (Figure 57).
Compound 299 can give a possible insight into the hydrogenation of ketones and
imines because it will not be able to reduce the ketone group of the acetophenone
due to lack of the -NH interaction required for six membered cyclic transition states.
In contrast, it would be predicted that imine reduction will not be affected that much
using compound 299 under similar conditions (as discussed in section 1.4.4).
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Figure 57: Proposed inhibition for ketone reduction using N,N-dimethyl-
TsDPEN Ru catalyst.
2.3.1 Asymmetric transfer hydrogenation of ketones and imines using N,N-
dimethyl-TsDPEN Ru catalyst
Complex 299 was synthesised as outlined in Scheme 55, starting from dimethyl
TsDPEN 300, itself prepared from TsDPEN 64. The reductive amination was
followed by complexation with benzene ruthenium(II)dichloride dimer. A similar
compound formation was attempted using p-cymene ruthenium(II)dichloride dimer
to afford compound 301. Compound 301 was isolated and analysed by 1H-NMR
(shown in Figure 58) during the first attempt of the synthesis on a small scale (125
mg). A similar attempt on larger scale (325 mg) failed to give the required
compound 301 in a pure form. These results suggest that for stability of compound
299 an unsubstituted arene ring is favoured.182
The crystal structure of the (S,S)-TsDPEN-Ru catalyst 153 showed the R
configuration at Ru with δ-configurated five membered ring176 and the crystal
structure of (R,R) complex 193d showed the S configuration at Ru.191 In contrast
the crystal structure of (R,R) compound 299 showed the R configuration at Ru
with a change of angle of the oxygens of sulfonyl group, possibly due to the
steric demand of the -NMe2 group.
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Scheme 55: Synthesis of N-[(1R,2R)-2-(dimethylamino)-1,2-diphenylethyl]-4-
methylbenzenesulfonamide benzeneruthenium chloride 299.
Figure 58: 1H-NMR spectra of compound 301
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The asymmetric transfer hydrogenation using compound 153 is well studied with the
formation of the amide compound 154 and the hydride compound 155 as discussed
in section 1.4.4. The -NH is group is not present in compound 299. Due to this
compound 299 may not be able to form the amide and the hydrido derivatives similar
to compound 153 under asymmetric transfer hydrogenation conditions. For similar
compounds with lack of -NH group, there are reports using pressure hydrogenation
and a silver salt to convert Ru-Cl to Ru-H.191-194 On the basis of these results,
compound 299 was used for pressure hydrogenation of ketone (acetophenone 112)
and imine 165 using different solvents and additives (Schemes 56 & 57, Tables 34 &
35) in the first attempt. As shown in Table 34, the level of acetophenone reduction
was quite low in IPA. To remove the chloride ion from the complex, AgSbF6 was
used as an additive with complex 299. However, reduction of acetophenone was
reduced with addition of AgSbF6. Addition of formic acid was attempted with
AgSbF6 for pressure hydrogenation.191,194 In these tests, formic acid showed little
promise in the solvents (Table 34, Entry 3). To compare the effect of AgSbF6, the
same reaction was attempted with only formic acid, which gave very low conversion
for acetophenone (Table 34, Entry 4).189-190
Scheme 56: Pressure hydrogenation of acetophenone using compound 299.
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Table 34: Pressure hydrogenation of acetophenone using compound 299.
Entry Additive a Solvent Time % Convb % eec
1 IPA 21h 18% 34% (S)
2 AgSbF6 IPA 21h 9% 48% (S)
3 FA (3 eq)/ AgSbF6 IPA 21h 29% 62% (R)
4 FA (3 eq) IPA 21h 9% 0%
a additive AgSbF6 = 4 mol%, b % conversion is calculated from chiral GC data, c The
enantiomeric excess is calculated from chiral GC. Reaction conditions: catalyst 299
(1 mol%), H2 gas = 30 bar, 30 oC, Time = 21 h.
At the same time, pressure hydrogenation of imine 165 was carried out using
complex 299 under the similar conditions as used for acetophenone reductions
(Scheme 57, Table 35). Reduction of imine 165 was quite low in IPA and even with
added AgSbF6 salt (Table 35, Entry 2).191,194 The use of 1 eq of formic acid gave low
conversion for the reduction of imine (Table 35, Entry 3). The use of excess formic
acid (3 eq) gave high conversion with and without AgSbF6 (Table 35, Entries 4-
5).189-190
Scheme 57: Pressure hydrogenation of Imine 165 using compound 299.
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Table 35: Pressure hydrogenation of Imine 165 using compound 299.
Entry Additive a Solvent Time % Convb % eec
1 IPA 21h 3% 2%
2 AgSbF6 IPA 21h 1.5% 2%
3 FA (1 eq)/ AgSbF6 IPA 42h 42% 8%
4 FA (3 eq)/ AgSbF6 IPA 21h 69% 2%
5 FA (3 eq) IPA 21h 76% 4%
a additive AgSbF6 = 4 mol%, FA:TEA = 2 eq, b % conversion is calculated from
chiral GC data, c The enantiomeric excess is calculated from chiral GC. Reaction
conditions: catalyst 299 (1 mol%), H2 gas = 30 bar, 30 oC, Time = 21-42 h.
The pressure hydrogenation reaction of imine 165 was promising using complex 299
using 3 eq of formic acid (Table 35, Entry 5). The reduction of acetophenone and
imine was also carried out using FA:TEA using complex 299 (Scheme 58). This
gave quite low conversion in FA:TEA and even with added AgSbF6 required up to 4
days (Table 36, Entries 1-2) for transfer hydrogenation of acetophenone.
Scheme 58: Asymmetric transfer hydrogenation of acetophenone using compound
299.
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Table 36: Asymmetric transfer hydrogenation of Imine 62 using FA:TEA (5:2)
compound 299.
Entry Substrate Solvent/Additivea Time % Convb % eec
1 112
21h 0.6% 0%
4days 1.1% 0%
2 112 AgSbF6 5 days 1.5% 17%
3 165
19h 36% 17% (S)
45h 71% 24% (S)
5 days 91% 18% (S)
4 165 CH3CN
22h 7% 4%
3 days 9% 0%
5 165 DCM
22h 8% 9% (S)
3 days 12% 11% (S)
6 165 DMF
22h 12% 0%
3 days 18% 15% (S)
7 165 MeOH
22h 6% 0%
3 days 32% 0%
8 165 IPA
22h 9% 11% (S)
69h 16% 10% (S)
9 165 EtOAc
22h 16% 5%
69h 30% 0%
a additive AgSbF6 = 4 mol%, b % conversion is calculated from chiral GC data, c The
enantiomeric excess is calculated from chiral GC. Reaction conditions: catalyst 299
(1 mol%), FA:TEA, 30 oC, Time = 19h – 5 days.
Results and Discussion
123
The transfer hydrogenation of acetophenone using compound 299 was very slow
under the different conditions used herein (Schemes 56 & 58, Tables 34 & 36).
These results can be compared to the initial predictions of low reactivity of
compound 299 for ketone reduction as shown in Figure 57. While for reduction of
imine 165, compound 299 gave 91 % conversion in 4 days using FA:TEA (Scheme
58, Table 36, Entry 3). In order to improve the rate of reduction for the imine,
different solvents were investigated for the transfer hydrogenation including CH3CN,
DCM, DMF, MeOH, IPA, EtOAc. None of the solvents gave an improvement in the
required conversion, indeed the reduction became slower in the presence of any of
the solvents used (Table 36, Entries 4-9). Compound 299 was reacted with FA:TEA
in CDCl3 in the NMR tube to detect the hydride formation by 1H-NMR. Compound
299 exhibited a hydride formation at δ -5.3 ppm, which was quite promising. The
slow catalytic reactivity of compound 299 for reduction of imine 165 may depend on
different factors such as stability of the complex, formation of the hydride, transfer
of the hydride to the substrate.
2.3.2 Asymmetric transfer hydrogenation of ketones and imines using N-
alkylated Ru-3C-tethered catalysts
Figure 59: N-alkylated analogues of Ru-3C-tethered complex 181.
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The next step was to form more stable and active complexes for imine reduction.
The Ru-3C-tethered catalyst 181 has exhibited high efficiency and selectivity for
transfer hydrogenation as discussed in section 1.4.6. N-Alkylated analogues of Ru-
3C-tethered catalysts 302 and 303 were selected to synthesise and study for transfer
hydrogenation (Figure 59).
Scheme 59: Synthesis of {N-[(1R,2R)-1,2-diphenylethyl-2-3-(3-
phenylpropyl)(methylamino)]-4-methylbenzenesulfonamide}ruthenium chloride
monomer (302).
Complex 303 was synthesised as outlined in Scheme 59.205 The reductive amination
of TsDPEN 64 with aldehyde 304 resulted in the formation of compound 179, which
was subjected to a second reductive amination with formaldehyde to give the N-
methyl derivative 305. Compound 305 was converted into a hydrochloride salt and
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reacted with ruthenium trichloride to give dimer 306, which was converted into
monomer 302 by using triethylamine in IPA. The crystal structure of (S,S)-Ru
catalyst 181 showed the R configuration at Ru205 whereas in contrast the crystal
structure of (R,R) compound 302 showed R configuration with a change of angel of
the oxygen of the sulfonyl group due to -NMe group, which is similar to the crystal
structure of compound 299. Similarly, complex 303 was synthesised as outlined in
Scheme 60. Compound 308 was synthesised by reductive amination of compound
179 with phenyl propionaldehyde 307. The hydrochloride salt of compound 308 was
then reacted with ruthenium trichloride to give the dimer 309, which was then
converted into the monomer 303 by using TEA in IPA.
Scheme 60: Synthesis of {N-[(1R,2R)-1,2-diphenylethyl-2-3-(3-phenylpropyl)(3-
phenylpropyl)amino]-4-methylbenzenesulfonamide}ruthenium chloride monomer
(303)
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Scheme 61: Asymmetric transfer hydrogenation of acetophenone using compounds
302, 306 and 303.
Table 37: Asymmetric transfer hydrogenation of acetophenone using FA:TEA (5:2)
compounds 302, 306 and 303.
a% conversion is calculated from chiral GC data, bThe enantiomeric excess is
calculated from chiral GC. Reaction conditions: catalyst 302/306/303 (1 mol%),
FA:TEA, 30 oC, Time = 18h – 8 days
Entry Catalyst Time % Conva % eeb
1 (S,S) tethered-NMe 302 18h 6% 73% (R)
2
(R,R) tethered-NMe dimer
306
45h 13% 74% (R)
2 days 18% 67% (S)
8 days 60% 67% (S)
3
(R,R) tethered-N(CH2)3Ph
303
24h 11% 70% (R)
4 days 17% 36% (R)
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Compounds 302, 306 (dimer) and 303 were used for asymmetric transfer
hydrogenation of acetophenone and imine 165 using FA:TEA (Scheme 61, Table
37). Compound 302 gave very low (6%) conversion for reduction of acetophenone
(Table 37, entry 1,). The reduction using dimer 306 was also quite slow with 18%
conversion after 2 days, the reaction was left running for a long time (up to 8 days)
to achieve 60% conversion (Table 37, Entry 2). Similarly, a low conversion was
obtained for the reduction of acetophenone using compound 303 (Table 37, Entry 3).
These results confirm the necessity of the -NH on the basic nitrogen atom for
reduction of a ketone group.
Similarly, asymmetric transfer hydrogenation of imine 165 was carried out using
compounds 302, 306 (dimer) and 303 (Scheme 62, Table 38). Compound 306
(dimer) gave high conversion (92%) in 20 h (Table 38, Entry 1). The monomer,
compound 302 also gave 91% conversion in 20 h for imine reduction (Table 38,
Entry 2), which was much faster compared to the reduction of acetophenone (7%
after 20 h). Compound 302 was studied using different solvents such as MeOH,
CH3CN, IPA to see the effect on imine reduction. But none of the solvents affected
the catalytic activity of compound 302 for reduction; all gave ~95% conversion over
a period of 20 h (Table 38, Entries 3-5). Thus, compound 302 was a stable and
effective catalyst for imine reduction.
Compound 303 gave a good conversion for imine reduction compared to complex
299, but not as good as with compound 302 (Table 38, Entry 6), which may be due
to the bulkier N-alkyl group. Compound 302 was analysed for hydride formation
using FA:TEA in CDCl3. Compound 302 has exhibited a Ru-H peak in NMR at δ -
5.4 ppm.
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Scheme 62: Asymmetric transfer hydrogenation of Imine 65 using compounds 302,
306 (dimer) and 303.
Table 38: Asymmetric transfer hydrogenation of Imine 165 using compounds 302,
306 (dimer) and 303.
Entry Catalyst Solvent Time % Conva % eeb
1 (R,R) tethered-NMe dimer 306 20h 92% 12% (S)
2 (S,S) tethered-NMe 302
16.5h 95% 27% (R)
20h 97% 24% (R)
3 (R,R) tethered-NMe 302 MeOH 20h 95% 8% (S)
4 (R,R) tethered-NMe 302 CH3CN 20h 95% 21% (S)
5 (R,R) tethered-NMe 302 IPA 20h 97% 14% (S)
6 (R,R) tethered-N(CH2)3Ph 303 24h 95% 7% (S)
a % conversion is calculated from chiral GC data, c The enantiomeric excess is
calculated from chiral GC. Reaction conditions: catalyst 302/306/303 (1 mol%),
FA:TEA, 30 oC, Time = 19h – 5 days
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A comparative study of compounds -NMe2 299, tethered-NMe 302 and tethered-N-
(CH2)3Ph 303 was carried out for asymmetric transfer hydrogenation of imine
(Figure 60). The independent reactions were monitored by chiral GC for the
conversion at different time intervals. Compound 302 gave quite good conversion for
imine reduction. Compound 303 was slower compared to compound 302 over the
reaction time. However, compound 299 was much slower compared to compounds
302 and 303 as observed earlier. Compounds 299, 302 and 303 were compared with
each other for the reduction of acetophenone and imine. But of more interest is how
they compare with their -NH analogues for reduction under similar conditions.
Figure 60: Asymmetric transfer hydrogenation of imine 165 using compounds 299,
302 and 303. Conditions: FA/TEA=5:2, [Imine]=0.5 M, 30 oC, S/C = 100. Followed
by chiral GC.
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2.3.3 Comparative studies for asymmetric transfer hydrogenation of ketones
and imines using NMR
From earlier studies in the Wills group, experimental data for the reduction of
ketones and imines was published for complexes 193 and 193a.195 Both compounds
193 and 193a gave high conversion and enantioselectivity for reduction of
acetophenone using FA:TEA (5:2). They gave high conversion and moderate
enantioselectivity for reduction of imine 136 using FA:TEA(5:2). Complex 299 can
be compared with compounds 193 and 193a by repeating the reduction of ketone and
imine under the similar conditions as published (Figure 61).195
Figure 61: Comparison of compounds 299 and 302 with literature compounds 193-
193a and 181 for asymmetric transfer hydrogenation of acetophenone 112 and imine
165.
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Similarly, compound 302 can be compared with Ru-3C-tethered catalyst 181, a
highly efficient and selective catalyst for the acetophenone reduction (Figure 61).205
The results obtained by this comparative study can be useful to explain the overall
effect of N-alkylated compounds 299 and 302 on the reduction of ketone and imines
compared to compounds 193, 193a and 181.
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Figure 62: Asymmetric transfer hydrogenation of acetophenone 112 using
compounds 193, 193a and 299. Conditions: FA/TEA=5:2, [Ketone]=0.86 M, 25 oC,
S/C = 100. Followed by 1H-NMR (400 MHz).
The data for ketone reductions with complexes 193 and 193a was compared with
complex 299 data for reduction of acetophenone using 400MHz NMR (Ozric) by
taking 1H-NMR at different time intervals. Complex 193a gave complete conversion
in less time than compound 193 for the transfer hydrogenation of acetophenone as
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shown in Figure 62. However, complex 299 was found to be much slower compared
to both compounds 193 and 193a for reduction of acetophenone under identical
reaction conditions. Complexes 181 and 302 were also compared for the reduction of
acetophenone under the similar conditions (Figure 63). Complex 181 was found to
be much faster compared to complex 302 for acetophenone reduction.
Figure 63: Asymmetric transfer hydrogenation of acetophenone 112 using
compounds 181 and 302. Conditions: FA/TEA=5:2, [Ketone]=0.86 M, 25 oC, S/C =
100. Followed by 1H-NMR (400 MHz).
These results show that the -NH group on the basic nitrogen atom is required for
ketone reduction. Compounds 299 and 302 which lack the -NH gave quite poor
conversion for the reduction of ketones. In the same way, data for imine reductions
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with complexes 193 and 193a were compared with complex 299 data for imine
reduction using 400MHz NMR (Ozric) by taking 1H-NMR spectra at different time
intervals. Complexes 193 and 193a were much faster compared to compound 299 for
reduction of imine under identical conditions (Figure 64).195
Figure 64: Asymmetric transfer hydrogenation of imine 165 using compounds 193,
193a and 299. Conditions: MeCN, FA/TEA=5:2, [Imine]=0.45 M, 25 oC, S/C =
100. Followed by 1H-NMR (400 MHz).
Compound 302 showed a steady increase in reduction over the period of the reaction,
but was quite slow compared to compound 181 (Figure 65). Both compounds 299
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and 302 gave conversions for transfer hydrogenation of imines compared to ketones
in the comparative study, although for imine reduction conversion was much slower
compared to compounds 193, 193a and 181.
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Figure 65: Asymmetric transfer hydrogenation of imine 165 using compounds 181
and 302. Conditions: MeCN, FA/TEA=5:2, [Imine]=0.45 M, 25 oC, S/C = 100.
Followed by 1H-NMR (400 MHz).
In this comparative study, ketone reduction was carried out without the use of any
additional solvent. To match with the published data, imine reduction was carried out
in acetonitrile. During the optimisation of conditions with compound 299, it was
found that the presence of solvent inhibits catalyst activity.
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Figure 66: Asymmetric transfer hydrogenation of imine 165 using compounds 299
and 302. Conditions: FA/TEA=5:2, [Imine]=0.50 M, 25 oC, S/C = 100 and 33.
Followed by 1H-NMR (700 MHz).
To overcome the solvent effect, both complexes 299 and 302 were used for imine
reduction in FA:TEA without any solvent. At the same time, the reaction was carried
out using 1 mol% and 3 mol% catalyst loading (Figure 66). These reactions were
carried out in an NMR tube and monitored by 1H-NMR to detect the hydride.
Complex 299 exhibited slow reaction with 1 mol% catalyst loading compared to 3
mol% (Figure 66). A similar effect was observed with the complex 302. However, it
can be seen that complex 302 is much faster than complex 299 (Figure 66).
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Figure 67: Change in hydride in asymmetric transfer hydrogenation of imine 165
using compound 299. Conditions: FA/TEA=5:2, [Imine]=0.50 M, 25 oC, S/C = 33.
Followed by 1H-NMR (700 MHz).
Figure 68: Change in hydride in asymmetric transfer hydrogenation of imine 165
using compound 302. Conditions: FA/TEA=5:2, [Imine]=0.50 M, 30 oC, S/C = 33.
Followed by 1H-NMR (700 MHz).
0
1
2
3
4
5
0 100 200
m
ol
%
of
H
yd
ri
de
re
la
ti
ve
to
su
bs
tr
at
e
Time in h
Change in hydride
of NMe2 (299)
0
1
2
3
4
5
0 2 4 6
m
ol
%
of
hy
dr
id
e
re
la
ti
ve
to
su
bs
tr
at
e
Time in h
Change in hydride
of Teth-Nme (302)
Results and Discussion
137
In NMR reaction studies, the reactions with 3 mol% of complexes 299 and 302, the
change in the hydride formation was calculated from NMR data. The reaction with 3
mol% loading of compounds 299 and 302 showed a peak for Ru-H at δ-5.4 ppm.
The Ru-H peak was integrated and plotted against reaction time (Figures 67 & 68).
The low reactivity of the N-alkylated catalysts 299 and 302 relative to the non-
alkylated ones could be due to a number of reasons183,205,207 including (i) catalyst
decomposition, (ii) slow formation of the Ru-H species or (iii) slow transfer of
the hydride from the Ru-H species to the substrate. The rapid formation of stable
Ru-H was observed for the compound 299 and 302, which would rule out the
possibilites of catalyst decomposition and slow hydride formation. Thus, the slow
reactivity of compounds 299 and 302 could be the lower rate of transfer of
hydride to the imine 165. Moreover, compounds 299 and 302 were found to be
very slow for reduction of ketone, which confirms the concerted mechanism for
reduction of ketones under asymmetric transfer hydrogenation conditions. While
both compounds 299 and 302 were able to reduced the imine 165 under the
asymmetric transfer hydrogenation conditions using FA:TEA, which proves the
ionic mechanism for the transfer hydrogenation of imines.
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2.4 Asymmetric transfer hydrogenation of hindered ketones
During the investigation of the reduction of 1,3-diketones using Ru-tethered
catalysts in the Wills group, project student John-Michel Collinson obtained
interesting results for the reduction of 2,2-dimethyl-1,3-cyclohexadione under my
supervision for his final year project. Compound 310 was reduced using Ru-3C-
tethered catalyst 181 with 2 mol% loading with good selectivity 84% ee and dr =
44.5:55.5 (Scheme 63). The racemic sample of compound 311 was easily prepared
by NaBH4 reduction. While compound 312 was reduced using Ru-3C-tethered
catalyst 181 with 2 mol% loading in 24 h. The racemic standard could not be
prepared using NaBH4 reduction for the enantioselectivity determination of the
product using chiral GC/ HPLC. As a result, both (1R,2R) and (1S,2S) versions of
complex 181 were used to prepare both enantiomers of compound 313 separately.
With the products in hand, it was revealed that the ee of the major trans isomer of
313 was of 99% ee (Scheme 63).
Scheme 63: Asymmetric transfer hydrogenation of 1,3-diketones using Ru-3C-
tethered complex 181.
Asymmetric transfer hydrogenation of ketones using η
6-arene-Ru- complexes is well
studied in terms of mechanism and origin of enantioselectivity as discussed in
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sections 1.4.4 and 1.4.5. High enantioselectivity was obtained for the ketones
containing an aryl group, which involves CH-π interaction between the η6-arene-Ru
and the aryl group of the substrate. As a result, the substrates lacking an aryl group
were reduced with lower enantioselectivity. Interestingly, compound 312 was
reduced with high enantio- and diastereo- selectivity compared to compound 310. To
understand these differences in selectivities between the reduction of compounds 310
and 312, a series of α,α-disubstituted ketones were synthesised and employed to
study the asymmetric transfer hydrogenation using Ru-3C-tethered catalyst 181.
2.4.1 Synthesis of derivatives of 1,3-cyclohexadione and cyclohexanone
Scheme 64: Synthesis of derivatives of 1,3-cyclohexadione.
The derivatives of 1,3-cyclohexadione were prepared for comparison of the
selectivity in asymmetric transfer hydrogenation (Scheme 64).241 1,3-
Cyclohexadione 314 was converted to the diallyl derivative 315. The diallyl
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compound 315 was subjected to ring closing metathesis using Grubb’s 1st generation
catalyst to afford compound 312.
Compound 316 was prepared by Pd/C hydrogenation of compound 312. 1,3-
cylcohexadione 314 was reacted under two different condition with 1,2-
(dibromomethyl)benzene in an attempt to prepare compound 317. None of the
conditions afforded the required product and one of the side products was identified
as compound 318 (Scheme 64).
To compare the selectivity between 1,3-diketone and mono ketone reductions, some
derivatives of cyclohexanone 319 were synthesised (Scheme 65).242-244
Cyclohexanone 319 was successfully reacted with 1,4-dibromobutane to give
compound 320 and with 1,4-dichloro-2-butene to afford compound 321.
Cyclohexanone 319 was reacted with 1,2-(dibromomethyl)benzene to give
compound 322.
Scheme 65: Synthesis of derivatives of cyclohexanone.
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Table 39: Asymmetric transfer hydrogenation of compounds 312, 316, 320, 321 and
322 using Ru-3C-tethered catalyst 181.
Compd
Catalyst
mol%
Temp Timea %eeb drtrans:cisd Product
312 2 mol% 28 oC 21 h 99% 99:1
OHHO
323a
316 2 mol % 45 oC 46 h 99% 35:65
trans 324a
cis 324c
318 1 mol% 30
oC +
60 oC
1 day
1 day NR - -
320 1 mol% 28
oC 22 h 71% -
OH
325a
321 1 mol% 28 oC 18 h 96% -
OH
326a
322 1 mol% 28 oC 22 h 93%c - OH
327a
a Completion of reaction was checked by 1H-NMR, bThe enantiomeric excess is
calculated from chiral GC after acetate derivative of reduced product, c The
enantiomeric excess is calculated from chiral HPLC, dThe dr is calculated from 1H-
NMR of crude product. NR = No reaction
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Compounds 312, 316, 320, 321 and 322 were used in asymmetric transfer
hydrogenation using Ru-3C-tethered catalyst 181 (Table 39). Compound 312 was
reduced at 28 oC in 21 h with high enantioselectivity (99% ee) and
diastereoselectivity (trans:cis 99:1) using 2 mol % of 181(Table 39). Asymmetric
transfer hydrogenation of compound 316 was required a higher temp (45 oC) for 36 h
to give complete conversion. The reduction of compound 316 was found to have low
diastereoselectivity with a trans:cis ratio 35:65, and the trans diastereomer was of
99% ee (Table 39). These contradictory results between enantio- and diastereo-
selectivities can be explained by undiastereoselective second reduction controlled by
the mono reduced product itself rather than catalyst. Compound 318 did not give any
reduction at 30 oC for 1 day followed by heating to 60 oC for 1 more day using Ru-
3C-tethered catalyst 181 (Table 39).
Compound 320 with mono ketone and a saturated ring, was reduced with a low
enantioselectivity of 71% ee for transfer hydrogenation using Ru-3C-tethered
catalyst 181 (Table 39). Interestingly, compound 321 was reduced with high
enantioselectivity (96% ee) in 18 h at 28 oC using Ru-3C-tethered catalyst 181
(Table 39). Similarly, compound 322 with an aromatic substituent was also reduced
with high enantioselectivity (93% ee) (Table 39). The differences in selectivity of
compounds 320, 321 and 322 may be due to the presence of an unsaturation or an
aromatic group. The alcohol compounds obtained by asymmetric transfer
hydrogenation of compounds 312, 316, 320, 321 and 322 (Table 39) were all novel.
It was required to first establish the configuration of these novel alcohols to
understand the difference in enantioselectivity between them during the asymmetric
transfer hydrogenation using complex 181.
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The configuration of a novel alcohol can be obtained by two different methods (i)
reaction of the enantiopure compound with known chiral compounds followed by X-
ray crystallography and (ii) Mosher’s method245.
Scheme 66: Identification of configuration of compounds 323a and 324b.
Compound 323a was reacted with (1S)-(+)-camphorsulfonyl chloride to give the
ester derivative 328 (Scheme 66), however attempts to crystallise this in different
solvents resulted in formation of an oily compound. Compound 328 was subjected to
Pd/C hydrogenation to reduce the double bond but the resulting compound 329 was
again found to be an oil (Scheme 66). As compounds 328 and 329 were both oils,
Mosher’s method was used to find the configuration of 323a.245 The alcohols 323a
and 323b were obtained using the (1R,2R) and (1S,2S) complexes of 181 and were
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reacted with (S)-(+)-MTPA-Cl to give two diastereomers 330a and 330b (Scheme
66).
Figure 69: Mosher’s method for absolute configuration.245
The 1H-NMR spectra of both Mosher’s esters 330a and 330b were analysed for
relative changes in peaks for substituents next to the alcohol group (Figure 69). From
the relative position of the group in 1H-NMR for both diastereomers, the
configuration of starting alcohol can be obtained using the model shown in Figure
69. Compound 312 was reduced in R,R configuration using (1R,2R) complex 181
(More details in Appendix 5.2 and 1H-NMR spectra in Appendix 5.2.1). At the same
time, compound 323b obtained using (1S,2S) complex 181 was reduced to
compound 324b, which is the opposite isomer to that obtained using (1R,2R) catalyst
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181 (Scheme 66). Thus, compounds 312 and 316 were reduced in the similar way by
(1R,2R) complex 181.
Scheme 67: Identification configuration of compounds 326a, 325a and 327a.
The alcohols 326a and 326b obtained by using the (1R,2R) and (1S,2S) complexes of
181 were reacted with (S)-(+)-MTPA-Cl to give two diastereomers 331a and 331b
(Scheme 67). The 1H-NMR spectra of both Mosher’s esters 331a and 331b were
analysed for relative changes in the peaks for substituents next to the alcohol group.
From the relative position of the group in 1H-NMR for both diastereomers,
compound 321 was reduced in R configuration using (1R,2R) complex 181(More
details in Appendix 5.2). At the same time, compound 326a obtained using (1R,2R)
complex 181 was reduced to compound 325a which is the same enantiomer to that
obtained using (1R,2R) catalyst 181 (Scheme 67). Compound 327a was reacted (1S)-
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(+)-camphorsulfonyl chloride to give sulfonyl ester 332, which was recrystallised to
give good quality crystals for X-ray crystallography (Scheme 67). The X-ray
structure of 332 confirmed its reduction in R configuration, similar to compounds
320 and 321.
Compounds 312, 316, 320, 321 and 322 were reduced to their alcohols with R
configurations at the chiral centre using (1R,2R) complex 181. Compound 181 gave
complete conversion in 18-22h with enantioselectivities in the range of 93-99% for
asymmetric transfer hydrogenation of compounds 312, 321 and 322 (Table 39). At
the same time, asymmetric transfer hydrogenation of compounds 316 and 320 were
found to be slower and less selective (Table 39). These differences in efficiency and
selectivity may be due to the presence of unsaturation or aryl group present in
compounds 312, 321 and 322, which can give some weak interaction between η6-
arene-Ru of compound 181 and unsaturation or aryl group of substrate.
2.4.2 Synthesis of derivatives of ethyl acetoacetate and acetylacetone
In order to improve the substrate scope and complete a comparative study of the
effect of unsaturation or an aryl group in the control of enantioselectivity, different
derivatives of ethyl acetoacetate were prepared.246-248 In these derivatives, the ketone
group is not part of the ring. Compounds 334 and 337 were prepared by the reaction
of EAA 333 with 1,4-dibromobutane and 1,2-(dibromomethyl)benzene respectively
as shown in Scheme 68. Compound 336 was prepared by diallyl derivative 334 of
EAA followed by ring closing metathesis using Grubb’s 1st generation catalyst
(Scheme 68). Compound 340 was prepared following a reported procedure.249
Acetylacetone 338 was reacted with 1,2-(dibromomethyl)benzene to give compound
339, which was alkylated using ethyl iodide to afford compound 340 (Scheme 69).
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Scheme 68: Synthesis of derivatives of ethyl acetoacetate.
Scheme 69: Synthesis of 1-(2-ethyl-2,3-dihydro-1H-inden-2-yl)ethanone.
Asymmetric transfer hydrogenation of compound 334 was found to be slow and took
47 h to give complete conversion using the (1R,2R) complex 181 (Table 40). At the
same time, NaBH4 reduction did not work to give a racemic sample. The reduction
of compound 334 was also carried out using the (1S,2S) complex 181 to get the
opposite isomer. Compound 334 was reduced with very low enantioselectivity (61%
ee, Table 40). On the other hand, compounds 336 and 337 were reduced with high
enantioselectivity with 92% and 90% ee respectively (Table 40).
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Table 40: Asymmetric transfer hydrogenation of compounds 334, 336, 337 and 340
using Ru-3C-tethered catalyst 181.
Compound
Catalyst
mol%
Temp Timea %ee Product
334 1 mol% 30 oC 47h 61%b O
OHO
341 a
336 1 mol% 28 oC 30 h 92%b O
OHO
342 a
337 1 mol% 28 oC 17 h 90%c
O
OHO
343 a
340 1 mol% 28 oC 24 h 73%c OH
344 a
a Completion of reaction was checked by 1H-NMR, b The enantiomeric excess is
calculated from chiral GC after acetate derivative of reduced product, c The
enantiomeric excess is calculated from chiral HPLC.
In contrast, compound 340 was reduced with moderate enantioselectivity with 73%
ee (Table 40). Asymmetric transfer hydrogenation of compound 340 can easily be
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compared with compound 337; the selectivity differences between both compounds
may be due to the ester group, which may give rise to an extra interaction with Ru-
catalyst and result in high enantioselectivity. The alcohols obtained by reductions of
compounds 334, 336, 337 and 340 were all novel (Table 40). The Mosher’s method
was used to identify the configuration of these alcohols (Scheme 70).
O
O O
O
Ph
F3C
OMe
O
O OH
O
O OH
O
O OH
R
O
O
Ph
F3C
OMe
R
OH
343a R = CO2Et,
344a R = Et
346 R = CO2Et,
347 R = Et
Reagents and Conditions: (a) (S)-(+)-MTPA-Cl, TEA, DMAP, DCM, 20-21
oC, 17 h, 46-66%; (b) Pd/C (10 mol%); H2 gas, MeOH, 21-22 oC, 18 h, 91%.
(a)
(b)
(a)
342a 341a
341a 345
Scheme 70: Identification of configuration of compounds 341a, 342a, 343a and
344a.
Mosher’s ester derivatives were prepared for compounds 341a and 341b (using
(1R,2R) and (1S,2S) complexes of 181 respectively) and compared by 1H-NMR for
respective shifts in the peak of substitution next to the alcohol(More details in
Appendix 5.2 and 1H-NMR spectra in Appendix 5.2.2).245 Compound 336 was
reduced in R configuration using (1R,2R) complex 181. Compound 342a (obtained
using (1R,2R) catalyst 181) was reduced using Pd/C to give compound 341a, which
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is same enantiomer as obtained by direct reduction of compound 334 using (1R,2R)
catalyst 181 (Scheme 70). Thus, both compounds 334 and 336 were reduced in a
similar way using (1R,2R) complex 181. Compounds 337 and 340 were also reduced
in R configuration using (1R,2R) complex 181, confirmed by Mosher’s ester analysis
(More details in Appendix 5.2 and 1H-NMR spectra in Appendix 5.2.3 & 5.2.4).
Asymmetric transfer hydrogenation using (1R,2R) Ru complex 181, was highly
enantioselective for compound 337 containing an aryl substituent and compound 336
with an unsaturated cyclic group compared to compound 334. Thus, unsaturated
cyclic ring or aryl substituents of the substrates can interact with catalyst to orient
ketone group to give enantioselective reduction. (1R,2R) Ru complex 181 gave
complete conversion with low enantioselectivity for asymmetric transfer
hydrogenation of compound 340, even though there was an aromatic ring in the
substrate (Table 40). This low enantioselectivity may be due to the hindered ethyl
group near to the carbonyl group. While in compounds 334, 336 and 337, the ester
group may have some interaction with the (1R,2R) Ru complex 181, but it is hard to
predict.
2.4.3 Synthesis of derivatives of β-tetralone and α-tetralone
As discussed in sections 2.4.1 and 2.4.2, the reduction of ketone derivatives
containing unsaturated cyclic rings or aryl substituents was more enantioselective
compared to compounds lacking such groups. The mechanism for acetophenone is
well studied and involves a CH-π interaction between arene ring of catalyst and the
aryl group of the substrate as discussed in section 1.4.5. To identify the dominating
interaction, the reductions of ketones having both an aryl substituent for CH-π
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interaction (such as acetophenone) and a cyclic ring with unsaturation or an aryl
group were selected.
Scheme 71: Synthesis of derivatives of β-tetralone.
Derivatives of β-tetralone and α-tetralone were synthesised as described in Schemes
71 and 72.250-25 β-Tetralone 348 was reacted with iodomethane to give compound
349. Compound 351 was prepared by formation of the diallyl derivative 350 of β-
tetralone 348 followed by ring closing metathesis using Grubb’s 1st generation
catalyst. Compound 351 was hydrogenated using Pd/C to give compound 352.
Compound 353 was prepared by reaction of β-tetralone with 1,2-
(dibromomethyl)benzene. Similarly, compounds 355 and 356 were prepared by
reaction of α-tetralone 354 with iodomethane and 1,2-(dibromomethyl)benzene
respectively.
β-Tetralone 348 was reduced with good enantioselectivity of 88% ee under
asymmetric transfer hydrogenation conditions using (1R,2R) Ru complex 181 (Table
41). Compound 349 was reduced with high enantioselectivity (94% ee) and at a
faster rate with complete conversion in 9 h at 28 oC (Table 41). Compounds 351 and
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352 were also reduced in 18-20 h with 99% ee using (1R,2R) Ru complex 181 (Table
41). Compound 353 was reduced in >99% ee at 28 oC in 24 h using (1R,2R) Ru
complex 181 (Table 41). High enantioselectivity for transfer hydrogenation of
compounds 349 and 351-353 was obtained compared to β-tetralone 348.
Scheme 72: Synthesis of derivatives of α-tetralone.
β-Tetralone 348 was reduced with good enantioselectivity of 88% ee under
asymmetric transfer hydrogenation conditions using (1R,2R) Ru complex 181 (Table
41). Compound 349 was reduced with high enantioselectivity (94% ee) and at a
faster rate with complete conversion in 9 h at 28 oC (Table 41). Compounds 351 and
352 were also reduced in 18-20 h with 99% ee using (1R,2R) Ru complex 181 (Table
41). Compound 353 was reduced in >99% ee at 28 oC in 24 h using (1R,2R) Ru
complex 181 (Table 41). High enantioselectivity for transfer hydrogenation of
compounds 349 and 351-353 was obtained compared to β-tetralone 348.
On the other hand, the derivatives of α-tetralone compound 355 and 356 required
higher temperatures to give complete conversion (Table 42). This may be due to the
bulkiness around the ketone group. The reduction of both compounds 355 and 356
was highly selective 98-99% ee using (1R,2R) Ru complex 181 at 45 oC over a
period of 48 h and 24 h respectively (Table 42).
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Table 41: Asymmetric transfer hydrogenation of compounds 348-349 and 351-353
using Ru-3C-tethered catalyst 181.
Compound Catalystmol% Temp Time
a %ee Compound
348 1 mol% 28 oC 30 h 88%b
OH
357a
349 1 mol% 28 oC 9 h 94%b
OH
358a
351 1 mol% 28 oC 20 h 99%c
OH
359a
352 1 mol% 28 oC 18 h 99%c
OH
360a
353 1 mol% 30 oC 24 h 99%c OH
361a
a Completion of reaction was checked by 1H-NMR, b The enantiomeric excess is
calculated from chiral GC after acetate derivative of reduced product, c The
enantiomeric excess is calculated from chiral HPLC.
The alcohol derivatives obtained by reduction of compounds 349, 351-353 and 356
were novel (Tables 41 & 42). It is necessary to identify the configurations of these
alcohols in order to understand the orientation of molecule in catalytic cycle. The
configuration of compounds 358a and 359a were obtained as R configurations by
using Mosher’s method(More details in Appendix 5.2 and 1H-NMR spectra in
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Appendix 5.2.5 & 5.2.6).245 Compound 359a was reduced by Pd/C to give
compound 360a, the same as that obtained by direct asymmetric transfer
hydrogenation of compound 352 by using (1R,2R) complex 181.
Table 42: Asymmetric transfer hydrogenation of compounds 355-356 using Ru-3C-
tethered catalyst 181.
Compound Catalyst mol% Temp Timea %ee Compound
355 1 mol% 45 oC 49 h 98%b
OH
362a
356 1 mol% 45 oC 24 h 99%c
OH
363a
a Completion of reaction was checked by 1H-NMR, b The enantiomeric excess is
calculated from chiral GC after acetate derivative of reduced product, c The
enantiomeric excess is calculated from chiral HPLC.
Scheme 73: Identification of configuration of compounds 358a, 359a and 360a.
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Scheme 74: Identification of configuration of compound 310a.
Compound 361a was reacted with (1S)-(+)-camphorsulfonyl chloride to give the
ester derivative 366, which was recrystallised to give a crystal for X-ray
crystallography (Scheme 74). The X-ray structure of compound 366 confirmed that
compound 353 was reduced in a similar way to give the R configuration as
compounds 349, 351 and 352. During an attempt to form the camphorsulfonyl ester
of compound 363a, the ether linked product 368 was formed as a meso ether instead
of the required compound 367 (Scheme 75). The structure of 368 was also confirmed
by X-ray structure analysis (Scheme 75). Mosher’s method was used to identify the
absolute configuration of compound 363a as “R configuration” by 1H-NMR analysis
of resulting Mosher’s ester (More details in Appendix 5.2 and 1H-NMR spectra in
Appendix 5.2.7).245
(1R,2R) complex 181 gave complete conversion and high enantioselectivities for
asymmetric transfer hydrogenation of compounds 348-349 and 351-353 with R
configuration. These results show that interaction between η
6-arene-Ru and aryl
group originally coming from the tetralone is much stronger compared to the
interaction between η
6-arene-Ru and the cyclic ring with unsaturation or aryl group.
Thus, enantioselectivity was controlled by stronger interactions to give the R
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configuration in all alcohol products. A similar trend of interactions was also
observed in asymmetric transfer hydrogenation of compound 355 using (1R,2R)
complex 181.
Scheme 75: Identification of configuration of compound 316a.
2.4.4 Asymmetric transfer hydrogenation of selected compounds using
Noyori’s catalyst 153
The bridging chain of (1R,2R) complex 181 may give rise to some interaction
during the catalytic cycle with the group placed on α position of ketone. To
overcome this possibilities, selected compounds were reduced using (1R,2R)
Noyori’s catalyst 153. For almost all tested compounds, (1R,2R) Noyori’s catalyst
153 was found to be much slower compared to the (1R,2R) Ru-3C-tethered catalyst
181 (Table 43). At the same time, the enantioselectivities were unaffected in all the
compounds and were almost similar to (1R,2R) Ru-3C-tethered catalyst 181. Thus,
the bridging chain of (1R,2R) complex 181 is not interacting with the substrates
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during the catalytic cycle. Interestingly, (1R,2R) Noyori’s catalyst 153 was not able
to reduce compound 356 even after a long reaction time at high temperature (Table
43). Thus, the asymmetric transfer hydrogenations of α,α-disubstituted ketones using
Ru-3C-tethered catalyst 181 is quite promising with the weak interaction of an
unsaturation or an aromatic group in substitution at the α-position of the ketone with
catalysts.
Table 43: Asymmetric transfer hydrogenation of selected compounds using (1R,2R)
Noyori’s catalyst 153.
Compd Catalystmol% Temp Time
a %ee Compound
312 4 mol% 30 oC 7 daysb 92% (R)c 323a
322 1 mol% 28 oC 48h 94% (R)d 327a
337 1 mol% 28 oC + 60 oC 24 h + 5h 91% (R)d 343a
353 1 mol% 28 oC 24 h 99% (R)d 361a
356 1 mol% 45 oC 48 h NRe -
a Completion of reaction was checked by 1H-NMR, b 15% of mono reduced product
was present by 1H-NMR, cThe enantiomeric excess is calculated from chiral GC
after acetate derivative of reduced product, d The enantiomeric excess is calculated
from chiral HPLC, e NR= No reaction.
The high enantioselectivity obtained for asymmetric transfer hydrogenation of
compounds 312, 321, 322, 336 and 337 using (1R,2R) complex 181, can be
explained by the possible CH-π interaction between the (1R,2R) complex 181 and
compounds 321, 322 and 337 as shown in Figures 70a, 70b and 70c respectively.
Moreover, the carbonyl group (as ketone or ester) present in compounds 312, 336
and 337 may give rise to a possible interaction between the carbonyl oxygen and the
-CH of the η6-arene-Ru complex as shown in Figures 70a and 70c.
Results and Discussion
158
Figure 70: Possible stabilizing interactions in transition states of reduction of α,α-
disubstituted ketones.
The β-tetralone is reduced with good enantioselectivity of 88% ee using (1R,2R)
complex 181 that can be explained by the already established CH-π interaction
(Figure 70d). Interestingly, the derivatives of β-tetralone were reduced with higher
enantioselectivity (94-99% ee) using (1R,2R) complex 181 compared to β-tetralone.
This may be possible due to CH-π interactions between the substituents on the α-
position and -CH of η6-arene-Ru complex (Figure 70e). To identify the dominating
interaction between the established CH-π interaction and observed interaction,
compound 356 was selected for the reduction. The (1R,2R) complex 181 gave high
enantioselectivity (99% ee, R enantiomer) for compound 356, which could arise via
established CH-π interaction as shown in Figure 70f. Taken together, these results
suggest that a cyclic ring with unsaturation or an aryl substituent at the α-position of
the ketone contributes positively to the enantiocontrol of the asymmetric transfer
hydrogenation by η
6-arene-Ru-TsDPEN complexes such as 181.
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2.5 Conclusion
In summary, 1,2-cyclohexanediamine derivative 260 was found to be less efficient
and selective compared to 1,2-diphenyl-1,2-ethanediamine derivative 56 for the
Michael addition of trans-β-nitrostyrene to acetone under optimised conditions. The
synthesis of other derivatives of 1,2-cyclohexanediamine such as 261 and 263 was
attempted, but it was not possible to prepare them. Successfully synthesized
compounds 260, 262 and 264 were used to screen for different asymmetric reactions
such as Michael addition of trans-β-nitrostyrene to diethyl malonate, aldol reaction
between 2-nitro-benzaldehyde and acetone/cyclohexanone and Henry reaction
between 2-nitro-benzaldehyde and nitromethane. However, none of these
compounds exhibited promising efficacy and selectivity for tested reactions.
The stable cyclic aminal 278 and similar derivatives of TsDPEN (282-284), which
have structural similarities to Macmillan organocatalysts, were synthesised.
Compounds 278 and 282-284 were successfully prepared as single diastereomers in
good to high yields. For the initial study, the Diels-Alder reaction between 1,3-
cyclohexadiene and acrolein was used to test compounds 278 and 282-284. The
hydrochloride salt of compounds 278 showed a good enantioselectivity of 72% ee (S
enantiomer) for the reaction of 1,3-cyclohexadiene and acrolein in acetonitrile:water
(95:5). On other hand, the hydrochloride salts of compounds 282 and 283 were
found to be less enantioselective, giving products of 44-45% ee. The results obtained
with compounds 278, 282 and 283, indicated that the good enantioselectivity
obtained with compound 278 is mostly due to the bulkier group (-OTBDPS) present
in it. The hydrochloride salt of compound 284 was found to be less stable and
resulted in low enantioselectivity for the tested reaction, which is similar to that
obtained using the hydrochloride salt of TsDPEN 64.
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The stable cyclic derivative 278 was screened for different asymmetric reactions.
Out of these the addition reaction of aldehyde to DEAD showed a promising result.
The reaction conditions were optimized using compound 278 for addition of
isovaleraldehyde to DEAD, including as catalyst loading, acid loading and effect of
temperature. Under the optimized reaction conditions, compounds 278 and 282-284
were studied for the reaction of propionaldehyde to DEAD, however compound only
278 has gave a high enantioselectivity in the tested reaction. Compound 278 was
selected to test for addition of different aldehydes to DEAD. Compound 278 has
gave high enantioselectivities for simple aldehydes. Compound 278 was found to be
moderately selective in control of the addition of propionaldehyde to DIAD and
DTAD. Moreover, compound 278 was found to be less efficient for addition of
branched aldehydes (e.g. formylcyclohexane) or a ketone (acetone) to DEAD. These
results show that compound 278 is good for addition of simple aldehydes to DEAD
under optimized conditions.
The asymmetric transfer hydrogenation of ketones and imines were studied with
compounds 299 and 302 using FA:TEA (5:2) as source of hydrogen. Moreover the
transfer hydrogenation of ketone and imine using compounds 299 and 302 were also
compared with the related -NH2 (193) and -NH (193a and 181) analogues under
similar conditions. The results obtained using N-alkylated complexes 299 and 302
for transfer hydrogenation of acetophenone 112 show that he ketone reduction was
quite slow compared to -NH2 (193) and -NH (193a and 181) analogues. Thus, the
transfer hydrogenation of ketone appears to require -NH in the complex for the
reduction to be achieved, which confirms that ketones reduction takes place via a six
membered cyclic transition state mechanism (concerted mechanism). On the other
hand, both 299 and 302 were active in reduction of imine 165 under transfer
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hydrogenation conditions using FA:TEA, Which requires the protonation of imine
165 with hydrogen source (FA:TEA) followed by hydride transfer from the Ru-H
formed in situ. Thus, transfer hydrogenation of imines using compounds 299 and
302 confirms an ionic or stepwise mechanism. Interestingly, both the compounds
299 and 302 were found to form the hydride intermediate quite fast using FA:TEA
and this can be detected using 1H-NMR in CDCl3 at δ -5.4. Moreover, hydride
formation was also detected for the reduction of imine 165 using a 3 mol% loading
of compounds 299 and 302. At the same time, the reduction of imine 165 was found
to be slower, which shows that rate determining step is transfer of hydride from
complex to imine substrate for transfer hydrogenation using compounds 299 and
302. Compound 302 can be applied to asymmetric reductive amination due to its
preference for the reduction of imines over ketones. Unfortunately, compound 302
was found to be less enantioselective for transfer hydrogenation of imines, probably
due to the steric effect of -NMe.
The asymmetric transfer hydrogenation of aryl alkyl ketones were reported to be
highly efficient and selective using complexes 153 and 181, which involves CH-π
interaction between η
6-arene ring of Ru complex and aryl ring of substrates. At the
same time transfer hydrogenation of the ketones without aryl groups were found to
be much slower and less enantioselective. This can limit the substrate scope for
asymmetric transfer hydrogenation of ketones and will require at least one aryl group
in the substrate. A series of ketone derivatives were prepared with substitution on the
α position containing a constrained cyclic group with an unsaturation, without
unsaturation and an aryl substituent on the ring. These ketones were used in
asymmetric transfer hydrogenation using (1R,2R) Ru-3C-tethered catalyst 181 in
FA:TEA as source of hydrogen. The ketones with a constrained cyclic group with an
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unsaturation or aryl substituent on the ring were reduced easily and with good-high
enantioselectivities using (1R,2R) Ru-3C-tethered catalyst 181. In contrast,
asymmetric transfer hydrogenation of ketones containing a constrained cyclic group
without unsaturation was less enantioselective.
These results can be explained by either (i) possible CH-π interaction between the
η
6-arene ring of Ru complex and properly placed cyclic group with an unsaturation
or aryl substituent in the ketone substrate, or (ii) the bridging chain present in
(1R,2R) Ru-3C-tethered catalyst 181 provides the stable interaction during the
catalytic cycle. To rule out the second possibility, selected compounds were used for
asymmetric transfer hydrogenation using Noyori’s catalyst 153 and were found to be
reduced with similar enantioselectivities. Moreover, compound 356 was prepared
having both aryl group next to ketone and a constrained cyclic group with an aryl
substituent on the ring to identify which interaction is stronger and dominating in
asymmetric transfer hydrogenation. The asymmetric transfer hydrogenation of
compound 356 using (1R,2R) Ru-3C-tethered catalyst 181 showed that established
CH-π interaction between η6-arene ring of Ru complex and aryl group next to ketone
is dominating (Figure 70f). At the same time, asymmetric transfer hydrogenation of
substituted ketones 312. 321 and 322 (lacking an aryl group next to the ketone) was
enantioselective with high ee using (1R,2R) Ru-3C-tethered catalyst 181. Thus, when
the dominating CH-π interaction between the η6-arene ring of Ru complex and the
aryl group is absent then a suitable group with single double bond or aromatic ring
can give rise to weak interaction η
6-arene ring of Ru complex (Figure 71a & 71b),
followed by highly enantioselective asymmetric transfer hydrogenation.
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3 Experimental
General Experimental:
All the air sensitive reactions were carried out under an argon atmosphere. NMR
spectra were recorded on a Bruker DPX-300 (300 MHz) or a Bruker DPX-400 (400
MHz). All chemical shifts are reported in ppm downfield from TMS (Me4Si).
Coupling constants (J) are reported in Hz. Multiplicity in 1H-NMR is reported as
singlet (s), doublet (d), double doublet (dd), double triplet (dt), broad singlet (br s),
broad doublet (br d),and multiplet (m). Mass spectra were recorded on an Esquire
2000. High resolution mass spectra were recorded on Bruker Micro ToF. Infrared
spectra were recorded on PerkinElmer spectrum100. The optical rotations were
measured on Optical Activity Ltd. AA-1000 Polarimeter. The Chiral HPLC
measurements were carried out on HPLC consisting of a Gilson 811B Dynamic
Mixer, a Gilson 805 Monometer Module, a Gilson 305 Piston Pump, Merck-Hitachi
L-4000 UV detector linked to HEWLETT PACKARD 3396 Series II integrator with
CHIRAL PAK IA/IB column (0.46 cm x 25 cm). The chiral GC measurements were
done on HEWLETT PACKARD 5890 linked to HEWLETT PACKARD HP3396A
integrator or PERKIN-ELMER 8500 chromatography linked to PC running
DataApex Clarity software with Chrompak CP-Chirasil Dex Cβ column. Melting
points were determined on a Stuart scientific melting point apparatus and are
uncorrected. Purification of compounds was done by using flash column
chromatography using silica gel of mesh size 230-400 or Florisil.
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3.1 Synthesis of derivatives of 1,2-cyalcohexanediamine
3.1.1 Synthesis of (1S,2S)-N-(diphenylphosphinyl)-1,2-diaminocyclohexane
(260).252
(1S,2S)-1-(N-t-Butyloxycarbonylamino)-2-aminocyclohexane (266).
This is a known compound and the method is based on a reported synthesis.252(b)
To a solution of (1S,2S)-1,2-cyclohexanediamine 265 (3.133 g, 27.436 mmol) in
dichloromethane (17 mL) was added dropwise a solution of Boc2O (2.0 g, 9.164
mol, 0.33 eq) in dichloromethane (17 mL) at 20-21 oC over a period of 10-12 min.
On addition, the reaction mixture was converted into a white emulsion. The resulting
suspension was stirred at 20-21 oC for 18 h. The reaction mixture was then diluted
with distilled water (15 mL) and extracted with dichloromethane (2 x 20 mL). The
organic layer was separated and the solvent removed on a rotavapor. The residue was
dissolved in a mixture of diethyl ether: distilled water (1:1) (5 mL) and the aqueous
layer was acidified to pH 5 by using 4M HCl solution. The organic layer was
separated and the aqueous phase was extracted with diethyl ether (2 x 20 mL). The
aqueous phase was basified to pH 11 by using 2N NaOH solution and extracted with
EtOAc (6 x 20 mL). The combined organic layers were dried over anhydrous
Na2SO4, filtered and the filtrate was concentrated under reduced pressure to give
compound (1S,2S)-1-(N-t-butyloxycarbonylamino)-2-aminocyclohexane 266 as an
off white solid (1.600 g, 7.477 mmol, 81%). δH (300 MHz, CDCl3) 4.41 (1H, br s, -
NHBoc), 3.11 (1H, m, -CHNHBoc), 2.34 (1H, dt, J 10.2, 5.2, -CHNH2), 1.95 (2H,
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m, -CH2 cycl), 1.67 (2H, m, -CH2 cycl), 1.45 (2H, s, -NH2), 1.42 (9H, s, -C(CH3)3),
1.34-0.97 (4H, m, -CH2 cycl); δc (75 MHz, CDCl3) 156.15, 68.36, 57.63, 55.66,
35.19, 32.91, 28.40(3C), 25.19, 25.08; ESI-MS [M+H]+ 215.1. The spectroscopic
data were in agreement with literature values.252(b)
(1S,2S)-1-(N-t-Butyloxycarbonylamino)-2-(N'-diphenylphosphonamide)-
cyclohexane (267).
The method is based on a reported synthesis; however the compound has not been
fully characterised.252(a)
To a solution of (1S,2S)-1-(N-t-butyloxycarbonylamino)-2-aminocyclohexane 266
(1.350 g, 6.308 mmol) in dichloromethane (48 mL) was added diisopropyl ethyl
amine (1.923 mL, 11.039 mmol, 1.75 eq) under an inert atmosphere and cooled to -
30 oC. To this, diphenylphosphinic chloride (1.318 mL, 6.920 mmol, 1.09 eq) was
added dropwise. The resulting mixture was stirred at 20-21 oC for 2 h. The reaction
mixture was diluted with dichloromethane (70 mL). The organic layer was washed
with 1N HCl solution (40 mL), saturated NaHCO3 solution (40 mL), distilled water
(40 mL) and brine solution. The organic layer was dried over anhydrous Na2SO4,
filtered and evaporated under reduced pressure to give a solid residue. The solid was
purified by flash column chromatography to give compound (1S,2S)-1-(N-t-
butyloxycarbonylamino)-2-(N'-diphenylphosphonamide)-cyclohexane 267 as a white
solid (2.46 g, 5.942 mmol, 94%). Mp 208-210 oC; [α]D15 = -13.9 (c 1 in CHCl3); νmax
3381, 2929, 2359, 2341, 1707, 1696, 1544, 1527, 1439, 1417, 1390 cm-1; δH (300
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MHz, CDCl3) 7.90 (2H, m, o-CH of Ph), 7.76 (2H, m, o-CH of Ph), 7.48-7.37 (6H,
m, m,p-CH of both Ph), 5.34 (1H, d, J 7.8, -NHBoc), 3.35-3.19 (2H, m, -CHNHBoc,
-NHP(O)Ph2), 2.79 (1H, m, -CHNHP(O)Ph2), 2.08 (2H, m, -CH2 cycl), 1.61 (2H, m,
-CH2 cycl), 1.48 (9H, s, -C(CH3)3), 1.40-1.10 (4H, m, -CH2 cycl); δc (75 MHz,
CDCl3) 132.31, 132.21, 131.86, 131.83, 131.78(2C), 131.74(2C), 128.51, 128.34,
55.69, 55.48, 36.18, 33.21, 28.53(3C), 25.05, 24.83; m/z ESI-MS [M+H]+ 415.2;
HRMS found 415.2106 (requires C23H31N2O3P+H+ 415.2145, error = -3.64 ppm).
The spectroscopic data were in agreement with literature values.252(a)
(1S,2S)-N-(Diphenylphosphinyl)-1,2-diaminocyclohexane (280).
This is a known compound and the method is based on a reported synthesis.252(a)
To a solution of (1S,2S)-1-(N-t-butyloxycarbonylamino)-2-(N'-
diphenylphosphonamide)-cyclohexane 267 (2.30 g, 5.556 mmol) in dichloromethane
(50 mL) was added trifluoroacetic acid (8.25 mL, 111.12 mmol, 20 eq) dropwise
over a period of 10-12 min. The resulting mixture was stirred at 20-21 oC for 1.5 h.
To the reaction mixture was added TEA (15.46 mL, 111.12 mmol, 20 eq) dropwise
at 0 oC over a period of 10 min to give a clear solution. The reaction mixture was
diluted with dichloromethane (50 mL) and distilled water (50 mL). The organic layer
was separated and washed with distilled water (2 x 50 mL). The organic layer was
dried over anhydrous MgSO4, filtered and evaporated under reduced pressure. The
solid residue was purified by flash column chromatography to give (1S,2S)-N-
(diphenylphosphinyl)-1,2-diaminocyclohexane 260 as an off white solid (1.20 g,
3.822 mmol, 68%). Mp 154-156 oC; [α]D15 = +7.4 (c 0.505 in CHCl3); νmax 3262,
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3054, 2931, 2857, 2360, 1686, 1522, 1438 cm-1; δH (300 MHz, CDCl3) 7.94-7.84
(4H, m, o-CH of Ph), 7.49-7.40 (6H, m, m,p-CH of Ph), 2.94 (1H, m, -
CHNHP(O)Ph2), 2.63-2.50 (1H, m, -CHNH2), 2.39-2.31 (1H, m, -CH2 cycl), 2.06
(1H, m, -CH2 cycl), 1.90 (1H, m, -NHP(O)Ph2), 1.61 (3H, m, -NH2, -CH2 cycl),
1.24-0.97 (5H, m, -CH2 cycl); δc (75 MHz, CDCl3) 131.77, 131.64, 131.31,
131.18(3C), 127.99(2C), 127.82(2C), 58.37, 56.43, 34.64, 34.38, 24.77, 24.37; δP
(121 MHz, CDCl3) 22.7318, m/z ESI-MS [M+H]+ 315.1; HRMS found 315.1621
(C18H23N2OP+H+ requires 315.1582, error = -3.88 ppm); The X-ray Structure was
obtained (more details in Appendix 5.1.1). The spectroscopic data were in agreement
with literature values.252(a)
3.1.2 Synthesis of (1S,2S)-phenylphosphonic bis(1-amino-2-cyclohexylamide)
(261).
(1S,2S)-Phenylphosphonic bis[1-(N-t-butyloxycarbonylamino)-2-
cyclohexylamide] (269).
This is a novel compound and the method is based on a reported synthesis.253
To a solution of phenylphosphonic dichloride (0.161 mL, 1.135 mmol, 0.486 eq) in
dichloromethane (10 mL) was added TEA (1.60 mL, 11.493 mmol, 4.92 eq) and
DMAP (13.8 mg, 0.113 mmol, 0.0486 eq) at 0 oC under inert atmosphere. To this, a
solution of (1S,2S)-1-(N-t-butyloxycarbonylamino)-2-aminocyclohexane 266 (0.500
g, 2.336 mmol) dichloromethane (10 mL) was added dropwise. The resulting
mixture was stirred at 20-21 oC for 3.5 h. The reaction mixture was diluted with
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dichloromethane (30 mL). The organic layer was washed with distilled water (20
mL), saturated NaHCO3 solution (20 mL), distilled water (20 mL), and brine
solution. The organic layer was separated, dried over anhydrous MgSO4, filtered and
the filtrate was concentrated under reduced pressure on a rotavapor to give an oil.
The oil was purified by flash column chromatography and pure compound was
eluted out in EtOAc. The pure compound (1S,2S)-phenyl phosphonic bis[1-(N-t-
butyloxycarbonylamino)-2-cyclohexylamide] 269 was obtained as an oil (0.300 g,
0.545 mmol, 47%). [α]D28 = -6.19 (c 0.105 in CHCl3); νmax 3376, 3312, 3221, 3144,
2929, 2857, 1708, 1684, 1512, 1450, 1439, 1237, 1126, 1110, 1091, 1017, 920, 759,
701 cm-1; δH (300 MHz, CDCl3) 7.82 (2H, m, o-CH of Ph), 7.44 (3H, m, m,p -CH of
Ph), 6.12 (1H, br s, -NH), 5.48 (1H, br s, -NH), 3.15 (2H, m, -CHNHBoc), 3.04-2.57
(4H, m, -CH cycl), 2.21 (1H, br d, -CH2 cycl), 2.07 (2H, m, -CH2 cycl), 1.87 (1H, br
d, -CH2 cycl), 1.61 (4H, m, -NH Phosphonamide, -CH2 cycl), 1.47 (9H, s, -C(CH3)3),
1.41 (9H, s, -C(CH3)3), 1.34-0.99 (8H, m, -CH2 cycl); δc (75 MHz, CDCl3) 130.98,
130.89, 130.76, 127.77, 127.59, 71.70, 71.63, 55.28, 35.23, 34.79, 28.01, 27.85,
27.44, 27.33, 26.07, 25.83, 24.69, 24.05, 23.90, 18.32; m/z ESI-MS [M+H]+ 551.2;
HRMS found 551.3365 (C28H47N4O5P+H+ requires 551.3357, error = -1.5 ppm).
Attempted synthesis of (1S,2S)-phenylphosphonic bis(1-amino-2-
cyclohexylamide) (261).
Using TFA: To a solution of (1S,2S)-phenylphosphonic bis[1-(N-t-
butyloxycarbonylamino)-2-cyclohexylamide] 269 (25 mg, 0.0454 mmol) in
dichloromethane (1 mL) was added TFA (33.7 µL, 0.454 mmol, 10 eq) dropwise
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over a period of 2-3 min. The resulting mixture was stirred at 19-20 oC for 1 h. To
the reaction mixture was added TEA (63.4 µL, 0.454 mmol, 10 eq) dropwise at 0 oC
over a period of 2-3 min to give a clear solution. The reaction mixture was diluted
with dichloromethane (5 mL) and distilled water (5 mL). The organic layer was
separated and washed with distilled water (5 mL). The organic layer was dried over
anhydrous MgSO4, filtered and evaporated under reduced pressure to give an oil.
The oil was analysed by 1H-NMR and ESI-MS. IH-NMR corresponded to TEA only.
Using ZnBr2254: To a solution of (1S,2S)-phenylphosphonic bis[1-(N-t-
butyloxycarbonylamino)-2-cyclohexylamide] 269 (0.150 g, 0.273mmol) in
dichloromethane (3.5 mL) was added zinc (II) bromide (0.307 g, 1.364 mmol, 5.02
eq) The resulting mixture was stirred at 19-20 oC for 24 h. The reaction mixture was
diluted with dichloromethane (20 mL) and distilled water (20 mL). The organic layer
was separated and washed with distilled water (5 mL). The organic layer was dried
over anhydrous MgSO4, filtered and evaporated under reduced pressure to give solid
residue (30 mg, 0.066 mmol, 24%). The solid was analysed by 1H-NMR and ESI-
MS. The IH-NMR spectrum was quite complex and product could not be identified.
ESI-MS [M+H]+ 451.2 corresponded to mono Boc- compound 270 instead of
required compound 261.
(1S,2S)-N-Phthaloyl-1,2-diaminocyclohexane (271).
This is a known compound and the method is based on a reported synthesis.255
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A solution of p-toluenesulfonic acid monohydrate (1.902 g, 10.0 mmol) in p-xylene
(50 mL) was dehydrated by azeotropic distillation. The resulting light brown
solution was cooled to 20-21 oC. To this solution was added (1S,2S)-1,2-
cyclohexanediamine 265 (1.14 g, 10.0 mmol) followed by phthalic anhydride (1.48
g, 10.0 mmol) to give a suspension. The mixture was heated at 132-135 oC to give a
homogenous solution at which point the solid was started separating out. The
reaction mixture was cooled to 25 oC, filtered under suction, washed with mixture of
p-xylene-hexane and dried to give the p-TsOH salt (4.10 g, 9.25 mmol, 98%). The
salt (4.0 g, 9.615 mmol) in dichloromethane (35 mL) was stirred overnight with
saturated NaHCO3 solution (10 mL). The organic layer was separated, dried over
anhydrous Na2SO4, filtered and concentrated on a rotavapor to give compound
(1S,2S)-N-phthaloyl-1,2-diaminocyclohexane 271 as a light brown solid (2.15 g,
8.811 mmol, 91%). δH (300 MHz, CDCl3) 7.81 (2H, m, o-CH of Ph), 7.69 (2H, m,
m-CH of Ph), 3.83 (1H, dt, J 11.4, 3.6, -CHNPhth), 3.45 (1H, dt, J 10.8, 4.2, -
CHNH2), 2.18 (1H, br d, -CH2 cycl), 2.06 (1H, br d, -CH2 cycl), 1.90-1.70 (4H, m, -
NH2, -CH2 cycl), 1.53-1.10 (4H, m, -CH2 cycl); δc (75 MHz, CDCl3) 168.18(2C),
133.21(2C), 131.32(2C), 122.51(2C), 57.45, 50.21, 35.56, 28.70, 24.95, 24.39; m/z
ESI-MS [M+H]+ 245.0. The spectroscopic data were in agreement with literature
values.255
(1S,2S)-Phenylphosphonic bis(N-phthaloyl-1-cyclohexyl-2-amide) (272).
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This is a novel compound and the method is based on a reported synthesis.253
To a solution of phenylphosphonic dichloride (0.290 mL, 1.992 mmol, 0.486 eq) in
dichloromethane (20 mL) was added TEA (2.805 mL, 20.162 mmol, 4.92 eq) and
DMAP (24 mg, 0.199 mmol, 0.0486 eq) at 0 oC under an inert atmosphere. To this, a
solution of (1S,2S)-N-Phthaloyl-1,2-diaminocyclohexane 271 (1.0 g, 4.098 mmol) in
dichloromethane (20 mL) was added dropwise. The resulting mixture was stirred at
20-21 oC for 18 h. The reaction mixture was diluted with distilled water (50 mL) and
extracted with dichloromethane (3 x 30 mL). The combined organic layer was
washed saturated NaHCO3 solution (20 mL), distilled water (2 x 50 mL), and brine
solution. The organic layer was separated, dried over anhydrous MgSO4, filtered and
the filtrate was concentrated under reduced pressure on a rotavapor to give a brown
oil. The oil was purified by flash column chromatography and a pure compound was
eluted in MeOH:CHCl3 (1:9). The pure compound (1S,2S)-phenylphosphonic bis(N-
phthaloyl-1-cyclohexyl-2-amide) 272 was obtained as an oil (0.600 g, 0.984 mmol,
48%). [α]D28 = +84.5 (c 0.110 in CHCl3); νmax 3348, 2932, 2856, 1765, 1700, 1390,
1372, 1192, 1152, 1074, 904, 716, 696 cm-1; δH (300 MHz, CDCl3) 7.90 (2H, br s, o-
CH of Phth), 7.81 (2H, m, o-CH of Phth), 7.53 (2H, m, m -CH of Phth), 7.47 (2H, m,
m -CH of Phth), 7.08 (2H, m, o-CH of Ph), 6.85 (1H, dt, J 7.5, 1.5, p-CH of Ph),
6.69 (2H, dt, J 7.5, 3.6, -CH of Ph), 3.78 (2H, m, -2 x CHNH), 3.65 (2H, m, -
CHNPhth), 2.29-2.06 (6H, m, -CH2 cycl), 1.78 (3H, br d, -CH2 cycl), 1.59 (2H, br d,
-CH2 cycl), 1.44-1.08 (7H, m, -CH2 cycl); δc (75 MHz, CDCl3) 168.39(4C), 133.37,
132.54(2C), 130.26, 130.14, 129.93, 126.96, 126.78, 122.75, 122.17, 55.78, 55.68,
55.62, 55.55, 50.42, 36.34, 36.28, 28.95, 28.38; m/z ESI-MS [M+H]+ 611.2; HRMS
found 633.2236 (C34H35N4O5P+Na requires 633.2237, error = 0.3 ppm).
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Attempted synthesis of (1S,2S)-phenylphosphonic bis(1-amino-2-
cyclohexylamide) (261).
The method is based on a reported synthesis.253
To a solution of compound 272 (0.600 g, 0.984 mmol) in ethanol (15 mL) was added
hydrazine hydrate (0.138 mL, 4.488 mmol, 4.50 eq) at 20-21 oC. The reaction
mixture was slowly heated to reflux at 77-78 oC and during 10 min the solid was
started separating out. The reaction mixture was refluxed for additional 2 h. The
reaction mixture was cooled to 20 oC, diluted with diethyl ether (10 mL) and a solid
was filtered off. The filtrate was concentrated under reduced pressure to give a
brown oil. The brown oil (0.400 g) was analysed by 1H-NMR and ESI-MS. Both
data do not comply for formation of required product and ESI-MS shows the
formation of low molecular weight product (282). δH (300 MHz, CDCl3) 7.84 (2H, br
s, o-CH of Ph), 7.49 (3H, m, m,p-CH of Ph ), 4.11 (2H, m), 2.64 (2H, m), 2.28 (1H,
m), 1.90 (2H, m), 1.30 (3H, m), 1.26-1.01 (4H, m); 31P-NMR δP (300 MHz, CDCl3)
21.94, 21.70; m/z ESI-MS [M+H]+ 283.1.
3.1.3 Synthesis of (1S,2S)-N,N-dimethyl-N’-(diphenylphosphinyl)-1,2-
diaminocyclohexane (262).252a, 255
(1S,2S)-N,N-Dimethyl-N'-phthaloyl-1,2-diaminocyclohexane (273).
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This is a known compound and the method is based on a reported synthesis.255
A mixture of (1S,2S)-N-phthaloyl-1,2-diaminocyclohexane 271 (2.00 g, 8.196
mmol), 80% formic acid (3.4 mL) and 37% formaldehyde solution (1.46 mL, 18.08
mmol, 2.20 eq) was stirred under reflux (heating temperature 125 oC) for 6 h. The
reaction mixture was cooled to 25-28 oC and concentrated under reduced pressure to
give a brown residue. The residue was taken up in dichloromethane (50 mL) and was
added slowly to saturated NaHCO3 solution (15 mL) with stirring. The organic layer
was separated, dried over anhydrous MgSO4 and evaporated under reduced pressure
to give brown solid. The solid was crystallised from benzene-hexane to give
compound (1S,2S)-N,N-dimethyl-N'-phthaloyl-1,2-diaminocyclohexane 273 as off
white solid (1.25 g, 4.595 mmol, 56%). δH (300 MHz, CDCl3) 7.78 (2H, m, o-CH of
Ph), 7.65 (2H, m, m-CH of Ph), 4.08 (1H, dt, J 11.5, 3.6, -CHNPhth), 3.28 (1H, dt, J
11.4, 3.6, -CHN(CH3)2), 2.12 (6H, s, -N(CH3)2), 1.97-1.70 (5H, m, -CH2 cycl), 1.40-
1.11(3H, m, -CH2 cycl); δc (75 MHz, CDCl3) 168.08, 132.94, 131.63, 122.36, 61.54,
51.63, 39.65, 29.64, 25.14, 24.48, 22.13; m/z ESI-MS [M+H]+ 273.1. The
spectroscopic data were in agreement with literature values.255
(1S,2S)-N,N-Dimethyl-1,2-diaminocyclohexane (274).
This is a known compound and the method is based on a reported synthesis.255
To a solution of (1S,2S)-(+)-N,N-dimethyl-N'-phthaloyl-1,2-diaminocyclohexane 273
(1.17 g, 5.032 mmol) in ethanol (20 mL) was added hydrazine hydrate (0.603 mL,
19.376 mmol, 3.85 eq) at 20-21 oC. The reaction mixture was slowly heated to reflux
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at 77-78 oC and during 10 min the solid started separating out. The reaction mixture
was refluxed for additional 2 h. The reaction mixture was cooled to 20 oC, diluted
with diethyl ether (10 mL) and solid was filtered off. The filtrate was concentrated
under reduced pressure to give a brown oil. The oil was dissolved in a mixture of
diethyl ether: distilled water (1:1) (5 mL) and the aqueous layer was acidified to pH
5 using 4M HCl solution. The organic layer was separated and the aqueous phase
was extracted with diethyl ether (2 x 20 mL). The aqueous phase was basified to pH
11 by using 2N NaOH solution and extracted with EtOAc (6 x 20 mL). The
combined organic layers were dried over anhydrous MgSO4, filtered and the filtrate
was concentrated under reduced pressure to give compound (1S,2S)-N,N-dimethyl-
1,2-diaminocyclohexane 274 as brown oil (0.386 g, 2.718 mmol, 63%). δH (300
MHz, CDCl3) 2.58 (1H, dt, J 10.2, 4.2, -CHNH2), 2.24 (6H, s, -N(CH3)2), 2.05 (1H,
m, -CHN(CH3)2), 1.95 (1H, m, -CH2 cycl), 1.82-1.63 (5H, m, -NH2, -CH2 cycl),
1.27-1.02 (4H, m, -CH2 cycl); δc (75 MHz, CDCl3) 69.73, 51.40, 40.19(2C), 35.11,
25.59, 25.07, 20.57; m/z ESI-MS [M+H]+ 143.1. The spectroscopic data were in
agreement with literature values.255
(1S,2S)-N,N-Dimethyl-N’-(diphenylphosphinyl)-1,2-diaminocyclohexane
(262).252(a)
This is a known compound and the method is based on a reported synthesis.252(a)
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To a solution of (1S,2S)-N,N-dimethyl-1,2-diaminocyclohexane 274 (0.35 g, 2.465
mmol) in dichloromethane (20 mL) was added diisopropyl ethyl amine (0.751 mL,
0.515 mmol, 1.75 eq) under inert atmosphere and cooled to -30 oC. To this,
diphenylphosphinic chloride (0.515 mL, 2.705 mmol, 1.097 eq) was added dropwise.
The resulting mixture was stirred at 20-21 oC for 2 h. The reaction mixture was
diluted with dichloromethane (70 mL). The organic layer was washed with saturated
NaHCO3 solution (20 mL), distilled water (20 mL), dried over anhydrous MgSO4,
filtered and the filtrate was concentrated under reduced pressure on a rotavapor to
give compound (1S,2S)-N,N-dimethyl-N’-(diphenylphosphinyl)-1,2-
diaminocyclohexane 262 as a off white solid (0.400 g, 1.169 mmol, 47%). Mp 104-
106 oC; [α]D15 = +42.75 (c 0.504 in CHCl3); νmax 3315, 3211, 2927, 2850, 2775,
2369, 1448, 1435, 1190, 1177, 1122, 1107, 1096, 751, 723, 697 cm-1; δH (300 MHz,
CDCl3) 7.88 (2H, m, o-CH of -POPh2), 7.77 (2H, m, o-CH of -POPh2), 7.52-7.39
(6H, m, m,p-CH of-POPh2), 4.75 (1H, d, J 7.2, -NHPOPh2), 3.14 (1H, m, -
CHNHPOPh2), 2.27 (1H, br d, -CHN(CH3)2), 2.20 (6H, s, -N(CH3)2), 2.14 (1H, br d,
-CH2 cycl), 1.73 (2H, br d, -CH2 cycl), 1.49 (1H, br d, -CH2 cycl), 1.27-1.02 (4H, m,
-CH2 cycl); δc (75 MHz, CDCl3) 164.22(2C), 132.15, 132.03, 131.49, 131.36(3C),
128.52, 128.35, 128.29, 128.12, 68.04, 67.93, 52.22, 40.00, 34.15, 25.28, 24.49,
20.69; m/z ESI-MS [M+H]+ 343.1; HRMS found 343.1925 (C20H27N2OP+H+
requires 343.1934, error = 2.43 ppm). The spectroscopic data were in agreement with
literature values.252(a)
3.1.4 Attempted Synthesis of (1S,2S)-phenylphosphonic bis(N,N-dimethyl-
cyclohexyl-2-amide) (263).
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The procedure is same as described for the synthesis of compound (1S,2S)-phenyl
phosphonic bis[1-(N-t-butyloxycarbonylamino)-2-cyclohexylamide] 269.
The crude residue was purified by scratching in hexane to give the solid (0.180 g).
The solid was analysed by 1H-MNR and ESI-MS. 1H-MNR was complex, the
compound was analysed by 31P-NMR δP (300 MHz, CDCl3) 21.14, 12.65; m/z ESI-
MS [M+H]+ 547.2; HRMS found 547.2960 (C28H45N4O3P2 H+ requires 547.2961,
error = 0.27 ppm).
3.1.5 (1R,2R)-N,N-Dimethyl-N’-tosyl-1,2-diaminocyclohexane (264).
This is a known compound, but not fully characterized.84 The method is based on a
reported synthesis.255
A mixture of (1R,2R)-N-tosyl-1,2-diaminocyclohexane 148 (1.00 g, 2.725 mmol),
80% formic acid (1.54 mL) and 37% formaldehyde solution (0.664 mL, 8.193 mmol,
2.20 eq) was stirred under reflux (heating temperature 125 oC) for 6 h. The reaction
mixture was cooled to 25-28 oC and concentrated under reduced pressure to give a
residue. The residue was dissolved in dichloromethane (50 mL) and was added
slowly to a saturated NaHCO3 solution (15 mL) with stirring. The organic layer was
separated, dried over anhydrous MgSO4 and evaporated under reduced pressure to
give a white solid. The solid was crystallised from diethyl ether to give compound
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(1R,2R)-N,N-dimethyl-N’-tosyl-1,2-diaminocyclohexane 264 as a colourless
crystalline solid (0.900 g, 3.040 mmol, 81%). Mp 96-98 oC; [α]D15 = -81.7 (c 0.500
in CHCl3); νmax 3168, 2930, 2866, 2369, 1598, 1453, 1395, 1381, 1342, 1158, 1087,
1040, 812, 713 cm-1; δH (300 MHz, CDCl3) 7.76 (2H, d, J 8.1, o-CH of -SO2PhCH3),
7.29 (2H, d, J 7.8, m-CH of -SO2PhCH3), 6.08 (1H, br s, -NHTs), 2.60 (1H, dt, J
10.35, 3.9, -CHNHTs), 2.42 (3H, s, -SO2PhCH3), 2.36 (1H, br d, -CH2 cycl), 2.14
(1H, dt, J 11.1, 3.0, -CHN(CH3)2), 1.92 (6H, s, -N(CH3)2), 1.75 (2H, br d, -CH2
cycl), 1.64 (1H, m, -CH2 cycl), 1.32-0.89 (4H, m, -CH2 cycl); δc (75 MHz, CDCl3)
129.51(2C), 127.37(2C), 66.18, 54.03, 39.61(2C), 32.58, 25.04, 24.21, 21.55, 20.98;
m/z ESI-MS [M+H]+ 297.1; HRMS found 297.1630 (C15H24N2O2+H+ requires
297.1631, error = 0.39 ppm).
3.2 Synthesis of derivatives of 1,2-diphenylethanediamine
3.2.1 Synthesis of (4R,5R)-2-[(t-butyldiphenylsilyloxy)methyl]-4,5-diphenyl-1-
tosylimidazolidine (278).
2-(t-Butyldiphenylsilyloxy) ethanol (287).
This is a known compound and the method is based on a reported synthesis.256
To a solution of ethylene glycol 286 (4.86 mL, 87.288 mmol, 6.0 eq) in dry THF (75
mL) was added imidazole (1.090 g, 16.017 mmol) under inert atmosphere and stirred
for 5-7 min. To this t-butyldiphenylsilyl chloride (3.78 mL, 14.548 mmol, 1.0 eq)
was added dropwise. The resulting hazy solution was stirred at 20-21 oC for 24 h
under inert atmosphere. The reaction mixture was quenched with mixture of distilled
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water and diethyl ether (80 mL, 1:1). The organic layer was separated and aqueous
layer was extracted with diethyl ether (3 x 40 mL). The combined organic layer was
dried over anhydrous MgSO4, filtered and evaporated to give a crude oil. The oil was
purified by column chromatography using pentane: EtOAc (4:1) to give compound
2-(t-butyldiphenylsilyloxy) ethanol 287 as an oil (3.80 g, 12.667 mmol, 87%). νmax
3491, 3071, 2931, 2858, 1589, 1472, 1427, 1107, 1048, 937, 822, 736, 699 cm-1; δH
(300 MHz, CDCl3) 7.67 (4H, dd, J 7.5, 1.5, o-CH of both Ph), 7.41 (6H, m, m,p-CH
of both Ph), 3.76 (2H, m, -CH2-OTBDPS), 3.69 (2H, br s, -CH2-OH), 2.14 (1H, br s,
-OH), 1.06 (9H, s, -C(CH3)3); δc (300 MHz, CDCl3) 134.92(4C), 132.63(2C),
129.21(2C), 127.16(4C), 64.36, 63.12, 26.23(3C), 18.77; m/z ESI-MS [M+Na]+
323.1. The spectroscopic data were in agreement with literature values.256
t-Butyldiphenylsiloxy acetaldehyde (276).
This is a known compound and the method is based on a reported synthesis.257
A solution of oxalyl chloride (2 M solution in DCM) (7.4 mL, 14.80 mmol, 1.2 eq)
into dry DCM (70 mL) was cooled to -78 oC under inert atmosphere. To this DMSO
(2.10 mL, 29.60 mmol, 2.4 eq) was added dropwise at -78 oC over a period of 10
min followed by solution of compound 2-(t-butyldiphenylsilyloxy) ethanol 287 (3.70
g, 12.333 mmol, 1.0 eq) into dry DCM (30 mL) over a period of 20-25 min by
maintaining temp below -70 oC. The resulting suspension was stirred at -78 oC for 30
min and quenched with TEA (8.58 mL, 61.665 mmol, 5.0 eq). The reaction mixture
was brought to 20-21 oC and stirred for 30 min. The reaction mixture was
concentrated on a rotavapor to give a residue. The residue was stirred in
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hexane:EtOAc (4:1) and filtered through bed of silica. The filtrate was concentrated
to give a yellow oil. The crude oil was purified by column chromatography using
mobile phase hexane:EtOAc (92:8) to give compound t-butyldiphenylsiloxy
acetaldehyde 276 as yellowish oil (2.80 g, 9.396 mmol, 76%). νmax 2957, 2932,
2891, 2858, 1737, 1472, 1463, 1427, 1105, 822, 737, 700 cm-1; δH (300 MHz,
CDCl3) 9.72 (1H, s, -CHO), 7.65 (4H, m, o-CH of both Ph), 7.42 (6H, m, m,p-CH of
both Ph), 4.21 (2H, s, -CH2), 1.10 (9H, s, -C(CH3)3); δc (75 MHz, CDCl3) 201.12,
134.90(4C), 131.87(2C), 129.46(2C), 127.32(4C), 69.38, 26.09(3C), 18.65; m/z ESI-
MS [M+H]+ 299.1. The spectroscopic data were in agreement with literature
values.257
(4R,5R)-2-[(t-Butyldiphenylsilyloxy)methyl]-4,5-diphenyl-1-tosylimidazolidine
(278).
To a solution of (1R,2R)-(-)-TsDPEN 64 (0.922 g, 2.516 mmol) into dry MeOH (10
mL) was added MS 4Å (1 g) under inert atmosphere. To this, a solution of
compound t-butyldiphenylsiloxy acetaldehyde 276 (0.9 g, 3.02 mmol, 1.2 eq) in dry
MeOH (10 mL) was added dropwise at 20-21 oC followed by acetic acid (170 µL,
2.966 mmol, 1.179 eq). The resulting mixture was stirred at 20-21 oC for 4 h during
which time a white solid was separated out in the reaction mixture. The solid was
filtered and washed with methanol. The solid was taken up in DCM (40 mL), filtered
and the filtrate was evaporated on rotavapor to give a white solid. The solid was
purified by column chromatography using DCM to give compound (4R,5R)-2-[(t-
butyldiphenylsilyloxy)methyl]-4,5-diphenyl-1-tosylimidazolidine 278 as white solid
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(1.3 g, 2.012 mmol, 80%). Mp 150-152 oC; [α]D15 = -31.9 (c 0.630 in CHCl3); νmax
3312, 3020, 2957, 2859, 1598, 1494, 1460, 1447, 1428, 1346, 1305, 1161, 1106,
1028, 1036, 983, 850, 836, 804, 761, 730, 702, 666, 653 cm-1; δH (300 MHz, CDCl3)
7.72 (4H, m, o-CH of -OTBDPS), 7.51 (2H, d, J 8.1, o-CH of -SO2PhCH3), 7.40
(6H, m, m,p-CH of -OTBDPS), 7.24-7.13 (10H, m, o,m,p-CH of both -Ph), 6.90 (2H,
dd, J 7.5, 1.2, m-CH of -SO2PhCH3), 4.90 (1H, m, -CH-CH2OTBDPS), 4.47 (1H, d,
J 6.0, -CH-NTs-), 4.15 (2H, dd, J 110.5, 6.3, -CH-NH- and -CH2-OTBDPS), 4.06
(1H, dd, J 10.8, 3.3, -CH2-OTBDPS), 2.80 (1H, br s, -NH), 2.39 (3H, s, -
SO2PhCH3), 1.09 (9H, s, -C(CH3)3); δc (75 MHz, CDCl3) 143.02, 139.18, 138.11,
135.11(2C), 135.07(2C), 133.32, 132.99, 132.43(2C), 129.25(2C), 128.90(2C),
127.83(2C), 127.71(4C), 127.23(2C), 127.19, 126.94, 126.86, 126.26(2C),
126.11(2C), 76.88, 70.44, 68.44, 64.38, 26.34(3C), 20.95, 18.67; m/z ESI-MS
[M+H]+ 647.3; HRMS found 647.2770 (C39H42N2O3SSi H+ requires 647.2758, error
= -1.9 ppm).
3.2.2 Synthesis of (4R,5R)-4,5-diphenyl-1-tosylimidazolidine-2-methanol (282).
This is a novel compound and the method is based on a reported synthesis.258
To a solution of compound (4R,5R)-2-[(t-butyldiphenylsilyloxy)methyl]-4,5-
diphenyl-1-tosylimidazolidine 278 (1.0 g, 1.548 mmol) in dry THF (10 mL) was
added TBAF (1 M solution in THF) (2.322 mL, 2.322 mmol, 1.5 eq) at 0 oC. The
resulting mixture was stirred at 20-21 oC for 24 h. The reaction mixture was
concentrated on a rotavapor to give a residue. The residue was purified by column
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chromatography using hexane: EtOAc (1:1) to give compound (4R,5R)-4,5-diphenyl-
1-tosylimidazolidine-2-methanol 282 as a white solid (0.540 g, 1.323 mmol, 85%).
Mp 154-156 oC; [α]D15 = -89.91 (c 0.585 in CHCl3); νmax 3494, 3322, 3288, 2923,
1597, 1494, 1449, 1339, 1325, 1151, 1090, 1061, 1015, 965, 812, 728, 703 cm-1; δH
(300 MHz, CDCl3) 7.62 (2H, d, J 8.1, o-CH of -SO2PhCH3), 7.22 (10H, m, o,m,p-
CH of of both -Ph), 6.93 (2H, dd, J 7.5, 1.5, m-CH of -SO2PhCH3), 5.02 (1H, br s, -
CH-CH2OH), 4.59 (1H, d, J 7.2, -CH-NTs-), 4.32-4.21 (1H, br s, -CH-NH-), 3.92
(2H, br m, -CH2OH), 2.54 (1H, br s, -OH), 2.42 (3H, s, -SO2PhCH3), 2.33 (1H, br s,
-C(CH3)3); δc (75 MHz, CDCl3) 144.09, 139.27, 137.44, 134.07, 129.76(2C),
128.82(2C), 128.53(2C), 128.10, 127.81(2C), 127.71, 126.78(2C), 126.50(2C),
77.95, 71.14, 69.95, 63.67, 21.58; m/z ESI-MS [M+H]+ 409.5; HRMS found
409.1577 (C23H24N2O3S H+ requires 409.1580, error = 0.9 ppm).
3.2.3 Synthesis of (4R,5R)-2-[(benzyloxy)methyl]-4,5-diphenyl-1-
tosylimidazolidine (283).
2-(Benzyloxy)ethanol (288).
This is a known compound and the method is based on a reported synthesis.259
To a solution of ethylene glycol (48.91 mL, 877.04 mmol, 10 eq) in DMF:MeOH
(50 mL, 1:1) was added NaH (5.12 g, 171.023 mmol, 1.95 eq) portionwise over a
period of 20-25 min. The resulting hazy solution was stirred at 20-21 oC for 17 h
under inert atmosphere. To this, benzyl bromide (10.43 mL, 87.704 mmol, 1.0 eq)
was added dropwise and the resulting mixture was stirred at 21-22 oC for 24 h. The
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reaction mixture was quenched with 10% HCl solution and extracted with EtOAc (3
x 100 mL). The combined organic layers were washed with brine, dried over
anhydrous Na2SO4, filtered and concentrated to give crude oil. The oil was purified
by fractional distillation at 78-90 oC at 1.5 mbar to give compound 2-
(benzyloxy)ethanol 288 as a colourless oil (3.8 g, 25.00 mmol, 28%). νmax 3388,
2928, 2866, 1718, 1662, 1453, 1066, 1027, 888, 736, 690 cm-1; δH (300 MHz,
CDCl3) 7.34 (5H, m, -C6H5), 4.56 (2H, s, -OCH2Ph), 3.76 (2H, t, J 4.5, -CH2-
OCH2Ph), 3.60 (2H, t, J 4.5, -CH2OH), 2.16 (1H, br s, -OH); δc (75 MHz, CDCl3)
132.27, 127.87, 127.23, 72.69, 70.79, 61.25; m/z ESI-MS [M+Na]+ 175.0. The
spectroscopic data were in agreement with the literature values. 259
2-(Benzyloxy)acetaldehyde (289).
This is a known compound and the method is based on a reported synthesis.260
A solution of oxalyl chloride (2 M solution in DCM) (7.89 mL, 15.789 mmol, 1.2
eq) into dry DCM (70 mL) was cooled to -78 oC under inert atmosphere. To this
DMSO (2.23 mL, 31.56 mmol, 2.4 eq) was added dropwise at -78 oC over a period
of 10 min followed by solution of compound 2-(benzyloxy)ethanol 288 (2.0 g,
13.150mmol, 1.0 eq) into dry DCM (30 mL) over a period of 20-25 min by
maintaining temp below -70 oC. The resulting suspension was stirred at -78 oC for 30
min and quenched with TEA (9.15 mL, 65.750 mmol, 5.0 eq). The reaction mixture
was brought to 20-21 oC and stirred for 30 min. The reaction mixture was diluted
with diethyl ether and filtered through bed of MgSO4. The filtrate was concentrated
to give a yellow oil. The crude oil was filtered through a short silica gel column to
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give compound 2-(benzyloxy)acetaldehyde 289 as yellowish oil (0.530 g, 3.533
mmol, 26%). The crude product was as such used for next step.
(4R,5R)-2-[(Benzyloxy)methyl]-4,5-diphenyl-1-tosylimidazolidine (283).
The procedure is same as for preparation of compound (4R,5R)-2-[(t-
butyldiphenylsilyloxy)methyl]-4,5-diphenyl-1-tosylimidazolidine 278. During the
reaction solid was not separated out. The reaction mixture was filtered, washed with
methanol and filtrate was concentrated to give a crude oil. The oil was purified by
column chromatography using hexane:EtOAc (8:2) to give compound (4R,5R)-2-
[(benzyloxy)methyl]-4,5-diphenyl-1-tosylimidazolidine 283 as a colourless oil (1.1
g, 2.209 mmol, 73%). [α]D15 = -44.9 (c 0.510 in CHCl3); νmax 1731, 1282, 1073, 968,
699 cm-1; δH (300 MHz, CDCl3) 7.55 (2H, d, J 8.4, o-CH of -SO2PhCH3), 7.31 (7H,
m, o,m,p-CH of both Ph), 7.18 (8H, m, o,m,p-CH of -OCH2Ph, -CH of both Ph),
6.92 (2H, dd, J 7.5, 1.5, m-CH of -SO2PhCH3), 5.04 (1H, m, -CH-CH2OCH2Ph),
4.67 (2H, dd, J 11.7, 5.4, -CH2 of -OCH2Ph), 4.58 (1H, d, J 6, -CH-NTs-), 4.28 (1H,
d, J 6, -CH-NH-), 4.03 (1H, dd, J 6, 4.2, -CH2-OCH2Ph), 3.92 (1H, dd, J 6.9, 3.3, -
CH2-OCH2Ph), 2.39 (3H, s, -SO2PhCH3), 2.17 (1H, s, -NH); δc (75 MHz, CDCl3)
143.61, 140.03, 138.40, 137.94, 134.22, 129.52(2C), 128.55(2C), 128.46(2C),
128.33(2C), 127.91(2C), 127.81, 127.74(2C), 127.60, 127.49, 126.76(4C), 76.36,
73.65, 71.32, 70.86, 69.60, 21.55; m/z ESI-MS [M+H]+ 499.5; HRMS found
499.2070 (C30H30N2O3S H+ requires 499.2050, error = -4.0 ppm).
3.2.4 (4R,5R)-2-Benzyl-4,5-diphenyl-1-tosylimidazolidine (284).
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The procedure is same as for preparation of compound (4R,5R)-2-[(t-
butyldiphenylsilyloxy)methyl]-4,5-diphenyl-1-tosylimidazolidine 278 During the
reaction a solid did not separate out. The reaction mixture was filtered, washed with
methanol and the filtrate was concentrated to give a crude oil. The oil was purified
by column chromatography using hexane:EtOAc (8:2) to give compound (4R,5R)-2-
benzyl-4,5-diphenyl-1-tosylimidazolidine 284 as yellowish solid (0.230 g, 0.491
mmol, 72%). Mp 68-70 oC; [α]D24 = -14.4 (c 0.540 in CHCl3); νmax 3028, 291, 1599,
1494, 1453, 1343, 1160, 1090, 812, 746, 699, 662 cm-1; δH (300 MHz, CDCl3) 7.61
(2H, d, J 11.2, o-CH of -SO2PhCH3), 7.31 (5H, m, o,m,p-CH of both Ph), 7.19 (10H,
m, o,m,p-CH of both Ph), 6.90 (2H, dd, J 9.6, 1.6, m-CH of -SO2PhCH3 ), 5.12 (1H,
dd, J 12, 4, -CH-CH2Ph), 4.54 (1H, d, J 8.8, -CH-NTs-), 4.29 (1H, d, J 8.83, -CH-
NH-), 3.46 (1H, dd, J 18.4, 4, -CH2Ph), 3.24 (1H, dd, J 18.4, 12.4, -CH2Ph), 2.40
(3H, s, -SO2PhCH3), 2.29 (1H, br s, -NH); δc (75 MHz, CDCl3) 143.67, 139.84,
138.14, 137.22, 134.27, 129.91(2C), 129.57(2C), 128.55(4C), 128.38(2C),
127.73(4C), 127.46, 126.78(2C), 126.52(2C), 78.98, 71.21, 69.64, 42.63, 21.56; m/z
ESI-MS [M+H]+ 469.1; HRMS found 469.1948 (C29H28N2O2S H+ requires
469.1944, error = -0.9 ppm).
3.3 Use of synthesised derivatives as organocatalysts in asymmetric
reactions
3.3.1 5-Nitro-4-phenylpentan-2-one (54).
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This is a known compound.
To a test tube fitted with a magnetic stirrer was added trans-β-nitrostyrene (90.4 mg,
0.606 mmol, 1.0 eq), acetone (0.445 mL, 6.06 mmol, 10 eq) distilled water (21.8 µL,
1.21 mmol, 2 eq), glacial acetic acid (3.47 µL, 0.0606mmol, 0.1 eq), catalyst (10
mol%) and solvent (1.0 mL). The reaction mixture was stirred at ambient
temperature for 17 h. The reaction was monitored by 1H-NMR. The small fraction of
reaction mixture was taken, filtered through a plug of silica, concentrated and taken
for 1H-NMR. After 5 days, the reaction mixture was concentrated on a rotavapor.
The residue was purified by flash column chromatography to give compound 5-
nitro-4-phenylpentan-2-one 54 as an off white solid (40 mg, 0.195 mmol, 32%). δH
(300 MHz, CDCl3) 7.21 (5H, m, -C6H5), 4.63 (1H, m, -CHHNO2), 4.53 (1H, m, -
CHHNO2), 3.94 (1H, m, -CHC6H5), 2.84 (2H, d, J 6.9, -CH2CO), 2.05 (3H, s, -CH3).
δc (75 MHz, CDCl3) 138.82, 129.09(2C), 127.93, 127.39(2C), 79.46, 46.13, 39.04,
30.42 (The chiral HPLC method was already optimised in the group after reduction
of the product75) The spectroscopic data were in agreement with literature values.78
5-Nitro-4-phenylpentan-2-ol (268).
This is a known compound.76
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To a solution of 5-nitro-4-phenylpentan-2-one 54 (35 mg, 0.169 mmol) in
dichloromethane (0.25 mL) and methanol (0.25 mL) was added sodium borohydride
(7 mg, 0.186 mmol, 1.1 eq) at ambient temperature. The reaction mixture was stirred
for 1.5 h. The reaction mixture was quenched with 1M HCl (2 mL) and stirred for 5-
8 min. The reaction mixture was extracted with dichloromethane (3 x 5 mL). The
organic layer was separated, washed with distilled water (5 mL), dried over
anhydrous MgSO4, filtered and evaporated under reduced pressure to give an oil.
The oil was purified by flash column chromatography to give 5-nitro-4-
phenylpentan-2-ol 268 as a colourless oil (15 mg, 0.071 mmol, 42%). νmax 3375,
2968, 2932, 1560, 1495, 1455, 1432, 1378, 764, 700, 668 cm-1; δH (300 MHz,
CDCl3, Me4Si) 7.29 (5H, m, -C6H5), 4.62 (2H, m, -CH2NO2), 3.64 (2H, m, -CH2),
1.95 (1H, m, -CH), 1.78 (1H, d, J 6.9, -CHOH), 1.58 (1H, br s, -OH), 1.16 (3H, m, -
CH3); m/z ESI-MS [M+Na]+ 232.0; The enantiomeric excess was obtained by HPLC
analysis (ChiralPak IB Column: 0.46 cm x 25 cm, hexane:IPA 95:5, 0.50 mL/min,
210 nM, 17
o
C). Method previously developed: separation achieved on IB column
with best separation on more polar isomer (HPLC conditions: Chiralpak IB, 0.46 cm
x 25 cm, hexane:IPA 95:5, 0.50 mL/min, 210 nm uv detection, 17
o
C; ‘fast’
diastereoisomer by flash chromatography; 43.8 min (overlapping, no separation),
‘slow’isomer; 56.7 min (Major from R ketone), 65.3 min (minor from S ketone). The
spectroscopic data were in agreement with literature values.76
3.3.2 Methyl 2-carbomethoxy-4-nitro-3-phenylbutyrate (72).
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This is a known compound.66
To a solution of trans-β-nitrostyrene (0.100 g, 0.670 mmol) and catalyst (10 mol%)
in dry toluene (2 mL) was added dimethyl malonate (0.153 mL, 1.340 mmol, 2.0 eq).
The resulting mixture was stirred at ambient temperature for 21 h. The reaction was
monitored by 1H-NMR. The small fraction of reaction mixture was taken, filtered
through a plug of silica, concentrated and taken for 1H-NMR. On 1H-NMR there was
only 9% conversion, the reaction mixture was stirred for 2 days and again checked as
mentioned above. There was only 27% conversion to the required compound methyl
2-carbomethoxy-4-nitro-3-phenylbutyrate 72. νmax 2956, 1732, 1550, 1497, 1455,
1434, 1379, 1152, 699 cm-1; δH (300 MHz, CDCl3, Me4Si) 7.37 (3H, m, m,p-CH of
Ph), 7.22 (2H, m, o-CH of both Ph), 4.87 (2H, m, -CH2NO2), 4.24 (1H, q, J 6.9, -
CH-C6H5), 3.86 (1H, d, J 9, -CH(COOCH3)2), 3.76 (3H, s, -COOCH3), 3.56 (3H, s, -
COOCH3); δc (75 MHz, CDCl3) 167.85, 167.25, 136.12, 129.04(2C), 128.44,
127.86(2C), 77.47, 54.75, 53.03, 52.85, 42.93; m/z ESI-MS [M+H]+ 282.1; The
enantiomeric excess was obtained by HPLC analysis (ChiralPak AD Column: 0.46
cm x 25 cm, hexane:IPA 70:30, 0.50 mL/min, 210 nM, 15
o
C) Rt (min) = 11.13
(minor enantiomer, R), 15.36 min (major enantiomer, S). The spectroscopic data
were in agreement with literature values. 66
3.3.3 4-Hydroxy-4-(2-nitrophenyl)butan-2-one (80).
To a catalyst (10 mol%) and/or metal complex (10 mol%) in acetone (0.270 mL) was
added 2-nitro benzaldehyde (25 mg, 0.166 mmol, 1 eq). The resulting mixture was
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stirred at 20-21 oC and monitored by TLC. For slower reaction, 1H-NMR was done
after 5 days to give % conversion. The reaction mixture was concentrated and crude
residue was purified by column chromatography to give 4-hydroxy-4-(2-
nitrophenyl)butan-2-one 80. The pure compound obtained was analysed by 1H-NMR
and chiral HPLC. δH (300 MHz, CDCl3, Me4Si) 7.96 (1H, dd, J 9.6, 1.2, -CH of Ph),
7.89 (1H, dd, J 7.8, 1.2, -CH of Ph), 7.66 (1H, dt, J 7.6, 1.2, -CH of Ph), 7.44 (1H,
dt, J 7.8, 1.5, -CH of Ph), 5.67 (1H, td, J 9.3, 2.1, -CHOH), 3.75 (1H, d, J 3.0, -OH),
3.14 (1H, dd, J 18.0, 2.1, -CH2), 2.72(1H, dd, J 17.7, 9.3, -CH2), 2.24 (3H, s, CH3);
The enantiomeric excess was obtained by HPLC analysis (ChiralPak IB Column:
0.46 cm x 25 cm, hexane:IPA 95:5, 0.50 mL/min, 210 nM, 18
o
C) Rt (min) = 33.58
(minor enantiomer), 35.83 min (major enantiomer). The spectroscopic data were in
agreement with literature values.40,95
3.3.4 2-Nitro-1-(2-nitrophenyl)ethanol (98).
This is a known compound.100-101
A solution of metal complex (10 mol%) and catalyst (10 mol%) in dry ethanol (0.7
mL) was stirred at 20-21 oC for 1-1.5 h. To this, 2-nitro benzaldehyde (25 mg, 0.166
mmol, 1 eq) was added followed by nitromethane (90 µL, 1.660 mmol, 10 eq). The
resulting mixture was stirred at 20-21 oC and monitored by TLC. For slower
reactions, 1H-NMR was done after 4 days to obtain % conversions. The reaction
mixture was concentrated and crude residue was purified by column chromatography
to give 2-nitro-1-(2-nitrophenyl)ethanol 98. νmax 3532, 2919, 1633, 1550, 1520,
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1494, 1454, 1417, 1377, 1343, 1065, 762, 697cm-1; δH (300 MHz, CDCl3, Me4Si)
7.37 (4H, m, -C6H4), 5.47 (1H, dd, J 6.3, 2.4, -CHOH), 4.66 (2H, m, -CH2NO2), 2.94
(1H, br s, -OH); δc (75 MHz, CDCl3) 146.58, 133.81, 133.39, 129.09, 128.09,
124.42, 79.44, 66.16; m/z ESI-MS [M+H]+ 212.1; The enantiomeric excess was
obtained by HPLC analysis (ChiralPak IB Column: 0.46 cm x 25 cm, hexane:IPA
95:5, 0.50 mL/min, 210 nM, 18
o
C) Rt (min) = 31 (major enantiomer, R), 34 min
(minor enantiomer, S).The spectroscopic data were in agreement with literature
values.100-101
3.3.5 Bicyclo[2.2.2.]oct-5-ene-2-carboxaldehyde (293a/293b).
This is a known compound.51,240
To a mixture of catalyst (42.7 mg, .0624 mmol, 0.1 eq) in CH3CN:H2O (1 mL, 95:5)
was added acrolein (0.125 mL, 1.872 mmol, 3.0 eq) and resulting solution was
stirred for 5 min. To this, 1,3-cyclohexadiene (69.5 µL, 0.824 mmol, 1.0 eq) was
added. The resulting mixture was stirred at 19-20 oC for 24h. The completion of the
reaction was checked by 1H-MNR. The reaction mixture was diluted with water (5
mL) and extracted with diethyl ether (3 x 5 mL). The combined organic layers were
dried over anhydrous Na2SO4, filtered and evaporated to give mixture of compound
endo 293a and exo 293b as crude oil. A crude 1H-NMR spectrum at this point was
used to determine the endo:exo ratio (known compounds). The crude product was
purified by column chromatography using hexane:EtOAc (92:8) to give endo
compound bicyclo[2.2.2.]oct-5-ene-2-carboxaldehyde 293a as an oil (35 mg, 0.257
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mmol, 41%). νmax 3046, 2940, 2868, 1787, 1700, 1413, 1317, 1236, 1206, 1173,
1049, 984, 949, 904, 695 cm-1; δH (300 MHz, CDCl3, Me4Si) 9.43 (1H, d, J 1.5, -
CHO), 6.31 (1H, t, J 7.5, -CH=CH), 6.09 (1H, t, J 7.5, -CH=CH), 2.93 (1H, m, -
CHH-CHCHO), 2.62 (1H, m, -CHH-CHCHO), 2.54 (1H, m, -CHCHO), 1.68 (3H,
m, -CH and -CH2), 1.53-1.48 (1H, m, -CH), 1.38-1.19 (2H, m, -CH2); δc (75 MHz,
CDCl3) 164.05, 134.75, 130.73, 41.93, 31.74, 28.95, 28.67, 24.71, 23.68; m/z ESI-
MS [M+Na]+ 169;. The enantiomeric excess by using Chiral GC (Chrompak CP-
Chirasil Dex Cβ Column, Oven temperature 115 oC, Injection temperature 220 oC,
Detection temperature 220 oC, Gas Helium) Rt (min) = 43.14 (minor enantiomer),
43.64 min (major enantiomer), %ee = 72%. The spectroscopic data were in
agreement with literature values.51,240
The sample of aldehyde formed 293a was reduced to the corresponding alcohol
using NaBH4 and shown by optical rotation to be of S- configuration; [α]D28 = -13.33
(c 0.06 in EtOH), 72% ee, S- enantiomer, [Literature values reported for this
compound show a wide variation however in all cases the S- enantiomer has a
negative sign: Lit. value 1;240b [α]D28 = +5.36 (c=1.5, EtOH), 100% ee R-
enantiomer, Lit. value 2;240c [α]D25 = +8.4 (c=2.7, EtOH), 71% ee R- enantiomer, Lit.
value 3;240d [α]D28 = -10.2 (c=0.94, EtOH), 99% ee S- enantiomer].
3.3.6 (R)-3-Ethoxycarbonylamino-4-methyl-2-oxazolidinone (109a).
This is a known compound.116
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To a catalyst (10 mol%) was added propionaldehyde 107a (0.110 mL, 1.50 mmol,
1.5 eq) followed by DEAD (0.164 mL, 1.0 mmol, 1.0 eq). The resulting mixture was
stirred at ambient temperature to give colourless solution from yellow (colour of
diethyl azodicarboxylate) (100% conversion). The reaction mixture was diluted with
MeOH (2.5 mL) followed by careful addition of NaBH4 (50 mg, 1.321 mmol, 1.321
eq) and mixture was stirred for 30 min. To this 0.5 N NaOH solution (2.5 mL) was
added and stirred at ambient temperature for 2.5 h. The reaction mixture was
concentrated on a rotavapor, diluted with water (10 mL) and extracted with EtOAc
(3 x 10 mL). The organic layers were combined, dried over anhydrous MgSO4,
filtered and concentrated under reduced pressure to give residue. The crude
compound was purified by flash column chromatography using hexane:EtOAc 20:80
to give compound (R)-3-ethoxycarbonylamino-4-methyl-2-oxazolidinone 109a as a
colourless oil (0.104 g, 0.553 mmol, 55%). [α]D28 = -19.85 (c 1.4 in CHCl3) [Lit.
value [α]D28 = -19.4 (c = 1.7g/100 mL CHCl3)] ; νmax 3284, 2982, 1769, 1721, 1512,
1480, 1416, 1383, 1200, 1114, 1042, 976, 781, 758, 690 cm-1; δH (300 MHz, CDCl3,
Me4Si) 6.60 (1H, br s, -NH), 4.50 (1H, t, J 8.2, -OCHH-CH-), 4.23 (2H, q, J 6.9, -
OCH2CH3), 4.09 (1H, br s, -CH), 3.91 (1H, t, J 8.7, -OCHH-CH-), 1.33-1.27 (6H, m,
-CHCH3 and -OCH2CH3); δc (75 MHz, CDCl3) 68.19, 61.89, 52.24, 16.26, 13.73;
m/z ESI-MS [M+H]+ 189, [M+Na]+ 211; The enantiomeric excess by using Chiral
GC (Chrompak CP-Chirasil Dex Cβ Column, Oven temperature 150 oC, Injection
temperature 220 oC, Detection temperature 220 oC, Gas Helium) Rt (min) = 170.07
min (major enantiomer, R), 172.02 min (minor enantiomer, S), %ee = 95%. The
spectroscopic data were in agreement with literature values.116
(R)- 4-Ethyl-3-ethoxycarbonylamino-2-oxazolidinone (109b).
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This is a known compound.116 The procedure is same as for preparation of compound
(R)-3-ethoxycarbonylamino-4-methyl-2-oxazolidinone 109a.
[α]D28 = -34.6 (c 0.4 in CHCl3) [Lit. value [α]D28 = -25.5 (c = 1.66g/100 mL CHCl3)];
νmax 3289, 2971, 2937, 1767, 1713, 1512, 1423, 1377, 1300,1215, 1121, 1049, 1014,
760, 692 cm-1; δH (300 MHz, CDCl3, Me4Si) 6.96-6.64 (1H, brs, -NH), 4.49 (1H, m,
-NCH), 4.20 (2H, q, J 7.2, OCH2CH3), 4.01(2H, m, OCH2-CH-), 1.84 (1H, m, -CH-
CHH-CH3), 1.59 (1H, m, -CH-CHH-CH3), 1.29 (3H, t, J 7.6, OCH2CH3), 0.93 (3H,
t, J 7.6, -CH2CH3); δc (75 MHz, CDCl3) 67.08, 62.45, 57.59, 24.31, 14.31, 8.41; m/z
ESI-MS [M+H]+ 203, [M+Na]+ 225; The enantiomeric excesses were determined by
Chiral GC (Chrompak CP-ChirasilDex Cβ Column, Oven temperature 150 oC,
Injection temperature 220 oC, Detection temperature 220 oC, Gas Helium) Rt (min) =
144.7 min (minor enantiomer, S), 149.1 min (major enantiomer, R), %ee = 97%. The
spectroscopic data were in agreement with literature value.116
(R)-3-Ethoxycarbonylamino-4-isopropyl-2-oxazolidinone (109c).
This is a known compound.116 The procedure is same as for preparation of compound
(R)-3-ethoxycarbonylamino-4-methyl-2-oxazolidinone 109a.
[α]D28 = -21.29 (c 0.425 in CHCl3) [Lit. value [α]D28 = -18.6 (c = 1.25g/100 mL
CHCl3)]; νmax 3285, 2965, 1770, 1716, 1512, 1482, 1371, 1297, 1215, 1118, 1050,
764, 699 cm-1; δH (300 MHz, CDCl3, Me4Si) 6.69-6.47 (1H, br s, -NH), 4.39 (1H, t, J
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8.7, -OCHH-CH-), 4.21 (2H, q, J 5.4, -OCH2CH3), 4.08 (1H, t, J 8.8, -OCHH-CH-),
3.97 (1H, br s, -OCH2-CH), 2.00 (1H, m, -CH(CH3)2), 1.27 (3H, t, J 5.4, -
OCH2CH3), 0.93 (3H, d, J 7.05, CH(CH3)2), 0.94 (3H, d, J 7.2, -CH3 of -CH(CH3)2);
δc (75 MHz, CDCl3) 63.97, 62.44 60.74, 28.430, 17.76, 15.78, 14.31; m/z ESI-MS
[M+H]+ 217, [M+Na]+ 239; The enantiomeric excess was obtained by using Chiral
GC (Chrompak CP-Chirasil Dex Cβ Column, Oven temperature 180 oC, Injection
temperature 220 oC, Detection temperature 220 oC, Gas Helium) Rt (min) = 72.16
min (minor enantiomer, S), 75.50 min (major enantiomer, R), %ee = 96%. The
spectroscopic data were in agreement with literature values. 116
(R)-4-Benzyl-3-ethoxycarbonylamino-2-oxazolidinone (109d).
This is a known compound.116 The procedure is same as for preparation of compound
(R)-3-ethoxycarbonylamino-4-methyl-2-oxazolidinone 109a.
[α]D28 = -29 (c 0.490 in CHCl3) [Lit. value [α]D28 = -30.6 (c = 1.78g/100 mL
CHCl3)]; νmax 3289, 2967, 1780, 1722, 1505, 1210, 1115, 1050, 751, 709 cm-1; δH
(300 MHz, CDCl3, Me4Si) 7.34-7.28 (3H, m, -Ph), 7.20-7.10 (2H, m, -Ph), 6.66-6.46
(1H, br s, -NH), 4.38-4.32 (2H, m, -CH2OCO), 4.24-4.20 (2H, m, -OCH2CH3), 4.08-
4.00 (1H, m, -NCH), 3.17 (1H, dd, J 13.6, 3.6, -CHH-Ph), 2.80 (1H, dd, J 13.6, 8.4, -
-CHH-Ph), 1.28 (3H, t, J 7.2, -OCH2CH3); δc (75 MHz, CDCl3) 135.12,
128.55(2C), 128.90(2C), 127.23, 67.06, 62.52, 57.69, 37.94, 14.32; m/z ESI-MS
[M+Na]+ 287; The spectroscopic data were in agreement with literature values. 116
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The alcohol was prepared by NaBH4 reduction of the initial addition product without
subsequent cyclisation and isolated in crude form for analysis to avoid inadvertent
enrichment of the ee: δH (300 MHz, CDCl3, Me4Si) 7.25 (5H, m, -Ph), 6.35 (1H, brs,
NH), 4.70-4.50 (1H, OH, two rotamers), 4.25 (3H, br m, -CH, -CH2), 4.05 (2H, br m,
CH2), 4.57-3.40 (2H, br m, CH2), 2.61 (2H, br m, CH2), 1.25 (3H, t, J 7.0, CH3),
1.15 (3H, t, J 6.5,CH3); δc (75 MHz, CDCl3) 137.3, 128.9, 128.8, 128.6, 128.5,
126.7, 63.0, 62.8, 62.0, 34.6, 14.3 (complicated by rotamers); m/z ESI-MS [M+Na]+
333; The enantiomeric excess (example in SI below)was determined by Chiral
HPLC (ChiralPak IA Column: 0.46 cm3x 25 cm, hexane:IPA 90:10, 0.50mL/min,
216 nM, 15 oC) Rt (min) = 22.02 (minor enantiomer), 24.86 min (major enantiomer),
%ee = 84%.
3.4 Synthesis of Ru complexes
3.4.1 Synthesis of N-[(1R,2R)-2-(dimethylamino)-1,2-diphenylethyl]-4-
methylbenzenesulfonamide benzene ruthenium chloride (299).
N-[(1R,2R)-2-(Dimethylamino)-1,2-diphenylethyl]-4-methylbenzenesulfonamide
(300).
This is a known compound.261
To a solution of (1R,2R)-TsDPEN 64 (1.00 g, 2.73 mmol) in dry methanol (30 mL)
was added 37% formaldehyde solution (1 mL, ~ 4.5 eq) and the mixture was stirred
for 15 min at 21 oC under inert atmosphere. To this NaBH3CN (0.684 g, 10.88
mmol, 4.0 eq) was added slowly and the mixture was stirred for 15 min followed by
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addition of acetic acid (2 mL, ~12.5 eq). The reaction mixture was heated to 50 oC
and stirred for 18 h, then cooled to room temperature and diluted with 2% MeOH in
DCM (100 mL). The mixture was washed with 1M NaOH (3 x 100 mL), dried over
anhydrous MgSO4, filtered and the solvent removed on a rotavapor to give
compound N-[(1R,2R)-2-(dimethylamino)-1,2-diphenylethyl]-4-
methylbenzenesulfonamide 300 as white solid (1.08 g, 2.741 mmol, 100%). Mp 102-
104 oC; [α]D24 = +54.9 (c 0.570 in CHCl3); νmax 1452, 1366, 1310, 1147, 1095, 1050,
937, 814, 700 cm-1; δH (300 MHz, CDCl3) 7.47 (2H, d, J 8.4, o-CH of -
SO2C6H4CH3), 7.16 (3H, m, ArH), 7.07 (2H, d, J 8.1, m-CH of -SO2C6H4CH3), 6.92
(7H, m, ArH), 6.81 (1H, br s, -NHTs), 4.61 (1H, d, J 11.1, -CHNHTs), 3.54 (1H, d, J
10.8, -CHN(CH3)2), 2.33 (3H, s, -CH3), 2.06 (6H, s, -N(CH3)2); δc (75 MHz,
CDCl3) 142.61, 137.95, 137.04, 130.89, 129.72(2C), 128.87(2C), 128.32(2C),
127.59(2C), 127.52(2C), 127.23(2C), 126.94(2C), 73.33, 57.21, 40.06(2C), 21.34;
m/z ESI-MS [M+H]+ 395.2; HRMS found 395.1791 (C23H26N2O2S H+ requires
395.1788, error = -1.1 ppm).
N-[(1R,2R)-2-(Dimethylamino)-1,2-diphenylethyl]-4-methylbenzenesulfonamide
benzeneruthenium chloride (299).
This is a novel compound.
A mixture of N-[(1R,2R)-2-(dimethylamino)-1,2-diphenylethyl]-4-
methylbenzenesulfonamide 300 (0.250 g, 0.635 mmol), benzeneruthenium (II)
Experimental
196
chloride dimer (0.318 g, 0.635 mmol, 1.0 eq) and triethylamine (0.353 mL, 2.54
mmol, 4.0 eq) in IPA (25 mL) was heated at 80 oC for 1 h under an inert atmosphere.
The reaction mixture was cooled to room temperature and concentrated to give a
residue. The residue was filtered and washed with water to leave a solid. The solid
was purified by flash column chromatography on Florisil. The complex was eluted in
Hexane:EtOAc:MeOH (5:4:1) to give compound N-[(1R,2R)-2-(dimethylamino)-1,2-
diphenylethyl]-4-methylbenzenesulfonamide benzeneruthenium chloride 299 as light
brown solid (0.145 g, 0.238 mmol, 38%). Mp 146-148 oC with decomposition; [α]D20
= +1687 (c 0.0048 in CHCl3); νmax 2921, 1452, 1437, 1252, 1129, 1086, 942, 809,
699, 663 cm-1; δH (300 MHz, CDCl3) 7.37 (2H, d, J 8.1, o-CH of -SO2C6H4CH3),
7.13 (2H, m, ArH), 6.96 (4H, m, ArH), 6.80 (2H, d, J 7.8, m-CH of -SO2C6H4CH3),
6.58 (4H, m, ArH), 5.79 (6H, s, -C6H6), 4.90 (1H, d, J 11.7, -CHNHTs), 4.58 (1H, d,
J 11.7, -CHN(CH3)2), 3.20 (3H, s, -N(CH3)2), 2.89 (3H, s, -N(CH3)2), 2.20 (3H, s, -
CH3); δc (75 MHz, CDCl3) 142.27, 139.65, 139.19, 130.11(2C), 129.65, 128.96,
128.56, 128.37, 128.10(2C), 127.67, 127.60, 126.80(2C), 126.33(2C), 125,46,
84.46(6C), 76.88, 66.38, 52.24, 50.15, 21.17; m/z ESI-MS [M-Cl]+ 573.0; HRMS
found 573.1147 (C29H31ClN2O2RuS-Cl requires 573.1147, error = 0.7 ppm); The X-
ray Structure was obtained (more details in Appendix 5.1.2).
3.4.2 Synthesis of {N-[(1R,2R)-1,2-diphenylethyl-2-3-(3-
phenylpropyl)(methyl)amino]-4-methylbenzenesulfonamide}ruthenium chloride
monomer (302).
N-[(1R,2R)-2-(3-Cyclohexa-1,4-dienylpropylamino)-1,2-diphenylethyl]-4-
methylbenzenesulfonamide (179).
Experimental
197
This is a known compound.205
To a solution of (1R,2R)-TsDPEN 64 (1.50 g, 4.09 mmol, 1.25 eq) in dry methanol
(20 mL) was added a solution of aldehyde 304 (0.445 g, 3.27 mmol, 1.0 eq) in dry
methanol (10 mL) and MS 4Å (1.5 g) followed by acetic acid (3-4 drops) at 21 oC
under an inert atmosphere. The resulting suspension was stirred for 2.5 h to form an
imine. To this, NaBH3CN (0. 4 g, 6.54 mmol, 2.0 eq) was added slowly and the
resulting mixture was stirred for 48 h at 22 oC. The reaction mixture was filtered and
concentrated to give residue. The residue was dissolved in DCM (50 mL) and
washed with 1M NaOH (2 x 50 mL), dried over anhydrous MgSO4, filtered and
evaporated on a rotavapor to give white solid. The crude compound was purified by
flash column chromatography using hexane:EtOAc (8:2) to give compound N-
[(1R,2R)-2-(3-cyclohexa-1,4-dienylpropylamino)-1,2-diphenylethyl]-4-
methylbenzenesulfonamide 179 as white solid (1.280 g, 2.633 mmol, 78%). Mp 106-
108 oC; [α]D24 = -10.35 (c 0.285 in CHCl3); νmax 3294, 2819, 1454, 1430, 1333,
1129, 1060, 806, 699, 684 cm-1; δH (300 MHz, CDCl3) 7.37 (2H, d, J 8.1, o-CH of -
SO2C6H4CH3), 7.13 (3H, m, ArH), 7.07 (5H, m, ArH), 6.90 (4H, m, ArH), 6.28 (1H,
br s, -NHTs), 5.68 (2H, m, -CH=CH), 5.30 (1H, m, -CH=C), 4.24 (1H, d, J 8.1, -
CHNHTs), 3.60 (1H, d, J 7.8, -CHNH(CH2)3-), 2.64 ( 2H, m, -CH2CH=CH-), 2.51
(2H, m,-CH2CH2CH2NH-), 2.43-2.22 (2H, m, -CH2 of -CH2CH=CH), 2.33 (3H, s, -
CH3), 1.87 (2H, m, -NH-CH2-), 1.70 (1H, br s, -NH(CH2)3-), 1.50 (2H, m, -
CH2CH2CH2); δc (75 MHz, CDCl3) 142.63, 139.31, 138.35, 137.01, 134.25,
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129.04(2C), 128.26(2C), 127.88(2C), 127.51(2C), 127.40, 127.33(2C), 127.23,
127.08(2C), 124.21(2C), 118.68, 67.75, 63.02, 46.64, 34.79, 29.77, 27.45, 26.70,
21.40; m/z ESI-MS [M+H]+ 487.2; HRMS found 487.2427 (C30H34N2O2S H+
requires 487.2414, error = -2.7 ppm). The spectroscopic data were in agreement with
literature values.205
N-[(1R,2R)-2-((3-Cyclohexa-1,4-dienyl)propyl)(methyl)amino)-1,2-
diphenylethyl]-4-methylbenzenesulfonamide (305).
This is a novel compound.
To a solution of N-[(1R,2R)-2-(3-cyclohexa-1,4-dienylpropylamino)-1,2-
diphenylethyl]-4-methylbenzenesulfonamide 179 (0.5 g, 1.03 mmol) in dry methanol
(15 mL) was added 37% formaldehyde solution (0.251mL, ~ 3.0 eq) and the mixture
was stirred for 15 min at 21 oC under an inert atmosphere. To this, NaBH3CN (0.129
g, 2.06 mmol, 2.0 eq) was added slowly and the mixture stirred for 15 min followed
by addition of acetic acid (2-3 drops). The reaction was heated to 50 oC and stirred
for 16 h, then cooled to room temperature and diluted with 2% MeOH in DCM (50
mL). The mixture was washed with 1M NaOH (3 x 40 mL), dried over anhydrous
MgSO4, filtered and evaporated on a rotavapor to give crude product. The crude
product was purified by flash column chromatography using Hexane:EtOAc
(8.8:1.2) to give compound N-[(1R,2R)-2-((3-cyclohexa-1,4-
dienyl)propyl)(methyl)amino)-1,2-diphenylethyl]-4-methylbenzenesulfonamide 305
as a colourless oil (0.375 g, 0.750 mmol, 73%). [α]D24 = +56.5 (c 0.115 in CHCl3);
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νmax 3663, 3028, 2927, 2818, 1599, 1453, 13112, 1151, 1092, 932, 809, 699, 663 cm-
1; δH (300 MHz, CDCl3) 7.45 (2H, d, J 8.1, o-CH of -SO2C6H4CH3), 7.16 (3H, m,
ArH), 7.06 (2H, d, J 8.1, m-CH of -SO2C6H4CH3), 6.93 (7H, m, ArH), 6.80 (1H, br
s, -NHTs), 5.73 (2H, m, -CH=CH), 5.48 (1H, m, -CH=), 4.67 (1H, d, J 11.1, -
CHNHTs), 3.62 (1H, d, J 10.8, -CHNH(CH2)3-), 2.70 (2H, m, -CH2CH=CH), 2.63
(2H, m, -NCH2CH2CH2), 2.33 (3H, s, -CH3), 2.23 (2H, m, -CH2CH=CH), 2.03 (3H,
s, -NCH3), 1.99 (2H, m, -NHCH2), 1.61 (2H, m, -CH2 of -NCH2CH2CH2); δc (75
MHz, CDCl3) 142.64, 138.13, 137.29, 134.41, 131.85, 129.74(2C), 128.94(2C),
128.40(2C), 127.72(2C), 127.65, 127.60(2C), 127.27(2C), 127.00, 124.28(2C),
118.69, 72.67, 57.22, 53.34, 36.04, 35.00, 29.00, 26.78, 25.50, 21.42; m/z ESI-MS
[M+H]+ 501.2; HRMS found 501.2575 (C31H36N2O2S H+ requires 501.2570, error =
-1.0 ppm).
{N-[(1R,2R)-1,2-diphenylethyl-2-3-(3-phenylpropyl)(methyl)ammonium
chloride)]-4-methylbenzenesulfonamide}ruthenium chloride dimer (306).
This is a novel compound.
To a solution of N-[(1R,2R)-2-((3-cyclohexa-1,4-dienyl)propyl)(methyl)amino)-
1,2-diphenylethyl]-4-methylbenzenesulfonamide 305 (0.355 g, 0.710 mmol) in
DCM (10 mL) was added a 2M solution of HCl in diethyl ether (0.89 mL, 1.77
mmol) and the mixture was stirred at 22 oC for 30 min under an inert atmosphere.
The solvents were removed under reduced pressure to give a residue. This was
dissolved in ethanol (20 mL) and ruthenium trichloride trihydrate (0.139 g, 0.532
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mmol) was added. The resulting mixture was heated at 78 oC for 16 h. The
reaction mixture was cooled, solid separated out filtered and washed by ethanol
to give compound {N-[(1R,2R)-1,2-diphenylethyl-2-3-(3-
phenylpropyl)(methyl)ammonium chloride)]-4
methylbenzenesulfonamide}ruthenium chloride dimer 306 as green solid (0.250
g, 0.177 mmol, 50%) which was used directly in the next step, m.p > 300 oC; m/z
ESI-MS [M-Cl]+ 599.1 (monomer formed by dimer cleavage and loss of HCl in-
situ); 1H NMR (300 MHz, d6-DMSO, TMS): δ 9.30-8.50 (2H, br s, NH), 7.60-
6.80 (30H, m, ArH), 6.08-6.00 (4H, m, η6C6H5), 5.95-5.80 (6H, m, η6C6H5),
5.15-5.05 (2H, m, -CH), 4.95-4.80 (2H, m, -CH), 2.90-2.00 (12H, m, -CH2), 2.40
(12H, brs, -CH3).
{N-[(1R,2R)-1,2-diphenylethyl-2-3-(3-phenylpropyl)(methyl)amino]-4-
methylbenzenesulfonamide}ruthenium chloride monomer (302).
This is a novel compound.
A mixture of {N-[(1R,2R)-1,2-diphenylethyl-2-3-(3-
phenylpropyl)(methyl)ammonium chloride)]-4-methylbenzenesulfonamide}
ruthenium chloride dimer 306 (0.275 g, 0.195 mmol and triethylamine (0.162 mL,
1.168 mmol, 6.0 eq) in IPA (15 mL) was heated at 80 oC for 1 h under an inert
atmosphere. The reaction mixture was cooled to room temperature and concentrated
to give a residue. This was filtered and washed with water. The solid was purified by
flash column chromatography on Florisil. The complex was eluted in
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Hexane:EtOAc:MeOH (5:4:1) to give compound {N-[(1R,2R)-1,2-diphenylethyl-2-
3-(3-phenylpropyl)(methyl)amino]-4-methylbenzenesulfonamide}ruthenium
chloride monomer 302 as a light brown solid (0.175 g, 0.276 mmol, 70%). Mp 184-
186 oC with decomposition; [α]D24 = +1394 (c 0.0052 in CHCl3); νmax 3435, 2973,
2924, 1600, 1454, 1267, 1129, 1085, 1045, 940, 841, 699, 664 cm-1; δH (300 MHz,
CDCl3) 7.44 (1H, br s, ArH), 7.28 (2H, d, J 7.6, ArH), 7.22 (1H, br s, ArH), 7.11
(1H, t, J 6.9, ArH), 6.97 (1H, br s, ArH), 6.89 (2H, br d, J 5.2, ArH), 6.73 (2H, d, J
7.6, m-CH of -SO2C6H4CH3), 6.60 (2H, m, ArH), 6.51 (2H, m, ArH), 6.44 (1H, t, J
4.9, p-CH of η6C6H5), 6.29 (1H, d, J 4.4, o-CH of η6C6H5), 5.74 (1H, t, J 5.3, m-CH
of η
6C6H5), 5.46 (1H, t, J 5.2, m-CH of η6C6H5), 5.31 (1H, d, J 5.6, o-CH of
η
6C6H5), 4.87 (1H, d, J 12.0, -CHNHTs), 4.70 (1H, d, J 11.6, -CHN(CH2)3-), 3.31
(1H, t, J 11.8, -NCH2), 2.93 (1H, br d, J 13.2, -NCH2), 2.83 (3H, s, -NCH3), 2.77
(1H, br d, J 9.2, -NCH2CH2CH2), 2.39 (1H, m, -NCH2CH2CH2), 2.29 (2H, m, -
NCH2CH2CH2), 2.17 (3H, s, -CH3); δc (75 MHz, CDCl3) 141.90, 139.52, 139.32,
134.40, 130.41, 130.12(2C), 129.86, 128.52, 128.14, 127.94(2C), 127.13,
126.74(2C), 126.24(2C), 125.20, 88.05, 87.12, 85.97, 85.05, 84.79, 84.59, 79.14,
66.42, 53.53, 48.40, 28.60, 23.77, 21.14; m/z ESI-MS [M-Cl]+ 599.1; HRMS found
599.1314 (C31H33ClN2O2RuS-Cl requires 599.1308, error = -1.0 ppm); The X-ray
Structure was obtained (more details in Appendix 5.1.3).
3.4.3 Synthesis of {N-[(1R,2R)-1,2-diphenylethyl-2-3-(3-phenylpropyl)(3-
phenylpropyl)amino]-4-methylbenzenesulfonamide}ruthenium chloride
monomer (303).
N-[(1R,2R)-2-((3-Cyclohexa-1,4-dienyl)propyl)(3-phenylpropyl)amino)-1,2-
diphenylethyl]-4-methylbenzenesulfonamide (308).
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This is a novel compound.
To a solution of N-[(1R,2R)-2-(3-cyclohexa-1,4-dienylpropylamino)-1,2-
diphenylethyl]-4-methylbenzenesulfonamide 179 (0.275 g, 0.566 mmol, 1.0 eq) in
dry methanol (24 mL) was added phenyl propionaldehyde 307 (75 µL, 0.566 mmol,
1.0 eq) followed by acetic acid (3-4 drops) at 21 oC under inert atmosphere. The
resulting suspension was stirred for 2.5 h to form the imine. To this, NaBH3CN (71.1
mg, 1.132 mmol, 2.0 eq) was added and resulting mixture was stirred at 50 oC for
22h. The reaction mixture was filtered and concentrated to give a residue. This was
dissolved in DCM (20 mL) and washed with 1M NaOH (2 x 15 mL), dried over
anhydrous MgSO4, filtered and evaporated on a rotavapor to give the crude product
which was purified by flash column chromatography using hexane:EtOAc (8.5:1.5)
to give compound N-[(1R,2R)-2-((3-cyclohexa-1,4-dienyl)propyl)(3-
phenylpropyl)amino)-1,2-diphenylethyl]-4-methylbenzenesulfonamide 308 as an oil
(0.190 g, 0.314 mmol, 55%). [α]D24 = +18.54 (c 0.240 in CHCl3); νmax 3676, 2972,
1600, 1453, 1347, 1151, 1076, 1057, 932, 810, 699, 663 cm-1; δH (300 MHz, CDCl3)
7.40 (2H, d, J 8.4, ArH), 7.13 (2H, m, ArH), 7.22-7.13 (6H, m, ArH), 7.02 (2H, d, J
8.1, m-CH of -SO2C6H4CH3), 6.90 (7H, m, ArH), 6.81 (1H, br s, -NHTs), 5.72 (2H,
m, -CH=CH), 5.45 (1H, m, -CH=), 4.74 (1H, d, J 10.8, -CHNHTs), 3.71 (1H, d, J
7.8, -CHNCH2), 2.79-2.47 (8H, m, -CH2), 2.31 (3H, s, -CH3), 2.16-1.81 (6H, m, -
CH2), 1.62 (2H, m, -CH2); δc (75 MHz, CDCl3) 142.54, 141.86, 138.15, 137.51,
134.36, 133.05, 129.70(2C), 129.86(2C), 128.38(5C), 127.82(2C), 127.63,
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127.58(2C), 127.19(2C), 126.98, 125.86(2C), 124.27(2C), 118.64, 69.31, 57.33,
49.11, 48.96, 35.12, 33.67, 30.06, 29.03, 26.75, 25.99, 21.39; m/z ESI-MS [M+H]+
605.3; HRMS found 605.3203 (C39H44N2O2S H+ requires 605.3196, error = -1.0
ppm).
{N-[(1R,2R)-1,2-diphenylethyl-2-3-(3-phenylpropyl)(3-phenylpropyl)ammonium
chloride]-4-methylbenzenesulfonamide}ruthenium chloride (309).
This is a novel compound.
To a solution of N-[(1R,2R)-2-((3-cyclohexa-1,4-dienyl)propyl)(3-
phenylpropyl)amino)-1,2-diphenylethyl]-4-methylbenzenesulfonamide 308 (0.175 g,
0.290 mmol) in DCM (10 mL) was added a 2M solution of HCl in diethyl ether
(0.44 mL, 0.869 mmol) and the mixture was stirred at 22 oC for 30 min under an
inert atmosphere. The solvents were removed under reduced pressure to give a
residue. The residue was dissolved in ethanol (15 mL) and ruthenium trichloride
trihydrate (61 mg, 0.232 mmol) was added. The resulting mixture was heated at 78
oC for 16 h. The reaction mixture was cooled, a solid separated out filtered and was
washed by ethanol to give compound {N-[(1R,2R)-1,2-diphenylethyl-2-3-(3-
phenylpropyl)(3-phenylpropyl)ammonium chloride]-4-
methylbenzenesulfonamide}ruthenium chloride dimer 309 as green solid (0.150 g,
0.097 mmol, 67%), Mp > 300 oC; m/z ESI-MS [M-Cl]+ 703.1 (monomer formed in-
situ). This was used directly in the next step.
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{N-[(1R,2R)-1,2-diphenylethyl-2-3-(3-phenylpropyl)(3-phenylpropyl)amino]-4-
methylbenzenesulfonamide}ruthenium chloride monomer (303).
This is a novel compound.
A mixture of {N-[(1R,2R)-1,2-diphenylethyl-2-3-(3-phenylpropyl)(3-
phenylpropyl)ammonium chloride]-4-methylbenzenesulfonamide}ruthenium
chloride dimer 309 (0.100 g, 0.062 mmol and triethylamine (51.5 µL, 0.370 mmol,
6.0 eq) in IPA (10 mL) was heated at 80 oC for 1 h under inert atmosphere. The
reaction mixture was cooled to room temperature and concentrated to give a residue.
This was filtered and washed with water. The solid was purified by flash column
chromatography on Florisil. The complex was eluted in Hexane:EtOAc:MeOH
(5:4:1) to give compound {N-[(1R,2R)-1,2-diphenylethyl-2-3-(3-phenylpropyl)(3-
phenylpropyl)amino]-4-methylbenzenesulfonamide}ruthenium chloride monomer
303 as light brown solid (45 mg, 0.061 mmol, 49%). Mp 156-158 oC with
decomposition; [α]D24 = +1525 (c 0.004 in CHCl3); νmax 2972, 1600, 1494, 1453,
1259, 1131, 1086, 939, 842, 699, 664 cm-1; δH (300 MHz, CDCl3) 7.41 (1H, br d,
ArH), 7.28-7.09 (7H, m, ArH), 6.95 (3H, m, ArH), 6.82 (2H, m, ArH), 6.70 (2H, d, J
8.1, m-CH of -SO2C6H4CH3), 6.57 (2H, m, ArH), 6.48 (2H, m, ArH), 6.37 (1H, d, J
5.19, o-CH of Ru-Ph), 6.32 (1H, t, J 5.7, o-CH of Ru-Ph), 5.74 (1H, t, J 5.8, m-CH
of Ru-Ph), 5.36 (1H, t, J 5.8, m-CH of Ru-Ph), 4.79 (1H, d, J 6, -CHNHTs), 4.73
(2H, m, -CHN(CH2), p-CH of Ru-Ph ), 3.58 (1H, dt, J 13.6, 3.9, -N(CH2)), 3.46-3.23
(3H, m, -N(CH2)), 2.78 (1H, m, -CH2), 2.30-2.20 (4H, m, -CH2), 2.16 (3H, s, -CH3),
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2.15 (1H, m, -CH2), 1.50 (1H, m, -CH2), 1.03 (1H, m, -CH2); δc (75 MHz, CDCl3)
141.68, 140.90, 139.60, 139.12, 134.09, 132.89, 130.18(2C), 128.90, 128.72,
128.44(3C), 128.38(2C), 127.91(2C), 127.43, 126.84(2C), 126.26, 126.15(2C),
125.08, 86.93, 86.82, 86.68, 85.92, 85.62, 83.70, 78.25, 68.09, 60.82, 49.73, 33.04,
28.52, 26.79, 24.15, 21.14; m/z ESI-MS [M-Cl]+ 703.1; HRMS found 703.1946
(C39H41ClN2O2RuS-Cl requires 703.1937, error = -1.3 ppm).
3.5 Synthesis of 6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline (165).
N-(3,4-Dimethoxyphenethyl)acetamide.
This is a known compound.262
To a solution of 3,4-dimethoxyphenethylamine (5.0 g, 27.624 mmol) in dry DCM
(50 mL) was added acetic anhydride (2.61 mL, 27.6 mmol) at 18 oC under an inert
atmosphere. The reaction mixture was stirred at 18-20 oC for 18 h. The reaction
mixture was washed with saturated citric acid (10 mL), saturated NaHCO3 (10 mL)
and brine (10 mL). The organic layer was separated, dried over anhydrous MgSO4,
filtered and evaporated on a rotavapor to give a solid. The solid was scratched in
hexane, filtered and dried to give compound N-(3,4-dimethoxyphenethyl)acetamide
as a light brown solid (6.10 g, 27.354 mmol, 99%) Mp 100-102 oC; νmax =3250,
3084, 2926, 2840, 1631, 1563, 1515, 1471, 1261, 1250, 1155, 1138, 1019, 814, 765
cm-1; 1H NMR (300 MHz, CDCl3, TMS): δ 6.85-6.73 (1H, m, ArH), 6.72-6.68 (2H,
m, ArH), 5.58 (1H, br s, -NH), 3.87 (3H, s, -OCH3), 3.86 (3H, s, -OCH3), 3.54-3.46
(2H, m, -CH2NHCO), 2.76 (2H, t, J = 6.9 Hz, -CH2), 1.94 (3H, s, -CH3); 13C NMR
(75 MHz, CDCl3, TMS): δ 170.10, 147.68, 131.34, 120.60, 111.86, 111.34, 55.91,
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55.87, 40.77, 35.18, 23.33; m/z ESI-MS [M+H]+ 224, [M+Na]+ 246. The
spectroscopic data were in agreement with literature values.262
6,7-Dimethoxy-1-methyl-3,4-dihydroisoquinoline (165).
This is a known compound.262
To a solution of N-(3,4-dimethoxyphenethyl)acetamide (6.0 g, 26.90 mmol) in dry
toluene (50 mL) was added POCl3 (2.50 mL, 26.90 mmol) at 20 oC under an inert
atmosphere. The resulting mixture was refluxed at 111 oC for 2 h. The reaction
mixture was cooled to room temperature and concentrated on a rotavapor to give a
brown solid. The solid was dissolved in DCM (70 mL) was washed with saturated
K2CO3 (2 x 25 mL) and brine (20 mL). The organic layer was separated, dried over
anhydrous Na2SO4, filtered and evaporated on a rotavapor to give a solid. The solid
was scratched in cold diethyl ether, filtered and dried to give compound 6,7-
dimethoxy-1-methyl-3,4-dihydroisoquinoline 165 as light yellow solid (4.60 g,
22.439 mmol, 95%). Mp 124-126 oC; νmax 2925, 1626, 1603, 1571, 1513, 1329,
1271, 1212, 1155, 1060, 871, 808 cm-1; δH (300 MHz, CDCl3) 6.99 (1H, s, -CH of
Ar), 6.69 (1H, m, -CH of Ar), 3.92 (3H, s, -OCH3), 3.91 (3H, s, -OCH3), 3.63 (2H, t,
J 7.5, -CH2N), 2.63 (2H, t, J 7.5, -CH2), 2.36 (3H, s, -CH3); δc (75 MHz, CDCl3)
163.54, 150.73, 147.36, 131.05, 122.43, 110.15, 108.92, 56.14, 55.89, 46.97, 25.68,
23.39; m/z ESI-MS [M+H]+ 206. The spectroscopic data were in agreement with
literature values. 262
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3.5 Use of synthesised Ru complexes in pressure hydrogenation and transfer
hydrogenation
3.5.1 Pressure hydrogenation:
A mixture of imine/ketone (50 mg) and catalyst (1 mol%) in solvent (0.5 mL) was
stirred under H2 (30 bar) at 30 oC for 18-22 h. An aliquot of the reaction mixture was
filtered through a plug of silica and analysed by chiral GC for % conversion and ee.
With additive
A mixture of imine/ketone (50 mg), catalyst (1 mol%) and AgSbF6 (4 mol%) in
solvent (0.5 mL) was stirred under H2 (30 bar) at 30 oC for 18-22 h. An aliquot of the
reaction mixture was filtered through a plug of silica and analysed by chiral GC for
% conversion and ee.
3.6.2 Asymmetric transfer Hydrogenation:
Without solvent:
A mixture of imine/ketone (50 mg), catalyst (1 mol%) in FA:TEA (5:2) (0.2 mL)
was stirred at 30 oC for 18-22 h under inert atmosphere. For reaction monitoring, a
aliquot of the reaction mixture was filtered through a plug of silica and analysed by
chiral GC for % conversion and ee.
In solvent
A mixture of imine/ketone (50 mg), catalyst (1 mol%) and FA:TEA (5:2) (0.2 mL)
in solvent (0.4 mL) was stirred at 30 oC for 18-22 h under an inert atmosphere. For
reaction monitoring, an aliquot of the reaction mixture was filtered through a plug of
silica and analysed by chiral GC for %conversion and ee.
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3.6.3 400MHz NMR Kinetic study for reduction of ketone and imine:
Asymmetric transfer hydrogenation of acetophenone 112:
To a 5 mm NMR tube were added the catalyst (0.01 mmol), and formic
acid/triethylamine 5:2 complex (1 mL). After 30 minutes acetophenone was added
(120 mg, 1 mmol) followed by 0.05 mL of C6D6 hence providing a substrate solution
of initially ca. 0.86M. The reaction was followed by 1H-NMR until the specified
conversion was achieved. The conversion was calculated by the integration of the
methyl peak from the starting material at 2.44 ppm and the CH from the product at
4.77 ppm. At the end of the reaction the reaction mixture was flushed through a short
pad of silica using EtOAc to elute. The alcohol was isolated by flash
chromatography on silica gel and its ee was determined by chiral GC.202
Asymmetric transfer hydrogenation of Imine165:
To a 5 mm NMR tube were added the catalyst (0.005 mmol), and formic
acid/triethylamine 5:2 complex (0.25 mL). After 30 minutes a solution of imine (0.5
mmol) in acetonitrile (0.8 mL) was added followed by 0.05 mL of C6D6 hence
providing a substrate solution of initially ca. 0.45M. The reaction was followed by
1H-NMR until complete reduction was observed. The conversion was calculated by
the integration of the aromatic proton peak from the starting material as two singlets
at 6.99, 6.69 ppm and the product at 6.50, 6.40 ppm. At the end of the reaction the
reaction mixture was flushed through a short pad of silica using EtOAc to elute. The
amine product was isolated by flash chromatography on silica gel and its ee was
determined by chiral GC.202
3.6.4 700 MHz NMR reactions for the asymmetric transfer hydrogenation of
imine 165.
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To a 5 mm NMR tube were added the imine (0.731 mmol), catalyst 299/302 (1/3
mol%), and formic acid/triethylamine 5:2 complex (0.6 mL) followed by 0.05 mL of
C6D6. The reaction was followed by 1H-NMR with hydride detection until complete
reduction was observed. The conversion was calculated by the integration of the
aromatic proton peak from the starting material as two singlets at 6.99, 6.69 ppm and
the product (quite close two singlet) at 6.50, 6.40 ppm. At the end of the reaction the
reaction mixture was flushed through a short pad of silica using EtOAc to elute. The
amine product was isolated by flash chromatography on silica gel and its ee was
determined by chiral GC.
700 MHz NMR reactions for hydride detection:
To a 5 mm NMR tube were added the catalyst (3 mol%), and formic
acid/triethylamine 5:2 complex (0.6 mL) followed by 0.05 mL of C6D6. The reaction
was followed by 1H-NMR with hydride detection.
1-Phenylethanol 113
OH
This is a known compound.
Enantiomeric excess and conversion determined by GC analysis (Chrompak
cyclodextrin-β-236M-19 50m, T = 115 oC, P = 15 psi, gas H2, Ketone 9.81 min, R
isomer 15.32 min, S isomer 16.41 min). δH (300 MHz, CDCl3) 7.38-7.24 (5H, m,
Ph), 4.87 (1H, q, J 6.5, -CH), 2.07 (1H, br s, -OH), 1.48 (3H, d, J 6.5, -CH3); δC (75
MHz, CDCl3): 145.20, 127.90(2C), 126.87, 124.78(2C), 69.81, 24.55.173,205
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6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline 166 (Salsolidine)
NH
Me
MeO
MeO
This is a known compound.
Enantiomeric excess and conversion determined by GC analysis (Chrompak
cyclodextrin-β-236M-19 50m, T = 170 oC, P = 15 psi, gas H2, Imine 38.46 min, S
isomer 35.12 min, R isomer 35.94 min). δH (300 MHz, CDCl3) 6.61 (1H, s, -CH of
Ar), 6.57 (1H, s, -CH of Ar), 4.14 (1H, q, J 6.6, -CH), 3.85 (6H, s, 2 x -OCH3), 3.36-
3.24 (1H, m, -CH2), 3.12-3.00 (1H, m, -CH2), 2.94-2.79 (1H, m, -CH2), 2.78-2.66
(1H, m, -CH2), 1.50 (3H, d, J 6.6, -CH3); δC (75 MHz, CDCl3) 147.36, 147.10,
128.61, 124.48, 110.91, 108.23, 55.43, 55.29, 50.48, 39.95, 27.01, 21.07.202,262
3.6 Synthesis of hindered ketones
3.6.1 Derivatives of 1,3-cyclohexadione
2,2-Di(prop-2-en-1-yl)cyclohexane-1,3-dione (315).
This is a known compound and the method is based on a reported synthesis.241
KF was added to a mixture of Celite stirred in H2O then stirred for 40 min. The
Celite was filtered off then dried in a desiccator overnight. The KF-Celite (1.77 g)
was added to a mixture of cyclohexane-1,3-dione 314 (0.500 g, 4.46 mmol) and allyl
bromide (1.16 mL, 13.38 mmol) in CH3CN (15 mL). The mixture was heated at
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75°C for 6 h. The reaction mixture was filtered under reduced pressure, washed with
CH3CN (2 x 15 mL) and the solvent evaporated to give a crude product as a yellow
oil. The crude compound was purified by column chromatography using
hexane:EtOAc (80:20) to give 2,2-di(prop-2-en-1-yl)cyclohexane-1,3-dione 315 as a
colourless oil (0.286 g, 1.48 mmol, 33%). νmax(film): 3029, 1692, 1723, 1692, 1210,
998, 919 cm-1; δH (300 MHz, CDCl3): 5.60-5.46 (2H, m, 2 x -CH=CH2), 5.04-4.98
(4H, m, 2 x -CH=CH2), 2.55-2.48 (8H, br s, 2 x -CH2CO, 2 x -CH2-CH=CH2), 1.94-
1.85 (2H, m, -CH2-); δC (75 MHz, CDCl3): 210.33(2C), 132.40(2C), 119.31(2C),
68.25, 40.88(2C), 39.55(2C), 16.4; m/z (ESI+) 215.0 (M+Na). HRMS Found
215.1039 (C12H16O2Na requires 215.1043). The spectroscopic data were in
agreement with literature values. 241
Spiro[4,5]dec-2-ene-6,10-dione (312).
This is a known compound and the method is based on a reported synthesis.241a
To a solution of 2,2-di(prop-2-en-1-yl)cyclohexane-1,3-dione 315 (0.300 g, 1.562
mmol) in dry DCM (18 mL) was added Grubb’s Catalyst 1st generation (66 mg, 5.15
mol%) under an inert atmosphere. The solution was stirred at 22-23 oC for 27 h. The
colour of the reaction changed from purple to brown. The reaction mixture was
concentrated on a rotary evaporator to give a crude residue. The crude compound
was purified by column chromatography using hexane:EtOAc (92:8) to give
spiro[4,5]dec-2-ene-6,10-dione 312 as white solid (0.207 g, 1.262 mmol, 80%). Mp
58-60 oC; νmax 3053, 2913, 1723, 1687, 1434, 1340, 1320, 1262, 1114, 1011, 912
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cm-1; δH (300 MHz, CDCl3) 5.54 (2H, m, -CH=CH), 2.87 (4H, m, -CH2-CH=CH-
CH2-), 2.72 (4H, br t, J 7.5, -CH2-CO-), 2.04-1.95 (2H, m, -CH2-); δc (75 MHz,
CDCl3) 207.03(2C), 127.02(2C), 39.08(2C), 37.54(2C), 17.48; m/z ESI-MS
[M+Na]+ 187.2; HRMS found 187.0721 (C10H12O2Na requires 187.0730, error = 4.4
ppm). The spectroscopic data were in agreement with literature values. 241a
Spiro[4,5]decane-6,10-dione (316).
This is a known compound.263
A solution of spiro[4,5]dec-2-ene-6,10-dione 312 (0.100 g, 0.610 mmol) in dry
methanol (10 mL) containing Pd/C (10 % on carbon) (65 mg) under atmospheric
pressure of hydrogen at 21-22 oC was stirred for 18 h. The reaction mixture was
filtered through Celite and filtrate was concentrated on a rotary evaporator to give a
crude residue. The crude compound was purified by column chromatography using
hexane:EtOAc (90:10) to give spiro[4,5]decane-6,10-dione 316 as a colourless oil
(0.100 g, 0.602 mmol, 99%). νmax 2954, 2870, 1722, 1689, 1448, 1314, 1273, 1031
cm-1; δH (300 MHz, CDCl3) 2.67 (4H, t, J 6.0, -CH2CO-), 2.08-2.03 (4H, m,-C(CH)2-
), 2.00-1.93 (2H, m, -CH2-CH2CO-), 1.69-1.65 (4H, m,-CH2-CH2-); δc (75 MHz,
CDCl3) 208.62(2C), 72.49, 37.91(2C), 33.17(2C), 26.42(2C), 17.70. The
spectroscopic data were in agreement with literature values. 263
3,4,6,11-Tetrahydrodibenzo[b,e]oxepin-1(2H)-one (318).
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This is a novel compound.
To a mixture of K2CO3 (3.08 g, 11.16 mmol, 5 eq) in dry acetone (10 mL) was added
cyclohexane-1,3-dione 314 (0.250 g, 2.232 mmol) under an inert atmosphere. The
mixture was stirred at 26-27 oC for 10-15 min. To this mixture, 1,2-
(dibromomethyl)benzene (0.550g, 2.232 mmol, 1.0 eq) was added and the resulting
mixture was stirred at 55-56 oC for 50 h. The reaction mixture was cooled to room
temperature, filtered through Celite and evaporated to give a crude oil. The oil was
purified by column chromatography using hexane:EtOAc (93:7) to give 3,4,6,11-
tetrahydrodibenzo[b,e]oxepin-1(2H)-one 318 as a colourless oil (0.110 g, 0.514
mmol, 23%). νmax 2946, 1708, 1640, 1597, 1458, 1426, 1385, 1362, 1293, 1249,
1183, 1106, 1005, 987, 871, 750, 674 cm-1; δH (300 MHz, CDCl3) 7.33-7.21 (4H, m,
-CH of -C6H4-), 5.25 (2H, s, -CH2-C6H4-CH2-O), 3.92 (2H, s, -CH2-C6H4-CH2-O),
2.39-2.31 (4H, m, -CH2-CH2-CH2CO), 1.89-1.80 (2H, m, -CH2CO); δc (300 MHz,
CDCl3) 197.80, 172.46, 141.08, 134.34, 128.81, 128.03, 127.64, 126.29, 112.07,
70.58, 36.30, 30.38, 26.96, 19.74; m/z ESI-MS [M+Na]+ 237.1; HRMS found
215.1070 (C14H14O2H+ requires 215.1067, error = -1.9 ppm).
3.6.2 Derivatives of cyclohexanone
Spiro[4,5]decane-6-one (320).
This is a known compound and the method is based on a reported synthesis.242
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To a mixture of KOtBu (2.54 g, 22.62 mmol, 2.22 eq) in dry toluene (20 mL) was
added cyclohexanone 319 (1.0 g, 10.189 mmol) under an inert atmosphere. The
mixture was stirred at 20-21 oC for 1 h. To this mixture, 1,4-dibromobutane (1.216
mL, 10.189 mmol, 1.0 eq) was added dropwise. The resulting mixture was stirred at
110-111 oC for 5 h. The reaction mixture was cooled to room temperature, diluted
with water (10 mL) and HCl (15%, 20 mL). The mixture was extracted with diethyl
ether (3 x 25 mL). The combined organic layer was dried over anhydrous MgSO4,
filtered and evaporated to give crude oil. The oil was purified by column
chromatography using n-pentane: diethyl ether (98:2) to give spiro[4,5]decane-6-one
320 as a colourless oil (0.330 g, 2.171 mmol, 21%). νmax 2934, 2863, 1703, 1443,
1345, 1311, 1126, 954 cm-1; δH (300 MHz, CDCl3) 2.42-2.38 (2H, m, -CH2CO-),
2.10-2.02 (2H, m, -CH2-C-CH2-), 1.86-1.78 (2H, m, -CH2-CH2CO-), 1.72-1.70 (4H,
m, -CH2-CH2-CH2-CH2CO-), 1.63-1.54 (4H, m, -CH2-CH2-), 1.44-1.35 (2H, m, -
CH2-C-CH2-); δc (300 MHz, CDCl3) 214.71, 56.82, 39.92, 39.43, 35.42(2C), 27.32,
25.22(2C), 22.82; m/z ESI-MS [M+Na]+ 175.0; HRMS found 175.1099 (C10H16ONa
requires 175.1093, error = -3.4 ppm). The spectroscopic data were in agreement with
literature values. 242
Spiro[4,5]dec-2-en-6-one (321).
This is a known compound and the method is based on a reported synthesis.243
A solution of Na (0.938 g, 40.816 mmol, 2.0 eq) in tert-amyl alcohol (20 mL) was
evaporated under reduced pressure to give white solid and added dry toluene (30
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mL). To this mixture was added cyclohexanone 319 (2.0 g, 20.408 mmol) followed
by 1,4-dichloro-2-butene (2.530 g, 20.408 mmol, 1.0 eq) under an inert atmosphere.
The mixture was stirred at 110-111 oC for 48 h. The reaction mixture was cooled to
room temperature, diluted with water (5 mL) and HCl (15%, 10 mL). The organic
layer was separated, dried over anhydrous MgSO4, filtered and evaporated to give
crude oil. The oil was purified by column chromatography using n-pentane: diethyl
ether (95:5) to give spiro[4,5]dec-2-en-6-one 321 as a colourless oil (0.500 g, 3.33
mmol, 16%). νmax 3056, 2928, 2850, 1702, 1623, 1449, 1351, 1336, 1271 1130,
1056, 940, 897, 666 cm-1; δH (300 MHz, CDCl3) 5.55 (2H, s, -CH=CH-), 2.87 (2H, d,
J 12.0, -CHH-CH=CH-CHH-), 2.44 (2H, t, J 7.5, -CH2CO), 2.20 (2H, d, J 12.0, -
CHH-CH=CH-CHH-), 1.89-1.71 (6H, m, -(CH2)3-CH2CO); δc (300 MHz, CDCl3)
127.82(2C), 41.72(2C), 40.11, 39.48, 27.19, 22.25; m/z ESI-MS [M+Na]+ 173.1;
HRMS found 151.1116 (C10H14ONa requires 151.1117, error = 0.6 ppm). The
spectroscopic data were in agreement with literature values.243
1’,3’- Dihydro-2H-spiro[cyclohexane-1,2’-inden]-2-one (322).
This is a known compound.244
To a mixture of KOtBu (1.27 g, 11.308 mmol, 2.22 eq) in dry tBuOH (12.5 mL) was
added cyclohexanone 319 (0.500 g, 5.094 mmol) under an inert atmosphere. The
mixture was stirred at 26-27 oC for 10-15 min. To this mixture, 1,2-
(dibromomethyl)benzene (1.34 g, 5.094 mmol, 1.0 eq) was added and the resulting
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mixture was stirred at 26-27 oC for 24 h. The reaction mixture was concentrated on a
rotary evaporator to give a residue. The residue was diluted with water (10 mL) and
15% HCl (10 mL). The mixture was extracted with DCM (3 x 50 mL). The
combined organic layer was dried over anhydrous MgSO4, filtered and evaporated to
give a crude oil. The oil was purified by column chromatography using
hexane:EtOAc (95:5) to give 1’,3’- dihydro-2H-spiro[cyclohexane-1,2’-inden]-2-one
322 as a colourless oil (0.460 g, 2.300 mmol, 45%). νmax 3023, 2930, 2860, 1700,
1485, 1444, 1428, 1337, 1311, 1220, 1127, 744, 727 cm-1; δH (300 MHz, CDCl3)
7.18-7.12 (4H, m, -CH of -C6H4-), 3.46 (2H, d, J 12.0, -CHH-C6H4-CHH-), 2.82
(2H, d, J 12.0, -CHH-C6H4-CHH-), 2.49 (2H, t, J 6.0, -CH2CO), 1.92-1.89 (2H, m, -
CH2-CH2CO), 1.87-1.84 (2H, m, -CH2-CH2-CH2CO), 1.83-1.76 (2H, m, -CH2-CH2-
CH2-CH2CO); δc (300 MHz, CDCl3) 212.93, 140.84(2C), 126.50(2C), 124.84(2C),
57.22, 41.31(2C), 39.53, 39.13, 27.48, 22.21; m/z ESI-MS [M+Na]+ 223.2; HRMS
found 223.1091 (C14H16ONa requires 223.1093, error = 0.9 ppm). The spectroscopic
data were in agreement with literature values. 244
3.6.3 Derivatives of ethyl acetoacetate
Ethyl 1-acetylcyclopentanecarboxylate (334).
This is a known compound and the method is based on a reported synthesis.246
To a mixture of KOtBu (2.65 g, 19.210 mmol, 2.5 eq) in DMSO (15 mL) was added
ethyl acetoacetate 333 (1.0 g, 7.684 mmol) under an inert atmosphere. The mixture
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was stirred at 21-22 oC for 10 min. 1,4-Dibromobutane (0.918 mL, 7.684 mmol, 1.0
eq) was then added dropwise. The resulting mixture was stirred at 21-22 oC for 3
days. The reaction mixture was poured into ice-cold water and extracted with EtOAc
(3 x 30 mL). The combined organic layer was dried over anhydrous MgSO4, filtered
and evaporated to give a crude oil. The oil was purified by column chromatography
using hexane:EtOAc (95:5) to give ethyl 1-acetylcyclopentanecarboxylate 334 as a
colourless oil (1.0 g, 5.434 mmol, 70%). νmax 2959, 2874, 1739, 1711, 1623, 1446,
1356, 1240, 1147, 1097, 1052, 1026, 857 cm-1; δH (300 MHz, CDCl3) 4.23-4.16 (2H,
q, J 7.0, -OCH2CH3), 2.16 (3H, s, -COCH3), 2.13-2.08 (4H, m, -CH2-C-CH2-), 1.71-
1.60 (4H, m, -CH2-CH2-), 1.26 (3H, t, J 7.0, -OCH2CH3); δc (300 MHz, CDCl3)
61.31, 32.96(2C), 26.04, 25.64(2C), 14.02; m/z ESI-MS [M+Na]+ 207.2; HRMS
found 207.0992 (C10H16O3Na requires 207.0992, error = -0.4 ppm). The
spectroscopic data were in agreement with literature values. 246
Ethyl 2-acetyl-2-(prop-2-en-1-yl)pent-4-enoate (335).
This is a known compound and the method is based on a reported synthesis.247
To a mixture of K2CO3 (3.22 g, 23.359 mmol, 3.04 eq) in DMF (10 mL) was added
ethyl acetoacetate 333 (1.0 g, 7.684 mmol) under an inert atmosphere. The resulting
mixture was stirred at 21-22 oC for 10 min. To this, a solution of allyl bromide
(1.649 mL, 19.056 mmol, 2.48 eq) in DMF (5 mL) was added dropwise. The
resulting mixture was heated to 80 oC for 20 h. The reaction mixture was cooled to
room temperature, diluted with water (20 mL) and extracted with diethyl ether (3 x
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20 mL). The combined organic layer was dried over anhydrous MgSO4, filtered and
evaporated to give a crude oil. The oil was purified by column chromatography using
hexane:EtOAc (92:8) to give ethyl 2-acetyl-2-(prop-2-en-1-yl)pent-4-enoate 335 as a
colourless oil (1.5 g, 7.142 mmol, 93%). νmax 3079 2981, 1740, 1715, 1641, 1442,
1356, 1278, 1207, 1179, 1138, 1017, 994, 918, 855 cm-1; δH (300 MHz, CDCl3) 5.67-
5.53 (2H, m, 2 x -CH2-CH=CH2), 5.14-5.08 (4H, m, 2 x -CH2-CH=CH2), 4.24-4.17
(2H, q, J 7.0, -OCH2CH3), 2.69-2.54 (4H, m, 2 x -CH2-CH=CH2), 2.14 (3H, s, -
COCH3), 1.27 (3H, t, J 7.0, -OCH2CH3); δc (300 MHz, CDCl3) 132.16(2C),
119.15(2C), 63.20, 61.38, 35.92(2C), 26.91, 14.10; m/z ESI-MS [M+Na]+ 233.2;
HRMS found 233.1153 (C12H18O3Na requires 233.1148, error = -2.0 ppm). The
spectroscopic data were in agreement with literature values. 247
Ethyl 1-acetylcyclopent-3-ene-1-carboxylate (336).
The method is based on a reported synthesis.247 This is a known compound.264
To a solution of ethyl 2-acetyl-2-(prop-2-en-1-yl)pent-4-enoate 335 (0.250 g, 1.190
mmol) in dry DCM (60 mL) was added Grubb’s 1st generation catalyst (49 mg, 5
mol%) under an inert atmosphere and the resulting mixture was stirred for 24 h at
22-23 oC. The colour of the reaction changed from purple to brown. The reaction
mixture was concentrated on a rotary evaporator to give a crude residue. The crude
compound was purified by column chromatography using n-pentane: diethyl ether
(94:6) to give ethyl 1-acetylcyclopent-3-ene-1-carboxylate 336 as a colourless oil
(0.200 g, 1.099 mmol, 92%). νmax 3063, 2983, 1713, 1445, 1357, 1260, 1230, 1153,
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1096, 1071, 1017 cm-1; δH (300 MHz, CDCl3) 5.59 (2H, br m, -CH=CH-), 4.25-4.18
(2H, q, J 7.0, -OCH2CH3), 2.94 (4H, br s, -CH2-CH=CH-CH2-), 2.19 (3H, s, -
COCH3), 1.27 (3H, t, J 7.0, -OCH2CH3); δc (300 MHz, CDCl3) 127.71(2C), 61.60,
39.22(2C), 25.91, 14.00; m/z ESI-MS [M+Na]+ 205.1; HRMS found 205.0837
(C10H14O3Na requires 205.0835, error = -1.2 ppm). The spectroscopic data were in
agreement with literature values. 264
Ethyl 2-acetyl-2,3-dihydro-1H-indene-2-carboxylate (337).
This is a known compound and the method is the same as for a reported synthesis.248
To a mixture of TBAB (31 mg, 0.0958 mmol, 0.05 eq) in 48% NaOH solution (1.1
mL) was added a solution of 1,2-(dibromomethyl)benzene (0.500g, 1.894 mmol) in
toluene (2.5 mL). To this, a solution of ethyl acetoacetate 333 (0.240 mL, 1.894
mmol, 1.0 eq) in toluene (0.5 mL) was added dropwise and during addition the
temperature increased from 22 oC to 38-40 oC. The reaction mixture was stirred at 22
oC for 3.5 h. The residue was diluted with water (20 mL) and extracted with toluene
(2 x 25 mL). The combined organic layer was dried over anhydrous MgSO4, filtered
and evaporated to give a crude oil. The oil was purified by column chromatography
using hexane:EtOAc (95:5) to give ethyl 2-acetyl-2,3-dihydro-1H-indene-2-
carboxylate 337 as a colourless oil (0.310 g, 1.336 mmol, 70%). νmax 2981, 1710,
1486, 1460, 1336, 1269, 1233, 1150, 1072, 1017, 858, 743 cm-1; δH (300 MHz,
CDCl3) 7.17-7.14 (4H, m, -CH of -C6H4-), 4.25-4.18 (2H, q, J 7.0, -OCH2CH3),
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3.53-3.46 (4H, m, -CH2-C6H4-CH2-), 2.23 (3H, s, -COCH3), 1.26 (3H, t, J 7.0, -
OCH2CH3); δc (300 MHz, CDCl3) 140.21(2C), 127.35(2C), 124.67(2C), 62.21,
38.38(2C), 26.50, 14.42; m/z ESI-MS [M+Na]+ 255.1; HRMS found 225.0997
(C14H16O3Na requires 225.0992, error = -2.0 ppm). The spectroscopic data were in
agreement with literature values. 248
3.6.4 Synthesis of 1-(2-ethyl-2,3-Dihydro-1H-inden-2-yl)ethanone (340).
1-(2,3-Dihydro-1H-inden-2-yl)ethanone (339).
This is a known compound and the method is the same as for a reported synthesis.249
To a mixture of TBAB (0.161 g, 0.50 mmol, 0.05 eq) in 48% NaOH solution (5 mL)
was added solution of 1,2-(dibromomethyl)benzene (2.640 g, 10.0 mmol) in toluene
(6 mL). To this, a solution of acetylacetone 338 (1.0 g, 10.0 mmol, 1.0 eq) in toluene
(6 mL) was added dropwise and during addition the temperature increased from 22
oC to 38-40 oC. The reaction mixture was heated to 80-85 oC for 5 h. The reaction
mixture was cooled to room temperature, diluted with water (20 mL) and extracted
with toluene (2 x 35 mL). The combined organic layer was dried over anhydrous
MgSO4, filtered and evaporated to give a crude oil. The oil was purified by column
chromatography using hexane: ethyl acetate (93:7) to give 1-(2,3-dihydro-1H-inden-
2-yl)ethanone 339 as a colourless oil (0.600 g, 3.75 mmol, 41%). νmax 3022, 2939,
2849, 1708, 1484, 1459, 1359, 1199, 1163, 745 cm-1; δH (300 MHz, CDCl3) 7.22-
7.14 (4H, m, -CH of -C6H4-), 3.50-3.38 (1H, m, -CHCOCH3), 3.19 (2H, d, J 7.5, -
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CHH-C6H4-CHH-), 3.21 (2H, d, J 7.5, -CHH-C6H4-CHH-), 2.24 (3H, s, -COCH3);
δc (300 MHz, CDCl3) 209.30, 141.43(2C), 126.61(2C), 124.39(2C), 51.86,
34.94(2C), 28.47; m/z ESI-MS [M+Na]+ 183.1; HRMS found 183.0785 (C11H12ONa
requires 183.0780, error = -2.8 ppm). The spectroscopic data were in agreement with
literature values. 249
1-(2-Ethyl-2,3-dihydro-1H-inden-2-yl)ethanone (340).
This is a known compound and the method is based on a reported synthesis.249
To a mixture of KOtBu (0.522 g, 4.657 mmol, 1.50 eq) in THF (15 mL) was added
1-(2,3-dihydro-1H-inden-2-yl)ethanone 339 (0.500 g, 3.125 mmol) under an inert
atmosphere. The resulting mixture was stirred at 21-22 oC for 10 min and cooled to -
20 oC. To this, ethyl iodide (0.275 mL, 3.438 mmol, 1.10 eq) was added dropwise.
The resulting mixture was stirred at -20 oC for 3 h and warmed to room temperature.
The reaction mixture was stirred at room temperature for 1.5 h. The reaction mixture
was diluted with water (20 mL) and extracted with ethyl acetate (3 x 50 mL). The
combined organic layer was dried over anhydrous MgSO4, filtered and evaporated to
give a crude oil. The oil was purified by column chromatography using hexane: ethyl
acetate (92:8) to give 1-(2-ethyl-2,3-dihydro-1H-inden-2-yl)ethanone 340 as a
colourless oil (0.325 g, 1.728 mmol, 55%). νmax 3023, 2964, 2931, 1701, 1484, 1459,
1355, 1218, 1135, 783, 743, 722 cm-1; δH (300 MHz, CDCl3) 7.19-7.12 (4H, m, -CH
of -C6H4-), 3.37 (2H, d, J 16.5, -CHH-C6H4-CHH-), 2.85 (2H, d, J 16.5, -CHH-
C6H4-CHH-), 2.19 (3H, s, -COCH3), 1.80 (2H, q, J 7.5, -CH2CH3), 0.83 (3H, t, J 7.5,
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-CH2CH3); δc (300 MHz, CDCl3) 141.20(2C), 126.51(2C), 124.53 (2C), 60.81,
40.28(2C), 30.82, 25.80, 9.56; m/z ESI-MS [M+Na]+ 211.1; HRMS found 211.1153
(C13H16ONa requires 211.1094, error = -0.1 ppm). The spectroscopic data were in
agreement with literature values. 249
3.6.5 Derivatives of β-tetralone
1,1-Dimethyl-3,4-dihydronaphthalen-2(1H)-one (349).
This is a known compound and the method is based on a reported synthesis.250
To a mixture of β-tetralone 348 (0.750 g, 5.136 mmol), TBAS (0.278 g, 0.822 mmol,
0.16 eq) and methyl iodide (0.959 mL, 15.408 mmol, 3.0 eq) in THF (3 mL) was
rapidly added 50% KOH solution in H2O (5 mL). The reaction mixture became
warm and turned blue. The reaction mixture was stirred for 30 min during which
time the colour changed from blue to green and finally light brown. The reaction
mixture was poured into water (20 mL) and extracted with diethyl ether (2 x 25 mL).
The combined organic layer was washed with sat. NH4Cl soln (2 x 25 mL), dried
over anhydrous MgSO4, filtered and evaporated to give a crude oil. The oil was
purified by column chromatography using hexane:EtOAc (96:4) to give 1,1-
dimethyl-3,4-dihydronaphthalen-2(1H)-one 349 as a white solid (0.775 g, 4.454
mmol, 86%). νmax 2972, 2933, 1709, 1488, 1449, 1380, 1244, 1091, 1042, 758, 742
cm-1; δH (300 MHz, CDCl3) 7.37-7.34 (1H, m, -CH of -C6H4-), 7.30-7.23 (1H, m, -
CH of -C6H4-), 7.20-7.18 (2H, m, -CH of -C6H4-), 3.10 (2H, t, J 6.7, -CH2-C6H4-),
2.69 (2H, d, J 6.7, -CH2CO-), 1.44 (6H, br s, -C(CH3)2-); δc (300 MHz, CDCl3)
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214.76, 143.52, 135.15, 128.13, 127.10, 126.37, 126.13, 47.76, 37.20, 28.59,
26.89(2C); m/z ESI-MS [M+Na]+ 175.2; HRMS found 175.1118 (C12H14O+H
requires 175.1117, error = -0.6 ppm). The spectroscopic data were in agreement with
literature values. 250
1,1-Di(prop-2-en-1-yl)-3,4-dihydronaphthalen-2(1H)-one (350).
This is a known compound265 and method is used same as for ethyl 2-acetyl-2-
allylpent-4-enoate.247
To a mixture of K2CO3 (1.44 g, 10.397 mmol, 3.04 eq) in DMF (15 mL) was added
β-tetralone 348 (0.500 g, 3.420 mmol) under an inert atmosphere and the resulting
mixture was stirred at 21-22 oC for 10 min. To this, a solution of allyl bromide
(0.734 mL, 8.482 mmol, 2.48 eq) in DMF (5 mL) was added dropwise. The resulting
mixture was heated to 80 oC for 4 h. The reaction mixture was cooled to room
temperature, diluted with water (25 mL) and extracted with diethyl ether (3 x 25
mL). The combined organic layer was dried over anhydrous MgSO4, filtered and
evaporated to give a crude oil. The oil was purified by column chromatography using
n-pentane: diethyl ether (97:3) to give 1,1-di(prop-2-en-1-yl)-3,4-dihydronaphthalen-
2(1H)-one 350 as a colourless oil (0.500 g, 2.212 mmol, 64%). νmax 3076, 2909,
1710, 1639, 1489, 1444, 1416, 1226, 1167, 997, 916, 760, 737 cm-1; δH (300 MHz,
CDCl3) 7.35-7.28 (2H, m, 2 -CH of -C6H4-), 7.22-7.14 (2H, m, 2 -CH of -C6H4-),
5.44-5.30 (2H, m, 2 x -CH2-CH=CH2), 4.95-4.85 (4H, m, 2 x -CH2-CH=CH2), 2.96
(2H, t, J 6.0, -CH2-C6H4-), 2.78 (2H, d, J 12.0, 8.0, 2 x -CHH-CH=CH2), 2.54 (2H, t,
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J 6.0, -CH2CO-), 2.52-2.47 (2H, m, 2 x -CHH-CH=CH2), δc (300 MHz, CDCl3)
139.12, 136.97, 133.34(2C), 128.00, 126.98, 126.87, 126.34, 118.28(2C), 55.98,
45.06(2C), 40.28, 27.83; m/z ESI-MS [M+H]+ 227.2; HRMS found 249.1248
(C16H18ONa requires 249.1250, error = 0.7 ppm). The spectroscopic data were in
agreement with literature values. 265
3’,4’-Dihydro-2’H-spiro[cyclopent-3-ene-1,1’-naphthalene]-2’-one (351).
This is a novel compound and the method is used is the same as for spiro[4,5]dec-2-
ene-6,10-dione.
To a solution of 1,1-diallyl-3,4-dihydronaphthalen-2(1H)-one 350 (0.400 g, 1.770
mmol) in dry DCM (80 mL) was added Grubb’s 1st generation catalyst (72.8 mg, 5
mol%) under an inert atmosphere and the resulting mixture was stirred for 24 h at
22-23 oC. The colour of the reaction changed from purple to brown. The reaction
mixture was concentrated on a rotary evaporator to give a crude residue. The crude
compound was purified by column chromatography using n-pentane: diethyl ether
(95:5) to give 3’,4’-dihydro-2’H-spiro[cyclopent-3-ene-1,1’-naphthalene]-2’-one 351
as a colourless oil (0.295 g, 1.489 mmol, 84%). νmax 3055, 2916, 2846, 1709, 1488,
1451, 1346, 1234, 1140, 1048, 972, 788, 754, 666 cm-1; δH (300 MHz, CDCl3) 7.27-
7.21 (2H, m, 2 -CH of -C6H4-), 7.19-7.13 (2H, m, 2 -CH of -C6H4-), 5.71 (2H, m, -
CH=CH-), 3.22-3.15 (2H, m, -CHH-CH=CH-CHH-), 3.10 (2H, t, J 7.5, -CH2-C6H4-
), 2.73 (2H, t, J 7.5, -CH2CO-), 2.68-2.59 (2H, m, -CHH-CH=CH-CHH-); δc (300
MHz, CDCl3) 212.91, 144.78, 134.59, 128.04(2C), 127.67, 127.37, 126.32, 126.14,
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46.83(2C), 37.63, 28.90; m/z ESI-MS [M+Na]+ 221.2; HRMS found 221.0935
(C14H14ONa requires 221.0937, error = 0.8 ppm).
3’,4’-Dihydro-2’H-spiro[cyclopentane-1,1’-naphthalene]-2’-one (352).
This is a known compound266 and the method used is the same as for
spiro[4,5]decane-6,10-dione.
A solution of 3’,4’-dihydro-2’H-spiro[cyclopent-3-ene-1,1’-naphthalene]-2’-one 351
(0.198 g, 1.000 mmol) in dry EtOAc (20 mL) containing added Pd/C (10 % on
carbon) (100 mg) was stirred under an atmospheric pressure of hydrogen at 21-22 oC
for 24 h. The reaction mixture was filtered through Celite and the filtrate was
concentrated on a rotary evaporator to give a crude residue. The crude compound
was purified by column chromatography using n-pentane: diethyl ether (95.5:4.5) to
give 3’,4’-dihydro-2’H-spiro[cyclopentane-1,1’-naphthalene]-2’-one 352 as a
colourless oil (0.140 g, 0.700 mmol, 70%). νmax 2950, 2867, 1706, 1487, 1449, 1346,
1236, 1045, 936, 754, 742 cm-1; δH (300 MHz, CDCl3) 7.29-7.20 (2H, m, -CH of -
C6H4-), 7.18-7.14 (2H, m, -CH of -C6H4-), 3.09 (2H, t, J 6.5, -CH2-CH2CO), 2.69
(2H, t, J 6.5, -CH2-CH2CO-), 2.39-2.29 (2H, m, -CHHCH2CH2CHH-), 1.93-1.81
(6H, m, -CHHCH2CH2CHH-); δc (300 MHz, CDCl3) 213.75, 143.83, 135.90,
127.85, 126.96, 126.14(2C), 59.25, 38.35(2C), 37.18, 28.77, 26.63(2C); m/z ESI-MS
[M+Na]+ 223.1; HRMS found 223.1094 (C14H16ONa requires 223.1093, error = -0.2
ppm). The spectroscopic data were in agreement with literature values. 252
1,3,3’,4’-Tetrahydro-spiro[2H-indene-1,2’-[2H]-naphthalene]-2’-one (353).
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This is a novel compound.
To a mixture of TBAB (27.7 mg, 0.0855 mmol, 0.05 eq) in 48% NaOH solution (1.1
mL) was added solution of 1,2-(dibromomethyl)benzene (0.451 g, 1.710 mmol) in
toluene (2.5 mL). To this, a solution of β-tetralone 348 (0.250 g, 1.710 mmol) in
toluene (0.5 mL) was added dropwise during which the temperature increased from
22 oC to 38-40 oC. The reaction mixture was stirred at 22-23 oC for 4 h. The residue
was diluted with water (20 mL) and extracted with toluene (2 x 25 mL). The
combined organic layer was dried over anhydrous MgSO4, filtered and evaporated to
give a crude oil. The oil was purified by column chromatography using n-
pentane:diethyl ether (88:12) to give 1,3,3’,4’-tetrahydro-spiro[2H-indene-1,2’-[2H]-
naphthalene]-2’-one 353 as a white solid (0.300 g, 1.210 mmol, 70%). Mp 128-130
o
C; νmax 3019, 2953, 2893, 1699, 1485, 1452, 1233, 1146, 1017, 760, 750, 743 cm-1;
δH (300 MHz, CDCl3) 7.21-7.14 (6H, m, 4 -CH of -C6H4-, 2 -CH of -C6H4-), 7.13-
7.08 (2H, m, 2-CH of -C6H4-), 3.79 (2H, d, J 16.5, -CHH-C6H4-CHH-), 3.21 (2H, d,
J 16.5, -CHH-C6H4-CHH-), 3.18 (2H, t, J 6.0, -CH2-CH2CO-), 2.77 (2H, t, J 6.0, -
CH2CO-); δc (300 MHz, CDCl3) 212.47, 142.97, 140.73(2C), 135.31, 128.00,
127.72, 126.93(2C), 126.65, 125.95, 124.17(2C), 58.93, 44.84(2C), 37.30, 28.62;
m/z ESI-MS [M+Na]+ 271.1; HRMS found 249.1275 (C18H16O +H requires
249.1274, error = -0.3 ppm).
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3.6.6 Derivatives of α-tetralone
2,2-Dimethyl-3,4-dihydronaphthalen-1(2H)-one (355).
This is a known compound and the method is based on a reported synthesis.251
To a suspension of NaH (0.957 g, 23.94 mmol, 3.54 eq) into THF (25 mL) was
added a solution of α-tetralone 354 (1.0 g, 6.840 mmol) in THF (2.5 mL). The
reaction mixture was stirred for 15 min. To this, iodomethane (1.49 mL, 23.94
mmol, 3.54 eq) was added dropwise. The resulting mixture was stirred at 40 oC for
45 min. The reaction mixture was cooled to room temperature and then in ice cold
water. The reaction mixture was quenched by slow addition of water. The mixture
was diluted with water (50 mL) and extracted with ethyl acetate (2 x 50 mL). The
combined organic layer was washed with water, brine solution, dried over anhydrous
Na2SO4, filtered and evaporated to give a crude oil. The oil was purified by column
chromatography using hexane:ethyl acetate (90:10) to give 2,2-dimethyl-3,4-
dihydronaphthalen-1(2H)-one 355 as an oil (0.780 g, 4.483 mmol, 65 %). δH (300
MHz, CDCl3) 8.04 (1H, dd, J 1.3, 7.0, -CH of -C6H4-), 7.45 (1H, dt, J 1.5, 7.3 -CH
of -C6H4-), 7.30 (1H, t, J 7.5, -CH of -C6H4-), 7.22 (1H, d, J 8.1, -CH of -C6H4-),
2.98 (2H, t, J 6.4, -CH2-C6H4-), 1.98 (2H, d, J 6.4, -CH2CO-), 1.22 (6H, br s, -
C(CH3)2-); δc (300 MHz, CDCl3) 143.35, 132.95, 131.37, 128.63, 127.93, 126.54,
41.56, 36.55, 25.65, 24.31(2C). The spectroscopic data were in agreement with
literature values. 251
1,3,3’,4’-Tetrahydro-spiro[2H-indene-2,2’-[2H]-naphthalene]-1’-one (356).
Experimental
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This is a known compound267 and the method used is the same as for 1’,3’- dihydro-
2H-spiro[cyclohexane-1,2’-inden]-2-one.244
To a mixture of KOtBu (0.426 g, 3.80 mmol, 2.22 eq) in dry tBuOH (10 mL) was
added α-tetralone 354 (0.250 g, 1.710 mmol) under an inert atmosphere and the
resulting solution was stirred at 26-27 oC for 10-15 min. To this mixture, 1,2-
(dibromomethyl)benzene (0.451 g, 1.710 mmol, 1.0 eq) was added and resulting
mixture was stirred at 26-27 oC for 18 h. The reaction mixture was concentrated on a
rotary evaporator to give a residue. The residue was diluted with water (10 mL) and
15% HCl (10 mL). The mixture was extracted with DCM (3 x 50 mL). The
combined organic layer was dried over anhydrous MgSO4, filtered and evaporated to
give a crude residue. The oil was purified by column chromatography using
hexane:EtOAc (94:6) to give 1,3,3’,4’-tetrahydro-spiro[2H-indene-2,2’-[2H]-
naphthalene]-1’-one 356 as a white solid (0.250 g, 1.008 mmol, 58%). Mp 88-90 oC;
νmax 3346, 3071, 2921, 2842, 1764, 1668, 1599, 1486, 1455, 1427, 1231, 1226, 1155,
906, 749, 739, 715 cm-1; δH (300 MHz, CDCl3) 8.05 (1H, dd, J 6.0, 1.2, -CH of -
C6H4-), 7.48 (1H, dt, J 6.0, 1.2, -CH of -C6H4-), 7.32 (1H, t, J 3.0, -CH of -C6H4-),
7.25 (1H, t, J 3.0, -CH of -C6H4-), 7.20-7.15 (4H, m, -CH of -C6H4-), 3.49 (2H, d, J
12.0, -CHH-C6H4-CHH-), 3.08 (2H, t, J 4.5, -CH2-CH2-C6H4-), 2.97 (2H, d, J 12.0, -
CHH-C6H4-CHH-), 2.22 (2H, t, J 4.5, -CH2-CO); δc (300 MHz, CDCl3) 143.30,
141.10(2C), 133.22, 131.59, 128.68, 128.18, 126.71, 126.59(2C), 124.57(2C), 53.50,
41.31(2C), 33.86, 26.08; m/z ESI-MS [M+Na]+ 271.1; HRMS found 271.1093
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(C18H16ONa requires 271.1093, error = -0.1 ppm). The spectroscopic data were in
agreement with literature values. 267
3.7 Asymmetric transfer hydrogenation of α,α-disubstituted ketones
General procedure for asymmetric transfer hydrogenation of 1,3-diketone
derivatives:
A mixture of catalyst (2 mol%) in FA:TEA (5:2) (0.3 mL) was stirred at 28 oC under
an inert atmosphere in a Schlenk tube. To this, ketone (0.3 mmol) was added and the
resulting mixture was stirred at 28 oC for 21-91 h under an inert atmosphere. The
completion of the reaction was confirmed by TLC. The reaction mixture was filtered
through a short column of silica using hexane: EtOAc (1:1) to EtOAc. The filtrate
was concentrated to give a crude alcohol. The crude compound was purified by flash
column chromatography.
General procedure for asymmetric transfer hydrogenation of α,α-disubstituted
ketones:
A mixture of catalyst (1 mol%) in FA:TEA (5:2) (0.15 mL) was stirred at 28 oC
under an inert atmosphere in a Schlenk tube. To this, ketone (0.3 mmol) was added
and stirred at 28-45 oC for 9-47 h under an inert atmosphere. The completion of the
reaction was confirmed by TLC. The reaction mixture was filtered through a short
column of silica using hexane: EtOAc (1:1) to EtOAc. The filtrate was concentrated
to give a crude alcohol. The crude compound was purified by flash column
chromatography.
Spiro[4,5]dec-2-ene-6,10-diol (323a).
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OHHO
This is a novel compound.
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (7.56 mg, 0.0122 mmol,
2 mol%) in FA:TEA (5:2) (0.610 mL) was stirred at 28 oC under an inert atmosphere
in a Schlenk tube. To this, spiro[4,5]dec-2-ene-6,10-dione 312 (0.100 g, 0.610
mmol) was added and the mixture was stirred at 28 oC for 21 h under an inert
atmosphere. The completion of the reaction was checked by TLC. The reaction
mixture was filtered through a short column of silica using hexane: EtOAc (1:1) to
EtOAc. The filtrate was concentrated to give a crude alcohol (0.100 g). The crude
compound was purified by flash column chromatography to give pure alcohol
spiro[4,5]dec-2-ene-6,10-diol 323a as a white solid (0.080 g, 0.476 mmol, 78%). Mp
98-100 oC; [α]D20 = -63.0 (c 0.197 in CHCl3); νmax 3331, 2940, 2919, 2852, 1455,
1404, 1288, 1257, 1093, 1062, 1049, 959, 689 cm-1; δH (300 MHz, CDCl3) 5.67 (2H,
m, -CH=CH-), 3.83 (1H, d, J 2.4, -CHOH), 3.82 (1H, d, J 3.0, -CHOH), 2.60 (2H, d,
J 15.0, -CHH-CH=CH-CHH-), 2.20 (2H, d, J 15.0, -CHH-CH=CH-CHH-), 1.72-
1.50 (8H, m, -(CH2)3-2 x -OH); δc (75 MHz, CDCl3) 129.66(2C), 73.95(2C),
38.89(2C), 30.14(2C), 18.47; m/z ESI-MS [M+Na]+ 191.1; HRMS found 191.1039
(C10H16O2Na requires 191.1043, error = 1.7 ppm); the enantiomeric excess was
determined by Chiral GC of the acetate derivative (Chrompak CP-Chirasil Dex Cβ
Column, Oven temperature 150 oC, Injection temperature 220 oC, Detection
temperature 220 oC, Gas Hydrogen, Pressure 15 psi) Rt (min) = 39.133 min (minor
enantiomer), 40.447 min (major enantiomer), %ee = 99%.
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NaBH4 reduction did not work in an attempt to prepare a racemic standard. The
enantiomer was prepared by using (1S,2S) 3C-tethered-Ru complex.
Mosher’s ester of (R,R)-spiro[4,5]dec-2-ene-6,10-diol (330a).
To a solution of (R,R)-spiro[4,5]dec-2-ene-6,10-diol 323a (5 mg, 0.0298 mmol) in
dry DCM (2 mL) was added TEA (0.014mL, 0.1044 mmol, 3.5 eq) and DMAP (1.0
mg). To the solution was added (S)-(+)-MTPA-Cl (0.014 mL, 0.0745 mmol, 2.5 eq)
at 0 oC. The resulting solution was stirred at 22-23 oC for 18 h. The completion of
the reaction was checked by TLC. The reaction mixture was concentrated on a rotary
evaporator to give an oil. The oil was purified by flash column chromatography
using hexane: EtOAc (95:5) to give mono ester compound as an oil (7 mg, 0.0182
mmol,43%). The compound was analysed by 1H-NMR.
1H-NMR (key peaks) L2 = 1.75-1.34 (6H, m, -(CH2)3-, -OH); L3 = 2.67-2.59 (1H, m,
-CHH-CH=CH-CHH-), 2.43-2.22 (2H, d, J 15.6, -CHH-CH=CH-CH2-), 2.13-2.04
(1H, m, -CHH-CH=CH-CHH-).
Mosher’s ester of (S,S)-spiro[4,5]dec-2-ene-6,10-diol (330b).
The compound was prepared similarly as described for the Mosher’s ester of (R,R)-
spiro[4,5]dec-2-ene-6,10-diol.
1H-NMR (key peaks) L3 = 1.79-1.47 (6H, m, -(CH2)3-); L2 = 2.64-2.56 (1H, m, -
CHH-CH=CH-CHH-), 2.38-2.16 (2H, d, J 15.6, -CHH-CH=CH-CH2-), 2.09-2.01
(1H, m, -CHH-CH=CH-CHH-).
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The relative positions of the L2 and L3 peaks indicate that the R-alcohol was formed
predominantly (Figure and Table in Appendix 5.2).245 The 1H-NMR spectra are
shown in Appendix 5.2.1.
(R,R)-Spiro[4,5]decane-6,10-diol (324a).
OHHO
(R,R)
OHHO
(R,S)
OHHO
(S,S)
Cis diastereomerT r ans diastereomer
This is a novel compound.
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (7.5 mg, 0.0120 mmol, 2
mol%) in FA:TEA (5:2) (0.602 mL) was stirred at 28 oC under an inert atmosphere
in a Schlenk tube. To this, spiro[4,5]decane-6,10-dione 316 (0.100 g, 0.602 mmol)
was added and stirred at 45 oC for 46 h under an inert atmosphere. The completion of
the reaction was checked by TLC. The reaction mixture was filtered through a short
column of silica using hexane: ethyl acetate (1:1) to ethyl acetate. The filtrate was
concentrated to give a crude alcohol (0.100 g). The crude compound was purified by
flash column chromatography to give pure cis alcohol 324c as white solid (0.055 g,
0.323 mmol, 53%) and trans alcohol 324a as white solid (0.025 g, 0.147 mmol,
24%). The ratio of cis:trans was calculated using crude 1H-NMR spectrum to be 65:
35. The diastereomeric ratio and enantiomeric excess were determined by Chiral GC
for acetate derivative GC (Chrompak CP-Chirasil Dex Cβ Column, Oven
temperature 140 oC, Injection temperature 220 oC, Detection temperature 220 oC,
Gas Hydrogen, Pressure 15 psi) Rt (min) = 64.537 min (minor enantiomer, trans),
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67.033 min (major enantiomer, trans), 68.363 min (cis diastereomer), dr = 65: 35
(cis:trans) %ee = 99%. GC quoted is of mixture prior to separation of cis and trans
isomers. The ee of the trans isomer after separation was unchanged. The
combination of ee and dr observed suggests that the second reduction is probably
substrate controlled rather than catalyst controlled.
Cis diastereomer 324c: Mp 94-95 oC; νmax 3276, 2953, 2928, 2862, 1449, 1349,
1334, 1025, 1009, 955, 900 cm-1; δH (300 MHz, CDCl3) 3.56 (2H, br s, -CHOH),
2.79 (2H, br s, -OH), 2.00-1.88 (1H, m, -CH2-CHH-CH2-), 1.81 (2H, t, J 7.5, -CH2-
(CH2)2-CH2-), 1.73-1.66 (4H, m, -CH2-CH2-CH2-), 1.64-1.55 (4H, m, -CH2-(CH2)2-
CH2-), 1.42 (2H, t, J 7.5, -CH2-(CH2)2-CH2-), 1.38-1.32 (1H, m, -CH2-CHH-CH2-),
δc (75 MHz, CDCl3) 75.28(2C), 34.69, 32.33, 30.02(2C), 25.94, 25.44, 14.47; m/z
ESI-MS [M+Na]+ 193.1; HRMS found 193.1201 (C10H18O2Na requires 193.1199,
error = -1.2 ppm);
Trans diastereomer 324a: Mp 114-115 oC; [α]D26 = -56.3 (c 0.175 in CHCl3); νmax
3327, 2939, 2865, 1443, 1392, 1273, 1050, 980, 957, 891, 878 cm-1; δH (300 MHz,
CDCl3) 3.75 (2H, dd, J 9.0, 3.0, -CHOH), 1.80-1.41 (16H, m, 14H of -CH2-, 2H of -
OH); δc (75 MHz, CDCl3) 73.68(2C), 31.73, 30.66(2C), 26.79(2C), 18.66(2C); m/z
ESI-MS [M+Na]+ 193.1; HRMS found 193.1199 (C10H18O2Na requires 193.1199,
error = 0.0 ppm); the enantiomeric excess was determined by Chiral GC for acetate
derivative GC (Chrompak CP-Chirasil Dex Cβ Column, Oven temperature 140 oC,
Injection temperature 220 oC, Detection temperature 220 oC, Gas Hydrogen,
Pressure 15 psi) Rt (min) = 65.230 min (minor enantiomer), 69.927 min (major
enantiomer), %ee = 99%.
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The racemic standard was prepared by NaBH4 reduction. The retention times of the
peaks in the GC of the diacetates of the crude product correlated with those of the cis
and trans products after separation.
(S,S)-Spiro[4,5]decane-6,10-diol (323b) by Pd/C hydrogenation of (S,S)-
spiro[4,5]dec-2-ene-6,10-diol (324b) to confirm that both were of same
configuration (S).
Pd (10 % on Carbon),
H2, MeOH,
21-22 oC, 20 h
OHHO OHHO
A solution of (S,S)-spiro[4,5]dec-2-ene-6,10-diol (99% ee) 323b (10 mg, 0.060
mmol) in dry methanol (2 mL) containing Pd/C (10 % on carbon) (6.39 mg) under
atmospheric pressure of hydrogen at 21-22 oC was stirred for 22 h. The reaction
mixture was filtered through Celite and the filtrate was concentrated on a rotary
evaporator to give (S,S)-spiro[4,5]decane-6,10-diol 324b (9 mg, 0.053 mmol, 88%).
the enantiomeric excess was determined by Chiral GC for acetate derivative GC
(Chrompak CP-Chirasil Dex Cβ Column, Oven temperature 140 oC, Injection
temperature 220 oC, Detection temperature 220 oC, Gas Hydrogen, Pressure 15 psi)
Rt (min) = 64.553 min (major enantiomer), 66.880 min (minor enantiomer), %ee =
99%.
Spiro[4,5]decane-6-ol (325a).
OH
The racemic compound is known.268
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A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (4.08 mg, 0.0066 mmol,
1 mol%) in FA:TEA (5:2) (0.329 mL) was stirred at 28 oC under an inert atmosphere
in a Schlenk tube. To this, spiro[4,5]decane-6-one 320 (0.100 g, 0.658 mmol) was
added and stirred at 28 oC for 22 h under an inert atmosphere. The completion of the
reaction was checked by TLC. The reaction mixture was filtered through a short
column of silica using hexane: EtOAc (1:1) to EtOAc. The filtrate was concentrated
to give a crude alcohol (0.100 g). The crude compound was purified by flash column
chromatography to give pure alcohol 325a as a white solid (0.095 g, 0.616 mmol,
93%). Mp 32-34 oC; [α]D26 = -14.1 (c 0.500 in CHCl3);νmax 3284, 2927, 2857, 1447,
1342, 1139, 1065, 1050, 981, 892, 729 cm-1; δH (300 MHz, CDCl3) 3.45-3.42 (1H,
m, -CHOH-), 1.75-1.15 (17H, m, 16H of -CH2-, 1H of -OH); δc (75 MHz, CDCl3)
75.75, 36.82, 35.75, 31.81, 25.78, 25.47, 22.93, 22.52; m/z ESI-MS [M+Na]+ 177.2;
HRMS found 177.1255 (C10H18ONa requires 177.1250, error = -2.6 ppm); the
enantiomeric excess was determined by Chiral GC for acetate derivative GC
(Chrompak CP-Chirasil Dex Cβ Column, Oven temperature 115 oC, Injection
temperature 220 oC, Detection temperature 220 oC, Gas Hydrogen, Pressure 15 psi)
Rt (min) = 39.067 min (minor enantiomer), 40.613 min (major enantiomer), %ee =
71%. The spectroscopic data were in agreement with literature values. 268
NaBH4 reduction failed in an attempt to prepare racemic standard. The opposite
enantiomer was prepared by using (1S,2S) 3C-tethered-Ru complex for the GC
comparison.
Spiro[4,5]dec-2-en-6-ol (326a).
OH
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This is a novel compound.
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (4.13 mg, 0.00667
mmol, 1 mol%) in FA:TEA (5:2) (0.333 mL) was stirred at 28 oC under an inert
atmosphere in a Schlenk tube. To this, spiro[4,5]dec-2-en-6-one 321 (0.100 g, 0.667
mmol) was added and stirred at 28 oC for 18 h under an inert atmosphere. The
completion of the reaction was checked by TLC. The reaction mixture was filtered
through a short column of silica using hexane: EtOAc (1:1) to EtOAc. The filtrate
was concentrated to give a crude alcohol (0.100 g). The crude compound was
purified by flash column chromatography to give pure alcohol 326a as a white solid
(0.091 g, 0.598 mmol, 89%). [α]D30 = -12.59 (c 0.975 in CHCl3); νmax 3389, 3050,
2926, 2857, 1622, 1449, 1350, 1271, 1136, 1094, 1060, 1034, 988, 940, 844, 801,
665 cm-1; δH (300 MHz, CDCl3) 5.54 (2H, s, -CH=CH-), 3.51-3.48 (1H, m, -CHOH),
2.48 (1H, d, J 18.0, -CHH-CH=CH-CHH-), 2.46 (1H, d, J 18.0, -CHH-CH=CH-
CHH-), 2.11 (1H, d, J 18.0, -CHH-CH=CH-CHH-), 2.05 (1H, d, J 18.0, -CHH-
CH=CH-CHH-), 1.79-1.64 (3H, m, -CH2-CHOH), 1.48-1.25 (6H, m, -(CH2)3-); δc
(75 MHz, CDCl3) 129.77, 128.97, 76.18, 46.80, 44.47, 38.06, 37.01 31.37, 23.53,
22.35; m/z ESI-MS [M+Na]+ 177.2; HRMS found 175.1093 (C10H16ONa requires
175.1093, error = 0.0 ppm); the enantiomeric excess was determined by Chiral GC
for acetate derivative GC (Chrompak CP-Chirasil Dex Cβ Column, Oven
temperature 115 oC, Injection temperature 220 oC, Detection temperature 220 oC,
Gas Hydrogen, Pressure 15 psi) Rt (min) = 34.573 min (minor enantiomer), 35.603
min (major enantiomer), %ee = 96%.
NaBH4 reduction failed in an attempt to prepare racemic standard. The opposite
enantiomer was prepared by using (1S,2S) 3C-tethered-Ru complex for the GC
comparison.
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Mosher’s ester of (R) spiro[4,5]dec-2-en-6-ol (331a).
To a solution of (R) spiro[4,5]dec-2-en-6-ol 326a (5 mg, 0.0329 mmol) in dry DCM
(2 mL) was added TEA (0.016mL, 0.1151 mmol, 3.5 eq) and DMAP (1.0 mg). To
the solution was added (S)-(+)-MTPA-Cl (0.015 mL, 0.0823 mmol, 2.5 eq) at 0 oC.
The resulting solution was stirred at 22-23 oC for 18 h. The completion of the
reaction was checked by TLC. The reaction mixture was concentrated on a rotary
evaporator to give an oil. The oil was purified by flash column chromatography
using hexane: EtOAc (95:5) to give mono ester compound as an oil (6 mg,
0.0163mmol, 49%). The compound was analysed by 1H-NMR.
1H-NMR (key peaks) L2 = 1.81-1.72 (1H, m, -CHH-CHOH); L3 = 5.59-5.52 (2H, m,
-CH=CH-), 2.43-2.36 (1H, m, -CHH-CH=CH-CHH-), 2.32-2.25 (1H, d, J 15.6, -
CHH-CH=CH-CHH-), 2.20-2.14 (1H, m, -CHH-CH=CH-CHH-), 2.09-2.01 (1H, m,
-CHH-CH=CH-CHH-).
Mosher’s ester of (S) spiro[4,5]dec-2-en-6-ol (331b).
The compound was prepared similarly as described for the Mosher’s ester of (R)
spiro[4,5]dec-2-en-6-ol (326b).
1H-NMR (key peaks) L3 = 1.89-1.80 (1H, m, -CHH-CHOH); L2 = 5.52-5.43 (2H, m,
-CH=CH-), 2.36-2.29 (1H, m, -CHH-CH=CH-CHH-), 2.26-2.17 (1H, d, J 15.6, -
CHH-CH=CH-CHH-), 2.16-2.07 (1H, m, -CHH-CH=CH-CHH-), 2.03-1.95 (1H, m,
-CHH-CH=CH-CHH-).
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The relative positions of the L2 and L3 peaks indicate that the R-alcohol was formed
predominantly (Figure and Table in Appendix 5.2).245
Spiro[4,5]decane-6-ol (325a) by Pd/C hydrogenation of (R) spiro[4,5]dec-2-en-6-
ol (326a) to confirm that both were of the same configuration.
OH
Pd (10 % on Carbon),
H2, MeOH,
21-22 oC, 20 h
OH
A solution of (R) spiro[4,5]dec-2-en-6-ol 326a (96% ee) (0.010 g, 0.066 mmol) in
dry methanol (2 mL) containing added Pd/C (10 % on carbon) (7 mg) under
atmospheric pressure of hydrogen at 21-22 oC, was stirred for 20 h. The reaction
mixture was filtered through Celite and the filtrate was concentrated on a rotary
evaporator to give spiro[4,5]decane-6-ol 325a (0.009 g, 0.058 mmol, 88%). The
enantiomeric excess was determined by Chiral GC for acetate derivative GC
(Chrompak CP-Chirasil Dex Cβ Column, Oven temperature 115 oC, Injection
temperature 220 oC, Detection temperature 220 oC, Gas Hydrogen, Pressure 15 psi)
Rt (min) = 39.010 min (minor enantiomer), 39.933 min (major enantiomer), %ee =
96%.
1’,3’-Dihydro-2H-spiro[cyclohexane-1,2’-inden]-2-ol (327a).
OH
This is a novel compound.
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (3.1 mg, 0.005 mmol, 1
mol%) in FA:TEA (5:2) (0.250 mL) was stirred at 28 oC under an inert atmosphere
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in a Schlenk tube. To this, 1’,3’-dihydro-2H-spiro[cyclohexane-1,2’-inden]-2-one
322 (0.100 g, 0.500 mmol) was added and the solution was stirred at 28 oC for 22 h
under an inert atmosphere. The completion of the reaction was checked by TLC. The
reaction mixture was filtered through a short column of silica using hexane:EtOAc
(1:1) to EtOAc. The filtrate was concentrated to give a crude alcohol (0.100 g). The
crude compound was purified by flash column chromatography to give pure alcohol
327a as a colourless oil (0.095 g, 0.570 mmol, 94%). [α]D26 = -6.4 (c 0.250 in
CHCl3); νmax 3391, 3021, 2926, 2857, 1697, 1484, 1448, 1300, 1222, 1060, 1029,
751, 729 cm-1; δH (300 MHz, CDCl3) 7.19-7.10 (4H, m, -CH of -C6H4-), 3.65-3.62
(1H, m, -CHOH-), 3.12 (1H, d, J 18.0, -CHH-C6H4-CHH-), 3.07 (1H, d, J 15.0, -
CHH-C6H4-CHH-), 2.71 (1H, d, J 18.0, -CHH-C6H4-CHH-), 2.66 (1H, d, J 15.0, -
CHH-C6H4- CHH-), 1.83-1.66 (3H, m, -CH2-), 1.57-1.25 (6H, m, -CH2-, -OH); δc
(75 MHz, CDCl3) 142.66, 142.17, 126.14, 126.08, 124.76, 124.59, 75.27, 48.38,
43.35, 38.47, 35.22, 31.55, 23.01, 22.18; m/z ESI-MS [M+Na]+ 225.2; HRMS found
225.1250 (C14H18ONa requires 225.1250, error = -0.4 ppm); the enantiomeric excess
was determined by Chiral HPLC (ChiralPak IA Column: 0.46 cm x 25 cm,
hexane:IPA 90:10, 0.50mL/min, 254 nM, 24 oC) Rt (min) = 14.014 (major
enantiomer), 15.715 min (minor enantiomer), %ee = 93%.
The racemic standard was prepared by LiAlH4 reduction.
(1S)-(+)-10-camphorsulfonyl ester derivative of 1’,3’-dihydro-2H-
spiro[cyclohexane-1,2’-inden]-2-ol (332).
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To a solution of 1’,3’-dihydro-2H-spiro[cyclohexane-1,2’-inden]-2-one 327a (100
mg, 0.495 mmol) in dry DCM (5 mL) was added TEA (0.172 mL, 1.238 mmol, 2.5
eq) and DMAP (1.2 mg, 0.02 eq). To the solution was added (S)-(+)-10-
camphorsulfonyl chloride (0.186 g, 0.742 mmol, 1.5 eq) at 0 oC. The resulting
solution was stirred at 22-23 oC overnight. The completion of the reaction was
checked by TLC. The reaction mixture was diluted with water (15 mL) followed by
extraction with DCM (2 x 15 mL). The combined organic layers were washed with 1
M HCl (2 x 10 mL), sat. NaHCO3 (2 x 10 mL) and brine (10 mL). The organic layer
was dried over anhydrous Na2SO4, filtered and concentrated on a rotary evaporator
to give an oil. The oil was purified by flash column chromatography using
hexane:EtOAc (84:16) to give compound 332 as oil (0.100 g, 0.240 mmol, 48%).
The oil converted into a solid on standing. The solid was recrystallised from n-
pentane:diethyl ether to give crystals for X-ray analysis. Mp 118-120 oC; [α]D21 = +
15.51 (c 0.290 in CHCl3); νmax 2945, 1741, 1486, 1393, 1347, 1280, 1165, 941, 900,
872, 736 cm-1; δH (300 MHz, CDCl3) 7.18-7.08 (4H, m, -CH of -C6H4-), 3.65-3.62
(1H, dd, J 9.0, 3.0, -CHOH-), 3.49 (1H, d, J 15.0, -SO2-CHH-), 3.14 (1H, d, J 15.0, -
CHH-C6H4-CHH-), 3.10 (1H, d, J 18.0, -CHH-C6H4-CHH-), 2.86 (1H, d, J 15.0, -
SO2-CHH-), 2.77 (1H, d, J 18.0, -CHH-C6H4-CHH-), 2.75 (1H, d, J 15.0, -CHH-
C6H4- CHH-), 2.44-2.31 (2H, m, Cam -CH2), 2.07 (1H, t, J 4.5, Cam -CH2), 2.02-
1.83 (4H, m, -CH2-CHOSO2-, Cam -CH2), 1.80-1.70 (2H, m, -CH2-CH2-CHOSO2-),
1.55-1.30 (6H, m, 4H of -C-CH2-CH2-, 2H of Cam -CH2), 1.05 (3H, s, Cam -CH3),
0.8 (3H, s, Cam -CH3); δc (75 MHz, CDCl3) 214.27, 141.84, 141.46, 126.28, 126.22,
124.66, 124.64, 86.29, 57.93, 48.29, 47.82, 47.52, 43.27, 42.69, 42.43, 39.80, 35.30,
29.88, 26.85, 24.77, 22.70, 21.65, 19.86, 19.66; m/z ESI-MS [M+Na]+ 439.1; HRMS
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found 439.1923 (C24H32O4SNa requires 439.1914, error = -2.2 ppm). The X-ray
Structure was obtained (more details in Appendix 5.1.4).
Ethyl 1-(1-hydroxyethyl)cyclopentanecarboxylate (341a).
O
OHO
This is a novel compound.
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (3.4 mg, 0.00543 mmol,
1 mol%) in FA:TEA (5:2) (0.270 mL) was stirred at 28 oC under an inert atmosphere
in a Schlenk tube. To this, ethyl 1-acetylcyclopentanecarboxylate 334 (0.100 g,
0.543 mmol) was added and the solution was stirred at 30 oC for 47 h under an inert
atmosphere. The completion of the reaction was checked by TLC. The reaction
mixture was filtered through a short column of silica using hexane: EtOAc (1:1) to
EtOAc. The filtrate was concentrated to give a crude alcohol (0.100 g). The crude
compound was purified by flash column chromatography to give pure alcohol 341a
as a colourless oil (0.095 g, 0.510 mmol, 94%). [α]D28 = +6.2 (c 0.335 in CHCl3);
νmax 3448, 2956, 2873, 1711, 1622, 1449, 1369, 1264, 1233, 1172, 1094, 1025, 897
cm-1; δH (300 MHz, CDCl3) 4.19 (2H, q, J 7.0, -OCH2CH3), 3.77-3.71 (1H, m, -
CHOH), 2.92 (1H, br s, -OH), 2.17-2.08 (1H, m, -CH2-), 2.00-1.95 (1H, m, -CH2-),
1.92-1.80 (1H, m, -CH2-), 1.73-1.59 (4H, m, -CH2-CH2-,), 1.52-1.42 (1H, m, -CH2-),
1.28 (3H, t, J 7.0, -OCH2CH3), 1.16 (3H, d, J 6.0, -CH3); δc (75 MHz, CDCl3) 72.63,
60.67, 58.84, 34.27, 32.79, 26.02, 25.59, 19.49, 14.19; m/z ESI-MS [M+Na]+ 209.2;
HRMS found 209.1152 (C10H18O3Na requires 209.1148, error = -1.7 ppm); the
enantiomeric excess by using Chiral GC (Chrompak CP-Chirasil Dex Cβ Column,
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Oven temperature 140 oC, Injection temperature 220 oC, Detection temperature 220
oC, Gas Hydrogen, Pressure 15 psi) Rt (min) = 12.903 min (minor enantiomer),
13.263 min (major enantiomer), %ee = 61%.
NaBH4 reduction failed in an attempt to prepare a racemic standard. The enantiomer
was prepared by using (1S,2S) 3C-tethered-Ru complex.
Mosher’s ester of ethyl (R) 1-(1-hydroxyethyl)cyclopentanecarboxylate (345a).
To a solution of ethyl (R) 1-(1-hydroxyethyl)cyclopentanecarboxylate 341a (5 mg,
0.0268 mmol) in dry DCM (2 mL) was added TEA (0.0075 mL, 0.0536 mmol, 2.0
eq) and DMAP (1 mg). To the solution was added (S)-(+)-MTPA-Cl (0.0063 mL,
0.0034 mmol, 1.25 eq) at 0 oC. The resulting solution was stirred at 22-23 oC for 18
h. The completion of the reaction was checked by TLC. The reaction mixture was
concentrated on a rotary evaporator to give an oil. The oil was purified by flash
column chromatography using hexane:ethyl acetate (90:10) to give the product as an
oil (5 mg, 0.0124 mmol, 46%). The compound was analysed by 1H-NMR.
1H-NMR (key peaks) of Mosher’s ester of alcohol from (1R,2R) 3C-tethered-Ru
complex 181.
L2= 1.24 (3H, d, J 6.0, -CH3); L3=1.63-1.55 (8H, m, -(CH2)4-)
Mosher’s ester of ethyl (S) 1-(1-hydroxyethyl)cyclopentanecarboxylate(345b).
The compound was prepared by the same method as that described for the Mosher’s
ester of ethyl (R) 1-(1-hydroxyethyl)cyclopentanecarboxylate (345a).
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1H-NMR (key peaks) of Mosher’s ester of alcohol from (1S,2S) 3C-tethered-Ru
complex 181.
L3= 1.31 (3H, d, J 6.0, -CH3); L2=1.60-1.49 (8H, m, -(CH2)4-)
The relative positions of the L2 and L3 peaks indicate that the R-alcohol was formed
predominantly (Figure and Table in Appendix 5.2).245 The 1H-NMR spectra are
shown in Appendix 5.2.2.
Ethyl 1-(1-hydroxyethyl)cyclopent-3-ene-1-carboxylate (342a).
O
OHO
This is a novel compound.
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (1.7 mg, 0.00275 mmol,
1 mol%) in FA:TEA (5:2) (0.138 mL) was stirred at 28 oC under an inert atmosphere
in a Schlenk tube. To this, ethyl 1-acetylcyclopent-3-enecarboxylate 336 (0.050 g,
0.275 mmol) was added and the solution was stirred at 28 oC for 30 h under an inert
atmosphere. The completion of the reaction was checked by TLC. The reaction
mixture was filtered through a short column of silica using hexane: EtOAc (1:1) to
EtOAc. The filtrate was concentrated to give a crude alcohol (0.050 g). The crude
compound was purified by flash column chromatography to give pure alcohol 342a
as a colourless oil (0.045 g, 0.244 mmol, 89%). [α]D26 = +31.27 (c 0.275 in CHCl3);
νmax 3447, 2979, 2934, 1713, 1446, 1368, 1264, 1210, 1094, 1041, 947, 906, 672
cm-1; δH (300 MHz, CDCl3) 5.68-5.63 (1H, m, -CH=CH-), 5.61-5.56 (1H, m, -
CH=CH-), 4.20 (2H, q, J 7.0, -OCH2CH3), 3.95 (1H, m, -CHOH), 2.89-2.71 (3H, m,
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-CHH-CH=CH-CH2-), 2.60-2.45 (2H, m, -CHH-, -OH), 1.28 (3H, t, J 7.0, -
OCH2CH3), 1.12 (3H, d, J 6.0, -CH3); δc (75 MHz, CDCl3) 177.36, 129.16, 128.00,
71.47, 60.95, 56.81, 40.45, 38.35, 18.05, 14.16; m/z ESI-MS [M+Na]+ 207.1; HRMS
found 207.0993 (C10H16O3Na requires 207.0992, error = -0.6 ppm); The
enantiomeric excess by using Chiral GC (Chrompak CP-Chirasil Dex Cβ Column,
Oven temperature 115 oC, Injection temperature 220 oC, Detection temperature 220
oC, Gas Hydrogen, Pressure 15 psi) Rt (min) = 25.412 min (minor enantiomer),
26.335 min (major enantiomer), %ee = 92%.
NaBH4 reduction failed in an attempt to prepare a racemic standard. The enantiomer
was prepared by using (1S,2S) 3C-tethered-Ru complex. The products were
combined to produce a racemic standard.
(R)-Ethyl 1-(1-hydroxyethyl)cyclopentanecarboxylate (341a) by Pd/C
hydrogenation of ethyl 1-(1-hydroxyethyl)cyclopent-3-ene-1-carboxylate (342a)
to confirm that both were of same configuration (R).
O
OHO
O
OHO
Pd (10 % on Carbon),
H2, MeOH,
21-22 oC, 20 h
A solution of ethyl 1-(1-hydroxyethyl)cyclopent-3-ene-1-carboxylate 342a (92% ee)
(0.025 g, 0.136 mmol) in dry methanol (2 mL) containing Pd/C (10 % on carbon)
(14.48 mg) under atmospheric pressure of hydrogen at 21-22 oC was stirred for 20 h.
The reaction mixture was filtered through Celite and the filtrate was concentrated on
a rotary evaporator to give ethyl 1-(1-hydroxyethyl)cyclopentanecarboxylate 341a
(0.023 g, 0.123 mmol, 91%). The enantiomeric excess was established by using
Chiral GC (Chrompak CP-Chirasil Dex Cβ Column, Oven temperature 140 oC,
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Injection temperature 220 oC, Detection temperature 220 oC, Gas Hydrogen,
Pressure 15 psi) Rt (min) = 12.717 min (minor enantiomer), 12.923 min (major
enantiomer), %ee = 92%.
Ethyl 2-(1-hydroxyethyl)-2,3-dihydro1H-indene-2-carboxylate (343a).
O
OHO
This is a novel compound.
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (2.7 mg, 0.00431 mmol,
1 mol%) in FA:TEA (5:2) (0.216 mL) was stirred at 28 oC under an inert atmosphere
in a Schlenk tube. To this, ethyl 2-acetyl-2,3-dihydro-1H-indene-2-carboxylate 337
(0.100 g, 0.431 mmol) was added and stirred at 28 oC for 17 h under an inert
atmosphere. The completion of the reaction was checked by TLC. The reaction
mixture was filtered through a short column of silica using hexane: EtOAc (1:1) to
EtOAc. The filtrate was concentrated to give crude alcohol (0.100 g). The crude
compound was purified by flash column chromatography to give pure alcohol 343a
as a colourless oil (0.095 g, 0.406 mmol, 94%). [α]D26 = +21.8 (c 0.415 in CHCl3);
νmax 3450, 2958, 1715, 1486, 1460, 1368, 1282, 1201, 1178, 1095, 1043, 902, 740
cm-1; δH (300 MHz, CDCl3) 7.20-7.13 (4H, m, -CH of -C6H4-), 4.20 (2H, q, J 7.2, -
OCH2CH3), 4.02-3.95 (1H, m, -CHOH), 3.47 (1H, d, J 18, -CHH-C6H4-CH2-), 3.39
(1H, d, J 16.5, -CH2-C6H4-CHH-), 3.20 (1H, d, J 18, -CH2-C6H4-CHH-), 3.05 (1H,
d, J 16.5, - CHH-C6H4-CH2-), 2.79 (1H, d, J 6.0, -OH), 1.25 (3H, t, J 7.2, -
OCH2CH3), 1.11 (3H, d, J 6.0, -CH3); δc (75 MHz, CDCl3) 176.65, 141.61, 140.70,
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126.65, 126.59, 124.27, 124.11, 71.73, 61.14, 58.43, 40.27, 38.24, 18.70, 14.15; m/z
ESI-MS [M+Na]+ 257.2; HRMS found 257.1152 (C14H18O3Na requires 257.1148,
error = -1.4 ppm); the enantiomeric excess was determined by Chiral HPLC
(ChiralPak IA Column: 0.46 cm x 25 cm, hexane:IPA 95:5, 0.50mL/min, 254 nM,
26 oC) Rt (min) = 21.654 (major enantiomer), 23.337 min (minor enantiomer), %ee =
90%.
The racemic standard was prepared by NaBH4 reduction.
Mosher’s ester of ethyl (R)-2-(1-hydroxyethyl)-2,3-dihydro1H-indene-2-
carboxylate (346a).
To a solution of ethyl 2-(1-hydroxyethyl)-2,3-dihydro1H-indene-2-carboxylate 343a
(39 mg, 0.167 mmol) in dry DCM (2 mL) was added TEA (0.046 mL, 0.334 mmol,
2.0 eq) and DMAP (2.0 mg, 0.1 eq). The solution was added (S)-(+)-MTPA-Cl
(0.046 mL, 0.250 mmol, 1.5 eq) at 0 oC. The resulting solution was stirred at 21-22
oC for 5 h. The completion of the reaction was checked by TLC. The reaction
mixture was concentrated on a rotary evaporator to give an oil. The oil was purified
by flash column chromatography using hexane: EtOAc (95:5) to give an oil (50 mg,
0.111 mmol, 66%). [α]D21 = + 48.03 (c 0.305 in CHCl3); νmax 2985, 1739, 1488,
1451, 1385, 1238, 1150, 1121, 1014, 858, 741, 715 cm-1; δH (300 MHz, CDCl3) 7.48-
7.46 (2H, m, -CH of -C6H5), 7.39-7.32 (3H, m, -CH of -C6H5), 7.14-7.12 (4H, m, -
CH of -C6H4-), 5.67-5.60 (1H, q, J 7.0, -CHOCO-), 4.19-4.04 (2H, m, -
COOCH2CH3), 3.58 (1H, d, J 18.0, -CHH-C6H4-CHH-), 3.47 (3H, d, -OCH3), 3.43
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(1H,d, J 15.0, -CHH-C6H4-CHH-), 3.10 (1H, d, J 18.0, -CHH-C6H4-CHH-), 3.03
(1H, d, J 15.0, -CHH-C6H4-CHH-), 1.20 (3H, t, J 9, -COOCH2CH3), 1.16 (3H, d, J
6.0, -OCHCH3), δc (75 MHz, CDCl3) 129.54, 128.34(2C), 127.39(2C), 126.86,
126.77, 124.16, 124.11, 76.61, 61.38, 57.04, 55.28, 39.33, 38.10, 15.27, 13.96; m/z
ESI-MS [M+Na]+ 473.1; HRMS found 473.1561 (C24H25F3O5Na requires 473.1546,
error = -3.1 ppm).
1H-NMR (key peaks) L2 = 1.16 (3H, d, J 6.0, -CH3); L3 = 3.58 (1H, d, J 18.0, -CHH-
C6H4-CHH-), 3.43 (1H,d, J 15.0, -CH2-C6H4-CHH-), 3.10 (1H, d, J 18.0, -CH2-
C6H4-CHH-), 3.03 (1H, d, J 15.0, -CHH-C6H4-CH2-),
Mosher’s ester of ethyl 2-(1-hydroxyethyl)-2,3-dihydro1H-indene-2-carboxylate
racemic alcohol(346b).
The compound was prepared as described for the Mosher’s ester of ethyl (R)-2-(1-
hydroxyethyl)-2,3-dihydro1H-indene-2-carboxylate.
1H-NMR (key peaks) L3 = 1.26 (3H, d, J 6.0, -CH3); L2 = 3.54 (1H, d, J 18.0, -CHH-
C6H4-CHH-), 3.38 (1H, d, J 15.0, -CH2-C6H4-CHH-), 3.06 (1H, d, J 15.0, -CH2-
C6H4-CHH-), 2.99 (1H, d, J 15.0, - CHH-C6H4-CH2-).
The relative positions of the L2 and L3 peaks indicate that the R-alcohol was formed
predominantly (Figure and Table in Appendix 5.2).245 The 1H-NMR spectra are
shown in Appendix 5.2.3.
(R) 1-(2-Ethyl-2,3-dihydro-1H-indene-2-yl)ethanol (344a).
OH
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This is a novel compound.
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (3.3 mg, 0.00532 mmol,
1 mol%) in FA:TEA (5:2) (0.266 mL) was stirred at 28 oC under an inert atmosphere
in a Schlenk tube. To this, 1-(2-ethyl-2,3-dihydro-1H-inden-2-yl)ethanone 340
(0.100 g, 0.532 mmol) was added and stirred at 28 oC for 24 h under an inert
atmosphere. The completion of the reaction was checked by TLC. The reaction
mixture was filtered through a short column of silica using hexane: ethyl acetate
(1:1) to ethyl acetate. The filtrate was concentrated to give crude alcohol (0.100 g).
The crude compound was purified by flash column chromatography to give pure
alcohol 344a as a colourless oil (0.090 g, 0.473 mmol, 89%). [α]D28 = -3.18 (c 0.550
in CHCl3); νmax 3391, 3021, 2965, 2918, 1587, 1484, 1459, 1377, 1301, 1066, 982,
894, 788, 740 cm-1; δH (300 MHz, CDCl3) 7.16-7.09 (4H, m, -CH of -C6H4-), 3.87
(1H, q, J 6.0, -CHOH), 3.04 (1H, d, J 18, -CHH-C6H4-CH2-), 2.98 (1H, d, J 18, -
CH2-C6H4-CHH-), 2.73 (1H, d, J 18, -CH2-C6H4-CHH-), 2.69 (1H, d, J 18, - CHH-
C6H4-CH2-), 1.70-1.58 (1H, m, -CHHCH3), 1.55-1.43 (1H, m, -CHHCH3), 1.39
(1H, br s, -OH), 1.13 (3H, d, J 6.0, -CH3), 0.83 (3H, t, J 7.5, -CH2CH3); δc (75 MHz,
CDCl3) 142.98, 142.78, 126.13(2C), 124.32, 124.21, 72.56, 50.50, 39.99(2C), 29.65,
18.63, 8.82; m/z ESI-MS [M+Na]+ 213.1; HRMS found 253.1258 (C13H18ONa
requires 213.1250, error = -4.0 ppm); the enantiomeric excess was determined by
Chiral HPLC (ChiralPak IA Column: 0.46 cm x 25 cm, hexane:IPA 95:5, 0.50
mL/min, 254 nM, 26 oC) Rt (min) = 14.769 (major enantiomer), 16.783 min (minor
enantiomer), %ee = 73%.
The racemic standard was prepared by NaBH4 reduction.
Mosher’s ester of (R) 1-(2-ethyl-2,3-dihydro-1H-indene-2-yl)ethanol (347a).
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To a solution of (R) 1-(2-ethyl-2,3-dihydro1H-indene-2-yl)ethanol 344a (5 mg,
0.0263 mmol) in dry DCM (1 mL) was added TEA (0.0073 mL, 0.0526 mmol, 2.0
eq) and DMAP (1 mg). The solution was added (S)-(+)-MTPA-Cl (0.0062 mL,
0.0329 mmol, 1.25 eq) at 0 oC. The resulting solution was stirred at 21-22 oC for 18
h. The completion of the reaction was checked by TLC. The reaction mixture was
concentrated on a rotary evaporator to give an oil. The oil was purified by flash
column chromatography using hexane: ethyl acetate (90:10) to give the product as an
oil (6 mg, 0.0148 mmol, 56%). The compound was analysed by 1H-NMR.
1H-NMR (key peaks) L2= 1.22 (3H, d, J 6.0, -CH3); L3=2.94 (1H, d, J 12.0, -CHH-
C6H4-CH2-), 2.93 (1H,d, J 12.0, -CH2-C6H4-CHH-), 2.74 (1H, d, J 12.0, -CH2-C6H4-
CHH-), 2.72 (1H, d, J 12.0, -CHH-C6H4-CH2-).
Mosher’s ester of 1-(2-ethyl-2,3-dihydro-1H-indene-2-yl)ethanol racemic
alcohol (347b).
The compound was prepared as described for the Mosher’s ester of ethyl (R) 1-(2-
ethyl-2,3-dihydro-1H-indene-2-yl)ethanol.
1H-NMR (key peaks) L3= 1.28 (3H, d, J 6.0, -CH3); L2=2.92 (1H, d, J 12.0, -CHH-
C6H4-CH2-), 2.85 (1H,d, J 12.0, -CH2-C6H4-CHH-), 2.70 (1H, d, J 12.0, -CH2-C6H4-
CHH-), 2.67 (1H, d, J 12.0, -CHH-C6H4-CH2-).
The relative positions of the L2 and L3 peaks indicate that the R-alcohol was formed
predominantly (Figure and Table in Appendix 5.2).245 The 1H-NMR spectra are
shown in Appendix 5.2.4.
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β-Tetralol (357a).
OH
This is a known compound.173,175
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (2.1 mg, 0.00342 mmol,
1 mol%) in FA:TEA (5:2) (0.171 mL) was stirred at 28 oC under an inert atmosphere
in a Schlenk tube. To this, β-tetralone 348 (0.050 g, 0.342 mmol) was added and the
solution was stirred at 28 oC for 30 h under an inert atmosphere. The completion of
the reaction was checked by TLC. The reaction mixture was filtered through a short
column of silica using hexane: EtOAc (1:1) to EtOAc. The filtrate was concentrated
to give a crude alcohol (0.050 g). The crude compound was purified by flash column
chromatography to give pure alcohol 357a as a light brown oil (0.045 g, 0.304
mmol, 88%). [α]D23 = +52.7 (c 0.370 in CHCl3) [lit. value [α]D23 = -51.4 (c 0.70 in
CHCl3) 82% ee (S)]173; νmax 3338, 3018, 2925, 2842, 1495, 1452, 1437, 1360, 1290,
1231, 1111, 1037, 962, 741 cm-1; δH (300 MHz, CDCl3) 7.14-7.06 (4H, m, -CH of -
C6H4-), 4.20-4.11 (1H, m, -CHOH), 3.12-3.06 (1H, dd, J 15.0, 3.0, -C6H4-
CHHCHOH), 3.01-2.84 (2H, m, -CH2-C6H4-), 2.81-2.73 (1H, dd, J 18.0, 6.0, -C6H4-
CH2CHOH), 2.11-2.01 (1H, m, -CHHCHOH), 1.88-1.76 (1H, m, -CHHCHOH),
1.71 (1H, br s, -OH); δc (75 MHz, CDCl3) 135.62, 134.20, 129.50, 128.58, 125.96,
125.84, 67.23, 38.38, 31.47, 26.95; m/z ESI-MS [M+Na]+ 171.2; HRMS found
171.0777 (C10H12ONa requires 171.0780, error = 2.1 ppm); the enantiomeric excess
was determined by Chiral HPLC (ChiralPak IA Column: 0.46 cm x 25 cm,
hexane:IPA 95:5, 0.50mL/min, 254 nM, 19 oC) Rt (min) = 17.390 (minor
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enantiomer, S), 18.791 min (major enantiomer, R), %ee = 88%. The spectroscopic
data were in agreement with literature values. 173,175
The racemic standard was prepared by NaBH4 reduction.
1,1-Dimethyl-1,2,3,4-tetrahydronaphthalen-2-ol (358a).
OH
The racemic compound is known.269
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (1.8 mg, 0.00287 mmol,
1 mol%) in FA:TEA (5:2) (0.150 mL) was stirred at 28 oC under an inert atmosphere
in a Schlenk tube. To this, 1,1-dimethyl-3,4-dihydronaphthalen-2(1H)-one 349
(0.050 g, 0.287 mmol) was added and the solution was stirred at 28 oC for 9 h under
an inert atmosphere. The completion of the reaction was checked by TLC. The
reaction mixture was filtered through a short column of silica using hexane:EtOAc
(1:1) to EtOAc. The filtrate was concentrated to give a crude alcohol (0.050 g). The
crude compound was purified by flash column chromatography to give pure alcohol
358a as a colourless oil (0.045 g, 0.255 mmol, 89%). [α]D21 = +23.48 (c 0.445 in
CHCl3); νmax 3370, 2967, 2937, 1489, 1446, 1383, 1361, 1286, 1038, 758, 727 cm-1;
δH (300 MHz, CDCl3) 7.36-7.33 (1H, m, -CH of -C6H4-,), 7.20-7.05 (3H, m, -CH of -
C6H4-), 3.77 (1H, dd, J 9.0, 3.0, -CHOH-), 3.01-2.80 (2H, m, C6H4-CH2-), 2.13 (1H,
br s, -OH), 2.08-1.87 (2H, m, -CH2-CHOH-), 1.34 (3H, s, -CH3), 1.29 (3H, br s, -
CH3); δc (75 MHz, CDCl3) 144.17, 134.46, 128.71, 126.85, 126.16, 125.66, 75.60,
39.08, 28.93, 26.98, 26.78, 24.98; m/z ESI-MS [M+Na]+ 199.2; HRMS found
199.1089 (C12H16ONa requires 199.1093, error = 2.2 ppm); the enantiomeric excess
by using Chiral GC (Chrompak CP-Chirasil Dex Cβ Column, Oven temperature 150
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oC, Injection temperature 220 oC, Detection temperature 220 oC, Gas Hydrogen,
Pressure 15 psi) Rt (min) = 28.643 min (minor enantiomer), 28.820 min (major
enantiomer), %ee = 94%. The spectroscopic data were in agreement with literature
values. 269
The racemic standard was prepared by NaBH4 reduction.
Mosher’s ester of (R) 1,1-dimethyl-1,2,3,4-tetrahydronaphthalen-2-ol (364a).
To a solution of 1,1-dimethyl-1,2,3,4-tetrahydronaphthalen-2-ol 358a (5 mg, 0.0284
mmol) in dry DCM (2 mL) was added TEA (0.008 mL, 0.057 mmol, 2.0 eq) and
DMAP (1 mg). The solution was added (S)-(+)-MTPA-Cl (0.0066 mL, 0.0355
mmol, 1.25 eq) at 0 oC. The resulting solution was stirred at 21-22 oC for 18 h. The
completion of the reaction was checked by TLC. The reaction mixture was
concentrated on a rotary evaporator to give an oil. The oil was purified by flash
column chromatography using hexane: ethyl acetate (90:10) to give the product as an
oil (6 mg, 0.0153mmol, 53%). The compound was analysed by 1H-NMR.
1H-NMR (key peaks) L2= 2.17-1.97 (2H, m, -CH2-CHOH-); L3= 1.33 (3H, s, -CH3),
1.26 (3H, br s, -CH3),
Mosher’s ester of racemic 1,1-dimethyl-1,2,3,4-tetrahydronaphthalen-2-ol
(364b).
The compound was prepared similarly as described for the Mosher’s ester of (R) 1,1-
dimethyl-1,2,3,4-tetrahydronaphthalen-2-ol.
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1H-NMR (key peaks) L3= 2.21-2.06 (2H, m, -CH2-CHOH-); L2= 1.27 (3H, s, -CH3),
1.19 (3H, br s, -CH3),
The relative positions of the L2 and L3 peaks indicate that the R-alcohol was formed
predominantly (Figure and Table in Appendix 5.2).245 The 1H-NMR spectra are
shown in Appendix 5.2.5.
3’,4’-Dihydro-2’H-spiro[cyclopent-3-ene-1,1’-naphthalene]-2’-ol (359a).
OH
This is a novel compound.
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (3.13 mg, 0.00505
mmol, 1 mol%) in FA:TEA (5:2) (0.250 mL) was stirred at 28 oC under an inert
atmosphere in a Schlenk tube. To this, 3’,4’-dihydro-2’H-spiro[cyclopent-3-ene-
1,1’-naphthalene]-2’-one 351 (0.100 g, 0.505 mmol) was added and the solution was
stirred at 28 oC for 20 h under an inert atmosphere. The completion of the reaction
was checked by TLC. The reaction mixture was filtered through a short column of
silica using hexane: EtOAc (1:1) to EtOAc. The filtrate was concentrated to give
crude alcohol (0.100 g). The crude compound was purified by flash column
chromatography to give pure alcohol 359a as a white solid (0.090 g, 0.450 mmol,
89%). Mp 84-86 oC; [α]D21 = +38.8 (c 0.350 in CHCl3); νmax 3347, 3062, 2937,
2851, 1624, 1488, 14532, 1426, 1344, 1283, 1243, 1185, 1085, 1059, 946, 936, 923,
754, 732, 702, 668 cm-1; δH (300 MHz, CDCl3) 7.27-7.24 (1H, m, -CH of -C6H4-),
7.17-7.03 (3H, m, -CH of -C6H4-), 5.79 (2H, m, -CH=CH-), 3.90 (1H, dd, J 9.0, 3.0,
-CHOH), 3.02-2.76 (3H, m, -CH2-C6H4- and -CHH-CH=CH-CH2-), 2.73-2.67 (2H,
Experimental
254
m, -CHH-CH=CH-CH2-), 2.48-2.39 (1H, m, -CH2-CH=CH-CHH-), 2.04-1.84 (2H,
m, -CH2-CHOH-), 1.67 (1H, br s, -OH); δc (75 MHz, CDCl3) 145.70, 133.71,
130.17, 129.37, 128.38, 126.77, 126.70, 125.74, 75.05, 49.51, 48.38, 44.28, 27.92,
27.00; m/z ESI-MS [M+Na]+ 223.2; HRMS found 223.1088 (C14H16ONa requires
223.1093, error = 2.5 ppm); the enantiomeric excess was determined by Chiral
HPLC (ChiralPak IA Column: 0.46 cm x 25 cm, hexane:IPA 98:2, 0.50mL/min, 254
nM, 15 oC) Rt (min) = 30.385 (minor enantiomer), 34.728 min (major enantiomer),
%ee = 99%.
The racemic standard was prepared by NaBH4 reduction.
Mosher’s ester of (R) 3’,4’-Dihydro-2’H-spiro[cyclopent-3-ene-1,1’-
naphthalene]-2’-ol (365a).
To a solution of 3’,4’-Dihydro-2’H-spiro[cyclopent-3-ene-1,1’-naphthalene]-2’-ol
359a (10 mg, 0.050 mmol) in dry DCM (2 mL) was added TEA (0.014 mL, 0.100
mmol, 2.0 eq) and DMAP (1 mg). The solution was added (S)-(+)-MTPA-Cl (0.014
mL, 0.075 mmol, 1.5 eq) at 0 oC. The resulting solution was stirred at 20-21 oC for
18 h. The completion of the reaction was checked by TLC. The reaction mixture was
concentrated on a rotary evaporator to give an oil. The oil was purified by flash
column chromatography using hexane: EtOAc (95:5) to give the product as oil (8
mg, 0.0192mmol, 38%). The compound was analysed by 1H-NMR.
1H-NMR (key peaks) L2= 2.11-1.93 (2H, m, -CH2-CHOH-); L3= 2.73-2.67 (2H, m, -
CHH-CH=CH-CH2-)
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Mosher’s ester of racemic 3’,4’-Dihydro-2’H-spiro[cyclopent-3-ene-1,1’-
naphthalene]-2’-ol (365b).
The compound was prepared similarly as described for the Mosher’s ester of (R)
3’,4’-Dihydro-2’H-spiro[cyclopent-3-ene-1,1’-naphthalene]-2’-ol.
1H-NMR (key peaks) L3= 2.17-2.09 (2H, m, -CH2-CHOH-); L2= 2.61-2.58 (2H, m, -
CHH-CH=CH-CH2-)
The relative positions of the L2 and L3 peaks indicate that the R-alcohol was formed
predominantly (Figure and Table in Appendix 5.2).245 The 1H-NMR spectra are
shown in Appendix 5.2.6.
(R)- 3’,4’-Dihydro-2’H-spiro[cyclopentane-1,1’-naphthalene]-2’-ol (360a).
OH
The racemic compound is known.264
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (3.1 mg, 0.005 mmol, 1
mol%) in FA:TEA (5:2) (0.250 mL) was stirred at 28 oC under an inert atmosphere
in a Schlenk tube. To this, 3’,4’-dihydro-spiro[cyclopentane-1,1’-[2H]-naphthalene]-
2’-one 352 (0.100 g, 0.500 mmol) was added and the solution was stirred at 28 oC
for 18 h under an inert atmosphere. The completion of the reaction was checked by
TLC. The reaction mixture was filtered through a short column of silica using
hexane:EtOAc (1:1) to EtOAc. The filtrate was concentrated to give a crude alcohol
(0.100 g). The crude compound was purified by flash column chromatography to
give pure alcohol 360a as white solid (0.090 g, 0.445 mmol, 89%). Mp 72-74 oC;
[α]D21 = -34.66 (c 0.225 in CHCl3); νmax 3348, 3055, 3022, 2954, 2937, 2871, 1574,
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1488, 1426, 1295, 1187, 1067, 945, 756, 709 cm-1; δH (300 MHz, CDCl3) 7.27-7.24
(1H, m, -CH of -C6H4-), 7.18-7.04 (3H, m, -CH of -C6H4-), 3.80 (1H, dd, J 9.0, 3.0, -
CHOH), 3.06-2.95 (1H, m, -CHH-C6H4-), 2.85-2.77 (1H, m, -CHH-C6H4-), 2.16-
1.78 (10H, m, -CH2-CHOH and-(CH2)4-), 1.55 (1H, br s, -OH); δc (75 MHz, CDCl3)
144.87, 134.65, 128.54, 127.50, 126.27, 125.46, 74.38, 51.14, 41.83, 37.10, 27.53,
27.22, 26.67, 25.57; m/z ESI-MS [M+Na]+ 225.2; HRMS found 225.1250
(C14H18ONa requires 225.1250, error = -0.4 ppm); The enantiomeric excess was
determined by Chiral HPLC (ChiralPak IA Column: 0.46 cm x 25 cm, hexane:IPA
98:2, 0.50mL/min, 254 nM, 12 oC) Rt (min) = 30.979 (minor enantiomer), 33.814
min (major enantiomer), %ee = 99%.
The racemic standard was prepared by NaBH4 reduction.
(R)- 3’,4’-Dihydro-2’H-spiro[cyclopentane-1,1’-naphthalene]-2’-ol (360a) by
Pd/C hydrogenation of 3’,4’-dihydro-2’H-spiro[cyclopent-3-ene-1,1’-
naphthalene]-2’-ol (359a) to confirm that both were of the same configuration.
OH
Pd (10 % on Carbon),
H2, MeOH,
21-22 oC, 20 h
OH
A solution of 3’,4’-dihydro-2’H-spiro[cyclopent-3-ene-1,1’-naphthalene]-2’-ol 359a
(99% ee) (0.010 g, 0.05 mmol) in dry methanol (2 mL) containing added Pd/C (10 %
on carbon) (5 mg) under atmospheric pressure of hydrogen at 21-22 oC, was stirred
for 20 h. The reaction mixture was filtered through Celite and the filtrate was
concentrated on a rotary evaporator to give 3’,4’-dihydro-2’H-spiro[cyclopentane-
1,1’-naphthalene]-2’-ol 360a (0.010 g, 0.049 mmol, 99%). The enantiomeric excess
was determined by Chiral HPLC (ChiralPak IA Column: 0.46 cm x 25 cm,
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hexane:IPA 98:2, 0.50mL/min, 254 nM, 12 oC) Rt (min) = 30.979 (minor
enantiomer), 34.079 min (major enantiomer), %ee = 99%.
1,3,3’,4’-Tetrahydro-spiro[2H-indene-2,2’-[2H]-naphthalene]-2’-ol (361a).
OH
This is a novel compound.
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (2.5 mg, 0.00403 mmol,
1 mol%) in FA:TEA (5:2) (0.200 mL) was stirred at 28 oC under an inert atmosphere
in a Schlenk tube. To this, 1,3,3’,4’-tetrahydro-spiro[2H-indene-1,2’-[2H]-
naphthalene]-2’-one 353 (0.100 g, 0.403 mmol) was added and the solution was
stirred at 30 oC for 24 h under an inert atmosphere. The completion of the reaction
was checked by TLC. The reaction mixture was filtered through a short column of
silica using hexane: EtOAc (1:1) to EtOAc. The filtrate was concentrated to give a
crude alcohol (0.100 g). The crude compound was purified by flash column
chromatography to give pure alcohol 361a as white solid (0.090 g, 0.360 mmol,
89%). Mp 90-92 oC; [α]D21 = -40.71 (c 0.350 in CHCl3); νmax 3570, 2934, 2872,
2832, 1486, 1455, 1216, 1110, 1079, 995, 759, 751, 729 cm-1; δH (300 MHz, CDCl3)
7.23-7.18 (4H, m, 4 -CH of -C6H4-), 7.10-7.05 (2H, m, 2-CH of -C6H4-), 7.03-6.97
(2H, m, 2-CH of -C6H4-), 4.06-3.96 (1H, m, -CHOH), 3.58 (1H, d, J 18.0, -CHH-
C6H4-CHH-), 3.31 (1H, d, J 15.0, -CH2-C6H4-CHH-), 3.16 (1H, d, J 15.0, -CHH-
C6H4-CHH-), 3.11 (1H, d, J 18.0, -CHH-C6H4-CH2), 3.08-3.00 (1H, m, -CHH-C6H4-
), 2.95-2.84 (1H, m, -CHH-C6H4-), 2.14-1.95 (2H, m, -CH2CHOH-), 1.64 (1H, br d,
-OH); δc (75 MHz, CDCl3) 144.19, 142.87, 142.06, 133.85, 128.70, 126.67,
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126.52(2C), 126.47, 126.03, 124.38, 124.33, 74.37, 50.85, 47.36, 43.61, 27.67,
26.08; m/z ESI-MS [M+Na]+ 273.2; HRMS found 273.1252 (C18H18ONa requires
273.1250, error = -1.1 p); the enantiomeric excess was determined by Chiral HPLC
(ChiralPak IA Column: 0.46 cm x 25 cm, hexane:IPA 98:2, 0.50mL/min, 254 nM,
23 oC) Rt (min) = 52.365 (minor enantiomer), 54.326 min (major enantiomer), %ee =
99%.
The racemic standard was prepared by NaBH4 reduction.
(1S)-(+)-10-camphorsulfonyl ester derivative 7 of 1,3,3’,4’-tetrahydro-spiro[2H-
indene-1,2’-[2H]-naphthalene]-2’-ol (366).
To a solution of 1,3,3’,4’-tetrahydro-spiro[2H-indene-1,2’-[2H]-naphthalene]-2’-ol
361a (50 mg, 0.200 mmol) in dry DCM (4 mL) was added TEA (0.055 mL, 0.400
mmol, 2.0 eq) and DMAP (0.5 mg, 0.02 eq). To the solution was added (S)-(+)-10-
camphorsulfonyl chloride (0.075 g, 0.300 mmol, 1.5 eq) at 0 oC. The resulting
solution was stirred at 21-22 oC for overnight. The completion of the reaction was
checked by TLC. The reaction mixture was diluted with water (10 mL) followed by
extraction with DCM (2 x 10 mL). The combined organic layers were washed with 1
M HCl (2 x 10 mL), sat. NaHCO3 (2 x 10 mL) and brine (10 mL). The organic layer
was dried over anhydrous Na2SO4, filtered and concentrated on a rotary evaporator
to give an oil. The oil was purified by flash column chromatography using
hexane:EtOAc (90:10) to give compound 366 as a colourless oil (0.060 g, 0.129
mmol, 64%). The oil converted into a solid on standing. The solid was recrystallised
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from n-pentane: diethyl ether to give crystals for X-ray analysis. Mp 126-128 oC;
[α]D26 = + 5.93 (c 0.295 in CHCl3); νmax 2967, 2909, 1746, 1488, 1351, 1361, 1712,
1059, 905, 888, 828, 745 cm-1; δH (300 MHz, CDCl3) 7.24-7.17 (4H, m, 4 -CH of -
C6H4-), 7.10-7.07 (2H, m, 2-CH of -C6H4-), 7.03-6.98 (2H, m, 2-CH of -C6H4-), 5.16
(1H, dd, J 6.0, 3.0, -CHOH), 3.56 (1H, d, J 12.0, -CHH-C6H4-CHH-), 3.53 (1H, d, J
9.0, -SO2-CHH-), 3.35 (1H, d, J 12.0, -CHH-C6H4-CHH-), 3.22 (1H, d, J 12.0, -CH-
H-C6H4-CHH-), 3.19 (1H, d, J 12.0, -CHH-C6H4-CHH-), 3.15-3.07 (1H, m, -CHH-
C6H4-), 2.99-2.94 (1H, m, -CHH-C6H4-), 2.93 (1H, d, J 9.0, -SO2-CHH-), 2.43-2.17
(4H, m, -CH2CHOSO2-, Cam -CH2), 2.05 (1H, t, J 3.0, Cam -CH2), 1.99-1.90 (1H,
m, Cam -CH2), 1.87 (1H, d, J 12.0, Cam -CH2), 1.51-1.44 (1H, m, Cam -CH2), 1.34-
1.28 (1H, m, Cam -CH2), 1.03 (3H, s, Cam -CH3), 0.82 (3H, s, Cam -CH3); δc (75
MHz, CDCl3) 214.13, 143.15, 142.24, 141.14, 133.28, 128.61, 126.87, 126.71,
126.65, 126.33, 125.91, 124.48, 124.49, 84.89, 57.92, 49.72, 48.36, 47.80, 47.68,
44.81, 42.70, 42.38, 26.81, 26.34, 25.98, 24.74, 19.80, 19.65; m/z ESI-MS [M+Na]+
487.0; HRMS found 487.1933 (C28H32O4SNa requires 487.1914, error = -3.6 ppm);
The X-ray Structure was obtained (more details in Appendix 5.1.5).
(R)-2,2-Dimethyl-1,2,3,4-tetrahydronaphthalen-1-ol (362a).
OH
This compound is known.270
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (3.56 mg, 0.00575
mmol, 1 mol%) in FA:TEA (5:2) (0.287 mL) was stirred at 28 oC under an inert
atmosphere in a Schlenk tube. To this, 2,2-dimethyl-3,4-dihydronaphthalen-1(2H)-
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one 355 (0.100 g, 0.575 mmol) was added and the solution was stirred at 45 oC for
49 h under an inert atmosphere. The completion of the reaction was checked by
TLC. The reaction mixture was filtered through a short column of silica using
hexane: ethyl acetate (1:1) to ethyl acetate. The filtrate was concentrated to give a
crude alcohol (0.100 g). The crude compound was purified by flash column
chromatography to give pure alcohol 362a as a colourless oil (0.090 g, 0.511 mmol,
89%). [α]D30 = -20.2 (c 1.125 in CHCl3) [lit. value [α]D22 = -23.5 (c 3.37 in CHCl3)
(R)]271; δH (300 MHz, CDCl3) 7.47-7.41 (1H, m, -CH of -C6H4-,), 7.22-7.17 (2H, m,
-CH of -C6H4-), 7.13-7.08 (1H, m, -CH of -C6H4-), 4.26 (1H, d, J 6.0, -CHOH-),
2.89-2.70 (2H, m, C6H4-CH2-), 1.86-1.77 (1H, m, C6H4-CH2-CHH-), 1.61-1.49 (2H,
m, -OH, C6H4-CH2-CHH-), 1.00 (3H, s, -CH3), 0.98 (3H, s, -CH3); δc (75 MHz,
CDCl3) 138.45, 135.87, 128.80, 128.73, 127.32, 126.12, 76.63, 33.83, 31.92, 25.93,
25.59, 22.53; m/z ESI-MS [M+Na]+ 199.1; the enantiomeric excess by using Chiral
GC (Chrompak CP-Chirasil Dex Cβ Column, Oven temperature 140 oC, Injection
temperature 220 oC, Detection temperature 220 oC, Gas Hydrogen, Pressure 15 psi)
Rt (min) = 29.423 min (major enantiomer), 29.917 min (major enantiomer), %ee =
98%. The spectroscopic data were in agreement with literature values. 269
The racemic standard was prepared by NaBH4 reduction.
Spiro[2H-indene-2,2’-[2H]-naphthalene]-1’-ol, 1,3,3’,4’-tetrahydro (363a).
OH
This is a novel compound.
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (2.5 mg, 0.00403 mmol,
1 mol%) in FA:TEA (5:2) (0.200 mL) was stirred at 28 oC under an inert atmosphere
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in a Schlenk tube. To this, 1,3,3’,4’-tetrahydro-spiro[2H-indene-2,2’-[2H]-
naphthalene]-1’-one 356 (0.100 g, 0.403 mmol) was added and the solution was
stirred at 45 oC for 24 h under an inert atmosphere. The completion of the reaction
was checked by TLC. The reaction mixture was filtered through a short column of
silica using hexane: EtOAc (1:1) to EtOAc. The filtrate was concentrated to give a
crude alcohol (0.100 g). The crude compound was purified by flash column
chromatography to give pure alcohol 363a as white solid (0.085 g, 0.340 mmol,
84%). Mp 74-75 oC; [α]D16 = +30.94 (c 0.265 in CHCl3); νmax 3565, 3020, 2903,
2841, 1484, 1450, 1382, 1262, 1176, 1103, 1031, 1008, 938, 794, 773, 736 cm-1; δH
(300 MHz, CDCl3) 7.35-7.32 (1H, m, -CH of -C6H4-), 7.27-7.11 (7H, m, -CH of -
C6H4-), 4.43 (1H, d, J 6.0, -CHOH-), 3.31 (1H, d, J 15.0, -CHH-C6H4-CHH-), 2.93-
2.89 (2H, m, -CH2-CH2-C6H4-), 2.83 (1H, d, J 15.0, -CHH-C6H4-CHH-), 2.78 (1H,
d, J 15.0, -CHH-C6H4-CHH-), 2.68 (1H, d, J 15.0, -CHH-C6H4-CHH-), 2.22-2.12
(1H, m, -CH2-C-), 1.80-1.72 (1H, m, -CH2-C-), 1.66 (1H, br d, -OH); δc (75 MHz,
CDCl3) 142.38, 142.04, 137.89, 136.06, 129.95, 129.10, 127.93, 126.35, 126.25,
126.20, 124.86, 124.67, 74.40, 46.98, 41.36, 40.67, 28.15, 26.30; m/z ESI-MS
[M+Na]+ 273.1; HRMS found 273.1254 (C18H18ONa requires 273.1250, error = -1.6
ppm); the enantiomeric excess was determined by Chiral HPLC (ChiralPak IA
Column: 0.46 cm x 25 cm, hexane:IPA 90:10, 0.50mL/min, 254 nM, 12 oC) Rt (min)
= 16.401 (major enantiomer), 22.026 min (minor enantiomer), %ee = 99%.
The racemic standard was prepared by NaBH4 reduction.
Mosher’s ester of (R) 1,3,3’,4’-tetrahydro-spiro[2H-indene-2,2’-[2H]-
naphthalene]-1’-ol 18 (369a).
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To a solution of 1,3,3’,4’-tetrahydro-spiro[2H-indene-2,2’-[2H]-naphthalene]-1’-ol
363a (12 mg, 0.048 mmol) into dry DCM (2 mL) was added TEA (0.017 mL, 0.120
mmol, 2.5 eq) and DMAP (1 mg). The solution was added (S)-(+)-MTPA-Cl (0.014
mL, 0.072 mmol, 1.5 eq) at 0 oC. The resulting solution was stirred at 21-22 oC for
1.5 h. The completion of the reaction was checked by TLC. The reaction mixture
was concentrated on a rotary evaporator to get oil. The oil was purified by flash
column chromatography using hexane:EtOAc (95:5) to give the product as oil (8 mg,
0.0172 mmol, 35%). The compound was analysed by 1H-NMR.
1H-NMR (key peaks) L2 = 2.96 (1H, d, J 15.0, -CHH-C6H4-CHH-), 2.82 (1H, d, J
15.0, -CHH-C6H4-CHH-), 2.65 (1H, d, J 15.0, -CHH-C6H4-CHH-), 2.58 (1H, d, J
15.0, CHH-C6H4-CHH-); L3 = Ph
Mosher’s ester of racemic 1,3,3’,4’-tetrahydro-spiro[2H-indene-2,2’-[2H]-
naphthalene]-1’-ol (369b).
The compound was prepared similarly as described for the Mosher’s ester of (R)
1,3,3’,4’-tetrahydro-spiro[2H-indene-2,2’-[2H]-naphthalene]-1’-ol.
1H-NMR (key peaks) L3 = 3.10 (1H, d, J 18.0, -CHH-C6H4-CHH-), 2.87 (1H, d, J
15.0, -CHH-C6H4-CHH-), 2.75 (1H, d, J 15.0, -CHH-C6H4-CHH-), 2.69 (1H, d, J
15.0, CHH-C6H4-CHH-); L2 = Ph
Experimental
263
The relative positions of the L2 and L3 peaks indicate that the R-alcohol was formed
predominantly (Figure and Table in Appendix 5.2).245 The 1H-NMR spectra are
shown in Appendix 5.2.7.
Attempted synthesis of (1S)-(+)-10 camphorsulfonyl ester derivative of 1,3,3’,4’-
tetrahydro-spiro[2H-indene-2,2’-[2H]-naphthalene]-1’-ol 18 (367); resulted in
formation of ether linked product (368):
To a solution of 1,3,3’,4’-tetrahydro-spiro[2H-indene-2,2’-[2H]-naphthalene]-1’-ol
363a (50 mg, 0.200 mmol) in dry DCM (4 mL) was added TEA (0.055 mL, 0.400
mmol, 2.0 eq) and DMAP (0.5 mg, 0.02 eq). To the solution was added (S)-(+)-10-
camphorsulfonyl chloride (0.075 g, 0.300 mmol, 1.5 eq) at 0 oC. The resulting
solution was stirred at 21-22 oC for overnight. The completion of the reaction was
checked by TLC. The reaction mixture was diluted with water (10 mL) followed by
extraction with DCM (2 x 10 mL). The combined organic layers were washed with 1
M HCl (2 x 10 mL), sat. NaHCO3 (2 x 10 mL) and brine (10 mL). The organic layer
was dried over anhydrous Na2SO4, filtered and concentrated on a rotary evaporator
to give an oil. The oil was purified by flash column chromatography using
hexane:EtOAc (90:10) to give a product as a colourless oil (0.028 g, 0.058 mmol,
58%). The oil converted into a solid on standing. The solid was recrystallised from
n-pentane: diethyl ether to give crystals for X-ray analysis. δH (300 MHz, CDCl3)
7.24-7.18 (6H, m, 6 -CH of -C6H4-), 7.08-7.98 (8H, m, 8-CH of -C6H4-), 6.88-6.68
(2H, m, 2-CH of -C6H4-), 4.17 (2H, s, -CHO-), 3.02-2.83 (4H, m, 2 x -CH2-C6H4),
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2.60-2.33 (8H, d, 2 x -CH2-C6H4-CH2-), 2.32-2.22 (2H, m, 2 x-C6H4-CH2-CHH-),
1.63-1.52 (2H, m, 2 x-C6H4-CH2-CHH-); The X-ray Structure was obtained (more
details in Appendix 5.1.6).
(S)-3,3-Dimethylbutan-3-ol.
O H
This compound is known and fully characterized.272
A mixture of catalyst (1R,2R) 3C-tethered-Ru complex 181 (6.2 mg, 0.010 mmol, 1
mol%) in FA:TEA (5:2) (0.500 mL) was stirred at 28 oC under an inert atmosphere
in a Schlenk tube. To this, 3,3-dimethylbutan-3-one (0.100 g, 1.00 mmol) was added
and stirred at 30 oC for 24 h under an inert atmosphere. The completion of the
reaction was checked by TLC. The reaction mixture was filtered through a short
column of silica using hexane:EtOAc (1:1). The filtrate was concentrated to give a
crude alcohol (0.100 g). The crude compound was purified by flash column
chromatography to give 3,3-dimethylbutan-3-ol as a colourless oil (0.055 g, 0.539
mmol, 56%). [α]D22 = +2.1 (c 0.750 in CHCl3) [lit. value [α]D = +31.0 (c 1.0 in
CHCl3) 60% ee (S)]272; δH (300 MHz, CDCl3) 3.51-3.43 (1H, m, -CHOH-), 1.40 (1H,
d, J 4.0, -CHOH-), 1.12 (3H, d, J 6.0, -CHOH-CH3), 0.89 (9H, s, -C(CH3)3); δc (75
MHz, CDCl3) 75.63, 34.87, 25.38(3C), 17.86; the enantiomeric excess was
determined by Chiral GC (Chrompak CP-Chirasil Dex Cβ Column, Oven
temperature 70 oC, Injection temperature 220 oC, Detection temperature 220 oC, Gas
Helium, Pressure 15 psi) Rt (min) = 19.513 min (minor enantiomer R), 20.237 min
(major enantiomer S), %ee = 10% (S). The spectroscopic data were in agreement
with literature values. 272
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5 Appendix
5.1 X-ray data
5.1.1 X-ray crystallography data of (1S,2S)-N-(diphenylphosphinyl)-1,2-
diaminocyclohexane 260.
X-ray data for sc1; Crystal Data: C18H23N2OP, M = 314.35, Orthorhombic, space
group P2(1)2(1)2(1), a = 6.75579(17), b = 15.9177(5), c = 16.3083(6) A, α = 90
deg., β = 90 deg., γ = 90 deg., U = 1753.74(9) A^3 (by least squares refinement on
4475 reflection positions), T = 296(2)K, λ = 0.71073 A, Z = 4, D(cal) = 1.191 
Mg/m^3, F(000) = 672. mu(MoK-α) = 0.160 mm^-1. Crystal character: colourless
block. Crystal dimensions 0.40 x 0.12 x 0.08 mm.
5.1.2 X-ray crystallography data of N-[(1R,2R)-2-(dimethylamino)-1,2-
diphenylethyl]-4-methylbenzenesulfonamide benzeneruthenium chloride 299.
X ray data for rs3; CCDC no. 793889, Crystal Data: C31H37ClN2O3RuS, M =
654.21, Triclinic, space group P1 a = 10.3603(2), b = 11.0519(3), c = 14.0747(3) A,
α = 90.6376(19) deg., β = 103.5283(17) deg., γ = 107.614(2) deg., U = 1487.56(6) 
A^3 (by least squares refinement on 22067 reflection positions), T = 100(2)K, λ =
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0.71073 A, Z = 2, D(cal) = 1.461 Mg/m^3, F(000) = 676. mu(MoK-α) = 0.721
mm^-1. Crystal character: orange block. Crystal dimensions 0.40 x 0.18 x 0.14 mm.
5.1.3 X-ray crystallography data of {N-[(1R,2R)-1,2-diphenylethyl-2-3-(3-
phenylpropyl)(methylamino)]-4-methylbenzenesulfonamide}ruthenium chloride
monomer 302.
X-ray data for rs4; CCDC no. 793888, Crystal Data: C31H33ClN2O2RuS, M =
634.17, Orthorhombic, space group P2(1)2(1)2(1) a = 8.39707(8), b = 9.14896(9), c
= 35.0858(3) A, α = 90 deg., β = 90 deg., γ = 90 deg., U = 2695.44(4) A^3 (by least 
squares refinement on 7176 reflection positions), T = 100(2)K, λ = 1.54184 A, Z = 4, 
D(cal) = 1.563 Mg/m^3, F(000) = 1304. mu(MoK-α) = 6.436 mm^-1. Crystal
character: orange block. Crystal dimensions 0.2108 x 0.1391 x 0.0319 mm.
5.1.4 X-ray crystallography data of (1S)-(+)-10 camphorsulfonyl ester
derivative of 1’,3’-dihydro-2H-spiro[cyclohexane-1,2’-inden]-2-ol 332.
X-ray crystallographic data for (R)-12 (‘RS5’); CCDC no. 817152, Crystal Data:
C24H32O4S, M = 416.56, Monoclinic, space group P2(1), a = 9.9752(2), b =
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10.52392(16), c = 11.2107(2) Ǻ , α = 90˚, β = 116.107(3)˚, γ = 90˚, U = 1056.81(3) 
Ǻ
3
(by least squares refinement on 14569 reflection positions), T = 100(2) K, λ = 
0.71073 Ǻ, Z =  2, D(cal) = 1.309 Mg/m3, F(000) = 448. mu(MoK-α) = 0.181 mm-1.
Crystal character: colourless block. Crystal dimensions 0.50 x 0.30 x 0.30 mm.
5.1.5 X-ray crystallography data of (1S)-(+)-10-camphorsulfonyl ester
derivative of 1,3,3’,4’-tetrahydro-spiro[2H-indene-1,2’-[2H]-naphthalene]-2’-ol
366.
X-ray crystalographic data for (R)-7 (‘RS7’); CCDC no. 817154, Crystal Data:
C28H32O4S, M = 464.60, Orthorhombic, space group P2(1)2(1)2(1), a = 7.43712(9),
b = 8.62914(9), c = 36.4793(4) Ǻ, α = 90˚, β = 90˚, γ = 90˚, U = 2341.09(5) Ǻ3 (by
least squares refinement on 26920 reflection positions), T = 100(2) K, λ = 1.54184 
Ǻ, Z = 4, D(cal) = 1.318 Mg/m
3, F(000) = 992. mu(MoK-α) = 1.491 mm-1. Crystal
character: colourless block. Crystal dimensions 0.20 x 0.16 x 0.08 mm.
5.1.6 X-ray crystallography data of ether linked product 368:
Attempted synthesis of (1S)-(+)-10 camphorsulfonyl ester derivative of 1,3,3’,4’-
tetrahydro-spiro[2H-indene-2,2’-[2H]-naphthalene]-1’-ol 367.
X-ray crystallographic data: (RS6-dimer); CCDC no. 817153, Crystal Data:
C36H34O, M = 482.63, Monoclinic, space group P2(1)/n, 10.3318(3), b = 18.3947(5),
c = 14.2896(4) Ǻ, α = 90˚, β = 108.039(3)˚, γ = 90˚, U = 2582.24(12) Ǻ3 (by least
squares refinement on 13397 reflection positions), T = 100(2) K, λ = 1.54184 Ǻ, Z =  
4, D(cal) = 1.241 Mg/m3, F(000) = 1032. mu(MoK-α) = 0.552 mm-1. Crystal
character: colourless block. Crystal dimensions 0.30 x 0.20 x 0.12 mm. Note that as
this molecule is in the centrosymmetric space group P2(1)/n, it must be racemic; the
space group contains two RR- and two SS- configuration molecules.
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5.2 Data for Mosher’s esters
Figure: Mosher’s ester derivatives and configuration correlation model.245
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Table : NMR chemical shift differences for diastereomeric Mosher’s esters.245
Compd Mosher’s esters L3 L2 δ (X-Y)L3
δ (X-Y)
L2
330
-CH2-
CH=CH-
CH2-
-CH2-
+0.03
+0.05
+0.04
-0.04
331
-CH2-
CH=CH-
CH2-
-CH2-
+0.07
+0.06
+0.04
+0.06
-0.08
345 -(CH2)4- -CH3 +0.03 -0.07
346
-CH2-
C6H4-CH2-
-
-CH3
+0.04
+0.05
+0.04
+0.04
-0.10
347
-CH2-
C6H4-CH2-
-
-CH3
+0.02
+0.08
+0.04
+0.05
-0.06
364 -(CH3)2 -CH2-
+0.06
+0.07 -0.04
365
-CH2-
CH=CH-
CH2-
-CH2- +0.12 -0.06
369 -C6H4-
-CH2-
C6H4-
CH2-
-
-0.15
-0.05
-0.10
-0.11
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5.2.1 1H-NMR of Mosher’s monoester of (R,R) spiro[4,5]dec-2-ene-6,10-diol
(330a).
1H-NMR of Mosher’s monoester of (S,S) spiro[4,5]dec-2-ene-6,10-diol (330b).
5.2.2 1H-NMR of Mosher’s ester of ethyl (R)1-(1-
hydroxyethyl)cyclopentanecarboxylate (345a).
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1H-NMR of Mosher’s ester of ethyl (S)1-(1-hydroxyethyl)cyclopentanecarboxylate
(345b).
5.2.3 1H-NMR of Mosher’s ester of ethyl (R)-2-(1-hydroxyethyl)-2,3-dihydro-1H-
indene-2-carboxylate (346a).
1H-NMR of Mosher’s ester of racemic ethyl 2-(1-hydroxyethyl)-2,3-dihydro-1H-
indene-2-carboxylate (346b).
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5.2.4 1H-NMR of Mosher’s ester of (R)1-(2-ethyl-2,3-dihydro-1H-indene-2-
yl)ethanol 347a.
1H-NMR of Mosher’s ester of racemic 1-(2-ethyl-2,3-dihydro-1H-indene-2-
yl)ethanol 347b.
5.2.5 1H-NMR of Mosher’s ester of (R) 1,1-dimethyl-3,4-dihydronaphthalen-2-ol
364a.
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1H-NMR of Mosher’s ester of racemic 1,1-dimethyl-1,2,3,4-tetrahydronaphthalen-2-
ol 364b.
5.2.6 1H-NMR of Mosher’s ester of (R) 3’,4’-dihydro-2’H-spiro[cyclopent-3-ene-
1,1’-naphthalene]-2’-ol 365a.
1H-NMR of Mosher’s ester of racemic 3’,4’-dihydro-2’H-spiro[cyclopent-3-ene-
1,1’-naphthalene]-2’-ol 365b.
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5.2.7 1H-NMR of Mosher’s ester of (R) 1,3,3’,4’-tetrahydro-spiro[2H-indene-2,2’-
[2H]-naphthalene]-1’-ol 369a.
1H-NMR of Mosher’s ester of 1,3,3’,4’-tetrahydro-spiro[2H-indene-2,2’-[2H]-
naphthalene]-1’-ol 369b.
